[
    {
        "id": 0,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., @DRUG1$) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, @DRUG2$, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1,
        "sentence": "ECG intervals (PR, QRS, and QT) were not affected by concurrent @DRUG1$    and @DRUG2$, diuretics, or propranolol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3,
        "sentence": "Penicillin blood levels may be prolonged by concurrent administration of @DRUG1$ which blocks the renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of @DRUG2$, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 6,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 7,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, @DRUG1$, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of @DRUG2$   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 8,
        "sentence": "Such occurrences have been reported when propoxyphene was administered to patients on @DRUG1$, @DRUG2$, or warfarin-like drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 9,
        "sentence": "In @DRUG1$/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG2$-treated monkeys.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 10,
        "sentence": "In vitro studies have identified @DRUG1$ and @DRUG2$ as CYP3A inhibitors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 11,
        "sentence": "The possibility of hypotensive effects with @DRUG1$    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with @DRUG2$   . If this is not possible, the starting dose of moexpril should be reduced..",
        "answer": "none",
        "label": 4
    },
    {
        "id": 12,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, @DRUG1$, nifedipine, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 13,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 14,
        "sentence": "Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when @DRUG1$ was coadministered with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 15,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 16,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, @DRUG2$, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 17,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when @DRUG1$ is administered in conjunction with @DRUG2$ (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 18,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 19,
        "sentence": "In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving @DRUG1$, treatment with @DRUG2$ once weekly for 4 weeks was associated with a mean increase of 16% in methadone AUC;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 20,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, @DRUG1$ and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, @DRUG2$, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 21,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, tacrolimus, @DRUG2$, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 22,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral @DRUG1$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 23,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG1$), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 24,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, @DRUG1$, calcium channel antagonists, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 25,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, @DRUG1$, metformin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 26,
        "sentence": "@DRUG1$ (such as suxamethonium chloride): Concurrent use of procaine hydrochloride and @DRUG2$ may result in prolongation or enhancement of the neuromuscular blockade.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 27,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 28,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG1$, penicillins, rifampin, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 29,
        "sentence": "No pharmacokinetic interaction was observed between rivastigmine and digoxin, @DRUG1$, diazepam, or @DRUG2$ in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 30,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 31,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 32,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 33,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG1$ (n=75), @DRUG2$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 34,
        "sentence": "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as @DRUG1$, dipyridamole, and @DRUG2$) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 35,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 36,
        "sentence": "@DRUG1$ has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 37,
        "sentence": "Furthermore, we present a case report in which a second @DRUG1$ treatment following @DRUG2$ resulted in the marked shrinkage of multiple metastatic tumors in HER2-positive breast cancer.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 38,
        "sentence": "Mean @DRUG1$ plasma concentrations were approximately 2 fold higher when @DRUG2$ was administered with ketoconazole, a potent CYP3A4 inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 39,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 40,
        "sentence": "Ticagrelor (Brilinta)--better than @DRUG1$ (@DRUG2$)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 41,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 42,
        "sentence": "Concurrent use of antibacterial drugs with oral @DRUG1$ may render oral @DRUG2$ less effective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 43,
        "sentence": "MAO Inhibitors - The pressor effect of @DRUG1$ is markedly potentiated in patients receiving monoamine oxidase inhibitors (@DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 44,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 45,
        "sentence": "@DRUG1$: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving @DRUG2$ (MAOI).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 46,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, prednisolone, oral contraceptives (norethindrone 1 mg/@DRUG2$ 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 47,
        "sentence": "Anticoagulants: @DRUG1$, as well as other @DRUG2$, may affect the hypoprothrombinemic response to anticoagulants;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 48,
        "sentence": "@DRUG1$ doses   1000 mg diminished @DRUG2$ absorption by an average of 49.6%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 49,
        "sentence": "In adult diabetic patients under treatment with either @DRUG1$ or insulin there is no change in the clinical effects of either @DRUG2$ or the hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 50,
        "sentence": "Given the primary CNS effects of paliperidone, @DRUG1$    should be used with caution in combination with other centrally acting drugs and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 51,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 52,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 53,
        "sentence": "In these subjects, @DRUG1$ did not alter warfarin pharmacokinetics and the average anticoagulant effect of @DRUG2$ as determined by prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 54,
        "sentence": "However, the evidence for a @DRUG1$ effect on iron absorption mainly comes from studies that did not isolate the effect of @DRUG2$ from that of other dietary components, because it was detected in single-meal studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 55,
        "sentence": "@DRUG1$ does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 56,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 57,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 58,
        "sentence": "When atropine and @DRUG1$ are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when @DRUG2$ is used alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 59,
        "sentence": "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of @DRUG1$, @DRUG2$, ethoxycoumarin, and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 60,
        "sentence": "Sulfonamides can also displace @DRUG1$ from plasma protein-binding sites, thus increasing free @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 61,
        "sentence": "In vitro, @DRUG1$ did not affect the binding of warfarin, phenytoin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 62,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 63,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 64,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, @DRUG1$, theophyllines, @DRUG2$, thiazide diuretics, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 65,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with @DRUG1$ (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 66,
        "sentence": "To date, there is no conclusive evidence of a clinically-relevant interaction between any of the @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 67,
        "sentence": "@DRUG1$, @DRUG2$, aminophylline, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 68,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 69,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 70,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 71,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), @DRUG1$, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 72,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, meperidine and fentanyl), @DRUG2$, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 73,
        "sentence": "The effect of curcumin (100 mg/kg) was similar to that of @DRUG1$ and imipramine (p > 0.05) but its addition to @DRUG2$ and imipramine did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 74,
        "sentence": "Potentiation occurs with @DRUG-DRUG$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 75,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG1$), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 76,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 77,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 78,
        "sentence": "The possibility of hypotensive effects can be minimized by either discontinuing the @DRUG1$ or increasing the salt intake prior to initiation of treatment with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 79,
        "sentence": "Antihypertensive effects of @DRUG1$ and related compounds may be counteracted when @DRUG2$ are used concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 80,
        "sentence": "Decreased seizure threshold has been reported in patients receiving @DRUG1$ concomitantly with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 81,
        "sentence": "Because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on @DRUG1$ therapy may require downward adjustment of their @DRUG2$ dosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 82,
        "sentence": "Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, @DRUG1$ and @DRUG2$ were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 83,
        "sentence": "Phase I trial of @DRUG1$ and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-@DRUG2$ interaction via P-glycoprotein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 84,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 85,
        "sentence": "@DRUG1$: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking @DRUG2$-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 86,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 87,
        "sentence": "We evaluated the effects of @DRUG1$ doses between 200 and 1500 mg on absorption of 5 mg nonheme iron (as @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 88,
        "sentence": "The synergistic antinociception activity of ibuprofen when administered with @DRUG1$ can be attributed to increased plasma concentration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 89,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, @DRUG1$, bacitracin, @DRUG2$, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 90,
        "sentence": "@DRUG1$: Following oral administration of midazolam, fluconazole resulted in substantial increases in @DRUG2$ concentrations and psychomotor effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 91,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 92,
        "sentence": "Oral @DRUG1$: In 10 healthy women, the pharmacokinetic profiles of norethindrone and @DRUG2$ following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 93,
        "sentence": "Other beta adrenergic aerosol bronchodilators should not be used concomitantly with @DRUG1$    (@DRUG2$ USP) because they may have additive effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 94,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with @DRUG2$: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 95,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, @DRUG2$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 96,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 97,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 98,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, @DRUG2$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 99,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 100,
        "sentence": "@DRUG1$: Serum @DRUG2$ levels may increase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 101,
        "sentence": "@DRUG1$ may add to or potentiate the action of other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 102,
        "sentence": "@DRUG1$ (such as @DRUG2$): Concurrent use of procaine hydrochloride and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 103,
        "sentence": "In a study of 11 HIV-infected patients receiving methadone-maintenance therapy (40 mg and 90 mg daily) with 600 mg of @DRUG1$ twice daily (twice the currently recommended dose), oral @DRUG2$ clearance increased 22% (90% CI 6% to 42%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 104,
        "sentence": "The difficulty in achieving adequate sedation may have been the result of decreased absorption of the @DRUG1$ due to both the gastrointestinal effects and stimulant effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 105,
        "sentence": "This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving @DRUG1$ than in those receiving @DRUG2$, indicating that, at the doses generally used in clinical practice, cyclosporine is the stronger of the two with respect to CYP3A inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 106,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 107,
        "sentence": "Drugs such as erythromycin, diltiazem, @DRUG1$, ketoconazole, @DRUG2$ and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 108,
        "sentence": "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. @DRUG1$ and @DRUG2$) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 109,
        "sentence": "@DRUG1$, particularly metaraminol, may cause serious cardiac arrhythmias during @DRUG2$ anesthesia and therefore should be used only with great caution or not at all.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 110,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 111,
        "sentence": "Less potent inhibitors include @DRUG1$, nefazodone, fluconazole, grapefruit juice, fluoxetine, @DRUG2$, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 112,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of @DRUG1$-containing or @DRUG2$ (like dihydroergotamine or methysergide) and sumatriptan within 24 hours of each other should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 113,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with @DRUG1$    Tablets, but an effect of digoxin on the plasma concentration of perindopril/@DRUG2$ has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 114,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that @DRUG2$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 115,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, @DRUG2$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 116,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include @DRUG1$, rifampin, @DRUG2$, ketoconazole, and fluconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 117,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 118,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (@DRUG1$) such as isocarboxazid (@DRUG2$), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 119,
        "sentence": "Mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to @DRUG1$   , has been reported to lower serum @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 120,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, @DRUG1$, polymyxin B, @DRUG2$, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 121,
        "sentence": "@DRUG1$, @DRUG2$, and Narcotics: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 122,
        "sentence": "Calcium was administered as @DRUG1$ in all studies and @DRUG2$ were ingested on an empty stomach.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 123,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG1$, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 124,
        "sentence": "Drug Interactions: The use of ZEMURON    (rocuronium bromide) Injection before @DRUG1$, for the purpose of attenuating some of the side effects of @DRUG2$, has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 125,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 126,
        "sentence": "Lithium: Increased serum lithium levels and symptoms of @DRUG1$ toxicity have been reported in patients receiving ACE inhibitors during therapy with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 127,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 128,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, miconazole) or @DRUG2$ (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 129,
        "sentence": "Potential for @DRUG1$    to Affect Other Drugs @DRUG2$ is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome P450 isozymes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 130,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, @DRUG2$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 131,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, @DRUG2$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 132,
        "sentence": "however, as with other @DRUG1$, concomitant administration of @DRUG2$ and aspirin is not generally recommended because of the potential for increased adverse effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 133,
        "sentence": "- @DRUG1$, pimozide: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 134,
        "sentence": "Additive sedative effects can occur when @DRUG1$ is given with @DRUG2$, sedatives, hypnotics, narcotics, or tranquilizers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 135,
        "sentence": "Therefore, as vitamin K absorption may be decreased with XENICAL, patients on chronic stable doses of @DRUG1$ who are prescribed @DRUG2$ should be monitored closely for changes in coagulation parameters.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 136,
        "sentence": "@DRUG1$: @DRUG2$ enhances the metabolism of concurrently administered DIFLUCAN.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 137,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 138,
        "sentence": "Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of @DRUG1$, can interact with Ropivacaine leading to increased @DRUG2$ plasma levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 139,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 140,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 141,
        "sentence": "Coadministration of @DRUG1$ with ferrous sulfate or @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 142,
        "sentence": "This is typical of the interaction of @DRUG1$ and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 143,
        "sentence": "Drugs such as erythromycin, @DRUG1$, verapamil, ketoconazole, @DRUG2$ and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 144,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on @DRUG1$ plasma levels . @DRUG2$, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 145,
        "sentence": "These data suggest that @DRUG1$ administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, @DRUG2$, cyclosporin).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 146,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, @DRUG1$, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 147,
        "sentence": "Cholestyramine: @DRUG1$ causes a 60% reduction in the absorption and enterohepatic cycling of @DRUG2$ and should not be coadministered with EVISTA.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 148,
        "sentence": "No significant adverse interactions with common premedications (such as @DRUG1$, scopolamine, @DRUG2$, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 149,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG1$, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 150,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 151,
        "sentence": "Concurrent administration of @DRUG1$ and @DRUG2$    has been reported to increase, decrease, or leave unchanged Mexitil    plasma levels;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 152,
        "sentence": "Since Celontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of @DRUG2$ and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 153,
        "sentence": "Digoxin: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, @DRUG1$ did not alter the pharmacokinetics of a single dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 154,
        "sentence": "Interactions for @DRUG1$ (@DRUG2$):  Alcohol - impairs the intestinal absorption of riboflavin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 155,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 156,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 157,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 158,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 159,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 160,
        "sentence": "requirements for @DRUG1$ may be increased in patients receiving @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 161,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, @DRUG1$, beta blockers, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 162,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 163,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 164,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral @DRUG1$, hormone replacement therapies, @DRUG2$, theophyllines, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 165,
        "sentence": "Aminoglutethimide administered concomitantly with @DRUG1$ may significantly decrease the serum concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 166,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, @DRUG1$, and @DRUG2$) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 167,
        "sentence": "The concurrent use of @DRUG1$ and phenytoin has been reported in one case to result in reduced @DRUG2$ cytotoxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 168,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, @DRUG1$, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 169,
        "sentence": "Use with @DRUG1$ and Other Cholinesterase Inhibitors: A synergistic effect may be expected when @DRUG2$ are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 170,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and @DRUG1$), the clearance of ondansetron was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 171,
        "sentence": "After 21 weeks of @DRUG1$ treatment, all @DRUG2$/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 172,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 173,
        "sentence": "Rifampin: @DRUG1$ enhances the metabolism of concurrently administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 174,
        "sentence": "Fenofibrate: In a pharmacokinetic study, concomitant @DRUG1$ administration increased total @DRUG2$ concentrations approximately 1.5-fold.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 175,
        "sentence": "Concomitant administration of TRENTAL and theophylline-containing drugs leads to increased @DRUG1$ levels and @DRUG2$ toxicity in some individuals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 176,
        "sentence": "Phenothiazines are capable of potentiating CNS depressants (e.g., barbiturates, @DRUG1$, opiates, @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 177,
        "sentence": "There was no effect of a single dose or multiple doses of @DRUG1$ on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and @DRUG2$ pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 178,
        "sentence": "The safety of using @DRUG1$ in combination with @DRUG2$ or other centrally acting alpha-2 agonists has not been systemically evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 179,
        "sentence": "The coadministration of @DRUG1$ at doses lower than 400 mg/day with @DRUG2$ should be carefully monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 180,
        "sentence": "Additive sedative effects can occur when @DRUG1$ is given with alcohol, sedatives, hypnotics, narcotics, or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 181,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 182,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, @DRUG1$, @DRUG2$, diazepam, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 183,
        "sentence": "In clinical studies of @DRUG1$, patients taking TOBI concomitantly with @DRUG2$ (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 184,
        "sentence": "Peak plasma concentrations and AUC of @DRUG1$ were reduced approximately 10% in the presence of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 185,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (@DRUG1$, heparin, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 186,
        "sentence": "Phenytoin, Carbamazepine, and @DRUG1$: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of @DRUG2$ was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 187,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., @DRUG1$, @DRUG2$, levodopa, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 188,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), @DRUG2$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 189,
        "sentence": "When daily doses of @DRUG1$ 2 g and weekly doses of @DRUG2$ 7.5 mg were coadministered to 15 rheumatoid arthritis patients in a drug-drug interaction study, the pharmacokinetic disposition of the drugs was not altered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 190,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as @DRUG1$, sedatives, antihistaminics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 191,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 192,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 193,
        "sentence": "Use of @DRUG1$ (spironolactone, @DRUG2$, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 194,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 195,
        "sentence": "@DRUG1$: In healthy volunteers (N= 11), @DRUG2$ did not influence the pharmacokinetics of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 196,
        "sentence": "@DRUG1$ are capable of potentiating CNS depressants (e.g., barbiturates, @DRUG2$, opiates, alcohol, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 197,
        "sentence": "Our data demonstrate that chronic treatment with the metabotropic glutamate receptor 5 antagonist, @DRUG1$, significantly reduces @DRUG2$ toxicity towards dopaminergic and noradrenergic cell groups in non-human primates.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 198,
        "sentence": "In a formal, single-dose interaction study (n = 6 males) the clearance of @DRUG1$ was decreased by 38% following the coadministration of @DRUG2$, an inhibitor of CYP1A2.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 199,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 200,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including @DRUG1$, barbiturates, @DRUG2$, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 201,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or @DRUG1$ (e.g., @DRUG2$ and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 202,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 203,
        "sentence": "Other eye drops or medications such as @DRUG1$ (Miochol) and carbachol (Carboptic, @DRUG2$) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 204,
        "sentence": "In the hot plate test in mice, co-administration of 15     g/kg @DRUG1$ with 10   mg/kg ephedrine intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 205,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 206,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, @DRUG2$, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 207,
        "sentence": "@DRUG1$ Anabolic steroids may increase sensitivity to oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 208,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (@DRUG2$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 209,
        "sentence": "@DRUG1$, theophylline, aminophylline, succinylcholine, reserpine, and @DRUG2$ should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 210,
        "sentence": "In the present study @DRUG1$ (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both @DRUG2$ writhing and formalin test, when it was administered with ibuprofen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 211,
        "sentence": "Warfarin users who initiated citalopram, @DRUG1$, paroxetine, amitriptyline, or @DRUG2$ had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 212,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), @DRUG2$, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 213,
        "sentence": "@DRUG1$ @DRUG2$ may increase sensitivity to oral anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 214,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 215,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 216,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general @DRUG1$, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 217,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, @DRUG2$, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 218,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 219,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, @DRUG1$ or @DRUG2$) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 220,
        "sentence": "Phenothiazines are capable of potentiating @DRUG1$ (e.g., @DRUG2$, anesthetics, opiates, alcohol, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 221,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), @DRUG1$, ketamine, @DRUG2$, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 222,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and @DRUG1$ are to be used concurrently, @DRUG2$ blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 223,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG2$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 224,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 225,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 226,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or @DRUG1$) should NOT be administered to patients who have received or are receiving a course of therapy with a proof @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 227,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 228,
        "sentence": "@DRUG1$: Pretreatment for four days with cholestyramine significantly increased the clearance of @DRUG2$ by 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 229,
        "sentence": "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), @DRUG1$ (OR   =   1.63 [95% CI, 1.11-2.38]), @DRUG2$ (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 230,
        "sentence": "@DRUG1$, @DRUG2$, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 231,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, @DRUG1$, tacrolimus, prednisolone, and @DRUG2$ pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 232,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 233,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 234,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, @DRUG1$, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 235,
        "sentence": "@DRUG1$ does not inhibit the absorption of 5 milligrams of nonheme or @DRUG2$ at doses less than 800 milligrams in nonpregnant women.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 236,
        "sentence": "We concluded that the combined administration of @DRUG1$ with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an @DRUG2$ in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 237,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 238,
        "sentence": "Other eye drops or medications such as @DRUG1$ (Miochol) and @DRUG2$ (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 239,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, @DRUG1$, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when @DRUG2$    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 240,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 241,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, @DRUG1$ and others), potassium supplements or other drugs capable of increasing serum potassium (@DRUG2$, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 242,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG1$, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 243,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 244,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, @DRUG1$, other opioids, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 245,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG1$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 246,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, @DRUG1$, @DRUG2$, prednisolone, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 247,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, @DRUG2$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 248,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 249,
        "sentence": "@DRUG1$ inhibits some of the liver's ability to metabolize some other drugs - terfenadine, @DRUG2$, cisapride, cyclosporine, and tricyclic antidepressants.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 250,
        "sentence": "@DRUG1$ can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - @DRUG2$: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "int",
        "label": 3
    },
    {
        "id": 251,
        "sentence": "Concurrent ingestion of @DRUG1$ (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and @DRUG2$) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 252,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, @DRUG1$, diazepam, @DRUG2$, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 253,
        "sentence": "Pharmacokinetic properties of abacavir were not altered by the addition of either @DRUG1$ or zidovudine or the combination of lamivudine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 254,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 255,
        "sentence": "In vitro perfusion of isolated rat liver has shown that cimetidine caused a significant reduction in @DRUG1$ metabolism and that @DRUG2$ altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 256,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 257,
        "sentence": "No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of muscle relaxants, inhalational agents, @DRUG1$, and local @DRUG2$) have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 258,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 259,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, @DRUG1$, general anesthetics, @DRUG2$, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 260,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 261,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 262,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 263,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG2$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 264,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  @DRUG1$: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 265,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of @DRUG1$, @DRUG2$, calcium channel antagonists, and macrolide antibiotics).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 266,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when @DRUG1$ is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . @DRUG2$, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 267,
        "sentence": "Rats treated with neonatal quinpirole enhanced time spent in the @DRUG1$-paired context compared with quinpirole-free controls conditioned with @DRUG2$, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 268,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 269,
        "sentence": "@DRUG1$ should be used with caution in digitalized patients, since the combination of @DRUG2$ and sympathomimetic amines may cause ectopic arrhythmias.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 270,
        "sentence": "In a study conducted in healthy subjects, mean pre-dose @DRUG1$ concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 271,
        "sentence": "Absorption of tetracyclines is impaired by @DRUG1$ containing @DRUG2$, calcium or magnesium, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 272,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 273,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG1$ such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 274,
        "sentence": "Since @DRUG1$ is a substrate for the metabolic pathways involving CYP2D6 and CYP1A2 enzymes, inhibition or induction of either of these enzymes would be expected to alter @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 275,
        "sentence": "Additionally, in one controlled study in five normal subjects and seven patients, the clearance of @DRUG1$ was decreased 50% following the administration of @DRUG2$   .",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 276,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG1$, pancuronium, morphine, vancomycin, @DRUG2$ and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 277,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG1$, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 278,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 279,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, @DRUG2$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 280,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG1$, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 281,
        "sentence": "Cyclosporine: Preliminary data from a XENICAL and @DRUG1$ drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 282,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 283,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 284,
        "sentence": "@DRUG1$: @DRUG2$, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 285,
        "sentence": "@DRUG1$ has been reported to enhance the sedative activity of @DRUG2$, alcohol, chlorpromazine, and reserpine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 286,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 287,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG1$, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 288,
        "sentence": "Dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, thioxanthines ) or @DRUG2$, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 289,
        "sentence": "Drugs such as @DRUG1$ and ketoconazole may inhibit the metabolism of @DRUG2$ and thus decrease its clearance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 290,
        "sentence": "Phenytoin, @DRUG1$, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of @DRUG2$ was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 291,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 292,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 293,
        "sentence": "This effect on @DRUG1$ appears to be more pronounced following oral administration of @DRUG2$ than with fluconazole administered intravenously.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 294,
        "sentence": "Because @DRUG1$ have been shown to depress plasma prothrombin activity, patients who are on @DRUG2$ therapy may require downward adjustment of their anticoagulant dosage.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 295,
        "sentence": "There is usually complete cross-resistance between @DRUG1$ (mercaptopurine) and TABLOID brand @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 296,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, tranquilizers, general anesthetics, phenothiazines, other @DRUG2$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 297,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 298,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and @DRUG2$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 299,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, @DRUG2$) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 300,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 301,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with @DRUG1$ (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other @DRUG2$, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 302,
        "sentence": "Results revealed that the strains were resistant to many drugs at high levels, only @DRUG1$, @DRUG2$, amikacin and ciprofloxacin showed resistances at comparatively lower levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 303,
        "sentence": "@DRUG1$ (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as @DRUG2$, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 304,
        "sentence": "There are reports of enhanced as well as diminished effects of @DRUG1$ when given concurrently with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 305,
        "sentence": "When phenytoin or other hepatic enzyme inducers such as @DRUG1$ and phenobarbital have been taken concurrently with @DRUG2$   , lowered Mexitil    plasma levels have been reported.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 306,
        "sentence": "@DRUG1$ has been used with a variety of antihypertensive agents, including hydrochlorothiazide, @DRUG2$, and guanethidine without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 307,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 308,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 309,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), @DRUG2$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 310,
        "sentence": "The interaction of @DRUG1$, @DRUG2$, with other drugs has not been well studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 311,
        "sentence": "EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose @DRUG1$ was added to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 312,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, @DRUG2$, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 313,
        "sentence": "CRM197 induced apoptosis, and furthermore, the combination of @DRUG1$ plus @DRUG2$ enhanced cytotoxicity in a T-ALL cell line.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 314,
        "sentence": "No formal interaction studies have been performed to assess the effect of @DRUG1$ on the kinetics of oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 315,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG1$, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 316,
        "sentence": "When @DRUG1$ and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when @DRUG2$ is used alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 317,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG2$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 318,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, @DRUG1$, @DRUG2$ or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 319,
        "sentence": "Although it was previously reported that lapatinib combined with @DRUG1$ improved the progression-free survival rate compared with lapatinib alone for patients with @DRUG2$-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 320,
        "sentence": "In vitro, raloxifene did not affect the binding of warfarin, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 321,
        "sentence": "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially @DRUG1$ such as paroxetine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 322,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), @DRUG2$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 323,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 324,
        "sentence": "Phenothiazines are capable of potentiating CNS depressants (e.g., barbiturates, @DRUG1$, @DRUG2$, alcohol, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 325,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG1$ (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 326,
        "sentence": "The concurrent administration of potent inhalational agents (eg, @DRUG1$, @DRUG2$, and halothane) during maintenance with DIPRIVAN Injectable Emulsion has not been extensively evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 327,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, @DRUG1$, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 328,
        "sentence": "Paroxetine and @DRUG1$ reduce the plasma concentration of @DRUG2$ by about 50%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 329,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 330,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (MAOI) such as @DRUG2$ (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 331,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, @DRUG2$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 332,
        "sentence": "The safety of using methylphenidate in combination with @DRUG1$ or other centrally acting @DRUG2$ has not been systemically evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 333,
        "sentence": "The use of AGGRASTAT, in combination with heparin and @DRUG1$, has been associated with an increase in bleeding compared to heparin and @DRUG2$ alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 334,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 335,
        "sentence": "@DRUG1$: @DRUG2$ may significantly increase cyclosporine levels in renal transplant patients with or without renal impairment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 336,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, amiloride, @DRUG2$ and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 337,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 338,
        "sentence": "@DRUG1$ enhances the antinociceptive effect of @DRUG2$ in mice.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 339,
        "sentence": "Isoflurane and @DRUG1$ (administered with @DRUG2$/oxygen to achieve 1.25 M.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 340,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 341,
        "sentence": "There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral @DRUG1$ and @DRUG2$, however, a causal relationship between LAMISIL    Tablets and these changes has not been established.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 342,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 343,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when @DRUG1$ and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing @DRUG2$, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 344,
        "sentence": "When @DRUG1$ or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with @DRUG2$   , lowered Mexitil    plasma levels have been reported.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 345,
        "sentence": "John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, @DRUG1$) may induce mifepristone metabolism (lowering serum levels of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 346,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 347,
        "sentence": "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, @DRUG1$, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 348,
        "sentence": "Concomitant administration of terfenadine with @DRUG1$, @DRUG2$, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 349,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 350,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG1$, carbamazepine, @DRUG2$, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 351,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, @DRUG1$, digitalis, @DRUG2$, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 352,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and @DRUG2$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 353,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., @DRUG1$, @DRUG2$) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 354,
        "sentence": "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as @DRUG1$,    -blockers, selective serotonin reuptake inhibitors (SSRIs), and @DRUG2$, if they have a narrow therapeutic window.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 355,
        "sentence": "Digoxin: @DRUG1$ 15 mg once daily for 7 days did not alter the plasma concentration profile of @DRUG2$ after b-acetyldigoxin administration for 7 days at clinical doses.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 356,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG1$), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 357,
        "sentence": "Concomitant administration of TRENTAL and @DRUG1$-containing drugs leads to increased @DRUG2$ levels and theophylline toxicity in some individuals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 358,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 359,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 360,
        "sentence": "Patients on @DRUG1$ treatment should be closely monitored when @DRUG2$ is introduced or withdrawn.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 361,
        "sentence": "Although this has not occurred in in vitro studies with @DRUG1$, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering @DRUG2$ to patients on coumarin-type anticoagulants and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 362,
        "sentence": "Reduced absorption of @DRUG1$ and @DRUG2$ have been reported when those agents were administered concomitantly with sulfasalazine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 363,
        "sentence": "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, @DRUG1$, @DRUG2$, cyclosporin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 364,
        "sentence": "In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg @DRUG1$ after pretreatments with oral ticlopidine (250 mg twice daily), @DRUG2$ (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 365,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 366,
        "sentence": "Interactions for Vitamin B1 (Thiamine):  @DRUG1$, Oral @DRUG2$, Stavudine, Tricyclic Antidepressants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 367,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 368,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and @DRUG1$) or macrolide antibiotics (e.g., erythromycin and @DRUG2$), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 369,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably @DRUG2$, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 370,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG1$, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 371,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, @DRUG1$, @DRUG2$, thiazide diuretics, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 372,
        "sentence": "@DRUG1$ may enhance the sedative effects of @DRUG2$ including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 373,
        "sentence": "If @DRUG1$    is administered following administration of succinylcholine, it should not be given until recovery from @DRUG2$ has been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 374,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, phenytoin, carbamazepine, @DRUG2$, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 375,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG1$ or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 376,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 377,
        "sentence": "Drugs such as @DRUG1$, diltiazem, @DRUG2$, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 378,
        "sentence": "and combinations of @DRUG1$ and sedatives (eg, benzodiazepines, barbiturates, @DRUG2$, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 379,
        "sentence": "The effects of indinavir, @DRUG1$ or @DRUG2$ on the pharmacokinetics of megestrol acetate were not studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 380,
        "sentence": "Sympathomimetics may reduce the antihypertensive effects of @DRUG1$, mecamylamine, reserpine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 381,
        "sentence": "@DRUG1$ decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 382,
        "sentence": "Mequitazine can interact with @DRUG1$, antichlolinergic, TCA, @DRUG2$, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 383,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG1$, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 384,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as @DRUG1$ (Marplan), tranylcypromine (@DRUG2$), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 385,
        "sentence": "@DRUG1$ and @DRUG2$ increase the effects of pseudoephedrine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 386,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin and @DRUG2$ may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 387,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG1$ (phenothiazines, @DRUG2$, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 388,
        "sentence": "The objective was to analyze the effects of neonatal @DRUG1$ treatment on effects of @DRUG2$ in adolescent rats using locomotor sensitization and conditioned place preference procedures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 389,
        "sentence": "Such occurrences have been reported when @DRUG1$ was administered to patients on antidepressants, anticonvulsants, or @DRUG2$-like drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 390,
        "sentence": "In 1984, Drs Rimmer and Richens at the University of Wales reported that administering @DRUG1$ with phenytoin lowered the serum @DRUG2$ concentration in patients with treatment-resistant epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 391,
        "sentence": "Synergism was also noted when methylglyoxal was combined with @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 392,
        "sentence": "Due to low systemic exposure to @DRUG1$ following topical application in patients, dosage adjustments for retapamulin are unnecessary when co-administered with CYP3A4 inhibitors, such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 393,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG2$, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 394,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, medroxyprogesterone acetate, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 395,
        "sentence": "AAV2-mediated retinal transduction is improved by co-injection of @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 396,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, meperidine and fentanyl), propofol, ketamine, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 397,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 398,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, @DRUG2$ did not alter the pharmacokinetics of a single 300-mg dose of phenytoin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 399,
        "sentence": "In clinical studies of TOBI, patients taking @DRUG1$ concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 400,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 401,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 402,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$, and rifampin may increase the clearance of methylprednisolone and may require increased in @DRUG2$ dose to achieve the desired response.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 403,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 404,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG1$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 405,
        "sentence": "Warfarin users who initiated citalopram, fluoxetine, @DRUG1$, @DRUG2$, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 406,
        "sentence": "@DRUG1$ and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with @DRUG2$ in basic media and multi-minerals in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 407,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, @DRUG1$, @DRUG2$, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 408,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or @DRUG1$-containing antacids, when administered 1 hour before @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 409,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 410,
        "sentence": "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 411,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, @DRUG1$, @DRUG2$, cyclosporine, and tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 412,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and @DRUG1$ may increase the clearance of methylprednisolone and may require increased in @DRUG2$ dose to achieve the desired response.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 413,
        "sentence": "In female rats, neonatal @DRUG1$ treatment enhanced amphetamine locomotor sensitization compared with @DRUG2$-free controls sensitized to amphetamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 414,
        "sentence": "The effect of @DRUG1$ on oral @DRUG2$ is variable.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 415,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 416,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, diphenylhydantoin, primidone), @DRUG2$, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 417,
        "sentence": "In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg S-ketamine after pretreatments with oral @DRUG1$ (250 mg twice daily), @DRUG2$ (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 418,
        "sentence": "There is evidence that meropenem may reduce serum levels of @DRUG1$ to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 419,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of @DRUG1$ is not significantly affected by concurrent administration of digoxin, @DRUG2$, diazepam, or fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 420,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG2$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 421,
        "sentence": "Concurrent use of @DRUG1$ with oral contraceptives may render oral @DRUG2$ less effective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 422,
        "sentence": "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, selective serotonin reuptake inhibitors (@DRUG1$), and @DRUG2$, if they have a narrow therapeutic window.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 423,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, prednisolone, oral @DRUG2$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 424,
        "sentence": "@DRUG1$ may have the potential to convert @DRUG2$-refractory to Herceptin-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 425,
        "sentence": "After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the @DRUG1$/@DRUG2$-treated monkeys were significantly affected.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 426,
        "sentence": "- did not change the pharmacokinetic profile of @DRUG1$ (a substrate of cytochromes P450 2A6 and 2C9) or influence the effect of a single 30-mg oral dose of @DRUG2$ on prothrombin time or the INR (International Normalized Ratio).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 427,
        "sentence": "Exposure to oral @DRUG1$ is unaffected by @DRUG2$ but greatly increased by ticlopidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 428,
        "sentence": "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of @DRUG1$ (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 429,
        "sentence": "Exert particular caution in combining @DRUG1$ with other anticholinergic drugs (tricyclic antidepressants and @DRUG2$): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 430,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 431,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, @DRUG1$, phenytoins, thiazide diuretics, beta blockers, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 432,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, @DRUG2$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 433,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG1$-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 434,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 435,
        "sentence": "Another study at a 400-mg and 800-mg daily dose of @DRUG1$ demonstrated that DIFLUCAN taken in doses of 400 mg per day or greater significantly increases plasma levels of @DRUG2$ when taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 436,
        "sentence": "@DRUG1$: In clinical trials, NSAIDs have produced an elevation of plasma lithium levels and a reduction in renal @DRUG2$ clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 437,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 438,
        "sentence": "Oral @DRUG1$: In 20 normal-weight female subjects, the treatment of @DRUG2$ 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral contraceptives.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 439,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 440,
        "sentence": "Oral @DRUG1$: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of @DRUG2$ were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 441,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG1$, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 442,
        "sentence": "Phenothiazines are capable of potentiating @DRUG1$ (e.g., barbiturates, anesthetics, opiates, @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 443,
        "sentence": "An inhibitor of CYP2C8 (such as @DRUG1$) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 444,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 445,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 446,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 447,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 448,
        "sentence": "@DRUG1$ should be administered with caution to patients taking @DRUG2$ because of the possibility of conduction disturbances.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 449,
        "sentence": "@DRUG1$    has been used in clinical trials concomitantly with calcium-channel-blocking agents, @DRUG2$, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 450,
        "sentence": "ECG intervals (PR, QRS, and QT) were not affected by concurrent Mexitil    and digoxin, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 451,
        "sentence": "@DRUG1$ may be used with sulfonamides, quinine and other @DRUG2$, and with other antibiotics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 452,
        "sentence": "When the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness (such as @DRUG1$), the agent should be administered at least 1 hour prior to or 2 hours after @DRUG2$ injection.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 453,
        "sentence": "Antacids: Absorption of a single dose of @DRUG1$ was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when @DRUG2$ was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 454,
        "sentence": "@DRUG1$ administered concomitantly with depo-subQ provera 104 may significantly decrease the serum concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 455,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 456,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 457,
        "sentence": "- @DRUG1$, pimozide: Other drugs such as @DRUG2$ or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 458,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of @DRUG2$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 459,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, @DRUG1$, theophyllines, phenytoins, thiazide diuretics, beta blockers, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 460,
        "sentence": "Being @DRUG1$ and lomefloxacin fluoroquinolones the interaction study of was carried out with @DRUG2$, gelusil, erythromycin and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 461,
        "sentence": "Administration of @DRUG1$ in combination with HERCEPTIN resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in @DRUG2$ serum levels in clinical studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 462,
        "sentence": "When concomitant administration of either of these two drugs with @DRUG1$ is initiated, the dose of @DRUG2$ should be slowly titrated to desired effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 463,
        "sentence": "[Efficacy of fixed combination @DRUG1$/@DRUG2$ in hospitalized patients with hypertensive disease]",
        "answer": "none",
        "label": 4
    },
    {
        "id": 464,
        "sentence": "Administration of @DRUG1$ in combination with @DRUG2$ resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 465,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 466,
        "sentence": "There are reports of enhanced as well as diminished effects of @DRUG1$ when given concurrently with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 467,
        "sentence": "Amantadine: Population pharmacokinetic analysis suggests that @DRUG1$ is unlikely to alter the oral clearance of @DRUG2$ (N= 54).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 468,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including @DRUG1$, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 469,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - @DRUG1$: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - @DRUG2$: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 470,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 471,
        "sentence": "@DRUG1$ (Brilinta)--better than @DRUG2$ (Plavix)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 472,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 473,
        "sentence": "In vitro, raloxifene did not affect the binding of @DRUG1$, @DRUG2$, or tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 474,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, @DRUG1$, @DRUG2$, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 475,
        "sentence": "Laboratory Tests There have been reports of false-positive urine screening tests for tetrahydrocannabinol (@DRUG1$) in patients receiving most proton pump inhibitors, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 476,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/@DRUG1$ 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 477,
        "sentence": "Moxifloxacin and Lomefloxacin reacts faster with @DRUG1$ and gelusil in acidic media whereas with erythromycin in basic media and @DRUG2$ in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 478,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 479,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 480,
        "sentence": "@DRUG1$, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and @DRUG2$), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 481,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and @DRUG1$ (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 482,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG1$, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 483,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG1$ (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 484,
        "sentence": "The ratio of norketamine AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the @DRUG1$ (P &lt; 0.001) and @DRUG2$ phases (P = 0.006) as compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 485,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 486,
        "sentence": "@DRUG1$ has been shown to increase serum @DRUG2$ levels when both drugs are co-administered.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 487,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, @DRUG1$, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 488,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG1$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 489,
        "sentence": "In conclusion, we demonstrated an isolated effect of @DRUG1$ (as chloride) on absorption of 5 mg of iron provided as @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 490,
        "sentence": "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, @DRUG1$, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 491,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG2$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 492,
        "sentence": "In a study of 11 HIV-infected patients receiving @DRUG1$-maintenance therapy (40 mg and 90 mg daily) with 600 mg of ZIAGEN twice daily (twice the currently recommended dose), oral @DRUG2$ clearance increased 22% (90% CI 6% to 42%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 493,
        "sentence": "@DRUG1$ may compete with other drugs, such as @DRUG2$, for sites of metabolism in the liver, thus elevating the serum levels of such compounds to potentially toxic levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 494,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$ and rifampin may increase the clearance of corticosteroids and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 495,
        "sentence": "Triprolidine may enhance the sedative effects of @DRUG1$ including @DRUG2$, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 496,
        "sentence": "Therefore, physicians should closely monitor patients for a change in @DRUG1$ dosage requirements when administering @DRUG2$ to patients on coumarin-type anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 497,
        "sentence": "and combinations of opioids and sedatives (eg, @DRUG1$, @DRUG2$, chloral hydrate, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 498,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, @DRUG1$, tricyclic antidepressant drugs (e.g., amitriptyline HCl, @DRUG2$) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 499,
        "sentence": "The induction dose requirements of @DRUG1$ Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, @DRUG2$, and fentanyl, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 500,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 501,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 502,
        "sentence": "Of the isoform-specific CYP inhibitors tested for an effect on the @DRUG1$ metabolite profile, only @DRUG2$ was noticeably effective, indicating a role of CYPs 2A6, 2C9, 2Cl9, and 2E1.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 503,
        "sentence": "Interactions for @DRUG1$ (Thiamine):  @DRUG2$, Oral Contraceptives, Stavudine, Tricyclic Antidepressants",
        "answer": "int",
        "label": 3
    },
    {
        "id": 504,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 505,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, tranquilizers, general @DRUG2$, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 506,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 507,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (@DRUG2$) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 508,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 509,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain @DRUG2$, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 510,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 511,
        "sentence": "Physicians should carefully monitor PT and INR in patients concurrently administered @DRUG1$ and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 512,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 513,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 514,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, @DRUG1$, prednisolone, sirolimus, nifedipine, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 515,
        "sentence": "Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. @DRUG1$: Concomitant administration of @DRUG2$ (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 516,
        "sentence": "However, on the basis of available data, no dosage adjustment for @DRUG1$ is recommended for patients on these drugs.1,3  @DRUG2$: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 517,
        "sentence": "Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG1$ and @DRUG2$ in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 518,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 519,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving @DRUG2$ is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 520,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG2$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 521,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 522,
        "sentence": "@DRUG1$: The safety and effectiveness of @DRUG2$ administered with fibrates have not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 523,
        "sentence": "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as @DRUG1$, carbamazepine, and phenytoin, induce metabolism and caused a markedly decreased C max and AUC of oral @DRUG2$ in adult studies.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 524,
        "sentence": "After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all @DRUG1$/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the @DRUG2$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 525,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG2$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 526,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 527,
        "sentence": "The objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (@DRUG1$) on the humoral immune responses of chickens to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 528,
        "sentence": "Macrolides: Clinical drug interaction studies indicate that erythromycin and @DRUG1$ can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of @DRUG2$, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 529,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 530,
        "sentence": "In adult diabetic patients under treatment with either @DRUG1$ or insulin there is no change in the clinical effects of either TOLECTIN or the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 531,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 532,
        "sentence": "@DRUG1$    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, @DRUG2$, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 533,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . @DRUG2$, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 534,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG2$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 535,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, @DRUG1$, or @DRUG2$) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 536,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 537,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (@DRUG1$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 538,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 539,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 540,
        "sentence": "This could lead to decreased salicylate serum levels or increase the risk of @DRUG1$ toxicity when @DRUG2$ is withdrawn.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 541,
        "sentence": "@DRUG1$ and @DRUG2$ reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 542,
        "sentence": "Absorption of @DRUG1$ is impaired by @DRUG2$ containing aluminum, calcium or magnesium, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 543,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG1$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 544,
        "sentence": "Drugs which may potentiate the myeloproliferative effects of Leukine, such as @DRUG1$ and @DRUG2$, should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 545,
        "sentence": "@DRUG1$ treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral @DRUG2$ by 2.4-fold, whereas itraconazole treatment did not increase the exposure to S-ketamine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 546,
        "sentence": "Lithium: Increased serum lithium levels and symptoms of @DRUG1$ toxicity have been reported in patients receiving @DRUG2$ during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 547,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (@DRUG2$, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 548,
        "sentence": "Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, @DRUG1$ and itraconazole were shown to significantly increase the C max and AUC of orally administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 549,
        "sentence": "Electroretinograms survived with higher concentrations of @DRUG1$ and @DRUG2$ than were required for optimal retinal transduction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 550,
        "sentence": "Sirolimus AUC was increased by 21% with no effect on Cmax in the presence of steady-state @DRUG1$ compared with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 551,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG1$, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 552,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 553,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 554,
        "sentence": "@DRUG1$ may enhance the effects of alcohol, @DRUG2$ and other CNS depressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 555,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of @DRUG1$ and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 556,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 557,
        "sentence": "In addition to bleeding associated with @DRUG1$ and vitamin K antagonists, drugs that alter platelet function (such as aspirin, @DRUG2$, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 558,
        "sentence": "@DRUG1$ inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, @DRUG2$, cyclosporine, and tricyclic antidepressants.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 559,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 560,
        "sentence": "In female rats, neonatal quinpirole treatment enhanced @DRUG1$ locomotor sensitization compared with @DRUG2$-free controls sensitized to amphetamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 561,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, diphenylhydantoin, @DRUG2$), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 562,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 563,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 564,
        "sentence": "Caution is advised for patients receiving high-dose aspirin and @DRUG1$ concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose @DRUG2$ and carbonic anhydrase inhibitors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 565,
        "sentence": "Since bacteriostatic drugs may interfere with the bactericidal action of @DRUG1$, it is advisable to avoid giving @DRUG2$ in conjunction with penicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 566,
        "sentence": "@DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG2$ ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 567,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 568,
        "sentence": "The objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (GSLS) on the humoral immune responses of chickens to @DRUG-DRUG$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 569,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 570,
        "sentence": "Although such a reaction has not been demonstrated with @DRUG1$, concomitant administration of @DRUG2$ with terfenadine or astemizole is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 571,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 572,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), @DRUG1$, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 573,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG2$), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 574,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 575,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 576,
        "sentence": "Therefore, use of @DRUG1$ in combination with @DRUG2$ should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 577,
        "sentence": "The elevation of prothrombin time induced by @DRUG1$ is not affected by administration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 578,
        "sentence": "@DRUG1$ has been used concurrently with antihypertensive drugs, beta blockers, digitalis, @DRUG2$, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 579,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 580,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., @DRUG1$, imipramine HCl) and other drugs and foods with known high @DRUG2$ content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 581,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 582,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 583,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain @DRUG2$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 584,
        "sentence": "The interaction of @DRUG1$ (@DRUG2$) with other drugs has not been studied in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 585,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 586,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and @DRUG1$ or @DRUG2$ dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 587,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 588,
        "sentence": "Coadministration of @DRUG1$ with @DRUG2$ or ferrous gluconate is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 589,
        "sentence": "@DRUG1$: Concomitant @DRUG2$ administration decreased the mean AUC of total ezetimibe approximately 55%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 590,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG1$ and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 591,
        "sentence": "This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving cyclosporine than in those receiving @DRUG1$, indicating that, at the doses generally used in clinical practice, @DRUG2$ is the stronger of the two with respect to CYP3A inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 592,
        "sentence": "Calcium does not inhibit the absorption of 5 milligrams of @DRUG-DRUG$ at doses less than 800 milligrams in nonpregnant women.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 593,
        "sentence": "Phenytoin, Carbamazepine, and @DRUG1$: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG2$, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 594,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 595,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 596,
        "sentence": "Hypokalemia may develop during concomitant use of @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 597,
        "sentence": "@DRUG1$ clearance is unaffected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 598,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 599,
        "sentence": "- Cisapride, pimozide: Other drugs such as @DRUG1$ or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 600,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 601,
        "sentence": "John   s Wort, and certain @DRUG1$ (@DRUG2$, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 602,
        "sentence": "Some @DRUG1$ can enhance aminoglycoside toxicity by altering @DRUG2$ concentrations in serum and tissue.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 603,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, @DRUG2$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 604,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled @DRUG1$, other anti-pseudomonal antibiotics, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 605,
        "sentence": "@DRUG1$ clearance is increased 100% by rifampin, a CyP450 enzyme inducer, and decreased 33% by @DRUG2$, a CyP450 enzyme inhibitor.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 606,
        "sentence": "Other Agents: No clinically important pharmacokinetic interactions occurred when @DRUG1$    was administered concomitantly with hydrochlorothiazide, @DRUG2$, or cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 607,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), @DRUG2$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 608,
        "sentence": "@DRUG1$, particularly metaraminol, may cause serious cardiac arrhythmias during @DRUG2$ anesthesia and therefore should be used only with great caution or not at all.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 609,
        "sentence": "The CNS-depressant effect of propoxyphene is additive with that of other @DRUG1$, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 610,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - @DRUG1$, astemizole, cisapride, @DRUG2$, and tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 611,
        "sentence": "Weekly intramuscular @DRUG1$ injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (@DRUG2$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 612,
        "sentence": "Several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 613,
        "sentence": "No pharmacokinetic interaction was observed between rivastigmine and digoxin, warfarin, @DRUG1$, or @DRUG2$ in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 614,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 615,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 616,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with @DRUG1$, similar @DRUG2$ or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 617,
        "sentence": "Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, @DRUG1$, or @DRUG2$-like drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 618,
        "sentence": "Given the primary CNS effects of paliperidone, INVEGA    should be used with caution in combination with other @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 619,
        "sentence": "Although specific drug or food interactions with @DRUG1$ have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that @DRUG2$, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 620,
        "sentence": "On day 8, a single @DRUG1$ dose was co-administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 621,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, @DRUG2$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 622,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 623,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG1$, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 624,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 625,
        "sentence": "Drugs such as @DRUG1$ and @DRUG2$ may inhibit the metabolism of methylprednisolone and thus decrease its clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 626,
        "sentence": "An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of @DRUG1$ and an inducer of CYP2C8 (such as @DRUG2$) may decrease the AUC of rosiglitazone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 627,
        "sentence": "@DRUG1$: Efficacy may be decreased due to urinary alkalizing effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 628,
        "sentence": "@DRUG1$: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since @DRUG2$ inhibit the breakdown of procaine hydrochloride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 629,
        "sentence": "Interactions for @DRUG1$ (Riboflavin):  @DRUG2$ - impairs the intestinal absorption of riboflavin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 630,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG1$ (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 631,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of @DRUG1$ (e.g., approximately 3 glasses of wine) did not result in alteration of @DRUG2$ pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 632,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 633,
        "sentence": "In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in @DRUG1$/@DRUG2$-treated monkeys.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 634,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., @DRUG1$ and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter @DRUG2$ mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 635,
        "sentence": "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as rifampin, carbamazepine, and @DRUG1$, induce metabolism and caused a markedly decreased C max and AUC of oral @DRUG2$ in adult studies.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 636,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 637,
        "sentence": "@DRUG1$: Meloxicam 15 mg once daily for 7 days did not alter the plasma concentration profile of @DRUG2$ after b-acetyldigoxin administration for 7 days at clinical doses.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 638,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 639,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, @DRUG1$, narcotic analgesics, @DRUG2$, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 640,
        "sentence": "Thus strong inhibitors of cytochrome P4501A2, such as @DRUG1$, given concomitantly during administration of Ropivacaine, can interact with @DRUG2$ leading to increased ropivacaine plasma levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 641,
        "sentence": "In elderly patients concurrently receiving certain @DRUG1$, primarily @DRUG2$, an increased incidence of thrombopenia with purpura has been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 642,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 643,
        "sentence": "Use of @DRUG1$ and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with @DRUG2$ and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 644,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, @DRUG1$, @DRUG2$ and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 645,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 646,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), @DRUG2$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 647,
        "sentence": "Therefore, when coadministered with @DRUG1$, adjustment of the dosage of @DRUG2$ or of such drugs may not be necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 648,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with @DRUG1$, @DRUG2$, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 649,
        "sentence": "John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, @DRUG1$) may induce @DRUG2$ metabolism (lowering serum levels of mifepristone).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 650,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG2$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 651,
        "sentence": "Azathioprine/@DRUG1$: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 652,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG1$, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 653,
        "sentence": "Furosemide: Clinical studies, as well as post-marketing observations, have shown that @DRUG1$ can reduce the natriuretic effect of furosemide and @DRUG2$ in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 654,
        "sentence": "Absorption of tetracyclines is impaired by antacids containing @DRUG1$, calcium or @DRUG2$, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 655,
        "sentence": "@DRUG1$ may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and @DRUG2$ Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 656,
        "sentence": "Patients with Congenital or Acquired QT Prolongation In a study of the effect of @DRUG1$ on the QT interval in 76 healthy women, the QT prolonging effect appeared less with @DRUG2$ 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 657,
        "sentence": "In experiment 2, the same regimen of @DRUG1$ was administered to chickens inoculated with @DRUG2$, and an enhanced serum antibody response to AI vaccination was also observed.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 658,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG2$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 659,
        "sentence": "@DRUG1$/@DRUG2$: Carbidopa/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 660,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 661,
        "sentence": "@DRUG1$ and enflurane (administered with @DRUG2$/oxygen to achieve 1.25 M.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 662,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that @DRUG1$ is a net inducer of @DRUG2$ or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 663,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or @DRUG1$ such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 664,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 665,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (@DRUG1$ 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (@DRUG2$ 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 666,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral @DRUG1$, hormone replacement therapies, hypoglycemics, theophyllines, @DRUG2$, thiazide diuretics, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 667,
        "sentence": "Those @DRUG1$ include divalproex sodium, @DRUG2$, and phenobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 668,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 669,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 670,
        "sentence": "Phenothiazines are capable of potentiating CNS depressants (e.g., @DRUG1$, anesthetics, opiates, @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 671,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (@DRUG2$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 672,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (@DRUG1$) such as isocarboxazid (Marplan), @DRUG2$ (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 673,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing @DRUG1$, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 674,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when @DRUG1$ is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of @DRUG2$ has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 675,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 676,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG1$, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 677,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG1$, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 678,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 679,
        "sentence": "Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, @DRUG1$, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 680,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG2$, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 681,
        "sentence": "The drug interaction between @DRUG1$ and @DRUG2$ has been the subject of much study in recent years.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 682,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as @DRUG1$, aminoglycosides, bacitracin, polymyxin B, colistin, viomycin, or @DRUG2$, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 683,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG1$, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 684,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG1$, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 685,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG1$ (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 686,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 687,
        "sentence": "@DRUG1$: Furosemide and probably other @DRUG2$ given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 688,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that @DRUG1$ and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 689,
        "sentence": "Concomitant administration of @DRUG1$ with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of @DRUG2$ with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 690,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 691,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG1$, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 692,
        "sentence": "Warfarin users who initiated @DRUG1$, fluoxetine, paroxetine, amitriptyline, or @DRUG2$ had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 693,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 694,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG1$), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 695,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG2$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 696,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG1$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 697,
        "sentence": "TOBI should not be administered concomitantly with ethacrynic acid, furosemide, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 698,
        "sentence": "Rats treated with neonatal quinpirole enhanced time spent in the @DRUG1$-paired context compared with @DRUG2$-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 699,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG1$, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 700,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 701,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as @DRUG1$, aminoglycosides, bacitracin, polymyxin B, @DRUG2$, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 702,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 703,
        "sentence": "The objective of this study was to evaluate the effect of oral administration of @DRUG1$ (GSLS) on the humoral immune responses of chickens to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 704,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, @DRUG1$, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 705,
        "sentence": "The effects of indinavir, @DRUG1$ or rifabutin on the pharmacokinetics of @DRUG2$ were not studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 706,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG1$ (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 707,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG1$, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 708,
        "sentence": "Methyldopa does not interfere with measurement of VMA (@DRUG1$), a test for pheochromocytoma, by those methods which convert VMA to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 709,
        "sentence": "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that @DRUG1$, itraconazole, @DRUG2$, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 710,
        "sentence": "ASPIRIN AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO @DRUG1$ AND MAY INCREASE PLASMA CONCENTRATIONS OF @DRUG2$ TO TOXIC LEVELS.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 711,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), @DRUG2$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 712,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of @DRUG1$ are potentiated by the presence of other CNS depressants such as @DRUG2$, sedatives, antihistaminics, or psychotropic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 713,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, @DRUG2$, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 714,
        "sentence": "Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of @DRUG1$ or @DRUG2$ to warrant dosage adjustment when megestrol acetate is administered with these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 715,
        "sentence": "@DRUG1$: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of @DRUG2$ (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 716,
        "sentence": "To minimize CNS depression and possible potentiation, barbiturates, antihistamines, narcotics, @DRUG1$ or @DRUG2$ should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 717,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, @DRUG2$, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 718,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 719,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG1$), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 720,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, @DRUG2$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 721,
        "sentence": "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of @DRUG1$ or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus @DRUG2$/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 722,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some @DRUG1$- or magnesium-containing @DRUG2$, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 723,
        "sentence": "Fluconazole tablets coadministered with @DRUG1$- and levonorgestrel-containing oral contraceptives produced an overall mean increase in @DRUG2$ and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 724,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 725,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and @DRUG1$ has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 726,
        "sentence": "Our objective was to establish potential effects of @DRUG1$ on absorption of nonheme and @DRUG2$ and the dose response for this effect in the absence of a meal.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 727,
        "sentence": "In female rats, neonatal @DRUG1$ treatment enhanced amphetamine locomotor sensitization compared with quinpirole-free controls sensitized to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 728,
        "sentence": "Methyldopa does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert @DRUG1$ to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 729,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG1$, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 730,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, triiodothyronine, phenytoin, @DRUG2$, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 731,
        "sentence": "Neuromuscular blocking agents (such as suxamethonium chloride): Concurrent use of @DRUG1$ and @DRUG2$ may result in prolongation or enhancement of the neuromuscular blockade.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 732,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, @DRUG2$, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 733,
        "sentence": "No clinically significant changes to @DRUG1$ or zidovudine pharmacokinetics were observed following concomitant administration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 734,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 735,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, @DRUG2$, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 736,
        "sentence": "@DRUG1$ is the only known component in the diet that may affect absorption of both @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 737,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (@DRUG1$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 738,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, @DRUG1$, digoxin, oral @DRUG2$, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 739,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, @DRUG1$, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 740,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), @DRUG1$, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 741,
        "sentence": "saline + saline, @DRUG1$ (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and ephedrine (10   mg/kg) + @DRUG2$ (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 742,
        "sentence": "The concurrent administration of potent inhalational agents (eg, @DRUG1$, enflurane, and @DRUG2$) during maintenance with DIPRIVAN Injectable Emulsion has not been extensively evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 743,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 744,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that @DRUG2$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 745,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, @DRUG1$, @DRUG2$, or tranquilizers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 746,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 747,
        "sentence": "Caution should be observed in administering @DRUG1$ to patients receiving phenothiazines or @DRUG2$ because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 748,
        "sentence": "Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other @DRUG1$ (e.g., @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 749,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, @DRUG1$, diazepam, hydroxyzine, and other @DRUG2$) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 750,
        "sentence": "@DRUG1$ may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that @DRUG2$ may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 751,
        "sentence": "Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or @DRUG1$ to warrant dosage adjustment when @DRUG2$ is administered with these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 752,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, @DRUG2$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 753,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 754,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), @DRUG2$ (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 755,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, @DRUG1$, @DRUG2$, and tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 756,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., @DRUG1$) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 757,
        "sentence": "@DRUG1$ did not have a significant effect on the pharmacokinetics of single doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 758,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 759,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG1$, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 760,
        "sentence": "Use of @DRUG1$ (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, @DRUG2$, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 761,
        "sentence": "These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in @DRUG1$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated animals than in @DRUG2$/vehicle-treated monkeys.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 762,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, @DRUG1$, certain heart medicines, birth control pills, anti-infective medicines, furosemide and @DRUG2$ Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 763,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (@DRUG2$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 764,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and @DRUG1$) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter @DRUG2$ mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 765,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 766,
        "sentence": "Laboratory Tests There have been reports of false-positive urine screening tests for @DRUG1$ (THC) in patients receiving most proton pump inhibitors, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 767,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (@DRUG2$ 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 768,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG1$, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 769,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 770,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that @DRUG1$ and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 771,
        "sentence": "@DRUG1$ may reduce the antihypertensive effects of methyldopa, mecamylamine, @DRUG2$ and veratrum alkaloids.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 772,
        "sentence": "Interactions for @DRUG1$ (Thiamine):  Loop Diuretics, Oral Contraceptives, Stavudine, @DRUG2$",
        "answer": "int",
        "label": 3
    },
    {
        "id": 773,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG1$), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 774,
        "sentence": "Therefore, do not administer @DRUG1$ with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral @DRUG2$, because of the potential to reduce the efficacy of Myfortic.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 775,
        "sentence": "however, as with other NSAIDs, concomitant administration of @DRUG1$ and @DRUG2$ is not generally recommended because of the potential for increased adverse effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 776,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 777,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 778,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (@DRUG1$ 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus @DRUG2$ 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 779,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 780,
        "sentence": "Phase I trial of @DRUG1$ and CCI-779 in patients with relapsed multiple myeloma: evidence for @DRUG2$-CCI-779 interaction via P-glycoprotein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 781,
        "sentence": "@DRUG1$: DIFLUCAN increases the plasma concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 782,
        "sentence": "Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with @DRUG1$, @DRUG2$, or cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 783,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted @DRUG1$ (clotrimazole, ketoconazole, @DRUG2$) were potent, non-competitive inhibitors of trimetrexate metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 784,
        "sentence": "In vitro perfusion of isolated rat liver has shown that @DRUG1$ caused a significant reduction in trimetrexate metabolism and that @DRUG2$ altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 785,
        "sentence": "@DRUG1$ may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, @DRUG2$, and tranquillisers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 786,
        "sentence": "Patients with Congenital or Acquired QT Prolongation In a study of the effect of @DRUG1$ on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of @DRUG2$ 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 787,
        "sentence": "Since @DRUG1$ is metabolized by a P450 enzyme system, drugs that induce or inhibit this drug metabolizing enzyme system may elicit important drug-drug interactions that may alter @DRUG2$ plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 788,
        "sentence": "Acute administration of @DRUG1$ or @DRUG2$ failed to influence locomotion in mice, while their combination normalized motor activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 789,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG1$, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 790,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, @DRUG1$, nifedipine, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 791,
        "sentence": "The neuromuscular blocking effect of @DRUG1$ may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral @DRUG2$, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 792,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 793,
        "sentence": "The concurrent administration of potent inhalational agents (eg, @DRUG1$, enflurane, and halothane) during maintenance with @DRUG2$ Injectable Emulsion has not been extensively evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 794,
        "sentence": "Methyldopa does not interfere with measurement of @DRUG1$ (@DRUG2$), a test for pheochromocytoma, by those methods which convert VMA to vanillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 795,
        "sentence": "Theophylline: @DRUG1$ clearance may decrease when hyperthyroid patients on a stable @DRUG2$ regimen become euthyroid;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 796,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG1$), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 797,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, amiloride) or @DRUG2$ supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 798,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 799,
        "sentence": "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 800,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 801,
        "sentence": "A pharmacokinetic study demonstrated that coadministration of @DRUG1$ and @DRUG2$ results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of indinavir.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 802,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 803,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (@DRUG1$) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of @DRUG2$ ophthalmic.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 804,
        "sentence": "Because @DRUG1$ may interfere with the absorption of @DRUG2$, simultaneous use of these drugs should be avoided.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 805,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 806,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG1$ (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 807,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as @DRUG1$ (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter @DRUG2$ mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 808,
        "sentence": "@DRUG1$ does not inhibit the absorption of 5 milligrams of @DRUG2$ at doses less than 800 milligrams in nonpregnant women.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 809,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to @DRUG1$, cisplatin, @DRUG2$ and etoposide   celecoxib following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 810,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 811,
        "sentence": "With respect to toxicity, the order of CYP inhibitor effectiveness was ABT>@DRUG1$~@DRUG2$>ketoconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 812,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, @DRUG2$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 813,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG1$ or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 814,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG1$, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 815,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with @DRUG1$, diuretics, H2 blockers, @DRUG2$, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 816,
        "sentence": "Methyldopa does not interfere with measurement of @DRUG1$ (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 817,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, diphenylhydantoin, primidone), @DRUG2$, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 818,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG1$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 819,
        "sentence": "@DRUG1$ (extended-release tablets): In 17 normal-weight subjects receiving @DRUG2$ 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of nifedipine (extended-release tablets).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 820,
        "sentence": "@DRUG1$: Concurrent use of @DRUG2$ and sulfonamides may result in a reduction of the antibacterial action of the sulfonamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 821,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and @DRUG2$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 822,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 823,
        "sentence": "and combinations of @DRUG1$ and sedatives (eg, @DRUG2$, barbiturates, chloral hydrate, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 824,
        "sentence": "Concurrent use with @DRUG1$ including ergot alkaloids, @DRUG2$, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 825,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other @DRUG1$, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 826,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG1$, procainamide, pancuronium, morphine, vancomycin, @DRUG2$ and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 827,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 828,
        "sentence": "@DRUG1$: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, @DRUG2$ pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 829,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 830,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 831,
        "sentence": "In the present study, the antidepressant like activity of @DRUG1$ and its combination with fluoxetine and @DRUG2$ was studied in acute model (three doses 24, 5 and 1 h before test) of forced swimming test (FST) in glass jar and tail suspension test (TST) in mice and in chronic model (14 day study) of FST with water wheel in rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 832,
        "sentence": "Although @DRUG1$ (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with @DRUG2$ to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 833,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and @DRUG1$, there is no evidence that fluconazole is a net inducer of @DRUG2$ or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 834,
        "sentence": "These effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g., @DRUG1$, inhaled @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 835,
        "sentence": "@DRUG1$ are capable of potentiating CNS depressants (e.g., barbiturates, anesthetics, @DRUG2$, alcohol, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 836,
        "sentence": "@DRUG1$: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving azole antifungals in conjunction with @DRUG2$, interaction studies have been performed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 837,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, @DRUG1$, grapefruit juice, @DRUG2$, fluvoxamine, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 838,
        "sentence": "While there is evidence that @DRUG1$ can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that @DRUG2$ is a net inducer of ethinyl estradiol or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 839,
        "sentence": "@DRUG1$: @DRUG2$, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in pramipexole AUC and a 40% increase in half-life (N= 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 840,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 841,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (@DRUG2$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 842,
        "sentence": "Although such a reaction has not been demonstrated with roxithromycin, concomitant administration of @DRUG1$ with terfenadine or @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 843,
        "sentence": "Although specific drug or food interactions with @DRUG1$ have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, @DRUG2$, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 844,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, tranquilizers, general anesthetics, @DRUG2$, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 845,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 846,
        "sentence": "The effect of @DRUG1$ and @DRUG2$, alone and in combination, was evaluated for growth inhibition (MTT), radiolabeled drug uptake, cellular thiol content (HPLC), and DNA strand breaks (Comet assay).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 847,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 848,
        "sentence": "@DRUG1$, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 849,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 850,
        "sentence": "Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of @DRUG1$ has no clinically significant effect on the pharmacokinetic properties of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 851,
        "sentence": "Patients receiving @DRUG1$ and @DRUG2$ concomitantly should be carefully monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 852,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 853,
        "sentence": "@DRUG1$ AUC was increased by 21% with no effect on Cmax in the presence of steady-state MYCAMINE compared with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 854,
        "sentence": "and combinations of opioids and sedatives (eg, benzodiazepines, barbiturates, @DRUG1$, @DRUG2$, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 855,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG2$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 856,
        "sentence": "As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, @DRUG1$, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent @DRUG2$ therapy.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 857,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 858,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG1$, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 859,
        "sentence": "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., @DRUG1$, sex steroids, anticonvulsants, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 860,
        "sentence": "The combined use of @DRUG1$ at doses of 400 mg or greater with @DRUG2$ is contraindicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 861,
        "sentence": "Since @DRUG1$ (@DRUG2$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 862,
        "sentence": "Those @DRUG1$ include @DRUG2$, valproic acid, and phenobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 863,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, @DRUG1$, and simethicone) did not significantly affect the exposure of oxybutynin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 864,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 865,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . @DRUG1$ plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing @DRUG2$   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 866,
        "sentence": "In post-marketing experience, as with other @DRUG1$, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving @DRUG2$ concurrently with warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 867,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 868,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, triiodothyronine, @DRUG2$, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 869,
        "sentence": "@DRUG1$ has been reported to enhance the sedative activity of barbiturates, @DRUG2$, chlorpromazine, and reserpine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 870,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or @DRUG1$ (like @DRUG2$ or methysergide) and sumatriptan within 24 hours of each other should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 871,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 872,
        "sentence": "Other eye drops or medications such as @DRUG1$ (Miochol) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of @DRUG2$ ophthalmic.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 873,
        "sentence": "The FDA has approved @DRUG1$ (Brilinta-AstraZeneca), an oral @DRUG2$, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 874,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 875,
        "sentence": "e.g., other belladonna alkaloids, antihistamines (including @DRUG1$), @DRUG2$, and muscle relaxants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 876,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of @DRUG1$ on the plasma concentration of perindopril/@DRUG2$ has not been excluded.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 877,
        "sentence": "Use with Anticholinergics: Because of their mechanism of action, @DRUG1$ have the potential to interfere with the activity of @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 878,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 879,
        "sentence": "John   s Wort, and certain anticonvulsants (@DRUG1$, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 880,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 881,
        "sentence": "The effect of curcumin (100 mg/kg) was similar to that of fluoxetine and imipramine (p > 0.05) but its addition to @DRUG1$ and @DRUG2$ did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 882,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, @DRUG2$, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 883,
        "sentence": "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as @DRUG1$,    -blockers, @DRUG2$ (SSRIs), and monoamine oxidase inhibitors (MAO-Is) Type B, if they have a narrow therapeutic window.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 884,
        "sentence": "The in vitro binding of @DRUG1$ to human plasma proteins is unaffected by @DRUG2$, and tolmetin does not alter the prothrombin time of normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 885,
        "sentence": "@DRUG1$ and @DRUG2$ reduce the plasma concentration of endoxifen by about 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 886,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG1$, modafinil, penicillins, rifampin, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 887,
        "sentence": "Use of @DRUG1$ in conjunction with oral @DRUG2$ may increase the risk of respiratory depression, hypotension and profound sedation or coma.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 888,
        "sentence": "@DRUG1$ users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), @DRUG2$ (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 889,
        "sentence": "To minimize CNS depression and possible potentiation, @DRUG1$, antihistamines, @DRUG2$, hypotensive agents or phenothiazines should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 890,
        "sentence": "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total @DRUG1$ clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total @DRUG2$ clearance in the same subjects in the absence of cimetidine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 891,
        "sentence": "@DRUG1$ should be used cautiously in conjunction with @DRUG2$ in patients suffering from hypoprothrombinemia.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 892,
        "sentence": "There is evidence that @DRUG1$ may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 893,
        "sentence": "A controlled study found that concomitant fluconazole 200 mg once daily and @DRUG1$ 20 mg four times a day yielded a significant increase in @DRUG2$ plasma levels and prolongation of QTc interval.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 894,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG2$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 895,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 896,
        "sentence": "CYP 3A4 Inhibitors (e.g. @DRUG1$ and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain @DRUG2$ (e.g. dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 897,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, @DRUG1$, and other muscle relaxants) or local @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 898,
        "sentence": "Other @DRUG1$: When MYKROX Tablets are used with other @DRUG2$, care must be taken, especially during initial therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 899,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, @DRUG2$, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 900,
        "sentence": "@DRUG1$: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as @DRUG2$) the most serious effect would be respiratory depression which could proceed to apnea.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 901,
        "sentence": "Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas @DRUG1$ treatment did not increase the exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 902,
        "sentence": "Anticholinesterases: Concurrent use of @DRUG1$ and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 903,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 904,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 905,
        "sentence": "@DRUG1$ decreased the toxicity of @DRUG2$, increased exposure to parent compound, and decreased metabolite levels in a dose-dependent manner.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 906,
        "sentence": "Potassium Supplements and @DRUG1$: @DRUG2$    can increase serum potassium because it decreases aldosterone secretion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 907,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG1$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 908,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 909,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 910,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 911,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., @DRUG2$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 912,
        "sentence": "Diuretics: @DRUG1$ and probably other @DRUG2$ given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 913,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., @DRUG2$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 914,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG1$, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 915,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, @DRUG2$, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 916,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG1$, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 917,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 918,
        "sentence": "Use with Other @DRUG1$: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, @DRUG2$, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 919,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, @DRUG2$, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 920,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 921,
        "sentence": "There was no effect of a single dose or multiple doses of @DRUG1$ on mycophenolate mofetil, @DRUG2$, tacrolimus, prednisolone, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 922,
        "sentence": "In clinical studies, patients on @DRUG1$ often needed higher serum pegvisomant concentrations to achieve appropriate IGF-I suppression compared with patients not receiving @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 923,
        "sentence": "Trilostane may interact with @DRUG1$ or @DRUG2$ (causing too great a decrease in adrenal function).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 924,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with @DRUG1$, similar neuromuscular blocking agents or cholinergic agonists such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 925,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 926,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 927,
        "sentence": "Mexitil    does not alter serum @DRUG1$ levels but @DRUG2$, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 928,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, @DRUG2$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 929,
        "sentence": "Interaction with Other @DRUG1$: @DRUG2$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 930,
        "sentence": "@DRUG1$ may reduce the effects of guanethidine (@DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 931,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, @DRUG1$, @DRUG2$, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 932,
        "sentence": "The neuromuscular blocking effect of @DRUG1$ may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered @DRUG2$ or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 933,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 934,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, @DRUG2$, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 935,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 936,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 937,
        "sentence": "@DRUG1$ can be a useful @DRUG2$ especially in cases which respond to drugs having mixed effects on serotonin and catecholamines levels in the brain.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 938,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, @DRUG2$, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 939,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG1$: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 940,
        "sentence": "The effect of @DRUG1$ (100 mg/kg) was similar to that of fluoxetine and imipramine (p > 0.05) but its addition to fluoxetine and @DRUG2$ did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 941,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 942,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG1$, oral contraceptives (@DRUG2$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 943,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, @DRUG1$, digitalis, diuretics, antidiabetic agents, and @DRUG2$, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 944,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 945,
        "sentence": "In vivo CYP3A activity is significantly lower in @DRUG1$-treated as compared with @DRUG2$-treated renal allograft recipients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 946,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 947,
        "sentence": "Concurrent use of @DRUG1$ and other @DRUG2$ may increase the CNS depressant effects of methyprylon or these other medications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 948,
        "sentence": "While co-administration of ZAVESCA    appeared to increase the clearance of @DRUG1$ by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 949,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 950,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 951,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - @DRUG1$: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 952,
        "sentence": "In vitro, raloxifene did not affect the binding of @DRUG1$, phenytoin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 953,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 954,
        "sentence": "@DRUG1$: A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of @DRUG2$ on the pharmacokinetics of methotrexate taken once weekly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 955,
        "sentence": "Drugs such as @DRUG1$, diltiazem, verapamil, ketoconazole, @DRUG2$ and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 956,
        "sentence": "@DRUG1$: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-@DRUG2$ containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 957,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG1$, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 958,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, @DRUG1$, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 959,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG1$ (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 960,
        "sentence": "@DRUG1$ containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, @DRUG2$, heparinase III, or chondroitin ABC lyase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 961,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG1$, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 962,
        "sentence": "Since Celontin (methsuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 963,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG1$ (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 964,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 965,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, @DRUG1$, sulfinpyrazone, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 966,
        "sentence": "Multiple dose studies of ezetimibe given in combination with @DRUG1$ (@DRUG2$) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 967,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 968,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 969,
        "sentence": "It has been reported that @DRUG1$ may prolong the prothrombin time in patients who are receiving the anticoagulant @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 970,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, @DRUG1$, grapefruit juice, fluoxetine, @DRUG2$, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 971,
        "sentence": "Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral @DRUG1$ containing @DRUG2$ 1 mg/ethinyl estradiol 35 mcg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 972,
        "sentence": "Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg @DRUG1$ may increase the plasma concentrations of phenytoin and @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 973,
        "sentence": "Therefore, as @DRUG1$ absorption may be decreased with XENICAL, patients on chronic stable doses of warfarin who are prescribed @DRUG2$ should be monitored closely for changes in coagulation parameters.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 974,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 975,
        "sentence": "Due to its effects on gastric emptying, @DRUG1$ therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as @DRUG2$) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 976,
        "sentence": "We also found that Bcl-2 was overexpressed in @DRUG1$ insensitive cells, and cotreatment with DZNep and @DRUG2$, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 977,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG1$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 978,
        "sentence": "Effect of @DRUG1$-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 979,
        "sentence": "The pharmacokinetic parameters of @DRUG1$ are not significantly modified by @DRUG2$ coadministration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 980,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 981,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 982,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 983,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., @DRUG2$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 984,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 985,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 986,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, @DRUG1$, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high @DRUG2$ content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 987,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and @DRUG1$ may increase the clearance of @DRUG2$ and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 988,
        "sentence": "@DRUG1$ or tricyclic antidepressants may potentiate the action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 989,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, @DRUG2$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 990,
        "sentence": "@DRUG1$: In a pharmacokinetic study, concomitant @DRUG2$ administration increased total ezetimibe concentrations approximately 1.7-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 991,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other @DRUG1$, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 992,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 993,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma @DRUG1$ concentrations when coadministered with ACEON    Tablets, but an effect of @DRUG2$ on the plasma concentration of perindopril/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 994,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), @DRUG2$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 995,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of @DRUG1$ with other macrolide antibiotics, including @DRUG2$, is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 996,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 997,
        "sentence": "- Cisapride, pimozide: Other drugs such as cisapride or @DRUG1$, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 998,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG1$ ) or @DRUG2$, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 999,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1000,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on @DRUG1$, @DRUG2$, tacrolimus, prednisolone, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1001,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1002,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that @DRUG1$ not be administered concomitantly with azathioprine or @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1003,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1004,
        "sentence": "If in certain cases, an @DRUG1$ is considered necessary, it may be advisable to replace tamoxifen with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1005,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1006,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, @DRUG2$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1007,
        "sentence": "Digoxin: In 12 normal-weight subjects receiving @DRUG1$ 120 mg three times a day for 6 days, @DRUG2$ did not alter the pharmacokinetics of a single dose of digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1008,
        "sentence": "Because @DRUG1$ exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, @DRUG2$ drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1009,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1010,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1011,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, @DRUG2$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1012,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1013,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, @DRUG2$, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1014,
        "sentence": "saline + saline, ephedrine (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and @DRUG1$ (10   mg/kg) + @DRUG2$ (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1015,
        "sentence": "Phase I trial of lenalidomide and @DRUG1$ in patients with relapsed multiple myeloma: evidence for lenalidomide-@DRUG2$ interaction via P-glycoprotein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1016,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1017,
        "sentence": "Cyclosporine: Preliminary data from a @DRUG1$ and cyclosporine drug interaction study indicate a reduction in @DRUG2$ plasma levels when XENICAL was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1018,
        "sentence": "As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or @DRUG1$) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent @DRUG2$ therapy.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1019,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1020,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1021,
        "sentence": "The concurrent use of streptozocin and @DRUG1$ has been reported in one case to result in reduced @DRUG2$ cytotoxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1022,
        "sentence": "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by @DRUG1$ is superior to @DRUG2$ followed by docetaxel and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1023,
        "sentence": "Phenothiazines are capable of potentiating CNS depressants (e.g., @DRUG1$, anesthetics, @DRUG2$, alcohol, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1024,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1025,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, @DRUG1$, rifampin, rifabutin, rifapentin, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1026,
        "sentence": "The bioavailability of @DRUG1$ was reduced by @DRUG2$, however, and this was associated with a decrease in plasma ACE inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1027,
        "sentence": "No cross-resistance with other @DRUG1$, radiotherapy or @DRUG2$ has been demonstrated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1028,
        "sentence": "- did not cause any clinically significant change in plasma profiles of prednisone or @DRUG1$ following administration of either oral @DRUG2$ or intravenous prednisolone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1029,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1030,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when @DRUG1$ and @DRUG2$ are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1031,
        "sentence": "Mean @DRUG1$ plasma concentrations were approximately 2 fold higher when DITROPAN XL was administered with @DRUG2$, a potent CYP3A4 inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1032,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, @DRUG2$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1033,
        "sentence": "@DRUG1$: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving @DRUG2$ in conjunction with terfenadine, interaction studies have been performed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1034,
        "sentence": "@DRUG1$ AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state MYCAMINE compared with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1035,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1036,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1037,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG1$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1038,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between @DRUG1$ and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of @DRUG2$.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1039,
        "sentence": "Interactions for Vitamin B2 (@DRUG1$):  Alcohol - impairs the intestinal absorption of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1040,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG2$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1041,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, triamterene and others), @DRUG2$ supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1042,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1043,
        "sentence": "Acromegalic patients with diabetes mellitus being treated with @DRUG1$ and/or oral @DRUG2$ agents may require dose reductions of these therapeutic agents after the initiation of therapy with SOMAVERT.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1044,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG1$ (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1045,
        "sentence": "morphine, theophylline, @DRUG1$, succinylcholine, @DRUG2$, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1046,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1047,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (@DRUG2$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1048,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$, and rifampin may increase the clearance of @DRUG2$ and may require increased in methylprednisolone dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1049,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with @DRUG1$, simvastatin, @DRUG2$, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1050,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG1$ - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1051,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, @DRUG2$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1052,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG2$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1053,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1054,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1055,
        "sentence": "Curariform Drugs: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of @DRUG1$ (such as @DRUG2$) the most serious effect would be respiratory depression which could proceed to apnea.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1056,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1057,
        "sentence": "Ticagrelor (@DRUG1$)--better than clopidogrel (@DRUG2$)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1058,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1059,
        "sentence": "The action of Mecamylamine may be potentiated by anesthesia, other @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1060,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1061,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1062,
        "sentence": "There was no effect of a single dose or multiple doses of @DRUG1$ on @DRUG2$, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1063,
        "sentence": "@DRUG1$ may be used with sulfonamides, quinine and other antimalarials, and with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1064,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or @DRUG1$, ordinarily should not be administered concurrently with @DRUG2$ (a dopamine agonist);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1065,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1066,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG2$), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1067,
        "sentence": "Use with @DRUG1$ and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or @DRUG2$ such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1068,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG2$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1069,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some @DRUG1$- or magnesium-containing antacids, when administered 1 hour before @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1070,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - @DRUG1$: may decrease patient's response to the @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1071,
        "sentence": "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of @DRUG1$ and 75    g of @DRUG2$ were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1072,
        "sentence": "Although ibuprofen (400 mg qid) can be administered with @DRUG1$ in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering @DRUG2$ concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1073,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1074,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, @DRUG2$, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1075,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, @DRUG1$, @DRUG2$ and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1076,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1077,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1078,
        "sentence": "The use of AGGRASTAT, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to @DRUG1$ and @DRUG2$ alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1079,
        "sentence": "@DRUG1$: Concurrent use of @DRUG2$ and procaine hydrochloride may extend the plasma half-life of procaine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1080,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., @DRUG2$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1081,
        "sentence": "Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving @DRUG1$ 120 mg three times a day for 6 days, @DRUG2$ did not alter the bioavailability of nifedipine (extended-release tablets).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1082,
        "sentence": "@DRUG1$ as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of @DRUG2$ followed by sunitinib is superior to sunitinib followed by docetaxel and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1083,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral @DRUG1$, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered @DRUG2$ or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1084,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1085,
        "sentence": "Glyburide: In 12 normal-weight subjects receiving @DRUG1$ 80 mg three times a day for 5 days, @DRUG2$ did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1086,
        "sentence": "@DRUG1$: Population pharmacokinetic analysis suggests that amantadine is unlikely to alter the oral clearance of @DRUG2$ (N= 54).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1087,
        "sentence": "Coadministration of @DRUG1$ with clarithromycin resulted in increased plasma @DRUG2$ concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1088,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and @DRUG1$), propofol, ketamine, @DRUG2$, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1089,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1090,
        "sentence": "Interactions for Vitamin B1 (@DRUG1$):  @DRUG2$, Oral Contraceptives, Stavudine, Tricyclic Antidepressants",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1091,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1092,
        "sentence": "@DRUG1$ or ACTH In patients with edema, concomitant administration with @DRUG2$ or ACTH may increase the edema.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1093,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, @DRUG1$, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1094,
        "sentence": "In clinical studies of @DRUG1$, patients taking TOBI concomitantly with dornase alfa (@DRUG2$   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1095,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1096,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with @DRUG1$ should be monitored for sirolimus or @DRUG2$ toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1097,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - @DRUG2$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1098,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1099,
        "sentence": "The data presently available indicate that the decreases in some individual @DRUG1$ and @DRUG2$ AUC values with fluconazole treatment are likely the result of random variation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1100,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1101,
        "sentence": "These medications included @DRUG1$, sedative hypnotics, non-steroidal anti-inflammatory agents, @DRUG2$, and decongestants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1102,
        "sentence": "Other @DRUG1$ Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other @DRUG2$ (e.g., valproic acid).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1103,
        "sentence": "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with @DRUG1$ (eg, morphine, @DRUG2$, and fentanyl, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1104,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG1$, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1105,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1106,
        "sentence": "@DRUG1$, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of @DRUG2$ was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1107,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1108,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, @DRUG1$, nifedipine, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1109,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by @DRUG1$, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, @DRUG2$, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1110,
        "sentence": "Enhancement of humoral immune responses to inactivated Newcastle disease and @DRUG1$ by oral administration of @DRUG2$ in chickens.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1111,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1112,
        "sentence": "Concomitant administration of substances that are also tubularly secreted (e.g., @DRUG1$) could potentially result in delayed clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1113,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG1$) or macrolide antibiotics (eg, erythromycin, clarithromycin) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1114,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG1$, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1115,
        "sentence": "Salicylates and Other @DRUG1$: May decrease the antihypertensive effects of @DRUG2$ Tablets.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1116,
        "sentence": "- did not cause any clinically significant change in plasma profiles of @DRUG1$ or @DRUG2$ following administration of either oral prednisone or intravenous prednisolone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1117,
        "sentence": "@DRUG1$, given at a common clinical dosage, increased the @DRUG2$ half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1118,
        "sentence": "Astemizole: The use of @DRUG1$ in patients concurrently taking @DRUG2$ or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1119,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1120,
        "sentence": "Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since @DRUG1$ inhibit the breakdown of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1121,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1122,
        "sentence": "If @DRUG1$ replacement is required, the @DRUG2$ dose should be carefully adjusted.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1123,
        "sentence": "@DRUG1$: In clinical trials, @DRUG2$ have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1124,
        "sentence": "@DRUG1$: The safety and effectiveness of ezetimibe administered with @DRUG2$ have not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1125,
        "sentence": "Additive sedative effects can occur when @DRUG1$ is given with alcohol, sedatives, @DRUG2$, narcotics, or tranquilizers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1126,
        "sentence": "Administration of paclitaxel in combination with @DRUG1$ resulted in a two-fold decrease in HERCEPTIN clearance in a non-human primate study and in a 1.5-fold increase in @DRUG2$ serum levels in clinical studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1127,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1128,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG2$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1129,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, @DRUG1$, @DRUG2$, ketoconazole, and fluconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1130,
        "sentence": "Oral @DRUG1$: In 20 normal-weight female subjects, the treatment of XENICAL 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1131,
        "sentence": "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or @DRUG1$, are co-administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1132,
        "sentence": "During maintenance of anesthesia or sedation, the rate of @DRUG1$ Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, @DRUG2$ or opioids).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1133,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1134,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1135,
        "sentence": "No pharmacokinetic interaction was observed between @DRUG1$ and digoxin, warfarin, @DRUG2$, or fluoxetine in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1136,
        "sentence": "Concurrent use of @DRUG1$ with alcohol or other @DRUG2$ can increase their sedative effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1137,
        "sentence": "As there is in vitro evidence that @DRUG1$ (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent @DRUG2$ therapy.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1138,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG1$, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1139,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, @DRUG2$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1140,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, @DRUG1$, @DRUG2$, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1141,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, griseofulvin, modafinil, @DRUG2$, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1142,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, @DRUG1$, sedatives, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1143,
        "sentence": "Co-administration of oral ketoconazole 200 mg twice daily increased @DRUG1$ geometric mean AUC(0-24) and Cmax by 81% after topical application of @DRUG2$ ointment, 1% on the abraded skin of healthy adult males.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1144,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1145,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG2$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1146,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1147,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, tranquilizers, general @DRUG2$, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1148,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1149,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1150,
        "sentence": "@DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with @DRUG2$ (a dopamine agonist);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1151,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1152,
        "sentence": "Rifabutin: There have been reports of uveitis in patients to whom @DRUG1$ and @DRUG2$ were coadministered.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1153,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1154,
        "sentence": "Use of @DRUG1$ and Antiplatelet Agents -- @DRUG2$, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1155,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1156,
        "sentence": "@DRUG1$ can interact with CNS depressant, @DRUG2$, TCA, MAOIs, and alcohol.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1157,
        "sentence": "No significant adverse interactions with common premedications (such as @DRUG1$, @DRUG2$, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1158,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . @DRUG1$, including @DRUG2$, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1159,
        "sentence": "@DRUG1$: Following oral administration of midazolam, @DRUG2$ resulted in substantial increases in midazolam concentrations and psychomotor effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1160,
        "sentence": "Macrolides: Clinical drug interaction studies indicate that erythromycin and @DRUG1$ can exert an effect on @DRUG2$ metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1161,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1162,
        "sentence": "Concomitant administrations not recommended:  - @DRUG1$ and astemizole: Certain macrolides interact with @DRUG2$ and astemizole leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1163,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (@DRUG1$), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1164,
        "sentence": "@DRUG1$ Reports suggest that @DRUG2$ may diminish the antihypertensive effect of angiotensin-converting enzyme (ACE) inhibitors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1165,
        "sentence": "Use with Other @DRUG1$: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as @DRUG2$, sedatives, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1166,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, @DRUG2$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1167,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG1$ - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1168,
        "sentence": "When @DRUG1$ is used concomitantly with these or other sulfonylurea oral hypoglycemic agents, blood glucose concentrations should be carefully monitored and the dose of the @DRUG2$ should be adjusted as necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1169,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG2$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1170,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1171,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1172,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, @DRUG2$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1173,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus @DRUG2$ 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1174,
        "sentence": "The bioavailability of SKELID is decreased 80% by @DRUG1$, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing @DRUG2$, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1175,
        "sentence": "Therefore, as @DRUG1$ absorption may be decreased with @DRUG2$, patients on chronic stable doses of warfarin who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1176,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG1$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1177,
        "sentence": "Severe toxicity has also been reported in patients receiving the combination of @DRUG1$ and @DRUG2$ and selective serotonin reuptake inhibitors and ELDEPRYL.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1178,
        "sentence": "Sulfoxone may increase the effects of @DRUG1$, @DRUG2$, and uricosurics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1179,
        "sentence": "Patients receiving @DRUG1$ or @DRUG2$ in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1180,
        "sentence": "Use with Cholinomimetics and Other @DRUG1$: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or @DRUG2$ such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1181,
        "sentence": "Sulfoxone may increase the effects of barbiturates, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1182,
        "sentence": "While there is evidence that @DRUG1$ can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1183,
        "sentence": "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as @DRUG1$, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after @DRUG2$    therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1184,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., @DRUG1$, @DRUG2$, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1185,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1186,
        "sentence": "In the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of @DRUG1$ evaluated by both acetic acid writhing and formalin test, when it was administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1187,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1188,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin, and rifampin may increase the clearance of @DRUG2$ and may require increased in methylprednisolone dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1189,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1190,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1191,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, @DRUG2$, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1192,
        "sentence": "In vitro studies with human liver microsomes showed that @DRUG1$ does not inhibit the metabolism of tolbutamide, @DRUG2$, ethoxycoumarin, and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1193,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1194,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG2$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1195,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1196,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1197,
        "sentence": "Patients receiving @DRUG1$ or nifedipine in combination with MYCAMINE should be monitored for @DRUG2$ or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1198,
        "sentence": "morphine, @DRUG1$, aminophylline, succinylcholine, @DRUG2$, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1199,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, @DRUG2$ and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1200,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG1$ (n=75), antidiabetics (n=21), @DRUG2$ (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1201,
        "sentence": "@DRUG1$ may increase the clearance of chronic high dose @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1202,
        "sentence": "Concomitant administration of @DRUG1$ and theophylline-containing drugs leads to increased @DRUG2$ levels and theophylline toxicity in some individuals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1203,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG1$, @DRUG2$), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1204,
        "sentence": "@DRUG1$: Since pramipexole is a @DRUG2$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1205,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1206,
        "sentence": "During maintenance of anesthesia or sedation, the rate of @DRUG1$ Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, nitrous oxide or @DRUG2$).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1207,
        "sentence": "@DRUG1$ may reduce the effects of @DRUG2$ (Ismelin).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1208,
        "sentence": "@DRUG1$ may inhibit the hepatic metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1209,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral @DRUG1$, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1210,
        "sentence": "@DRUG1$: There have been reports of uveitis in patients to whom fluconazole and @DRUG2$ were coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1211,
        "sentence": "Absorption of tetracyclines is impaired by antacids containing aluminum, @DRUG1$ or magnesium, and @DRUG2$-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1212,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1213,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, @DRUG1$, other @DRUG2$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1214,
        "sentence": "The effects of @DRUG1$, zidovudine or rifabutin on the pharmacokinetics of @DRUG2$ were not studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1215,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted @DRUG1$ (@DRUG2$, ketoconazole, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1216,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1217,
        "sentence": "Mexitil    does not alter serum @DRUG1$ levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to @DRUG2$   , has been reported to lower serum digoxin levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1218,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1219,
        "sentence": "Concomitant administration of @DRUG1$ with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other @DRUG2$, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1220,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1221,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG1$ ) or metoclopramide, ordinarily should not be administered concurrently with @DRUG2$ (a dopamine agonist);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1222,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1223,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1224,
        "sentence": "Treatment of HEY xenograft-bearing mice with @DRUG1$ plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, @DRUG2$ + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1225,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, @DRUG2$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1226,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG1$), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1227,
        "sentence": "The induction dose requirements of @DRUG1$ Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, meperidine, and @DRUG2$, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1228,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1229,
        "sentence": "In clinical trials, the concomitant use of sulfonylureas or @DRUG1$ did not alter the adverse event profile of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1230,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1231,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1232,
        "sentence": "No significant adverse interactions with common premedications (such as @DRUG1$, scopolamine, glycopyrrolate, diazepam, @DRUG2$, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1233,
        "sentence": "Phenothiazines are capable of potentiating CNS depressants (e.g., barbiturates, anesthetics, @DRUG1$, @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1234,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1235,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1236,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG1$, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1237,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1238,
        "sentence": "In vitro activity of @DRUG1$ combined with fosfomycin against clinical isolates of @DRUG2$-resistant Staphylococcus aureus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1239,
        "sentence": "John   s Wort, and certain anticonvulsants (@DRUG1$, phenobarbital, carbamazepine) may induce @DRUG2$ metabolism (lowering serum levels of mifepristone).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1240,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG2$) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1241,
        "sentence": "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with @DRUG1$ have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on @DRUG2$ and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1242,
        "sentence": "and/or antibiotic drug @DRUG1$ (100 mg/kg, p. o.), as well as that of neurotoxin @DRUG2$ (MPTP) (4 x 20 mg/kg, i. p.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1243,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to @DRUG1$, and @DRUG2$, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1244,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, @DRUG2$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1245,
        "sentence": "Isoflurane and enflurane (administered with @DRUG1$/@DRUG2$ to achieve 1.25 M.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1246,
        "sentence": "The effect of @DRUG1$ on the anticoagulant effect of @DRUG2$ was studied in a group of healthy subjects receiving daily doses of warfarin that produced an INR (International Normalized Ratio) between 1.2 and 1.8.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1247,
        "sentence": "@DRUG1$: A multidose study of @DRUG2$, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1248,
        "sentence": "The effect of @DRUG1$ on the absorption of supplemental vitamin D, @DRUG2$, and nutritionally-derived vitamin K is not known at this time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1249,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1250,
        "sentence": "Moxifloxacin and @DRUG1$ reacts faster with @DRUG2$ and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1251,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1252,
        "sentence": "Furthermore, in patients receiving both drugs, careful monitoring of the INR or PT, and adjustment of the @DRUG1$ dosage if indicated are recommended when the @DRUG2$ dose is changed or discontinued.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1253,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG1$, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1254,
        "sentence": "@DRUG1$ may reduce the antihypertensive effects of methyldopa, @DRUG2$, reserpine and veratrum alkaloids.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1255,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, @DRUG2$ and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1256,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1257,
        "sentence": "Drugs such as erythromycin, @DRUG1$, verapamil, ketoconazole, fluconazole and @DRUG2$ were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1258,
        "sentence": "@DRUG1$ or other medications with anticholinergic activity when used concurrently with @DRUG2$ may result in increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1259,
        "sentence": "Drugs that impair intestinal absorption of @DRUG1$, such as cholestyramine, may interfere with the absorption of @DRUG2$ Capsules.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1260,
        "sentence": "Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in @DRUG1$ plasma levels when @DRUG2$ was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1261,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1262,
        "sentence": "Absorption of tetracyclines is impaired by @DRUG1$ containing aluminum, @DRUG2$ or magnesium, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1263,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1264,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1265,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, @DRUG2$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1266,
        "sentence": "Since Celontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg @DRUG2$ may increase the plasma concentrations of phenytoin and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1267,
        "sentence": "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of @DRUG1$ or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (@DRUG2$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1268,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG2$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1269,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), @DRUG1$, inhaled corticosteroids, other @DRUG2$, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1270,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1271,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG1$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1272,
        "sentence": "Phenytoin: In 12 normal-weight subjects receiving @DRUG1$ 120 mg three times a day for 7 days, @DRUG2$ did not alter the pharmacokinetics of a single 300-mg dose of phenytoin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1273,
        "sentence": "Curariform Drugs: @DRUG1$-induced hypokalemia may enhance neuromuscular blocking effects of @DRUG2$ (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1274,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other @DRUG1$, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1275,
        "sentence": "Accordingly, patients should be advised to avoid alcohol while taking @DRUG1$. @DRUG2$: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1276,
        "sentence": "@DRUG1$ can interact with CNS depressant, antichlolinergic, @DRUG2$, MAOIs, and alcohol.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1277,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and @DRUG1$, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1278,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . @DRUG1$ plasma levels returned to pre-@DRUG2$    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1279,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG1$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1280,
        "sentence": "Pindolol has been used with a variety of @DRUG1$, including hydrochlorothiazide, @DRUG2$, and guanethidine without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1281,
        "sentence": "Rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with @DRUG1$, but only female controls conditioned with @DRUG2$ spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1282,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG1$), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1283,
        "sentence": "In vitro perfusion of isolated rat liver has shown that @DRUG1$ caused a significant reduction in @DRUG2$ metabolism and that acetaminophen altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1284,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1285,
        "sentence": "@DRUG1$ (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, @DRUG2$, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1286,
        "sentence": "@DRUG1$: DIFLUCAN increases the serum concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1287,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG1$, phenytoin, @DRUG2$, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1288,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1289,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1290,
        "sentence": "The effect of @DRUG1$, an inhibitor of Src and Abl kinases, on @DRUG2$ sensitivity was measured in ovarian cancer cells and HEY xenografts.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1291,
        "sentence": "The bioavailability of SKELID is decreased 80% by @DRUG1$, when calcium and @DRUG2$ are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1292,
        "sentence": "Interaction with @DRUG1$: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1293,
        "sentence": "@DRUG1$ inhibits some of the liver's ability to metabolize some other drugs - @DRUG2$, astemizole, cisapride, cyclosporine, and tricyclic antidepressants.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1294,
        "sentence": "Because @DRUG1$ have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their @DRUG2$ dosage.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1295,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, @DRUG2$, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1296,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1297,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG2$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1298,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin and rifampin may increase the clearance of @DRUG2$ and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1299,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1300,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and @DRUG2$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1301,
        "sentence": "2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of pralidoxime: since @DRUG1$ are potentiated by the @DRUG2$, they should be used cautiously in the treatment of convulsions;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1302,
        "sentence": "Tacrolimus: There have been reports of nephrotoxicity in patients to whom @DRUG1$ and @DRUG2$ were coadministered.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1303,
        "sentence": "Agents that might be coadministered with @DRUG1$ in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, ketoconazole, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1304,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG1$, OTHER TRANQUILIZERS, @DRUG2$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1305,
        "sentence": "Cholestyramine and Drugs that Bind Bile Acids: These drugs interrupt enterohepatic recirculation and reduce @DRUG1$ exposure when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1306,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG1$, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1307,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to @DRUG1$, cisplatin, doxorubicin and @DRUG2$   celecoxib following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1308,
        "sentence": "When @DRUG1$ or other hepatic enzyme inducers such as rifampin and @DRUG2$ have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1309,
        "sentence": "@DRUG1$ can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1310,
        "sentence": "Oral Anticoagulants: Interaction studies with @DRUG1$ failed to identify any clinically important effect on the serum concentrations of the @DRUG2$ or on its anticoagulant effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1311,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1312,
        "sentence": "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of @DRUG1$, sodium salicylate and @DRUG2$ displaced protein-bound teniposide in fresh human serum to a small but significant extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1313,
        "sentence": "The effect of meloxicam on the anticoagulant effect of @DRUG1$ was studied in a group of healthy subjects receiving daily doses of @DRUG2$ that produced an INR (International Normalized Ratio) between 1.2 and 1.8.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1314,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG1$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1315,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG1$), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1316,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., @DRUG2$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1317,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1318,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, @DRUG2$, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1319,
        "sentence": "@DRUG1$: Increased serum @DRUG2$ and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1320,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1321,
        "sentence": "@DRUG1$ and/or stimulantes of the ephedrine/amphetamine type may counteract the specific actions of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1322,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1323,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1324,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1325,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1326,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1327,
        "sentence": "Coadministration of @DRUG1$ with drugs that are eliminated by active renal tubular secretion may increase the serum concentration of @DRUG2$ and/or the coadministered drug due to competition for this elimination pathway.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1328,
        "sentence": "Ethanol decreases the elimination of @DRUG1$ causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1329,
        "sentence": "In clinical studies of TOBI, patients taking @DRUG1$ concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled @DRUG2$, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1330,
        "sentence": "It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the @DRUG1$ @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1331,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1332,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, @DRUG1$, cyclosporine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1333,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1334,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, @DRUG1$, @DRUG2$, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1335,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1336,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, triamterene, @DRUG2$) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1337,
        "sentence": "@DRUG1$ and @DRUG2$ are incompatible with sodium bicarbonate solution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1338,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of @DRUG1$, @DRUG2$, diazepam, or fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1339,
        "sentence": "Lithium: Increased serum @DRUG1$ levels and symptoms of lithium toxicity have been reported in patients receiving @DRUG2$ during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1340,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1341,
        "sentence": "@DRUG1$ may accentuate the orthostatic hypotension that may occur with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1342,
        "sentence": "@DRUG1$ has been used concurrently with @DRUG2$, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1343,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or @DRUG1$ (e.g., erythromycin and @DRUG2$), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1344,
        "sentence": "@DRUG1$ has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1345,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (@DRUG1$ 1 mg/ethinyl estradiol 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1346,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG1$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1347,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1348,
        "sentence": "After 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all @DRUG1$/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG2$-treated monkeys were significantly affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1349,
        "sentence": "Reduced absorption of @DRUG1$ and digoxin have been reported when those agents were administered concomitantly with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1350,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1351,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since @DRUG2$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1352,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing @DRUG1$ has been demonstrated in patients chronically administered phenytoin or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1353,
        "sentence": "Concurrent administration of bacteriostatic antibiotics (e.g., erythromycin, @DRUG1$) may diminish the bactericidal effects of @DRUG2$ by slowing the rate of bacterial growth.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1354,
        "sentence": "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of @DRUG1$ followed by @DRUG2$ is superior to sunitinib followed by docetaxel and concurrent administration.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1355,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1356,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (@DRUG1$   , Genentech), (beta)-agonists, inhaled @DRUG2$, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1357,
        "sentence": "Coadministration of TRITEC with @DRUG1$ resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased @DRUG2$ plasma concentrations (31%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1358,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG2$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1359,
        "sentence": "@DRUG1$: In a multiple-dose study in 30 normal weight subjects, coadministration of @DRUG2$ and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1360,
        "sentence": "In addition to bleeding associated with heparin and @DRUG1$, drugs that alter platelet function (such as aspirin, @DRUG2$, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1361,
        "sentence": "(ii) @DRUG1$ elicits a significant protective effect on DEB induced toxicity, which was potentiated by  @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1362,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1363,
        "sentence": "TOBI should not be administered concomitantly with @DRUG1$, furosemide, urea, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1364,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG1$,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1365,
        "sentence": "Oral @DRUG1$ Oxandrolone may inhibit the metabolism of oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1366,
        "sentence": "Agents that might be coadministered with @DRUG1$ in AIDS patients for other indications that could elicit this activity include @DRUG2$, rifampin, rifabutin, ketoconazole, and fluconazole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1367,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1368,
        "sentence": "Triprolidine may enhance the sedative effects of @DRUG1$ including alcohol, barbiturates, @DRUG2$, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1369,
        "sentence": "No pharmacokinetic interaction was observed between @DRUG1$ and digoxin, warfarin, diazepam, or @DRUG2$ in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1370,
        "sentence": "@DRUG1$ users had an increased odds ratio of gastrointestinal bleeding upon initiation of @DRUG2$ (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1371,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, @DRUG1$, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when @DRUG2$    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1372,
        "sentence": "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as @DRUG1$ or rifampin, are co-administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1373,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (@DRUG2$, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1374,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG1$ can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1375,
        "sentence": "@DRUG1$: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of @DRUG2$ pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1376,
        "sentence": "Moxifloxacin and Lomefloxacin reacts faster with sucralfate and @DRUG1$ in acidic media whereas with @DRUG2$ in basic media and multi-minerals in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1377,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and @DRUG1$) did not significantly affect the exposure of @DRUG2$ or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1378,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1379,
        "sentence": "Phenothiazines are capable of potentiating CNS depressants (e.g., @DRUG1$, @DRUG2$, opiates, alcohol, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1380,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., @DRUG1$, tetracycline, @DRUG2$, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1381,
        "sentence": "Ticagrelor (@DRUG1$)--better than @DRUG2$ (Plavix)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1382,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1383,
        "sentence": "Although such a reaction has not been demonstrated with roxithromycin, concomitant administration of @DRUG1$ with @DRUG2$ or astemizole is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1384,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG2$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1385,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing @DRUG1$   . If Mexitil and theophylline are to be used concurrently, @DRUG2$ blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1386,
        "sentence": "Due to low systemic exposure to retapamulin following topical application in patients, dosage adjustments for @DRUG1$ are unnecessary when co-administered with CYP3A4 inhibitors, such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1387,
        "sentence": "Caution should be used when @DRUG1$ is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, @DRUG2$, diazepam, and diazoxide.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1388,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG1$ (SSRIs) (e.g., fluoxetine, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1389,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG1$ - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1390,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, @DRUG2$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1391,
        "sentence": "Curariform Drugs: @DRUG1$-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as @DRUG2$) the most serious effect would be respiratory depression which could proceed to apnea.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1392,
        "sentence": "Evaluation of antidepressant like activity of @DRUG1$ and its combination with @DRUG2$ and imipramine: an acute and chronic study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1393,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1394,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG1$, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1395,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG1$), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1396,
        "sentence": "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, @DRUG1$, @DRUG2$, and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1397,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1398,
        "sentence": "There was a >75% reduction in cellular glutathione and cysteine with @DRUG1$ but not @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1399,
        "sentence": "Therefore, as vitamin K absorption may be decreased with @DRUG1$, patients on chronic stable doses of @DRUG2$ who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1400,
        "sentence": "Gentamicin: Animal data have suggested the possibility of interaction between @DRUG1$ and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1401,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of @DRUG1$ and 40 grams of @DRUG2$ (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1402,
        "sentence": "The effect of @DRUG1$ on the absorption of supplemental @DRUG2$, vitamin A, and nutritionally-derived vitamin K is not known at this time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1403,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG1$, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1404,
        "sentence": "Careful monitoring of @DRUG1$ concentrations in patients receiving @DRUG2$ and phenytoin is recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1405,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1406,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1407,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when @DRUG1$ is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, @DRUG2$, and macrolide antibiotics).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1408,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1409,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, @DRUG1$, @DRUG2$, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1410,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG1$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1411,
        "sentence": "@DRUG1$ and enflurane (administered with nitrous oxide/@DRUG2$ to achieve 1.25 M.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1412,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG1$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1413,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1414,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., @DRUG1$, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of @DRUG2$   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1415,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, @DRUG2$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1416,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - @DRUG1$: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - @DRUG2$: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1417,
        "sentence": "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with @DRUG1$ (eg, @DRUG2$, meperidine, and fentanyl, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1418,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1419,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1420,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1421,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, @DRUG1$, doxorubicin and etoposide   @DRUG2$ following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1422,
        "sentence": "@DRUG1$ may increase the effects of @DRUG2$, tolbutamide, and uricosurics.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1423,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, @DRUG1$, @DRUG2$, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1424,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1425,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (@DRUG2$), or phenelzine (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1426,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1427,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, @DRUG1$, certain heart medicines, birth control pills, @DRUG2$, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1428,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1429,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of @DRUG1$ pharmacokinetics, @DRUG2$ pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1430,
        "sentence": "These data suggest that @DRUG1$ administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., @DRUG2$, sex steroids, anticonvulsants, cyclosporin).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1431,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG2$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1432,
        "sentence": "The FDA has approved @DRUG1$ (@DRUG2$-AstraZeneca), an oral antiplatelet drug, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1433,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and rifampin may increase the clearance of @DRUG1$ and may require increased in @DRUG2$ dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1434,
        "sentence": "Preliminary evidence suggests that @DRUG1$ inhibits mebendazole metabolism and may result in an increase in plasma concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1435,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1436,
        "sentence": "In addition to bleeding associated with @DRUG1$ and @DRUG2$, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1437,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1438,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, @DRUG1$, @DRUG2$, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1439,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), @DRUG1$ (Parnate), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1440,
        "sentence": "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, @DRUG1$, heparinase III, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1441,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1442,
        "sentence": "In humans, @DRUG1$, etoposide, and cisplatin do not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1443,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1444,
        "sentence": "Caution should be used when @DRUG1$ is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, @DRUG2$, ibuprofen, diazepam, and diazoxide.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1445,
        "sentence": "Interaction with @DRUG1$: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or @DRUG2$) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1446,
        "sentence": "In this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg @DRUG1$ after pretreatments with oral @DRUG2$ (250 mg twice daily), itraconazole (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1447,
        "sentence": "DRUG INTERACTIONS  There are no known drug/drug interactions with oral @DRUG1$  Vaccinations with @DRUG2$ are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1448,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1449,
        "sentence": "@DRUG1$: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with @DRUG2$, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1450,
        "sentence": "@DRUG1$ may interact with @DRUG2$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1451,
        "sentence": "@DRUG1$: Concurrent use of acetazolamide and @DRUG2$ may extend the plasma half-life of procaine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1452,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1453,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, @DRUG1$, furosemide and theophylline Please note that @DRUG2$ may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1454,
        "sentence": "Anticoagulants (oral): The activity of oral @DRUG1$ may be potentiated by anti-vitamin-K activity attributed to @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1455,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG1$), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1456,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, tacrolimus, @DRUG2$, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1457,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and @DRUG1$ are to be used concurrently, theophylline blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1458,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG1$, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1459,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, @DRUG2$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1460,
        "sentence": "Studies to evaluate potential interactions of @DRUG1$ with @DRUG2$ are in progress.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1461,
        "sentence": "The metabolism of @DRUG1$ is accelerated by @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1462,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1463,
        "sentence": "For information on drug interactions associated with @DRUG1$, refer to the @DRUG2$     package insert.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1464,
        "sentence": "@DRUG1$: @DRUG2$, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence pramipexole pharmacokinetics (N= 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1465,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1466,
        "sentence": "e.g., other belladonna alkaloids, antihistamines (including @DRUG1$), tricyclic antidepressants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1467,
        "sentence": "@DRUG1$ AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO @DRUG2$ AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1468,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1469,
        "sentence": "This study examined drug-drug interactions of oral @DRUG1$ with the cytochrome P450 (CYP) 2B6 inhibitor @DRUG2$ and the CYP3A inhibitor itraconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1470,
        "sentence": "@DRUG1$ are capable of potentiating CNS depressants (e.g., @DRUG2$, anesthetics, opiates, alcohol, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1471,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1472,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1473,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1474,
        "sentence": "We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with DZNep and @DRUG1$, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of @DRUG2$ insensitive MM cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1475,
        "sentence": "Although this has not occurred in in vitro studies with @DRUG1$, interactions with coumarin-type anticoagulants have been reported with @DRUG2$ since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1476,
        "sentence": "2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of @DRUG1$: since barbiturates are potentiated by the @DRUG2$, they should be used cautiously in the treatment of convulsions;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1477,
        "sentence": "e.g., other @DRUG1$, antihistamines (including @DRUG2$), tricyclic antidepressants, and muscle relaxants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1478,
        "sentence": "Although @DRUG1$ (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between @DRUG2$ and succinylcholine has not been systematically studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1479,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1480,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1481,
        "sentence": "Dosages of concomitantly administered @DRUG1$ should be reduced by approximately half, because @DRUG2$ amplifies the therapeutic actions and side-effects of opioids.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1482,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-@DRUG1$    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, @DRUG2$ blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1483,
        "sentence": "It has been reported that the incidence of bradycardia was increased when @DRUG1$ was combined with @DRUG2$ for induction of anesthesia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1484,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG1$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1485,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  @DRUG1$: Although no pharmacokinetic drug interaction between ondansetron and @DRUG2$ has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1486,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (@DRUG1$ 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (@DRUG2$ 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1487,
        "sentence": "Sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1488,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, @DRUG1$, polymyxin B, colistin, @DRUG2$, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1489,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1490,
        "sentence": "When @DRUG1$ is administered with an HMG-CoA reductase inhibitor in a woman of childbearing potential, refer to the pregnancy category and package labeling for the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1491,
        "sentence": "Concomitant administration of @DRUG1$ with @DRUG2$, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1492,
        "sentence": "@DRUG1$ Supplements and @DRUG2$: ACEON    Tablets may increase serum potassium because of its potential to decrease aldosterone production.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1493,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, @DRUG2$, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1494,
        "sentence": "Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with @DRUG1$ infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1495,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, @DRUG1$, and miconazole) to @DRUG2$, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1496,
        "sentence": "Interactions for @DRUG1$ (Thiamine):  Loop Diuretics, Oral Contraceptives, @DRUG2$, Tricyclic Antidepressants",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1497,
        "sentence": "No significant adverse interactions with common premedications (such as @DRUG1$, scopolamine, glycopyrrolate, @DRUG2$, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1498,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1499,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1500,
        "sentence": "@DRUG1$ in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1501,
        "sentence": "Concomitant use of @DRUG1$ and clopidogrel was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by @DRUG2$ of CYP2C19, a cytochrome P450 (CYP) enzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1502,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1503,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when @DRUG1$ and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1504,
        "sentence": "Those anticonvulsants include @DRUG1$, @DRUG2$, and phenobarbital.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1505,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of @DRUG1$ and levonorgestrel, there is no evidence that @DRUG2$ is a net inducer of ethinyl estradiol or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1506,
        "sentence": "Interactions for Vitamin B2 (@DRUG1$):  @DRUG2$ - impairs the intestinal absorption of riboflavin",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1507,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG1$ (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1508,
        "sentence": "In female rats, neonatal quinpirole treatment enhanced amphetamine locomotor sensitization compared with @DRUG1$-free controls sensitized to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1509,
        "sentence": "Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of Ropivacaine, can interact with @DRUG1$ leading to increased @DRUG2$ plasma levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1510,
        "sentence": "This study examined drug-drug interactions of oral S-ketamine with the cytochrome P450 (CYP) 2B6 inhibitor @DRUG1$ and the CYP3A inhibitor @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1511,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-@DRUG1$    values within 48 hours after discontinuing Mexitil   . If @DRUG2$ and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1512,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some @DRUG1$, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that @DRUG2$ may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1513,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . Selective serotonin reuptake inhibitors (@DRUG2$) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1514,
        "sentence": "The effect of curcumin (100 mg/kg) was similar to that of @DRUG1$ and imipramine (p > 0.05) but its addition to fluoxetine and @DRUG2$ did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1515,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., @DRUG2$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1516,
        "sentence": "Thus, @DRUG1$ and @DRUG2$ should not be mixed and must be administered separately.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1517,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, @DRUG1$, @DRUG2$, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1518,
        "sentence": "Other @DRUG1$ Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of ZOLINZA and other HDAC inhibitors (e.g., @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1519,
        "sentence": "John   s Wort, and certain anticonvulsants (phenytoin, @DRUG1$, carbamazepine) may induce @DRUG2$ metabolism (lowering serum levels of mifepristone).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1520,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1521,
        "sentence": "Exert particular caution in combining levomepromazine with other @DRUG1$ (tricyclic antidepressants and @DRUG2$): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1522,
        "sentence": "In vitro studies with human liver microsomes showed that @DRUG1$ does not inhibit the metabolism of @DRUG2$, ethinylestradiol, ethoxycoumarin, and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1523,
        "sentence": "The CNS-depressant effect of @DRUG1$ is additive with that of other CNS depressants, including @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1524,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1525,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that @DRUG1$, such as the neuroleptics (phenothiazines, @DRUG2$, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1526,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1527,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG1$, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1528,
        "sentence": "@DRUG1$ users who initiated citalopram, fluoxetine, paroxetine, @DRUG2$, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1529,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1530,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG2$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1531,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1532,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (@DRUG2$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1533,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, amiloride) or potassium supplements concomitantly with @DRUG2$ can increase the risk of hyperkalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1534,
        "sentence": "@DRUG1$/Mycophenolate Mofetil: Given that @DRUG2$ and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1535,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral @DRUG1$, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, @DRUG2$, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1536,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, @DRUG2$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1537,
        "sentence": "In vitro activity of @DRUG1$ combined with @DRUG2$ against clinical isolates of methicillin-resistant Staphylococcus aureus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1538,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1539,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG1$ (n=21), @DRUG2$ (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1540,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1541,
        "sentence": "Results revealed that the strains were resistant to many drugs at high levels, only @DRUG1$, carbenicillin, amikacin and @DRUG2$ showed resistances at comparatively lower levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1542,
        "sentence": "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, @DRUG1$, @DRUG2$, and fentanyl, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1543,
        "sentence": "Male rats demonstrated sensitization to @DRUG1$, although this was muted compared with female rats, and were unaffected by neonatal @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1544,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1545,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1546,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1547,
        "sentence": "Patients receiving sirolimus or @DRUG1$ in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and @DRUG2$ or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1548,
        "sentence": "Use of @DRUG1$ (spironolactone, @DRUG2$, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1549,
        "sentence": "@DRUG1$, Carbamazepine, and @DRUG2$: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1550,
        "sentence": "Warfarin users who initiated citalopram, fluoxetine, @DRUG1$, amitriptyline, or @DRUG2$ had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1551,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1552,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1553,
        "sentence": "TOBI should not be administered concomitantly with @DRUG1$, @DRUG2$, urea, or mannitol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1554,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., @DRUG1$ and miconazole) or @DRUG2$ (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1555,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG1$) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1556,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain @DRUG1$) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1557,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), @DRUG2$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1558,
        "sentence": "Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, @DRUG1$, @DRUG2$ esters, and iron salts).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1559,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, @DRUG1$, glycopyrrolate, diazepam, hydroxyzine, and other @DRUG2$) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1560,
        "sentence": "@DRUG1$, theophylline, @DRUG2$, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1561,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1562,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG1$ or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1563,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1564,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG2$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1565,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1566,
        "sentence": "As there is in vitro evidence that @DRUG1$ (e.g., olsalazine, mesalazine, or @DRUG2$) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1567,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1568,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, @DRUG1$, and rifampicin), the clearance of ondansetron was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1569,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as @DRUG1$ (e.g., @DRUG2$ and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1570,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1571,
        "sentence": "In experiment 1, oral administration of @DRUG1$ at a dose of 5 mg/kg of BW for 7 d on the immune response in chickens intramuscularly injected with @DRUG2$ was evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1572,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1573,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1574,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or @DRUG1$-containing @DRUG2$, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1575,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG1$ ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1576,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG2$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1577,
        "sentence": "No significant adverse interactions with common premedications (such as @DRUG1$, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other @DRUG2$) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1578,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1579,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1580,
        "sentence": "We concluded that the combined administration of dexmedetomidine with @DRUG1$ may have beneficial effects in the treatment of pain without causing sedation, which limits the use of @DRUG2$ as an analgesic in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1581,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1582,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1583,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., @DRUG1$ and miconazole) or macrolide antibiotics (e.g., @DRUG2$ and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1584,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG1$ - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1585,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1586,
        "sentence": "@DRUG1$: @DRUG2$-induced hypokalemia can increase the sensitivity of the myocardium to digitalis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1587,
        "sentence": "If @DRUG1$, which are metabolized by the cytochrome P450 system, are concomitantly administered with fluconazole, consideration should be given to decreasing the @DRUG2$ dosage, and the patients should be appropriately monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1588,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1589,
        "sentence": "Neuromuscular blocking agents (such as @DRUG1$): Concurrent use of @DRUG2$ and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1590,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - @DRUG1$: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - @DRUG2$: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1591,
        "sentence": "@DRUG1$: In 12 normal-weight subjects, administration of @DRUG2$ 120 mg three times a day for 16 days did not result in any change in either warfarin pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1592,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1593,
        "sentence": "Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, @DRUG1$ did not alter the bioavailability of @DRUG2$ (extended-release tablets).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1594,
        "sentence": "@DRUG1$ had a limited effect and @DRUG2$ was ineffective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1595,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, @DRUG2$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1596,
        "sentence": "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of @DRUG1$ and @DRUG2$ following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1597,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, @DRUG1$, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1598,
        "sentence": "Furafylline and @DRUG1$ had no effect, while quinidine appeared to augment @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1599,
        "sentence": "Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1600,
        "sentence": "Concurrent ingestion of @DRUG1$ (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1601,
        "sentence": "however, in patients with Paget's Disease prior @DRUG1$ use appears to reduce the anti-resorptive response to @DRUG2$ nasal spray.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1602,
        "sentence": "The objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (@DRUG1$) on the humoral immune responses of chickens to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1603,
        "sentence": "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with @DRUG1$, @DRUG2$, erythromycin and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1604,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG1$, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1605,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG1$ (i.e., pentazocine, @DRUG2$, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1606,
        "sentence": "Pindolol has been used with a variety of @DRUG1$, including hydrochlorothiazide, hydralazine, and @DRUG2$ without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1607,
        "sentence": "@DRUG1$ and/or stimulantes of the ephedrine/@DRUG2$ type may counteract the specific actions of levomepromazine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1608,
        "sentence": "Patients studied in clinical trials of @DRUG1$ were routinely treated with @DRUG2$ and aspirin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1609,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1610,
        "sentence": "@DRUG1$: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1611,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1612,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1613,
        "sentence": "In addition, @DRUG1$ insensitivity might be associated with overexpression of Bcl-2, and the combination of ABT-737 and @DRUG2$ could synergistically induced apoptosis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1614,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, @DRUG2$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1615,
        "sentence": "The siRNA knockdown of p27(Kip1) decreased @DRUG1$- and @DRUG2$-induced apoptosis compared with a negative control siRNA (sub-G1 fraction, control siRNA vs. p27(Kip1) siRNA: 42.5% vs. 20.1%, difference = 22.4%, 95% CI = 20.1% to 24.7%, P = .017).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1616,
        "sentence": "@DRUG1$ tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in @DRUG2$ and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1617,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and @DRUG2$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1618,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG1$ (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1619,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG1$, sirolimus, nifedipine, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1620,
        "sentence": "In vitro studies show that @DRUG1$ does not displace @DRUG2$ from its binding site on protein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1621,
        "sentence": "Concomitant administration of @DRUG1$ with clarithromycin, erythromycin, or @DRUG2$ is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1622,
        "sentence": "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with @DRUG1$ for breast cancer, especially SSRI antidepressants such as paroxetine and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1623,
        "sentence": "The finding that @DRUG1$ releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1624,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1625,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1626,
        "sentence": "Use of @DRUG1$ (spironolactone, amiloride, @DRUG2$ and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1627,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (@DRUG2$) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1628,
        "sentence": "Lithium: Increased serum @DRUG1$ levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1629,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as @DRUG1$ (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and @DRUG2$), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1630,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1631,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, @DRUG1$, @DRUG2$, polymyxin B, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1632,
        "sentence": "Triprolidine may enhance the sedative effects of @DRUG1$ including alcohol, barbiturates, hypnotics, @DRUG2$, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1633,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, @DRUG1$, clarithromycin) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1634,
        "sentence": "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and @DRUG1$ following administration of a single dose containing 1.0 mg of @DRUG2$ and 75    g of ethinyl estradiol were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1635,
        "sentence": "The bioavailability of SKELID is decreased 80% by @DRUG1$, when @DRUG2$ and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1636,
        "sentence": "The induction dose requirements of @DRUG1$ Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with @DRUG2$ (eg, morphine, meperidine, and fentanyl, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1637,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1638,
        "sentence": "A greater potentiation of the neuromuscular blocking effects of @DRUG1$ may be expected with higher concentrations of enflurane or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1639,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1640,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as @DRUG1$, aminoglycosides, @DRUG2$, polymyxin B, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1641,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as @DRUG1$, indomethacin, @DRUG2$, ibuprofen, diazepam, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1642,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1643,
        "sentence": "Considering the safety of @DRUG1$, because no adverse effect was found throughout the experiments, @DRUG2$ may be a promising oral adjuvant to improve immunization in poultry.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1644,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as @DRUG1$ (Marplan), @DRUG2$ (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1645,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1646,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain @DRUG2$, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1647,
        "sentence": "Evaluation of antidepressant like activity of @DRUG1$ and its combination with fluoxetine and @DRUG2$: an acute and chronic study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1648,
        "sentence": "@DRUG1$ may interact with aminoglutethimide or @DRUG2$ (causing too great a decrease in adrenal function).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1649,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG1$, pancuronium, morphine, @DRUG2$, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1650,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG1$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1651,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG1$, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1652,
        "sentence": "@DRUG1$ and dobutamine are incompatible with @DRUG2$ solution.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1653,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1654,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), @DRUG2$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1655,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG2$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1656,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1657,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, polymyxin B, colistin, @DRUG1$, or @DRUG2$, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1658,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with @DRUG1$ (PULMOZYME   , Genentech), (beta)-agonists, inhaled @DRUG2$, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1659,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG1$, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1660,
        "sentence": "Patients receiving sirolimus or @DRUG1$ in combination with MYCAMINE should be monitored for @DRUG2$ or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1661,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1662,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1663,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1664,
        "sentence": "@DRUG1$ tablets coadministered with ethinyl estradiol- and @DRUG2$-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1665,
        "sentence": "A pharmacokinetic study demonstrated that coadministration of @DRUG1$ and indinavir results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1666,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, @DRUG2$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1667,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1668,
        "sentence": "@DRUG1$ Supplements and Potassium-Sparing Diuretics: @DRUG2$    can increase serum potassium because it decreases aldosterone secretion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1669,
        "sentence": "@DRUG1$: Pretreatment for four days with @DRUG2$ significantly increased the clearance of meloxicam by 50%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1670,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1671,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1672,
        "sentence": "Given the primary CNS effects of paliperidone, @DRUG1$    should be used with caution in combination with other @DRUG2$ and alcohol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1673,
        "sentence": "Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral @DRUG1$ produced an overall mean increase in @DRUG2$ and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1674,
        "sentence": "@DRUG1$: Concurrent use of @DRUG2$ and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1675,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1676,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1677,
        "sentence": "The use of @DRUG1$ before @DRUG2$ to attenuate some of the side effects of succinylcholine has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1678,
        "sentence": "MAO Inhibitors - The pressor effect of @DRUG1$ is markedly potentiated in patients receiving @DRUG2$ (MAOI).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1679,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1680,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG2$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1681,
        "sentence": "Concomitant administration of terfenadine with @DRUG1$, erythromycin, or @DRUG2$ is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1682,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (Miochol) and @DRUG1$ (Carboptic, @DRUG2$) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1683,
        "sentence": "@DRUG1$ treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas @DRUG2$ treatment did not increase the exposure to S-ketamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1684,
        "sentence": "Less potent inhibitors include @DRUG1$, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1685,
        "sentence": "SKELAXIN may enhance the effects of alcohol, @DRUG1$ and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1686,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1687,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., @DRUG1$ and @DRUG2$) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1688,
        "sentence": "@DRUG1$ medications: Concurrent use of procaine hydrochloride and @DRUG2$ may result in additive depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1689,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG2$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1690,
        "sentence": "In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving @DRUG1$, treatment with PEG-Intron once weekly for 4 weeks was associated with a mean increase of 16% in @DRUG2$ AUC;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1691,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, erythromycin, or @DRUG1$ is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other @DRUG2$, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1692,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1693,
        "sentence": "Use with Other @DRUG1$: The depressant effects of @DRUG2$ are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1694,
        "sentence": "Dopamine antagonists, such as the @DRUG1$ (phenothiazines, @DRUG2$, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1695,
        "sentence": "@DRUG1$ - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1696,
        "sentence": "@DRUG1$, particularly @DRUG2$, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1697,
        "sentence": "Moxifloxacin and @DRUG1$ reacts faster with sucralfate and @DRUG2$ in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1698,
        "sentence": "During maintenance of anesthesia or sedation, the rate of DIPRIVAN Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental @DRUG1$ (eg, nitrous oxide or @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1699,
        "sentence": "No clinically significant changes to lamivudine or @DRUG1$ pharmacokinetics were observed following concomitant administration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1700,
        "sentence": "and combinations of opioids and sedatives (eg, benzodiazepines, @DRUG1$, @DRUG2$, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1701,
        "sentence": "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain @DRUG1$ (e.g. @DRUG2$ and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1702,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., @DRUG1$, tetracycline, levodopa, ethanol, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1703,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1704,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, @DRUG2$, vancomycin, metformin and tenofovir).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1705,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, triamterene, amiloride) or @DRUG2$ supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1706,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, @DRUG2$, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1707,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1708,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and @DRUG1$) or @DRUG2$ (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1709,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1710,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1711,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of @DRUG1$ on the plasma concentration of @DRUG2$/perindoprilat has not been excluded.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1712,
        "sentence": "Absorption of @DRUG1$ is impaired by antacids containing aluminum, @DRUG2$ or magnesium, and iron-containing preparations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1713,
        "sentence": "Drugs such as @DRUG1$ and @DRUG2$ may inhibit the metabolism of corticosteroids and thus decrease their clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1714,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and @DRUG1$) or macrolide antibiotics (e.g., @DRUG2$ and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1715,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, ketoconazole, @DRUG1$) were potent, non-competitive inhibitors of @DRUG2$ metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1716,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1717,
        "sentence": "Oral @DRUG1$ has been reported to potentiate the anticoagulant effect of coumarin and @DRUG2$, resulting in a prolongation of prothrombin time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1718,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG2$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1719,
        "sentence": "In an in vitro assay, @DRUG1$ induced HER2 expression at the cell surface of HER2-positive breast cancer cell lines, leading to the enhancement of @DRUG2$-mediated ADCC.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1720,
        "sentence": "Mean oxybutynin chloride plasma concentrations were approximately 2 fold higher when @DRUG1$ was administered with @DRUG2$, a potent CYP3A4 inhibitor.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1721,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, @DRUG1$, @DRUG2$, and macrolide antibiotics).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1722,
        "sentence": "Fluconazole tablets coadministered with @DRUG1$- and @DRUG2$-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1723,
        "sentence": "Caution should be exercised when Methergine    (@DRUG1$) is used concurrently with other @DRUG2$ or ergot alkaloids.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1724,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when @DRUG1$ is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1725,
        "sentence": "In humans, @DRUG1$, etoposide, and @DRUG2$ do not affect the pharmacokinetics of ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1726,
        "sentence": "Caution is advised for patients receiving high-dose @DRUG1$ and @DRUG2$ concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and carbonic anhydrase inhibitors.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1727,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG1$, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1728,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1729,
        "sentence": "If in certain cases, an antidepressant is considered necessary, it may be advisable to replace @DRUG1$ with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1730,
        "sentence": "@DRUG1$ has been used with a variety of antihypertensive agents, including @DRUG2$, hydralazine, and guanethidine without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1731,
        "sentence": "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of @DRUG1$ followed by sunitinib is superior to sunitinib followed by @DRUG2$ and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1732,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, @DRUG1$, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1733,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG1$, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1734,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG1$, primidone), phenylbutazone, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1735,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, @DRUG1$, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1736,
        "sentence": "In the absence of data regarding potential interaction between ALIMTA and @DRUG1$ with longer half-lives, all patients taking these @DRUG2$ should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1737,
        "sentence": "A variety of antiarrhythmics such as @DRUG1$ or @DRUG2$ were also added, sometimes with improved control of ventricular ectopy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1738,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, @DRUG1$, ephedrine, @DRUG2$ or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1739,
        "sentence": "Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as @DRUG1$) and agents that slow the intestinal absorption of nutrients (e.g., @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1740,
        "sentence": "Accordingly, patients should be advised to avoid alcohol while taking @DRUG1$. Diazepam: Concomitant administration of @DRUG2$ (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1741,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with @DRUG2$ (a dopamine agonist);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1742,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since @DRUG2$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1743,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1744,
        "sentence": "@DRUG1$/Levodopa: @DRUG2$/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1745,
        "sentence": "Use with Cholinomimetics and Other @DRUG1$: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar @DRUG2$ or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1746,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1747,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1748,
        "sentence": "@DRUG1$ may decrease bioavailability of @DRUG2$ by up to 50% when taken 2 hours after SKELID.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1749,
        "sentence": "Both @DRUG1$/ganciclovir and @DRUG2$ concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1750,
        "sentence": "Patients with mild to moderate renal insufficiency should avoid taking @DRUG1$ with short elimination half-lives for a period of 2 days before, the day of, and 2 days following administration of @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1751,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG1$, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1752,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, @DRUG2$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1753,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when @DRUG1$ was co-administered with atorvastatin, simvastatin, pravastatin, @DRUG2$, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1754,
        "sentence": "Additive sedative effects and confusional states may emerge if @DRUG1$ is given with benzodiazepines or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1755,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1756,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some @DRUG1$, warfarin, certain heart medicines, birth control pills, anti-infective medicines, @DRUG2$ and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1757,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, erythromycin, or @DRUG1$ is contraindicated: Pending full characterization of potential interactions, concomitant administration of @DRUG2$ with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1758,
        "sentence": "@DRUG1$    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, digoxin, oral @DRUG2$, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1759,
        "sentence": "HEY cells treated with @DRUG1$ plus @DRUG2$ formed fewer colonies than did cells treated with either agent alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1760,
        "sentence": "In adult diabetic patients under treatment with either sulfonylureas or @DRUG1$ there is no change in the clinical effects of either @DRUG2$ or the hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1761,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ (equivalent to 60 g) had a minimal effect on plasma levels of mirtazapine (15 mg) in 6 healthy male subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1762,
        "sentence": "While co-administration of @DRUG1$    appeared to increase the clearance of Cerezyme by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1763,
        "sentence": "@DRUG1$ plasma concentration was also increased when it was administered with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1764,
        "sentence": "In a study conducted in healthy subjects, mean pre-dose @DRUG1$ concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with @DRUG2$ 15 mg QD as compared to subjects receiving lithium alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1765,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the @DRUG1$ virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - @DRUG2$: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1766,
        "sentence": "Such occurrences have been reported when @DRUG1$ was administered to patients on antidepressants, @DRUG2$, or warfarin-like drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1767,
        "sentence": "Phenytoin, @DRUG1$, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, @DRUG2$, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1768,
        "sentence": "@DRUG1$ was administered as @DRUG2$ in all studies and minerals were ingested on an empty stomach.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1769,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG2$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1770,
        "sentence": "@DRUG1$ should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, tranquilizers, or @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1771,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1772,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1773,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG1$ (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1774,
        "sentence": "Displacement of @DRUG1$ from plasma protein binding sites will elevate the level of free @DRUG2$ in the serum.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1775,
        "sentence": "Anticoagulation and @DRUG1$ After Treatment for Myocardial Infarction -- In the treatment of acute myocardial infarction, the use of @DRUG2$ has been shown to reduce the incidence of reinfarction and stroke.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1776,
        "sentence": "and combinations of @DRUG1$ and sedatives (eg, benzodiazepines, @DRUG2$, chloral hydrate, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1777,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of @DRUG1$ (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1778,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1779,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (Miochol) and @DRUG1$ (Carboptic, Isopto Carbachol) may decrease the effects of @DRUG2$ ophthalmic.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1780,
        "sentence": "Use of @DRUG1$ (@DRUG2$, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1781,
        "sentence": "Coadministration with a high dose of @DRUG1$ (170 mEq) results in a 28% decrease in plasma concentrations of @DRUG2$ and may decrease plasma concentrations of bismuth from TRITEC.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1782,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and @DRUG1$ inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1783,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG1$), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1784,
        "sentence": "Use with @DRUG1$ and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar @DRUG2$ or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1785,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1786,
        "sentence": "The effects of anticholinergic drugs, such as @DRUG1$ and @DRUG2$ may be enhanced by the concomitant administration of triprolidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1787,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG1$ (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1788,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1789,
        "sentence": "@DRUG1$: When studied in stable renal transplant patients, @DRUG2$, USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of Myfortic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1790,
        "sentence": "In the absence of data regarding potential interaction between @DRUG1$ and NSAIDs with longer half-lives, all patients taking these @DRUG2$ should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1791,
        "sentence": "When @DRUG1$ or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered @DRUG2$    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1792,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG1$ or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1793,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG1$ (i.e., pentazocine, nalbuphine, @DRUG2$, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1794,
        "sentence": "Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1795,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of @DRUG1$ and @DRUG2$, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1796,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1797,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG2$, pancuronium, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1798,
        "sentence": "@DRUG1$ has been used concurrently with antihypertensive drugs, beta blockers, @DRUG2$, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1799,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, @DRUG2$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1800,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1801,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG1$, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1802,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1803,
        "sentence": "Those @DRUG1$ include divalproex sodium, valproic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1804,
        "sentence": "Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and @DRUG1$ and @DRUG2$ and ELDEPRYL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1805,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1806,
        "sentence": "@DRUG1$ has been studied on a background of aspirin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1807,
        "sentence": "- Cisapride, @DRUG1$: Other drugs such as cisapride or @DRUG2$, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1808,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1809,
        "sentence": "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of @DRUG1$, @DRUG2$ and sulfamethizole displaced protein-bound teniposide in fresh human serum to a small but significant extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1810,
        "sentence": "A controlled study found that concomitant @DRUG1$ 200 mg once daily and cisapride 20 mg four times a day yielded a significant increase in @DRUG2$ plasma levels and prolongation of QTc interval.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1811,
        "sentence": "@DRUG1$ should be used with caution in patients receiving other local anesthetics or agents structurally related to @DRUG2$, since the toxic effects of these drugs are additive.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1812,
        "sentence": "Antacids: Absorption of a single dose of @DRUG1$ was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing @DRUG2$ (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1813,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1814,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, @DRUG1$, @DRUG2$, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1815,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1816,
        "sentence": "norepinephrine and @DRUG1$ are incompatible with @DRUG2$ solution.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1817,
        "sentence": "Metopirone inhibits the glucuronidation of @DRUG1$ and could possibly potentiate @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1818,
        "sentence": "@DRUG1$ and Other Non-Steroidal Anti-Inflammatory Drugs: May decrease the antihypertensive effects of @DRUG2$ Tablets.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1819,
        "sentence": "@DRUG1$: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1820,
        "sentence": "In the treatment of acute MI, @DRUG1$, when not otherwise contraindicated, should be administered with @DRUG2$ ( see below ).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1821,
        "sentence": "The CNS depressant effects of @DRUG1$ may be additive with that of other @DRUG2$..",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1822,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1823,
        "sentence": "Coadministration of a selective and potent inhibitor of CYP3A4, @DRUG1$ (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1824,
        "sentence": "Moxifloxacin and Lomefloxacin reacts faster with @DRUG1$ and @DRUG2$ in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1825,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, @DRUG2$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1826,
        "sentence": "When @DRUG1$ is used with other @DRUG2$, potentiation of antihypertensive effect may occur.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1827,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1828,
        "sentence": "The concomitant use of other @DRUG1$ including @DRUG2$, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1829,
        "sentence": "A controlled study found that concomitant @DRUG1$ 200 mg once daily and @DRUG2$ 20 mg four times a day yielded a significant increase in cisapride plasma levels and prolongation of QTc interval.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1830,
        "sentence": "Due to the chemical similarity of other @DRUG1$ (including fluconazole, metronidazole, and miconazole) to @DRUG2$, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1831,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1832,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1833,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, griseofulvin, @DRUG2$, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1834,
        "sentence": "Anticholinesterases: Concurrent use of procaine hydrochloride and @DRUG1$ may result in increased systemic toxicity since @DRUG2$ inhibit the breakdown of procaine hydrochloride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1835,
        "sentence": "Since Celontin (methsuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of @DRUG2$ and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1836,
        "sentence": "John   s Wort, and certain @DRUG1$ (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1837,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and @DRUG1$) to ketoconazole, and @DRUG2$, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1838,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, @DRUG1$, and @DRUG2$), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1839,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1840,
        "sentence": "Possible interactions with drugs known to be metabolized by CYP1A2 via competitive inhibition such as @DRUG1$ and @DRUG2$ may also occur.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1841,
        "sentence": "Based on this experience, we suggest that low-dose ketamine added to @DRUG1$ may be associated with prevention of EA in children with a history of EA with @DRUG2$ TIVA.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1842,
        "sentence": "Alcohol, @DRUG1$, and @DRUG2$: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1843,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG1$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG2$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1844,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - @DRUG2$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1845,
        "sentence": "However, increased prothrombin time and bleeding have been reported in patients on concomitant @DRUG1$ and @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1846,
        "sentence": "The pressor response of @DRUG1$ may also be potentiated by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1847,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1848,
        "sentence": "Triprolidine may enhance the sedative effects of @DRUG1$ including alcohol, @DRUG2$, hypnotics, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1849,
        "sentence": "Therefore, caution should be exercised when administering @DRUG1$ to patients on @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1850,
        "sentence": "@DRUG1$: Population pharmacokinetic analysis suggests that @DRUG2$ is unlikely to alter the oral clearance of pramipexole (N= 54).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1851,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1852,
        "sentence": "Interactions for Vitamin B1 (Thiamine):  @DRUG1$, Oral Contraceptives, @DRUG2$, Tricyclic Antidepressants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1853,
        "sentence": "Rats treated with neonatal @DRUG1$ enhanced time spent in the amphetamine-paired context compared with @DRUG2$-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1854,
        "sentence": "@DRUG1$: There have been reports of uveitis in patients to whom @DRUG2$ and rifabutin were coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1855,
        "sentence": "and combinations of opioids and @DRUG1$ (eg, benzodiazepines, @DRUG2$, chloral hydrate, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1856,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1857,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1858,
        "sentence": "Pharmacokinetic properties of abacavir were not altered by the addition of either @DRUG1$ or @DRUG2$ or the combination of lamivudine and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1859,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on @DRUG1$, cyclosporine, tacrolimus, prednisolone, and @DRUG2$ pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1860,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1861,
        "sentence": "Based on in vitro P450 inhibition studies and the low systemic exposure observed following topical application of @DRUG1$, @DRUG2$ is unlikely to affect the metabolism of other P450 substrates.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1862,
        "sentence": "Lithium renal clearance is reduced by @DRUG1$, increasing the risk of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1863,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., @DRUG2$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1864,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that @DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1865,
        "sentence": "@DRUG1$ is not a substitute for @DRUG2$ for cardiovascular prophylaxis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1866,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1867,
        "sentence": "We elucidated the expression of HB-EGF in T-ALL cell lines, and evaluated the effect of @DRUG1$ on these cells alone or in combination with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1868,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, @DRUG2$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1869,
        "sentence": "Evidence of spontaneous recovery from @DRUG1$ should be observed before the administration of @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1870,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, meperidine and fentanyl), propofol, @DRUG2$, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1871,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (@DRUG2$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1872,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1873,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a @DRUG2$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1874,
        "sentence": "Methyldopa does not interfere with measurement of @DRUG1$ (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert @DRUG2$ to vanillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1875,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, @DRUG2$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1876,
        "sentence": "In addition to bleeding associated with heparin and @DRUG1$, drugs that alter platelet function (such as @DRUG2$, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1877,
        "sentence": "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (@DRUG1$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus @DRUG2$/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1878,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and @DRUG1$ are administered at the same time, and 60% by some aluminum- or @DRUG2$-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1879,
        "sentence": "Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, @DRUG1$ + @DRUG2$ vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1880,
        "sentence": "This study examined drug-drug interactions of oral @DRUG1$ with the cytochrome P450 (CYP) 2B6 inhibitor ticlopidine and the CYP3A inhibitor @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1881,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and @DRUG2$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1882,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1883,
        "sentence": "These data suggest that @DRUG1$ administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, @DRUG2$, anticonvulsants, cyclosporin).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1884,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, @DRUG1$, cisapride, @DRUG2$, and tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1885,
        "sentence": "@DRUG1$ should be administered with caution to patients being treated with @DRUG2$ or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1886,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), @DRUG2$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1887,
        "sentence": "There was no change in the plasma kinetics of @DRUG1$ when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1888,
        "sentence": "Mequitazine can interact with CNS depressant, @DRUG1$, TCA, MAOIs, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1889,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, @DRUG2$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1890,
        "sentence": "The effects of anti-parkinsonian drug @DRUG1$ [@DRUG2$] (10 mg/kg, p. o.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1891,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1892,
        "sentence": "Thalidomide has been reported to enhance the sedative activity of barbiturates, @DRUG1$, @DRUG2$, and reserpine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1893,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by @DRUG2$, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1894,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1895,
        "sentence": "and/or @DRUG1$ doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (@DRUG2$) (4 x 20 mg/kg, i. p.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1896,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1897,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1898,
        "sentence": "The ratio of @DRUG1$ AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the @DRUG2$ (P &lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1899,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG1$ - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1900,
        "sentence": "Effect of @DRUG1$-mediated CYP3A4 inhibition on clinical pharmacokinetics of @DRUG2$ (LBH589), an orally active histone deacetylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1901,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between @DRUG1$ and @DRUG2$ has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1902,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG2$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1903,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1904,
        "sentence": "@DRUG1$: In healthy volunteers (N= 11), selegiline did not influence the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1905,
        "sentence": "as well as @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1906,
        "sentence": "@DRUG1$ and/or stimulantes of the @DRUG2$/amphetamine type may counteract the specific actions of levomepromazine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1907,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1908,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), @DRUG2$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1909,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when @DRUG1$ was co-administered with atorvastatin, simvastatin, @DRUG2$, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1910,
        "sentence": "In clinical studies of @DRUG1$, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled @DRUG2$, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1911,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and @DRUG1$), @DRUG2$, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1912,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1913,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 1914,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, @DRUG1$, @DRUG2$, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1915,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral @DRUG2$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1916,
        "sentence": "@DRUG1$: @DRUG2$ may increase the diffusion rate of procaine hydrochloride, resulting in a decreased time of onset, but an increase in systemic toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1917,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1918,
        "sentence": "@DRUG1$: Concomitant administration of aspirin (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1919,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, @DRUG2$, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1920,
        "sentence": "@DRUG1$ may antagonize the effects of drugs that alter gastrointestinal motility, such as @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1921,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, @DRUG1$, @DRUG2$ and etoposide   celecoxib following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1922,
        "sentence": "Drugs such as @DRUG1$, diltiazem, verapamil, @DRUG2$, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1923,
        "sentence": "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of @DRUG1$ followed by sunitinib is superior to @DRUG2$ followed by docetaxel and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1924,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-@DRUG1$    values within 48 hours after discontinuing @DRUG2$   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1925,
        "sentence": "Use of Anticoagulants and @DRUG1$ -- @DRUG2$, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1926,
        "sentence": "The effect of orlistat on the absorption of supplemental @DRUG1$, vitamin A, and nutritionally-derived @DRUG2$ is not known at this time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1927,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1928,
        "sentence": "We concluded that the combined administration of dexmedetomidine with @DRUG1$ may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an @DRUG2$ in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1929,
        "sentence": "In vitro studies with human liver microsomes showed that @DRUG1$ does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1930,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1931,
        "sentence": "Laboratory Tests There have been reports of false-positive urine screening tests for tetrahydrocannabinol (@DRUG1$) in patients receiving most @DRUG2$, including pantoprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1932,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1933,
        "sentence": "@DRUG1$ at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing @DRUG2$ 1 mg/ethinyl estradiol 35 mcg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1934,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1935,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG1$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1936,
        "sentence": "Less potent inhibitors include @DRUG1$, @DRUG2$, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1937,
        "sentence": "Diuretics: @DRUG1$ and probably other loop diuretics given concomitantly with @DRUG2$ can cause unusually large or prolonged losses of fluid and electrolytes.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1938,
        "sentence": "In a study of 11 HIV-infected patients receiving @DRUG1$-maintenance therapy (40 mg and 90 mg daily) with 600 mg of @DRUG2$ twice daily (twice the currently recommended dose), oral methadone clearance increased 22% (90% CI 6% to 42%).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1939,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG1$ (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1940,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1941,
        "sentence": "DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with @DRUG1$ are not recommended in immunocompromised individuals  @DRUG2$ together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1942,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on @DRUG1$, cyclosporine, @DRUG2$, prednisolone, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1943,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1944,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1945,
        "sentence": "Anticoagulants (such as heparin and @DRUG1$) and drugs that alter platelet function (such as @DRUG2$, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1946,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1947,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including @DRUG1$, @DRUG2$, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1948,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, @DRUG1$, and @DRUG2$) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1949,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1950,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain @DRUG1$) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered @DRUG2$ or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1951,
        "sentence": "Use with Cholinomimetics and Other @DRUG1$: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1952,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If @DRUG1$ and theophylline are to be used concurrently, @DRUG2$ blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1953,
        "sentence": "To minimize CNS depression and possible potentiation, barbiturates, @DRUG1$, narcotics, @DRUG2$ or phenothiazines should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1954,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with @DRUG1$, diuretics, @DRUG2$, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1955,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1956,
        "sentence": "Concurrent use of @DRUG1$ and other CNS depression-producing drugs may increase the CNS depressant effects of @DRUG2$ or these other medications.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1957,
        "sentence": "morphine, theophylline, aminophylline, succinylcholine, @DRUG1$, and @DRUG2$ should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1958,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, @DRUG2$, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1959,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1960,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1961,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG1$, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1962,
        "sentence": "Concomitant administration of @DRUG1$ with @DRUG2$ results in increased plasma levels of both drugs.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1963,
        "sentence": "Laboratory Tests There have been reports of false-positive urine screening tests for tetrahydrocannabinol (THC) in patients receiving most @DRUG1$, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1964,
        "sentence": "Coadministration with @DRUG1$ results in a slight decrease in the rate of @DRUG2$ absorption that is clinically unimportant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1965,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1966,
        "sentence": "@DRUG1$: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, @DRUG2$, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1967,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., @DRUG2$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1968,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1969,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1970,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing @DRUG1$, magnesium hydroxide, and simethicone) did not significantly affect the exposure of @DRUG2$ or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1971,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, @DRUG2$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1972,
        "sentence": "Concurrent use of @DRUG1$ with @DRUG2$ or other CNS depressants can increase their sedative effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1973,
        "sentence": "However, the impairment of cognitive and motor skills produced by @DRUG1$    were shown to be additive with those produced by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1974,
        "sentence": "@DRUG1$ and Drugs that Bind Bile Acids: These drugs interrupt enterohepatic recirculation and reduce MPA exposure when coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1975,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1976,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, @DRUG1$, thiazide diuretics, @DRUG2$, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1977,
        "sentence": "@DRUG1$: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when @DRUG2$ was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1978,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1979,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1980,
        "sentence": "It will compete with clopidogrel (@DRUG1$) and prasugrel (@DRUG2$) for such use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1981,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1982,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1983,
        "sentence": "Therefore, do not administer Myfortic with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral @DRUG1$, because of the potential to reduce the efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1984,
        "sentence": "The effect of @DRUG1$ (100 mg/kg) was similar to that of fluoxetine and @DRUG2$ (p > 0.05) but its addition to fluoxetine and imipramine did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1985,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, @DRUG2$, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1986,
        "sentence": "@DRUG1$    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, @DRUG2$, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1987,
        "sentence": "@DRUG1$ reduces the metabolism of tolbutamide, glyburide, and @DRUG2$ and increases the plasma concentration of these agents.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 1988,
        "sentence": "Thalidomide has been reported to enhance the sedative activity of @DRUG1$, alcohol, @DRUG2$, and reserpine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1989,
        "sentence": "There is usually complete cross-resistance between PURINETHOL (mercaptopurine) and @DRUG1$ brand @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1990,
        "sentence": "Patients treated with @DRUG1$ and @DRUG2$ concomitantly should be monitored for increases in INR and prothrombin time.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1991,
        "sentence": "@DRUG1$: Concomitant administration of alcohol (equivalent to 60 g) had a minimal effect on plasma levels of @DRUG2$ (15 mg) in 6 healthy male subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1992,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1993,
        "sentence": "We present an interesting case of an HIV-positive woman on @DRUG1$ therapy having tubal pregnancies on two separate occasions with @DRUG2$ in place.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 1994,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG1$, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1995,
        "sentence": "During maintenance of anesthesia or sedation, the rate of @DRUG1$ Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental @DRUG2$ (eg, nitrous oxide or opioids).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 1996,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., @DRUG1$, pseudoephedrine, ephedrine, phenylpropanolamine or @DRUG2$) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1997,
        "sentence": "@DRUG1$: Concurrent use of procaine hydrochloride and sulfonamides may result in a reduction of the antibacterial action of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1998,
        "sentence": "Phenytoin, @DRUG1$, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG2$, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 1999,
        "sentence": "Exert particular caution in combining @DRUG1$ with other anticholinergic drugs (@DRUG2$ and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2000,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral @DRUG1$, glucocorticoids, or certain @DRUG2$) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2001,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of @DRUG1$ has no effect on piroxicam plasma levels . @DRUG2$, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2002,
        "sentence": "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, @DRUG1$ (SSRIs), and @DRUG2$, if they have a narrow therapeutic window.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2003,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2004,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, @DRUG2$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2005,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2006,
        "sentence": "Mitotane has been reported to accelerate the metabolism of @DRUG1$ by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2007,
        "sentence": "Although this has not occurred in in vitro studies with @DRUG1$, interactions with @DRUG2$ have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2008,
        "sentence": "Dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, @DRUG2$ ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2009,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG1$) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2010,
        "sentence": "The effect of orlistat on the absorption of supplemental vitamin D, @DRUG1$, and nutritionally-derived @DRUG2$ is not known at this time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2011,
        "sentence": "@DRUG1$: A controlled pharmacokinetic study has shown no effect on plasma @DRUG2$ concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2012,
        "sentence": "The effects of anticholinergic drugs, such as atropine and @DRUG1$ may be enhanced by the concomitant administration of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2013,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG1$, @DRUG2$, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2014,
        "sentence": "The FDA has approved @DRUG1$ (Brilinta-AstraZeneca), an oral antiplatelet drug, for use with low-dose @DRUG2$ to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2015,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2016,
        "sentence": "Caution should be exercised when @DRUG1$    (@DRUG2$) is used concurrently with other vasoconstrictors or ergot alkaloids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2017,
        "sentence": "@DRUG1$ - The pressor effect of @DRUG2$ is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2018,
        "sentence": "These medications included thyroid hormones, sedative hypnotics, @DRUG1$, @DRUG2$, and decongestants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2019,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2020,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2021,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2022,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2023,
        "sentence": "This study was aimed to investigate the efficacy of single use of sunitinib and that of concurrent or sequential administration of @DRUG1$ and @DRUG2$ in NSCLC cell lines that are resistant to EGFR TKIs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2024,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG1$ (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2025,
        "sentence": "Vasopressors, particularly @DRUG1$, may cause serious cardiac arrhythmias during @DRUG2$ anesthesia and therefore should be used only with great caution or not at all.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2026,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2027,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2028,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2029,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by @DRUG1$, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., @DRUG2$, tetracycline, levodopa, ethanol, cyclosporine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2030,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, @DRUG2$, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2031,
        "sentence": "Cholestyramine: Concomitant @DRUG1$ administration decreased the mean AUC of total @DRUG2$ approximately 55%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2032,
        "sentence": "Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and ELDEPRYL and @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2033,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2034,
        "sentence": "@DRUG1$: Absorption of a single dose of @DRUG2$ was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2035,
        "sentence": "Combination therapy with @DRUG1$    (@DRUG2$) and ZAVESCA    is not indicated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2036,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2037,
        "sentence": "@DRUG1$ can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - @DRUG2$: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2038,
        "sentence": "Caution is advised for patients receiving high-dose aspirin and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2039,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including @DRUG1$, barbiturates, hypnotics, @DRUG2$, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2040,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, @DRUG1$, @DRUG2$, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2041,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG1$ - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2042,
        "sentence": "Our objective was to establish potential effects of @DRUG1$ on absorption of @DRUG2$ and the dose response for this effect in the absence of a meal.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2043,
        "sentence": "@DRUG1$ containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including @DRUG2$, hyaluronan lyase, heparinase III, or chondroitin ABC lyase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2044,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, @DRUG2$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2045,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG1$, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2046,
        "sentence": "Oral @DRUG1$ has been reported to potentiate the anticoagulant effect of @DRUG2$ and warfarin, resulting in a prolongation of prothrombin time.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2047,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, @DRUG1$, @DRUG2$, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2048,
        "sentence": "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of norethindrone and @DRUG1$ following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of @DRUG2$ were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2049,
        "sentence": "Concurrent use of @DRUG1$ with oral @DRUG2$ may render oral contraceptives less effective.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2050,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, @DRUG1$, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2051,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG1$ with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2052,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG1$ (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2053,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG2$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2054,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, @DRUG1$, ephedrine, phenylpropanolamine or @DRUG2$) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2055,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2056,
        "sentence": "When administered concomitantly with @DRUG1$   , @DRUG2$ may enhance or precipitate bradycardia, A.V.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2057,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other @DRUG2$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2058,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing @DRUG2$, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2059,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG2$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2060,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - @DRUG1$: can increase seizure activity - @DRUG2$: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2061,
        "sentence": "@DRUG1$: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in @DRUG2$ half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2062,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG1$, pancuronium, @DRUG2$, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2063,
        "sentence": "In conclusion, we demonstrated an isolated effect of calcium (as chloride) on absorption of 5 mg of iron provided as @DRUG-DRUG$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2064,
        "sentence": "@DRUG1$ may increase the clearance of chronic high dose @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2065,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2066,
        "sentence": "@DRUG1$ may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, @DRUG2$ and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2067,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, @DRUG1$, butorphanol, or @DRUG2$) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2068,
        "sentence": "- @DRUG1$, @DRUG2$: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2069,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or @DRUG1$ (eg, erythromycin, clarithromycin) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2070,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2071,
        "sentence": "Cholestyramine: @DRUG1$ causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2072,
        "sentence": "There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral @DRUG1$ and warfarin, however, a causal relationship between @DRUG2$    Tablets and these changes has not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2073,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG1$, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2074,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, prednisolone, oral @DRUG2$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2075,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2076,
        "sentence": "As there is in vitro evidence that aminosalicylate derivatives (e.g., @DRUG1$, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent @DRUG2$ therapy.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2077,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2078,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, @DRUG1$, morphine, @DRUG2$, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2079,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, @DRUG2$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2080,
        "sentence": "@DRUG1$ at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral @DRUG2$ containing norethindrone 1 mg/ethinyl estradiol 35 mcg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2081,
        "sentence": "Although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with @DRUG1$ with and without anticoagulants or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2082,
        "sentence": "The data presently available indicate that the decreases in some individual @DRUG1$ and levonorgestrel AUC values with @DRUG2$ treatment are likely the result of random variation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2083,
        "sentence": "Less potent inhibitors include saquinavir, @DRUG1$, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2084,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG1$, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2085,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2086,
        "sentence": "Macrolides: Clinical drug interaction studies indicate that @DRUG1$ and @DRUG2$ can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2087,
        "sentence": "Since @DRUG1$ (methsuximide) may interact with concurrently administered @DRUG2$, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2088,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (@DRUG1$   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2089,
        "sentence": "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, sodium salicylate and @DRUG1$ displaced protein-bound @DRUG2$ in fresh human serum to a small but significant extent.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2090,
        "sentence": "Because @DRUG1$ exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., @DRUG2$, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2091,
        "sentence": "Interactions for Vitamin B1 (Thiamine):  Loop Diuretics, Oral @DRUG1$, Stavudine, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2092,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2093,
        "sentence": "Drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and @DRUG1$ were shown to significantly increase the C max and AUC of orally administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2094,
        "sentence": "@DRUG1$: A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of meloxicam on the pharmacokinetics of @DRUG2$ taken once weekly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2095,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2096,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and @DRUG1$), the clearance of @DRUG2$ was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2097,
        "sentence": "@DRUG1$ and Lomefloxacin reacts faster with @DRUG2$ and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2098,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (@DRUG1$ 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (@DRUG2$ 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2099,
        "sentence": "In a large compassionate use program @DRUG1$    has been used concurrently with commonly employed antianginal, @DRUG2$, and anticoagulant drugs without observed interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2100,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2101,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG1$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2102,
        "sentence": "Live Vaccines: During treatment with @DRUG1$, the use of @DRUG2$ should be avoided and patients should be advised that vaccinations may be less effective.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2103,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2104,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, @DRUG2$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2105,
        "sentence": "Concomitant administration of terfenadine with @DRUG1$, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of @DRUG2$ with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2106,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG1$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2107,
        "sentence": "Anticholinesterases: Concurrent use of procaine hydrochloride and @DRUG1$ may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2108,
        "sentence": "@DRUG1$, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2109,
        "sentence": "Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. @DRUG1$: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of @DRUG2$ (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2110,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2111,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG1$, phenytoin, sulfinpyrazone, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2112,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2113,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG1$, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2114,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2115,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when @DRUG1$ is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, @DRUG2$, calcium channel antagonists, and macrolide antibiotics).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2116,
        "sentence": "Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as @DRUG1$, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2117,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with @DRUG1$ (3900 mg/day), but concomitant administration of @DRUG2$ has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2118,
        "sentence": "@DRUG1$: Concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2119,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, @DRUG1$, other opioids, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2120,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2121,
        "sentence": "2 - 4 The following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of @DRUG1$: since @DRUG2$ are potentiated by the anticholinesterases, they should be used cautiously in the treatment of convulsions;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2122,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when @DRUG1$ are given concurrently with succinylcholine, similar neuromuscular blocking agents or @DRUG2$ such as bethanechol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2123,
        "sentence": "Less potent inhibitors include @DRUG1$, nefazodone, @DRUG2$, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2124,
        "sentence": "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and @DRUG1$) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and @DRUG2$) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2125,
        "sentence": "Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with @DRUG1$, resulted in a mean increase in @DRUG2$ half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2126,
        "sentence": "@DRUG1$ does not interfere with measurement of @DRUG2$ (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert VMA to vanillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2127,
        "sentence": "Isoflurane and @DRUG1$ (administered with nitrous oxide/@DRUG2$ to achieve 1.25 M.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2128,
        "sentence": "These results suggest that rat liver slices do not reproduce the reported in vivo biotransformation of @DRUG1$ and therefore may not be an appropriate model for @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2129,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, @DRUG2$, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2130,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, @DRUG1$, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2131,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some @DRUG1$, warfarin, certain heart medicines, birth control pills, @DRUG2$, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2132,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2133,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2134,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - @DRUG1$: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2135,
        "sentence": "Rats treated with neonatal @DRUG1$ enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with @DRUG2$, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2136,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, @DRUG2$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2137,
        "sentence": "@DRUG1$ has been used with a variety of @DRUG2$, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2138,
        "sentence": "Caution is advised for patients receiving high-dose aspirin and @DRUG1$ concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2139,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG1$, sirolimus, nifedipine, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2140,
        "sentence": "Acyclovir/@DRUG1$: may be taken with @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2141,
        "sentence": "@DRUG1$: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving @DRUG2$ concomitantly with coumarin-derivative anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2142,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG1$) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2143,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG1$, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2144,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when @DRUG1$ is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of @DRUG2$, protease inhibitors, calcium channel antagonists, and macrolide antibiotics).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2145,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG1$, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2146,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG1$ salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2147,
        "sentence": "@DRUG1$ may enhance the effects of alcohol, barbiturates and other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2148,
        "sentence": "Drugs such as @DRUG1$ and ketoconazole may inhibit the metabolism of @DRUG2$ and thus decrease their clearance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2149,
        "sentence": "When phenytoin or other hepatic enzyme inducers such as @DRUG1$ and @DRUG2$ have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2150,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG1$, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2151,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG2$, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2152,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, @DRUG1$, hypnotics, @DRUG2$, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2153,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, @DRUG1$, levodopa, @DRUG2$, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2154,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin, and rifampin may increase the clearance of methylprednisolone and may require increased in @DRUG2$ dose to achieve the desired response.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2155,
        "sentence": "convulsions have been reported with concurrent use of @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2156,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2157,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2158,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG2$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2159,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, erythromycin, or @DRUG1$ is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including @DRUG2$, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2160,
        "sentence": "@DRUG1$ may increase the effects of barbiturates, @DRUG2$, and uricosurics.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2161,
        "sentence": "@DRUG1$: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of digoxin with the co-administration of 100 mg @DRUG2$ for 10 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2162,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG1$, carbamazepine, rifampin, rifabutin, @DRUG2$, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2163,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (Carboptic, @DRUG1$) may decrease the effects of @DRUG2$ ophthalmic.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2164,
        "sentence": "Pyrimethamine may be used with @DRUG1$, quinine and other antimalarials, and with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2165,
        "sentence": "@DRUG1$, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the @DRUG2$ metabolic clearance rate by 30%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2166,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG1$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2167,
        "sentence": "Concurrent use with vasoconstrictor agents including @DRUG1$, sumatriptan, and @DRUG2$ (e.g. smoking) may result in enhanced vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2168,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (@DRUG2$), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2169,
        "sentence": "@DRUG1$ may interact with the following drugs: @DRUG2$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2170,
        "sentence": "Patients receiving sirolimus or @DRUG1$ in combination with @DRUG2$ should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2171,
        "sentence": "@DRUG1$ and beta adrenergic blockers increase the effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2172,
        "sentence": "But the use of fixed combination @DRUG1$/@DRUG2$ compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2173,
        "sentence": "Other @DRUG1$ Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of @DRUG2$ and other HDAC inhibitors (e.g., valproic acid).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2174,
        "sentence": "Dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with @DRUG2$ (a dopamine agonist);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2175,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2176,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., @DRUG2$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2177,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of @DRUG1$ and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of @DRUG2$ pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2178,
        "sentence": "@DRUG1$ or @DRUG2$ may potentiate the action of sympathomimetic amines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2179,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2180,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2181,
        "sentence": "Phenobarbital, which induces hepatic metabolism, decreased the AUC of @DRUG1$ approximately 40% following a single 10-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2182,
        "sentence": "Sympathomimetics may reduce the antihypertensive effects of methyldopa, @DRUG1$, @DRUG2$ and veratrum alkaloids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2183,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2184,
        "sentence": "Because @DRUG1$ exhibits some monoamine oxidase inhibitory activity, @DRUG2$, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2185,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, @DRUG2$, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2186,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and @DRUG1$ are administered at the same time, and 60% by some @DRUG2$- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2187,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2188,
        "sentence": "@DRUG1$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing MOBIC therapy in patients receiving @DRUG2$ or similar agents, since these patients are at an increased risk of bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2189,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2190,
        "sentence": "Potassium Supplements and @DRUG1$: @DRUG2$    Tablets may increase serum potassium because of its potential to decrease aldosterone production.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2191,
        "sentence": "The addition of @DRUG1$ or @DRUG2$ greatly enhanced transduction of the retinal ganglion cell layer and increased the depth of transduction into the outer retina.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2192,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2193,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, tranquilizers, general anesthetics, phenothiazines, other opioids, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2194,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, @DRUG1$, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2195,
        "sentence": "No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of @DRUG1$, inhalational agents, analgesic agents, and local @DRUG2$) have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2196,
        "sentence": "Although @DRUG1$ (400 mg qid) can be administered with @DRUG2$ in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2197,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or @DRUG1$ toxicity and sirolimus or @DRUG2$ dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2198,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG2$ and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2199,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2200,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral @DRUG1$ (norethindrone 1 mg/@DRUG2$ 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2201,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, @DRUG2$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2202,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2203,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2204,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when @DRUG1$ are given concurrently with @DRUG2$, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2205,
        "sentence": "Use of @DRUG1$ (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2206,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2207,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2208,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2209,
        "sentence": "Patients receiving @DRUG1$ and sulfonamides generally should not be treated with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2210,
        "sentence": "However, the extent of biotransformation of @DRUG1$ to the active metabolite, @DRUG2$, is reduced approximately 43%, resulting in a reduction in the plasma ACE inhibition curve of approximately 20%, probably clinically insignificant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2211,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG1$, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2212,
        "sentence": "Cyclosporine: Preliminary data from a @DRUG1$ and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when @DRUG2$ was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2213,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG2$, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2214,
        "sentence": "Itraconazole: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and @DRUG1$ in clinical trials of @DRUG2$ and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2215,
        "sentence": "Phenytoin: @DRUG1$ increases the plasma concentrations of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2216,
        "sentence": "and/or @DRUG1$ @DRUG2$ (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (MPTP) (4 x 20 mg/kg, i. p.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2217,
        "sentence": "Fat-soluble Vitamin Supplements and Analogues: A pharmacokinetic interaction study showed a 30% reduction in @DRUG1$ supplement absorption when concomitantly administered with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2218,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, @DRUG2$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2219,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2220,
        "sentence": "Patients receiving sirolimus or @DRUG1$ in combination with MYCAMINE should be monitored for sirolimus or @DRUG2$ toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2221,
        "sentence": "Concomitant use of @DRUG1$ and @DRUG2$ was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by omeprazole of CYP2C19, a cytochrome P450 (CYP) enzyme.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2222,
        "sentence": "It will compete with @DRUG1$ (Plavix) and @DRUG2$ (Effient) for such use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2223,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2224,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2225,
        "sentence": "Mixing @DRUG1$ and Insulin The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant @DRUG2$ immediately prior to injection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2226,
        "sentence": "John   s Wort, and certain @DRUG1$ (phenytoin, @DRUG2$, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2227,
        "sentence": "@DRUG1$ tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral @DRUG2$ produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2228,
        "sentence": "Concomitant administrations not recommended:  - @DRUG1$ and astemizole: Certain macrolides interact with terfenadine and @DRUG2$ leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2229,
        "sentence": "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as @DRUG1$,    -blockers, selective serotonin reuptake inhibitors (@DRUG2$), and monoamine oxidase inhibitors (MAO-Is) Type B, if they have a narrow therapeutic window.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2230,
        "sentence": "Although @DRUG1$ (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering @DRUG2$ concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2231,
        "sentence": "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total @DRUG1$ clearance in the same subjects in the absence of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2232,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2233,
        "sentence": "@DRUG1$ may enhance the sedative effects of central nervous system depressants including alcohol, @DRUG2$, hypnotics, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2234,
        "sentence": "Concurrent administration of @DRUG1$ (e.g., erythromycin, @DRUG2$) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2235,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, @DRUG1$, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2236,
        "sentence": "@DRUG1$: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in @DRUG2$ plasma levels when XENICAL was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2237,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2238,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2239,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG1$, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2240,
        "sentence": "Warfarin users who initiated @DRUG1$, fluoxetine, @DRUG2$, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2241,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG1$, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2242,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2243,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2244,
        "sentence": "At the same time, the locomotor inhibitory effect of @DRUG1$ was counteracted by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2245,
        "sentence": "Sympathomimetics may reduce the antihypertensive effects of methyldopa, @DRUG1$, reserpine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2246,
        "sentence": "Drugs that impair intestinal absorption of fat-soluble vitamins, such as @DRUG1$, may interfere with the absorption of @DRUG2$ Capsules.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2247,
        "sentence": "@DRUG1$: @DRUG2$ increases the serum concentrations of theophylline.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2248,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2249,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG1$ (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2250,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, @DRUG1$, levodopa, ethanol, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2251,
        "sentence": "Dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2252,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2253,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2254,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, @DRUG2$, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2255,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, @DRUG1$, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2256,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG2$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2257,
        "sentence": "Nifedipine (extended-release tablets): In 17 normal-weight subjects receiving @DRUG1$ 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of @DRUG2$ (extended-release tablets).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2258,
        "sentence": "Cyclosporine: Preliminary data from a @DRUG1$ and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2259,
        "sentence": "Concurrent administration of bacteriostatic antibiotics (e.g., @DRUG1$, tetracycline) may diminish the bactericidal effects of @DRUG2$ by slowing the rate of bacterial growth.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2260,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2261,
        "sentence": "Use with @DRUG1$: Because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2262,
        "sentence": "Absorption of @DRUG1$ is impaired by antacids containing @DRUG2$, calcium or magnesium, and iron-containing preparations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2263,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2264,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG1$, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2265,
        "sentence": "We evaluated mechanisms of interaction between the alkyating agent @DRUG1$ (@DRUG2$) and the pro-oxidant, imexon, in the human A375 melanoma cell line.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2266,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG2$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2267,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and @DRUG1$ (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2268,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and @DRUG1$ may increase the clearance of @DRUG2$ and may require increased in methylprednisolone dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2269,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2270,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2271,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2272,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2273,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2274,
        "sentence": "The bioavailability of SKELID is decreased 80% by @DRUG1$, when calcium and SKELID are administered at the same time, and 60% by some @DRUG2$- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2275,
        "sentence": "John   s Wort, and certain anticonvulsants (phenytoin, @DRUG1$, @DRUG2$) may induce mifepristone metabolism (lowering serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2276,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2277,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2278,
        "sentence": "Moxifloxacin and @DRUG1$ reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and @DRUG2$ in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2279,
        "sentence": "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-@DRUG1$ containing @DRUG2$ (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2280,
        "sentence": "@DRUG1$, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, @DRUG2$, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2281,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG1$), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2282,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2283,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2284,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2285,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), @DRUG1$, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2286,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2287,
        "sentence": "@DRUG1$: Preliminary data from a XENICAL and @DRUG2$ drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2288,
        "sentence": "After 21 weeks of @DRUG1$ treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG2$-treated monkeys were significantly affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2289,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with alcohol, @DRUG1$, @DRUG2$, narcotics, or tranquilizers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2290,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2291,
        "sentence": "@DRUG1$ users who initiated @DRUG2$, fluoxetine, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2292,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG1$, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2293,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2294,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), calcium channel blockers (n=75), @DRUG2$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2295,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG2$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2296,
        "sentence": "@DRUG1$: Furosemide and probably other loop diuretics given concomitantly with @DRUG2$ can cause unusually large or prolonged losses of fluid and electrolytes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2297,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, @DRUG1$, ketoconazole, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2298,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, @DRUG2$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2299,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG1$) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2300,
        "sentence": "Uncontrolled hy-per-parathyroidism causes bone marrow fibrosis, leading to @DRUG1$ (@DRUG2$) resistance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2301,
        "sentence": "@DRUG1$ users who initiated citalopram, fluoxetine, paroxetine, amitriptyline, or @DRUG2$ had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2302,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2303,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG2$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2304,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, @DRUG2$, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2305,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, cisplatin, doxorubicin and @DRUG1$   @DRUG2$ following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2306,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of @DRUG1$ is not significantly affected by concurrent administration of @DRUG2$, warfarin, diazepam, or fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2307,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2308,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, meperidine and fentanyl), propofol, ketamine, @DRUG2$, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2309,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2310,
        "sentence": "However, the co   administration of SPIRIVA with other @DRUG1$   containing drugs (e.g., @DRUG2$) has not been studied and is therefore not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2311,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2312,
        "sentence": "Careful monitoring of cyclosporine concentrations and serum creatinine is recommended in patients receiving @DRUG1$ and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2313,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, @DRUG2$, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2314,
        "sentence": "Prevention of emergence agitation in seven children receiving low-dose @DRUG1$ and @DRUG2$ total intravenous anesthesia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2315,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2316,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2317,
        "sentence": "Oral metronidazole has been reported to potentiate the anticoagulant effect of @DRUG1$ and @DRUG2$, resulting in a prolongation of prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2318,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG1$ salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2319,
        "sentence": "The concurrent use of @DRUG1$ and @DRUG2$ has been reported in one case to result in reduced streptozocin cytotoxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2320,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2321,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG1$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2322,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, @DRUG1$, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2323,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, meperidine and fentanyl), propofol, ketamine, @DRUG2$, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2324,
        "sentence": "Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with @DRUG1$, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in @DRUG2$ half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2325,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2326,
        "sentence": "Neuromuscular blocking agents (such as @DRUG1$): Concurrent use of procaine hydrochloride and @DRUG2$ may result in prolongation or enhancement of the neuromuscular blockade.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2327,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG1$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2328,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2329,
        "sentence": "Adrenal steroids or @DRUG1$ In patients with edema, concomitant administration with @DRUG2$ or ACTH may increase the edema.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2330,
        "sentence": "Exert particular caution in combining levomepromazine with other @DRUG1$ (@DRUG2$ and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2331,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, @DRUG1$, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2332,
        "sentence": "@DRUG1$ and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2333,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2334,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2335,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain @DRUG2$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2336,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2337,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2338,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, @DRUG2$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2339,
        "sentence": "In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving @DRUG1$ doses ranging from 804 to 1072 mg BID with @DRUG2$ 15 mg QD as compared to subjects receiving lithium alone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2340,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, @DRUG2$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2341,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with @DRUG2$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2342,
        "sentence": "Patients receiving sirolimus or @DRUG1$ in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or @DRUG2$ dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2343,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as @DRUG1$, aminoglycosides, bacitracin, polymyxin B, colistin, @DRUG2$, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2344,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2345,
        "sentence": "@DRUG1$: @DRUG2$ increases the plasma concentrations of phenytoin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2346,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2347,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2348,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general @DRUG1$, phenothiazines, other opioids, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2349,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2350,
        "sentence": "Concurrent ingestion of @DRUG1$ (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of @DRUG2$ or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2351,
        "sentence": "Therefore, caution should be used in administering @DRUG1$ (@DRUG2$ injection) to patients receiving these other agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2352,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$ is contraindicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2353,
        "sentence": "Interaction with @DRUG1$: Agonist/antagonist analgesics (i.e., pentazocine, @DRUG2$, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2354,
        "sentence": "TOBI should not be administered concomitantly with ethacrynic acid, @DRUG1$, @DRUG2$, or mannitol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2355,
        "sentence": "In vitro testing found no protein binding drug interaction between @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2356,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG1$, penicillins, @DRUG2$, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2357,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2358,
        "sentence": "Prothrombin time or other suitable anticoagulation test should be monitored if @DRUG1$ is administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2359,
        "sentence": "The effect of curcumin (100 mg/kg) was similar to that of fluoxetine and @DRUG1$ (p > 0.05) but its addition to fluoxetine and @DRUG2$ did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2360,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2361,
        "sentence": "@DRUG1$: Concomitant administration of @DRUG2$ (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of meloxicam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2362,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2363,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG1$), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2364,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/@DRUG2$ 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2365,
        "sentence": "When a single 100 mg dose of @DRUG1$ was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total @DRUG2$ clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2366,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, @DRUG1$, certain heart medicines, birth control pills, anti-infective medicines, @DRUG2$ and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2367,
        "sentence": "@DRUG1$ may enhance the effects of @DRUG2$, barbiturates and other CNS depressants.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2368,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG1$, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2369,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2370,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG1$, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2371,
        "sentence": "The possibility of hypotensive effects with UNIVASC    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with @DRUG1$   . If this is not possible, the starting dose of @DRUG2$ should be reduced..",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2372,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG1$, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2373,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG1$ - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2374,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, @DRUG1$, polymyxin B, colistin, viomycin, or @DRUG2$, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2375,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  @DRUG1$: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that @DRUG2$ may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2376,
        "sentence": "Coadministration with a high dose of @DRUG1$ (170 mEq) results in a 28% decrease in plasma concentrations of ranitidine and may decrease plasma concentrations of bismuth from @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2377,
        "sentence": "The response of @DRUG1$ and @DRUG2$ after interaction with co-administered drugs at different conditions and temperature were noted using a Shimadzu HPLC system with PDA detector.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2378,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2379,
        "sentence": "Patients receiving @DRUG1$ and @DRUG2$ concomitantly should be carefully monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2380,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of @DRUG1$, warfarin, diazepam, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2381,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG2$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2382,
        "sentence": "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, @DRUG1$, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2383,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2384,
        "sentence": "In humans, carmustine, etoposide, and @DRUG1$ do not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2385,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG2$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2386,
        "sentence": "The @DRUG1$ treatment also had a significant effect on the @DRUG2$-induced loss of norepinephrine neurons in the locus coeruleus and adjoining A5 and A7 noradrenaline cell groups.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2387,
        "sentence": "We also found that Bcl-2 was overexpressed in @DRUG1$ insensitive cells, and cotreatment with @DRUG2$ and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2388,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2389,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2390,
        "sentence": "@DRUG1$ and sulfaphenazole had no effect, while quinidine appeared to augment @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2391,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2392,
        "sentence": "Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after @DRUG1$) caused a 15% reduction in in-vivo plasma clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2393,
        "sentence": "No pharmacokinetic interaction was observed between @DRUG1$ and @DRUG2$, warfarin, diazepam, or fluoxetine in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2394,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, triamterene, amiloride) or @DRUG1$ supplements concomitantly with @DRUG2$ can increase the risk of hyperkalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2395,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2396,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, amiloride, triamterene and others), @DRUG2$ supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2397,
        "sentence": "@DRUG1$ should be used with caution in digitalized patients, since the combination of digitalis and @DRUG2$ may cause ectopic arrhythmias.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2398,
        "sentence": "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by @DRUG1$ is superior to sunitinib followed by @DRUG2$ and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2399,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2400,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2401,
        "sentence": "This effect on @DRUG1$ appears to be more pronounced following oral administration of fluconazole than with @DRUG2$ administered intravenously.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2402,
        "sentence": "Concomitant administration of terfenadine with @DRUG1$, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including @DRUG2$, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2403,
        "sentence": "Theophylline: @DRUG1$ increases the serum concentrations of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2404,
        "sentence": "@DRUG1$ and @DRUG2$ show additive effects in vitro but not in vivo in human A375 melanoma cells.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2405,
        "sentence": "In clinical studies of TOBI, patients taking @DRUG1$ concomitantly with @DRUG2$ (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2406,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2407,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2408,
        "sentence": "@DRUG1$: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, @DRUG2$ did not affect the pharmacokinetics of pravastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2409,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2410,
        "sentence": "Due to the chemical similarity of other @DRUG1$ (including fluconazole, metronidazole, and miconazole) to ketoconazole, and @DRUG2$, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2411,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2412,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2413,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, @DRUG2$) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2414,
        "sentence": "Due to the chemical similarity of other @DRUG1$ (including fluconazole, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with @DRUG2$ is not recommended pending full examination of potential interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2415,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG2$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2416,
        "sentence": "Severe toxicity has also been reported in patients receiving the combination of @DRUG1$ and ELDEPRYL and @DRUG2$ and ELDEPRYL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2417,
        "sentence": "Monoamine oxidase inhibitors or @DRUG1$ may potentiate the action of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2418,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that @DRUG1$, such as the neuroleptics (@DRUG2$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2419,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG1$ (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2420,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2421,
        "sentence": "These include @DRUG1$, methylxanthines, and oral and inhaled @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2422,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG1$) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2423,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, @DRUG2$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2424,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2425,
        "sentence": "Phenytoin, Carbamazepine, and @DRUG1$: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, @DRUG2$, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2426,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2427,
        "sentence": "@DRUG1$: In 12 normal-weight subjects, administration of XENICAL 120 mg three times a day for 16 days did not result in any change in either @DRUG2$ pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2428,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG2$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2429,
        "sentence": "To minimize CNS depression and possible potentiation, barbiturates, @DRUG1$, @DRUG2$, hypotensive agents or phenothiazines should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2430,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG1$, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2431,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2432,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., @DRUG2$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2433,
        "sentence": "- did not change the plasma concentration profile of terfenadine (a substrate of cytochrome P450 3A4) or @DRUG1$, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with @DRUG2$ 60 mg twice daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2434,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG2$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2435,
        "sentence": "Although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with TRENTAL with and without @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2436,
        "sentence": "Drugs that impair intestinal absorption of @DRUG1$, such as @DRUG2$, may interfere with the absorption of Zemplar Capsules.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2437,
        "sentence": "It will compete with clopidogrel (@DRUG1$) and @DRUG2$ (Effient) for such use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2438,
        "sentence": "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), @DRUG1$ (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), @DRUG2$ (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2439,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2440,
        "sentence": "@DRUG1$ and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of @DRUG2$ in an animal model, possibly enhancing the toxicity of methotrexate.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2441,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of @DRUG1$-containing or ergot-type medications (like @DRUG2$ or methysergide) and sumatriptan within 24 hours of each other should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2442,
        "sentence": "Caution should be used when administering @DRUG1$ with @DRUG2$ since patients on warfarin may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2443,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing @DRUG1$   . If @DRUG2$ and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2444,
        "sentence": "@DRUG1$ should be used with caution in patients receiving other local @DRUG2$ or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2445,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . @DRUG2$ plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2446,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (@DRUG2$ 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2447,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2448,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG2$, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2449,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2450,
        "sentence": "@DRUG1$ blood levels may be prolonged by concurrent administration of @DRUG2$ which blocks the renal tubular secretion of penicillins.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2451,
        "sentence": "Caffeine and/or stimulantes of the ephedrine/@DRUG1$ type may counteract the specific actions of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2452,
        "sentence": "@DRUG1$: Probenecid, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence @DRUG2$ pharmacokinetics (N= 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2453,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2454,
        "sentence": "Careful monitoring of @DRUG1$ concentrations and serum creatinine is recommended in patients receiving DIFLUCAN and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2455,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2456,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2457,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG1$, may diminish the effectiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2458,
        "sentence": "Laboratory Tests There have been reports of false-positive urine screening tests for @DRUG1$ (@DRUG2$) in patients receiving most proton pump inhibitors, including pantoprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2459,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that @DRUG1$ may be associated with an increase in patient controlled administration of @DRUG2$.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2460,
        "sentence": "Drug-Drug Interactions Effect of Exelon    (@DRUG1$) on the Metabolism of Other Drugs: @DRUG2$ is primarily metabolized through hydrolysis by esterases.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2461,
        "sentence": "Drugs such as erythromycin, diltiazem, @DRUG1$, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2462,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some @DRUG1$, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and @DRUG2$ Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2463,
        "sentence": "Increases of @DRUG1$ plasma concentrations by approximately 20% have been observed with doses of 130 mg/m2 @DRUG2$ dosed every 3 weeks.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2464,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2465,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2466,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2467,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., @DRUG2$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2468,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2469,
        "sentence": "The purpose of this study was to evaluate whether the psychostimulant drug @DRUG1$ has any effect on @DRUG2$-induced antinociception and locomotor inhibitor activity in mice in acute application.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2470,
        "sentence": "Less potent inhibitors include @DRUG1$, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, @DRUG2$, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2471,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (@DRUG1$ 100 mg/kg plus @DRUG2$ 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2472,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2473,
        "sentence": "Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving @DRUG1$ 120 mg three times a day for 6 days, @DRUG2$ did not affect the pharmacokinetics of pravastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2474,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as @DRUG1$, sedatives, @DRUG2$, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2475,
        "sentence": "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of @DRUG1$, ethinylestradiol, ethoxycoumarin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2476,
        "sentence": "When @DRUG1$ is administered with an @DRUG2$ in a woman of childbearing potential, refer to the pregnancy category and package labeling for the HMG-CoA reductase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2477,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, @DRUG1$, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2478,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or @DRUG1$ (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2479,
        "sentence": "Concomitant treatment with @DRUG1$ resulted in a 21% increase in the AUC of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2480,
        "sentence": "Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral @DRUG1$ produced an overall mean increase in ethinyl estradiol and @DRUG2$ levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2481,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for sirolimus or @DRUG1$ toxicity and @DRUG2$ or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2482,
        "sentence": "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total @DRUG1$ clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2483,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2484,
        "sentence": "@DRUG1$ users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), @DRUG2$ (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2485,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2486,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with @DRUG1$ (@DRUG2$   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2487,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2488,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, cisplatin, @DRUG1$ and etoposide   @DRUG2$ following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2489,
        "sentence": "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including @DRUG1$, @DRUG2$, heparinase III, or chondroitin ABC lyase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2490,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of @DRUG1$ are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2491,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2492,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, @DRUG1$, ibuprofen, diazepam, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2493,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG1$ (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2494,
        "sentence": "Itraconazole: Torsades de pointes and elevated parent @DRUG1$ levels have been reported during concomitant use of terfenadine and @DRUG2$ in clinical trials of itraconazole and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2495,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2496,
        "sentence": "@DRUG1$ (oral): The activity of oral @DRUG2$ may be potentiated by anti-vitamin-K activity attributed to methimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2497,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2498,
        "sentence": "@DRUG1$ was administered as calcium chloride in all studies and @DRUG2$ were ingested on an empty stomach.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2499,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2500,
        "sentence": "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain @DRUG1$ (e.g. dihydroergotamine and @DRUG2$) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2501,
        "sentence": "While co-administration of @DRUG1$    appeared to increase the clearance of @DRUG2$ by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of Cerezyme.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2502,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2503,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2504,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2505,
        "sentence": "Absorption of tetracyclines is impaired by antacids containing @DRUG1$, calcium or magnesium, and @DRUG2$-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2506,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, @DRUG2$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2507,
        "sentence": "and/or antibiotic drug @DRUG1$ (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (@DRUG2$) (4 x 20 mg/kg, i. p.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2508,
        "sentence": "Antacids: Absorption of a single dose of @DRUG1$ was decreased when administered to 12 stable renal transplant patients also taking @DRUG2$-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2509,
        "sentence": "These medications included @DRUG1$, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2510,
        "sentence": "Although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with @DRUG1$ with and without @DRUG2$ or platelet aggregation inhibitors.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2511,
        "sentence": "Those anticonvulsants include divalproex sodium, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2512,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2513,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, @DRUG1$, @DRUG2$, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2514,
        "sentence": "Dosages of concomitantly administered @DRUG1$ should be reduced by approximately half, because levomepromazine amplifies the therapeutic actions and side-effects of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2515,
        "sentence": "Therefore, when concomitant use of @DRUG1$ and @DRUG2$ is anticipated, it may be necessary to monitor blood levels and/or reduce the dosage of such compounds.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2516,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG1$, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2517,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, @DRUG1$, lovastatin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2518,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, @DRUG1$, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2519,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2520,
        "sentence": "@DRUG1$: Concurrent use of procaine hydrochloride and @DRUG2$ may result in a reduction of the antibacterial action of the sulfonamide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2521,
        "sentence": "Dopamine antagonists, such as the @DRUG1$ (@DRUG2$, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2522,
        "sentence": "This is especially true if the total dose of @DRUG1$ has been large and the administration of @DRUG2$ has been delayed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2523,
        "sentence": "Short-acting Benzodiazepines: Following oral administration of @DRUG1$, @DRUG2$ resulted in substantial increases in midazolam concentrations and psychomotor effects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2524,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, @DRUG1$, @DRUG2$, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2525,
        "sentence": "Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, @DRUG1$, ampicillin esters, and @DRUG2$ salts).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2526,
        "sentence": "@DRUG1$ tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and @DRUG2$ levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2527,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, @DRUG1$, hypnotics, narcotic analgesics, @DRUG2$, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2528,
        "sentence": "The FDA has approved ticagrelor (@DRUG1$-AstraZeneca), an oral antiplatelet drug, for use with low-dose @DRUG2$ to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2529,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of @DRUG1$ are potentiated by the presence of other @DRUG2$ such as alcohol, sedatives, antihistaminics, or psychotropic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2530,
        "sentence": "Those anticonvulsants include @DRUG1$, valproic acid, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2531,
        "sentence": "We evaluated the effects of @DRUG1$ doses between 200 and 1500 mg on absorption of 5 mg @DRUG2$ (as ferrous sulfate).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2532,
        "sentence": "Concomitant administrations not recommended:  - Terfenadine and @DRUG1$: Certain macrolides interact with @DRUG2$ and astemizole leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2533,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, @DRUG1$, antidiabetic agents, and @DRUG2$, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2534,
        "sentence": "Caution should be exercised when administering @DRUG1$ therapy in combination with other @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2535,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, @DRUG2$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2536,
        "sentence": "Additive sedative effects can occur when @DRUG1$ is given with alcohol, @DRUG2$, hypnotics, narcotics, or tranquilizers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2537,
        "sentence": "A few spontaneous accounts of QT interval prolongation with ventricular arrhythmia including torsades de pointes, have been reported in patients receiving @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2538,
        "sentence": "@DRUG1$, a bacteriostatic antibiotic, may antagonize the bactericidal effect of @DRUG2$ and concurrent use of these drugs should be avoided.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2539,
        "sentence": "This study evaluated the effect of a potent CYP3A inhibitor, @DRUG1$, on the pharmacokinetics and safety of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2540,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2541,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2542,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG2$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2543,
        "sentence": "John   s Wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce @DRUG1$ metabolism (lowering serum levels of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2544,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2545,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2546,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG1$ may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2547,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, @DRUG1$, @DRUG2$, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2548,
        "sentence": "Warfarin: A multidose study of @DRUG1$, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in @DRUG2$ half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2549,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, @DRUG1$, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2550,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and @DRUG1$ Please note that @DRUG2$ may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2551,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2552,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2553,
        "sentence": "Careful monitoring of phenytoin concentrations in patients receiving @DRUG1$ and @DRUG2$ is recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2554,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2555,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG1$, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2556,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2557,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of @DRUG1$ is not significantly affected by concurrent administration of digoxin, warfarin, @DRUG2$, or fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2558,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2559,
        "sentence": "In vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2560,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general @DRUG1$, phenothiazines, other opioids, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2561,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2562,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, @DRUG2$, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2563,
        "sentence": "Thalidomide has been reported to enhance the sedative activity of @DRUG1$, @DRUG2$, chlorpromazine, and reserpine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2564,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2565,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG1$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2566,
        "sentence": "Triprolidine may enhance the sedative effects of @DRUG1$ including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2567,
        "sentence": "@DRUG1$: There have been reports of nephrotoxicity in patients to whom fluconazole and @DRUG2$ were coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2568,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG1$ and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2569,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG1$, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2570,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of @DRUG2$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2571,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2572,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG2$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2573,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG2$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2574,
        "sentence": "@DRUG1$ should not be administered concomitantly with ethacrynic acid, @DRUG2$, urea, or mannitol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2575,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2576,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2577,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, miconazole) or @DRUG2$ (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2578,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2579,
        "sentence": "Other @DRUG1$: When @DRUG2$ Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2580,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2581,
        "sentence": "Fluconazole tablets coadministered with @DRUG1$- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and @DRUG2$ levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2582,
        "sentence": "The use of AGGRASTAT, in combination with @DRUG1$ and @DRUG2$, has been associated with an increase in bleeding compared to heparin and aspirin alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2583,
        "sentence": "@DRUG1$: The effects of chronic cimetidine use on the metabolism of @DRUG2$ are not known.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2584,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$ has been associated with erythema and histamine-like flushing and anaphylactoid reactions.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2585,
        "sentence": "TRENTAL has been used concurrently with @DRUG1$, @DRUG2$, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2586,
        "sentence": "@DRUG1$ with @DRUG2$ may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2587,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, @DRUG1$, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2588,
        "sentence": "Sulfonamides: Concurrent use of @DRUG1$ and sulfonamides may result in a reduction of the antibacterial action of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2589,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG1$, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2590,
        "sentence": "You cannot take @DRUG1$ if you have taken a @DRUG2$ (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2591,
        "sentence": "Although not studied, the potent cytochrome P450 3A4 inhibitors @DRUG1$ and @DRUG2$ may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2592,
        "sentence": "@DRUG1$: The coadministration of EVISTA and @DRUG2$ has not been assessed under chronic conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2593,
        "sentence": "Moxifloxacin and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with @DRUG1$ in basic media and @DRUG2$ in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2594,
        "sentence": "@DRUG1$ containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, @DRUG2$, or chondroitin ABC lyase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2595,
        "sentence": "@DRUG1$ may be used with @DRUG2$, quinine and other antimalarials, and with other antibiotics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2596,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, @DRUG1$, @DRUG2$, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2597,
        "sentence": "In clinical trials, the concomitant use of @DRUG1$ or @DRUG2$ did not alter the adverse event profile of SYMLIN.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2598,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2599,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, @DRUG1$, @DRUG2$, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2600,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2601,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2602,
        "sentence": "The effects of @DRUG1$ @DRUG2$ [(2-adamantyl)hexamethylenimine] (10 mg/kg, p. o.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2603,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (@DRUG1$ 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2604,
        "sentence": "Less potent inhibitors include saquinavir, @DRUG1$, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, @DRUG2$, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2605,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG1$), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2606,
        "sentence": "There is usually complete cross-resistance between @DRUG1$ (@DRUG2$) and TABLOID brand Thioguanine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2607,
        "sentence": "Use with @DRUG1$ and Other @DRUG2$: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2608,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, @DRUG1$, vancomycin, @DRUG2$ and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2609,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG2$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2610,
        "sentence": "@DRUG1$ and other @DRUG2$ have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2611,
        "sentence": "Such occurrences have been reported when propoxyphene was administered to patients on @DRUG1$, anticonvulsants, or @DRUG2$-like drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2612,
        "sentence": "The possibility of hypotensive effects with @DRUG1$    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with UNIVASC   . If this is not possible, the starting dose of @DRUG2$ should be reduced..",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2613,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, @DRUG1$, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other @DRUG2$, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2614,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of @DRUG1$ has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including @DRUG2$, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2615,
        "sentence": "Synergism was also noted when @DRUG1$ was combined with @DRUG2$ and amikacin.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2616,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2617,
        "sentence": "This study aimed to evaluate the in vitro activity of @DRUG1$ combined with @DRUG2$ against isolates of methicillin-resistant Staphylococcus aureus (MRSA).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2618,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2619,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2620,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2621,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2622,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG1$ such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2623,
        "sentence": "@DRUG1$: Concomitant administration of 200 mg cimetidine QID did not alter the single-dose pharmacokinetics of 30 mg @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2624,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2625,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2626,
        "sentence": "@DRUG1$: Spontaneous adverse reaction reports of patients taking concomitant ketoconazole with recommended doses of @DRUG2$ demonstrate QT interval prolongation and rare serious cardiac events, e.g.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2627,
        "sentence": "Drug Interactions: Women on oral @DRUG1$ have shown a significant increase in plasma @DRUG2$ levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2628,
        "sentence": "In conclusion, we demonstrated an isolated effect of @DRUG1$ (as chloride) on absorption of 5 mg of iron provided as nonheme (as sulfate) and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2629,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2630,
        "sentence": "As there is in vitro evidence that @DRUG1$ (e.g., @DRUG2$, mesalazine, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2631,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, @DRUG2$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2632,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2633,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2634,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2635,
        "sentence": "MAO inhibitors and @DRUG1$ increase the effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2636,
        "sentence": "Rate of achievement of target BP with fixed combination @DRUG1$/@DRUG2$ (93%) was comparable with that on traditional therapy (90%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2637,
        "sentence": "@DRUG1$, Barbiturates, and Narcotics: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2638,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2639,
        "sentence": "The bioavailability of @DRUG1$ is increased 2-4 fold by @DRUG2$ but is not significantly altered by coadministration of diclofenac.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2640,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2641,
        "sentence": "In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that @DRUG1$ does not affect the clearance of antipyrine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2642,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and @DRUG2$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2643,
        "sentence": "When @DRUG1$ or other hepatic enzyme inducers such as @DRUG2$ and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2644,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (@DRUG1$), tranylcypromine (Parnate), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2645,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2646,
        "sentence": "@DRUG1$ medications: Concurrent use of @DRUG2$ and CNS depressant medications may result in additive depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2647,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2648,
        "sentence": "Terfenadine: Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving @DRUG1$ in conjunction with @DRUG2$, interaction studies have been performed.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2649,
        "sentence": "@DRUG1$: Animal data have suggested the possibility of interaction between perindopril and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2650,
        "sentence": "Triprolidine may enhance the sedative effects of @DRUG1$ including alcohol, barbiturates, hypnotics, narcotic analgesics, @DRUG2$, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2651,
        "sentence": "Concurrent administration of bacteriostatic antibiotics (e.g., @DRUG1$, @DRUG2$) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2652,
        "sentence": "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, @DRUG1$, @DRUG2$, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2653,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2654,
        "sentence": "This study aimed to evaluate the in vitro activity of @DRUG1$ combined with fosfomycin against isolates of @DRUG2$-resistant Staphylococcus aureus (MRSA).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2655,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG1$ (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2656,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2657,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2658,
        "sentence": "a reduction of the @DRUG1$ dosage should be considered in patients receiving @DRUG2$ concurrently.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2659,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2660,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2661,
        "sentence": "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of @DRUG1$ and ethinyl estradiol following administration of a single dose containing 1.0 mg of @DRUG2$ and 75    g of ethinyl estradiol were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2662,
        "sentence": "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including @DRUG1$, hyaluronan lyase, @DRUG2$, or chondroitin ABC lyase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2663,
        "sentence": "These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in @DRUG1$/@DRUG2$-treated animals than in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated monkeys.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2664,
        "sentence": "The effect of @DRUG1$ (100 mg/kg) was similar to that of @DRUG2$ and imipramine (p > 0.05) but its addition to fluoxetine and imipramine did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2665,
        "sentence": "Short-acting Benzodiazepines: Following oral administration of @DRUG1$, fluconazole resulted in substantial increases in @DRUG2$ concentrations and psychomotor effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2666,
        "sentence": "Treatment of HEY xenograft-bearing mice with @DRUG1$ plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + @DRUG2$ vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2667,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2668,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2669,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2670,
        "sentence": "In humans, @DRUG1$, @DRUG2$, and cisplatin do not affect the pharmacokinetics of ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2671,
        "sentence": "Dopamine antagonists, such as the neuroleptics (@DRUG1$, @DRUG2$, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2672,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, @DRUG1$, hydroxyzine, and other @DRUG2$) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2673,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), @DRUG1$ supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2674,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG1$, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2675,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as @DRUG1$ (Marplan), tranylcypromine (Parnate), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2676,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2677,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2678,
        "sentence": "Furthermore, @DRUG1$, @DRUG2$, St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2679,
        "sentence": "Accordingly, patients should be advised to avoid alcohol while taking @DRUG1$. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of @DRUG2$ (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2680,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2681,
        "sentence": "The preclinical combination of @DRUG1$ with the mTOR inhibitor @DRUG2$ has displayed synergy in vitro and represents a novel combination in MM.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2682,
        "sentence": "However, on the basis of available data, no dosage adjustment for @DRUG1$ is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and @DRUG2$ has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2683,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2684,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG1$, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2685,
        "sentence": "Concomitant administration of low-dose @DRUG1$ with @DRUG2$ may result in an increased rate of GI ulceration or other complications, compared to use of MOBIC alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2686,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as @DRUG2$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2687,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2688,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., @DRUG2$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2689,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG2$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2690,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2691,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2692,
        "sentence": "Pharmacokinetic data indicate that @DRUG1$ markedly inhibits the metabolism of @DRUG2$, resulting in elevated plasma terfenadine levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2693,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2694,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG1$, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2695,
        "sentence": "The concurrent use of @DRUG1$ and @DRUG2$ has been reported to result in fatal renal toxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2696,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2697,
        "sentence": "A greater potentiation of the neuromuscular blocking effects of @DRUG1$ may be expected with higher concentrations of @DRUG2$ or isoflurane.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2698,
        "sentence": "@DRUG1$: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with @DRUG2$    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2699,
        "sentence": "Although @DRUG1$ (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between MIVACRON and @DRUG2$ has not been systematically studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2700,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2701,
        "sentence": "Multiple dose studies of ezetimibe given in combination with HMG-CoA reductase inhibitors (@DRUG1$) in rats and rabbits during organogenesis result in higher @DRUG2$ and statin exposures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2702,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general @DRUG1$, phenothiazines, other @DRUG2$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2703,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG2$, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2704,
        "sentence": "While the effects of chronic @DRUG1$ or @DRUG2$ therapy on the action of MIVACRON are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2705,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, @DRUG2$, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2706,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2707,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, phenytoin, carbamazepine, rifampin, @DRUG2$, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2708,
        "sentence": "No pharmacokinetic interaction was observed between rivastigmine and digoxin, @DRUG1$, @DRUG2$, or fluoxetine in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2709,
        "sentence": "Addition of @DRUG1$ to propafenone did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2710,
        "sentence": "In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg BID with @DRUG1$ 15 mg QD as compared to subjects receiving @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2711,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG1$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2712,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as @DRUG1$, indomethacin, naproxen, ibuprofen, diazepam, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2713,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2714,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2715,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), @DRUG2$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2716,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2717,
        "sentence": "Dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2718,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (@DRUG1$, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2719,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2720,
        "sentence": "Oral @DRUG1$: In 10 healthy women, the pharmacokinetic profiles of @DRUG2$ and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2721,
        "sentence": "We found antagonism between @DRUG1$ and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between @DRUG2$ and doxorubicin in all cell lines except for two combinations in HCT116 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2722,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or @DRUG1$) and @DRUG2$ within 24 hours of each other should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2723,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG1$), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2724,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG1$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2725,
        "sentence": "TRENTAL has been used concurrently with @DRUG1$, beta blockers, digitalis, diuretics, @DRUG2$, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2726,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2727,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG1$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2728,
        "sentence": "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially @DRUG1$ such as @DRUG2$ and fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2729,
        "sentence": "@DRUG1$ and sulfaphenazole had no effect, while @DRUG2$ appeared to augment precocene I toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2730,
        "sentence": "The roles of p27(Kip1), Bcl-2, and Cdk1 in apoptosis induced by @DRUG1$ and @DRUG2$ were assessed using a terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, siRNA knockdown of gene expression, transfection with Bcl-2 and Cdk1 expression vectors, and flow cytometry.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2731,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with @DRUG1$, @DRUG2$, hypnotics, narcotics, or tranquilizers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2732,
        "sentence": "Drug Interactions: The use of ZEMURON    (@DRUG1$) Injection before @DRUG2$, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2733,
        "sentence": "Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain macrolides interact with @DRUG1$ and @DRUG2$ leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2734,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, @DRUG1$, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2735,
        "sentence": "Combination therapy with Cerezyme    (@DRUG1$) and @DRUG2$    is not indicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2736,
        "sentence": "The effect of curcumin (100 mg/kg) was similar to that of fluoxetine and @DRUG1$ (p > 0.05) but its addition to @DRUG2$ and imipramine did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2737,
        "sentence": "Treatment of HEY xenograft-bearing mice with dasatinib plus @DRUG1$ inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, @DRUG2$ + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2738,
        "sentence": "The use of AGGRASTAT, in combination with @DRUG1$ and aspirin, has been associated with an increase in bleeding compared to heparin and @DRUG2$ alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2739,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2740,
        "sentence": "The FDA has approved ticagrelor (Brilinta-AstraZeneca), an oral @DRUG1$, for use with low-dose @DRUG2$ to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2741,
        "sentence": "Warfarin users who initiated citalopram, @DRUG1$, paroxetine, @DRUG2$, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2742,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (@DRUG2$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2743,
        "sentence": "Agents that might be coadministered with @DRUG1$ in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, @DRUG2$, and fluconazole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2744,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG1$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2745,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2746,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG1$ and fentanyl), propofol, ketamine, @DRUG2$, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2747,
        "sentence": "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as rifampin, @DRUG1$, and @DRUG2$, induce metabolism and caused a markedly decreased C max and AUC of oral midazolam in adult studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2748,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, @DRUG1$, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2749,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2750,
        "sentence": "When cells were exposed to @DRUG1$ followed by @DRUG2$, synergism was observed.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2751,
        "sentence": "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of @DRUG1$, sodium salicylate and sulfamethizole displaced protein-bound @DRUG2$ in fresh human serum to a small but significant extent.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2752,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG2$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2753,
        "sentence": "Warfarin users who initiated citalopram, fluoxetine, paroxetine, @DRUG1$, or @DRUG2$ had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2754,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG1$ salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2755,
        "sentence": "Lithium: Increased serum @DRUG1$ and symptoms of @DRUG2$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2756,
        "sentence": "Because @DRUG1$ exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, @DRUG2$) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2757,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2758,
        "sentence": "@DRUG1$: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG2$ therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2759,
        "sentence": "Usage with Alcohol: Due to the potential for increased CNS depressants effects, @DRUG1$ should be used with caution in patients who are currently receiving @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2760,
        "sentence": "Therefore, do not administer Myfortic with @DRUG1$ or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2761,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), @DRUG2$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2762,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2763,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2764,
        "sentence": "A variety of @DRUG1$ such as @DRUG2$ or propranolol were also added, sometimes with improved control of ventricular ectopy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2765,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, @DRUG2$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2766,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (MAOI) such as isocarboxazid (Marplan), @DRUG2$ (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2767,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2768,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2769,
        "sentence": "Cyclosporine: The total @DRUG1$ level increased 12-fold in one renal transplant patient receiving multiple medications, including @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2770,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2771,
        "sentence": "The objective of this study was to evaluate the effect of oral administration of @DRUG1$ (@DRUG2$) on the humoral immune responses of chickens to inactivated ND and AI vaccines.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2772,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral @DRUG1$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2773,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2774,
        "sentence": "TRENTAL has been used concurrently with @DRUG1$, beta blockers, digitalis, diuretics, antidiabetic agents, and @DRUG2$, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2775,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2776,
        "sentence": "Concomitant administration of low-dose aspirin with @DRUG1$ may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2777,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2778,
        "sentence": "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, @DRUG1$ and @DRUG2$ displaced protein-bound teniposide in fresh human serum to a small but significant extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2779,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., pentazocine, @DRUG1$, @DRUG2$, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2780,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2781,
        "sentence": "Less potent inhibitors include saquinavir, @DRUG1$, @DRUG2$, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2782,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, @DRUG2$ and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2783,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG2$, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2784,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2785,
        "sentence": "In post-marketing experience, as with other azole antifungals, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving @DRUG1$ concurrently with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2786,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of @DRUG1$ are potentiated by the presence of other CNS depressants such as alcohol, @DRUG2$, antihistaminics, or psychotropic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2787,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2788,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), @DRUG2$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2789,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2790,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2791,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG1$) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2792,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2793,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain @DRUG2$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2794,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2795,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2796,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, @DRUG1$, morphine, vancomycin, @DRUG2$ and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2797,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with @DRUG1$ (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including @DRUG2$, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2798,
        "sentence": "Limited published data indicate that @DRUG1$ treatment increases cytochrome P450 (CP450) mediated @DRUG2$ clearance in man.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2799,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG1$) or @DRUG2$ (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2800,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG1$ with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2801,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2802,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG1$, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2803,
        "sentence": "@DRUG1$ reduce @DRUG2$ clearance, significantly increasing systemic exposure.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2804,
        "sentence": "Interactions for Vitamin B1 (@DRUG1$):  Loop Diuretics, Oral Contraceptives, Stavudine, @DRUG2$",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2805,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2806,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2807,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, @DRUG1$, prednisolone, sirolimus, nifedipine, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2808,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral @DRUG1$, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, beta blockers, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2809,
        "sentence": "In the @DRUG1$ and @DRUG2$ phases, the areas under the effect-time curves (self-reported drowsiness and performance) were significantly higher than those in the placebo phase (P < 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2810,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2811,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2812,
        "sentence": "Although single or concurrent use of @DRUG1$ and @DRUG2$ has some anti-proliferative effects, the sequential administrations of both drugs remarkably enhanced anti-tumor activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2813,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2814,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG2$, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2815,
        "sentence": "Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of @DRUG1$ or rifabutin to warrant dosage adjustment when @DRUG2$ is administered with these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2816,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and @DRUG1$) to ketoconazole, and itraconazole, concomitant use of these products with @DRUG2$ is not recommended pending full examination of potential interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2817,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2818,
        "sentence": "Being moxifloxacin and lomefloxacin @DRUG1$ the interaction study of was carried out with sucralfate, @DRUG2$, erythromycin and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2819,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, @DRUG2$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2820,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG2$ (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2821,
        "sentence": "@DRUG1$: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, @DRUG2$, pravastatin, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2822,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2823,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, @DRUG2$, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2824,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including @DRUG1$, metronidazole, and miconazole) to ketoconazole, and @DRUG2$, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2825,
        "sentence": "Impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous @DRUG1$ and who subsequently received @DRUG2$ to prevent graft-versus-host disease",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2826,
        "sentence": "Carcinogenesis, Mutagenesis, Impairment of Fertility A 104-week dietary carcinogenicity study with @DRUG1$ was conducted in rats at doses up to 1500 mg/kg/day (males) and 500 mg/kg/day (females) (~20 times the human exposure at 10 mg daily based on AUC0-24hr for total @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2827,
        "sentence": "@DRUG1$: The total ezetimibe level increased 12-fold in one renal transplant patient receiving multiple medications, including @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2828,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, tacrolimus, prednisolone, sirolimus, nifedipine, @DRUG2$, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2829,
        "sentence": "In vitro data indicate that the phosphorylation of @DRUG1$ is also inhibited at relevant concentrations by doxorubicin and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2830,
        "sentence": "Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing @DRUG1$ 1 mg/ethinyl @DRUG2$ 35 mcg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2831,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2832,
        "sentence": "Probenecid competes with @DRUG1$ for active tubular secretion and thus inhibits the renal excretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2833,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2834,
        "sentence": "Thalidomide has been reported to enhance the sedative activity of @DRUG1$, alcohol, chlorpromazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2835,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2836,
        "sentence": "The use of @DRUG1$, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to @DRUG2$ and aspirin alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2837,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2838,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (@DRUG1$), tranylcypromine (Parnate), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2839,
        "sentence": "Mexitil    does not alter serum digoxin levels but @DRUG1$, when used to treat gastrointestinal symptoms due to @DRUG2$   , has been reported to lower serum digoxin levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2840,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (@DRUG1$) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2841,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2842,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2843,
        "sentence": "However, the impairment of motor skills produced by @DRUG1$ has been shown to be additive with those caused by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2844,
        "sentence": "There have been postmarketing reports of increased INR and prothrombin time in patients receiving @DRUG1$, including @DRUG2$, and warfarin concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2845,
        "sentence": "While the effects of chronic @DRUG1$ or carbamazepine therapy on the action of @DRUG2$ are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2846,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., @DRUG1$, nalbuphine, @DRUG2$, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2847,
        "sentence": "@DRUG1$ may also affect the effects of other drugs, which include some @DRUG2$, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2848,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG1$, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2849,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2850,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG1$ (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2851,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with @DRUG1$, sedatives, @DRUG2$, narcotics, or tranquilizers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2852,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, @DRUG2$, morphine, vancomycin, metformin and tenofovir).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2853,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2854,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or @DRUG2$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2855,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If @DRUG1$ and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2856,
        "sentence": "Dosages of concomitantly administered opioids should be reduced by approximately half, because @DRUG1$ amplifies the therapeutic actions and side-effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2857,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2858,
        "sentence": "Cimetidine: @DRUG1$, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in @DRUG2$ AUC and a 40% increase in half-life (N= 12).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2859,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG2$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2860,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG2$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2861,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2862,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2863,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG2$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2864,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2865,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2866,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG1$, SEDATIVE-HYPNOTICS (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2867,
        "sentence": "saline + saline, @DRUG1$ (10   mg/kg) + saline, saline + @DRUG2$ (15     g/kg) and ephedrine (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2868,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2869,
        "sentence": "Use of a @DRUG1$ may further increase the risk of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2870,
        "sentence": "Addition of @DRUG1$ to @DRUG2$ did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than propafenone alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2871,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (@DRUG1$ 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (@DRUG2$ 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2872,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, @DRUG2$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2873,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG1$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2874,
        "sentence": "Efficacy and tolerability of fixed @DRUG1$/@DRUG2$ combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2875,
        "sentence": "@DRUG1$: single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2876,
        "sentence": "Use of @DRUG1$ (@DRUG2$, triamterene, amiloride) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2877,
        "sentence": "Exposure to oral @DRUG1$ is unaffected by itraconazole but greatly increased by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2878,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2879,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG1$, oral contraceptives (norethindrone 1 mg/@DRUG2$ 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2880,
        "sentence": "A @DRUG1$ dose of 800 mg diminished absorption of 5 mg @DRUG2$ by 37.7%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2881,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . Theophylline plasma levels returned to pre-@DRUG2$    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2882,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, @DRUG1$, prednisolone, @DRUG2$, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2883,
        "sentence": "@DRUG1$: Metolazone may decrease arterial responsiveness to @DRUG2$, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2884,
        "sentence": "Drug-Drug Interactions: The pharmacokinetic and pharmacodynamic interactions between @DRUG1$ capsules and other @DRUG2$ have not been determined.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2885,
        "sentence": "In vivo, the plasma clearance of @DRUG1$ was reduced by 70% during coadministration of @DRUG2$ (25 mg bid for 2 days), a selective and potent CYP1A2 inhibitor.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2886,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including @DRUG1$, barbiturates, hypnotics, narcotic analgesics, @DRUG2$, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2887,
        "sentence": "The action of @DRUG1$ may be potentiated by anesthesia, other antihypertensive drugs and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2888,
        "sentence": "In vitro data indicate that the phosphorylation of @DRUG1$ is also inhibited at relevant concentrations by @DRUG2$ and ribavirin.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2889,
        "sentence": "The synergistic antinociception activity of @DRUG1$ when administered with piperine can be attributed to increased plasma concentration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2890,
        "sentence": "Cholestyramine: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of @DRUG1$ and should not be coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2891,
        "sentence": "@DRUG1$ can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the @DRUG2$ virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2892,
        "sentence": "Concomitant use of @DRUG1$ with @DRUG2$ may result in an adverse drug interaction.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 2893,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG2$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2894,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, @DRUG1$, naproxen, ibuprofen, diazepam, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2895,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2896,
        "sentence": "The primary objective of the study was to ascertain the difference in @DRUG1$ responsiveness before and after 12 months of @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2897,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - @DRUG1$: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - @DRUG2$: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2898,
        "sentence": "@DRUG1$ (oral): The activity of oral anticoagulants may be potentiated by anti-vitamin-K activity attributed to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2899,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, @DRUG2$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2900,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2901,
        "sentence": "Concomitant administration of @DRUG1$ with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including @DRUG2$, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2902,
        "sentence": "Oral @DRUG1$: In 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of @DRUG2$ and 75    g of ethinyl estradiol were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2903,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2904,
        "sentence": "As there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, @DRUG1$, or @DRUG2$) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2905,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2906,
        "sentence": "Pharmacokinetic properties of abacavir were not altered by the addition of either @DRUG1$ or zidovudine or the combination of @DRUG2$ and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2907,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2908,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, @DRUG1$, @DRUG2$, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2909,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2910,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, griseofulvin, modafinil, penicillins, rifampin, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2911,
        "sentence": "Cyclosporine: Preliminary data from a @DRUG1$ and @DRUG2$ drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2912,
        "sentence": "Additive sedative effects and confusional states may emerge if @DRUG1$ is given with @DRUG2$ or barbiturates.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2913,
        "sentence": "Pharmacokinetic data indicate that ketoconazole markedly inhibits the metabolism of @DRUG1$, resulting in elevated plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2914,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving @DRUG2$ 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2915,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG1$, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2916,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2917,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma @DRUG1$ concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of @DRUG2$/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2918,
        "sentence": "Regulatory agencies state that the combination of @DRUG1$ and the CYP2C19 inhibitors omeprazole and @DRUG2$ should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2919,
        "sentence": "Sulfoxone may increase the effects of @DRUG1$, tolbutamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2920,
        "sentence": "The concurrent administration of potent inhalational agents (eg, isoflurane, @DRUG1$, and @DRUG2$) during maintenance with DIPRIVAN Injectable Emulsion has not been extensively evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2921,
        "sentence": "@DRUG1$ (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not alter the bioavailability of @DRUG2$ (extended-release tablets).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2922,
        "sentence": "Warfarin users who initiated @DRUG1$, @DRUG2$, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2923,
        "sentence": "In vitro activity of minocycline combined with @DRUG1$ against clinical isolates of @DRUG2$-resistant Staphylococcus aureus.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2924,
        "sentence": "Prior administration of @DRUG1$ can potentiate the neuromuscular blocking effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2925,
        "sentence": "In the present study, we tested whether the highly specific metabotropic glutamate receptor 5 antagonist, @DRUG1$, reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2926,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, @DRUG2$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2927,
        "sentence": "Carbidopa/Levodopa: Carbidopa/@DRUG1$ does not influence the pharmacokinetics of @DRUG2$ in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2928,
        "sentence": "Drugs such as erythromycin, diltiazem, verapamil, @DRUG1$, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2929,
        "sentence": "Use with @DRUG1$ and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2930,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2931,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including @DRUG2$, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2932,
        "sentence": "In female rats, neonatal @DRUG1$ treatment enhanced @DRUG2$ locomotor sensitization compared with quinpirole-free controls sensitized to amphetamine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2933,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, @DRUG2$, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2934,
        "sentence": "Because the action of @DRUG1$ will influence the delivery of food to the intestines and thus the rate of absorption, @DRUG2$ dosage or timing of dosage may require adjustment.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2935,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, @DRUG1$, @DRUG2$, and fluconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2936,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other @DRUG1$, including @DRUG2$, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2937,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other @DRUG2$ (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2938,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include @DRUG1$, @DRUG2$, rifabutin, ketoconazole, and fluconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2939,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when @DRUG1$ is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on @DRUG2$ plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2940,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$ and rifampin may increase the clearance of @DRUG2$ and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2941,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, griseofulvin, modafinil, penicillins, rifampin, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2942,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2943,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2944,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, meperidine and @DRUG2$), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2945,
        "sentence": "@DRUG1$, which induces hepatic metabolism, decreased the AUC of montelukast approximately 40% following a single 10-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2946,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2947,
        "sentence": "Use with Cholinomimetics and Other @DRUG1$: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with @DRUG2$, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2948,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, @DRUG1$, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2949,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as @DRUG1$, aminoglycosides, bacitracin, @DRUG2$, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2950,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of @DRUG1$ and levonorgestrel, there is no evidence that fluconazole is a net inducer of @DRUG2$ or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2951,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG1$, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2952,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2953,
        "sentence": "Although such a risk is not verified for @DRUG1$, combination of @DRUG2$ with such drugs is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2954,
        "sentence": "Anticoagulants (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as @DRUG1$, @DRUG2$, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2955,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., @DRUG1$) by @DRUG2$, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2956,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2957,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG1$, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2958,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2959,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG1$, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2960,
        "sentence": "TOBI should not be administered concomitantly with ethacrynic acid, @DRUG1$, urea, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2961,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, @DRUG2$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2962,
        "sentence": "Interactions for @DRUG1$ (Riboflavin):  Alcohol - impairs the intestinal absorption of @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2963,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general @DRUG1$, @DRUG2$, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2964,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, @DRUG1$ or dihydroergotamine) may enhance or potentiate the pressor effects of @DRUG2$   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2965,
        "sentence": "@DRUG1$ AND OTHER SALICYLATE DRUGS WILL BE ADDITIVE TO DISALCID AND MAY INCREASE PLASMA CONCENTRATIONS OF @DRUG2$ TO TOXIC LEVELS.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2966,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG2$ (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2967,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG1$, primidone), phenylbutazone, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2968,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG1$, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2969,
        "sentence": "Results from limited in vitro and in vivo drug-drug interaction studies between @DRUG1$ and @DRUG2$ are inconclusive.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2970,
        "sentence": "With respect to toxicity, the order of CYP inhibitor effectiveness was ABT>diethyldithiocarbamate~@DRUG1$>@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2971,
        "sentence": "The molecular basis of this synergism is that the signaling pathways that were initially activated by @DRUG1$ exposure were efficiently suppressed by the subsequent exposure to @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2972,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2973,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2974,
        "sentence": "@DRUG1$ may decrease arterial responsiveness to @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2975,
        "sentence": "ASPIRIN AND OTHER @DRUG1$ WILL BE ADDITIVE TO @DRUG2$ AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 2976,
        "sentence": "Careful monitoring of @DRUG1$ concentrations in patients receiving DIFLUCAN and @DRUG2$ is recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2977,
        "sentence": "Warfarin users who initiated @DRUG1$, fluoxetine, paroxetine, @DRUG2$, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2978,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG1$ (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2979,
        "sentence": "Patients receiving @DRUG1$ and @DRUG2$ generally should not be treated with ganglion blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2980,
        "sentence": "It will compete with clopidogrel (Plavix) and @DRUG1$ (@DRUG2$) for such use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2981,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2982,
        "sentence": "Patients receiving @DRUG1$ or nifedipine in combination with @DRUG2$ should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 2983,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, @DRUG1$, furosemide and @DRUG2$ Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2984,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including @DRUG2$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2985,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2986,
        "sentence": "@DRUG1$ has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and @DRUG2$, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2987,
        "sentence": "Alcohol, @DRUG1$, and Narcotics: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2988,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2989,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, @DRUG2$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2990,
        "sentence": "Depression does not always require @DRUG1$ therapy, and @DRUG2$ have no proven preventive impact on hot flushes linked to the menopause.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2991,
        "sentence": "@DRUG1$: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2992,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG1$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2993,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2994,
        "sentence": "@DRUG1$: Following oral administration of @DRUG2$, fluconazole resulted in substantial increases in midazolam concentrations and psychomotor effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2995,
        "sentence": "Because @DRUG1$ is approximately 90% bound to plasma proteins, caution should be exercised if @DRUG2$ is coadministered with other drugs known to affect protein binding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2996,
        "sentence": "Coadministration of @DRUG1$ with @DRUG2$ resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 2997,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2998,
        "sentence": "Phenytoin: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, @DRUG1$ did not alter the pharmacokinetics of a single 300-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 2999,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3000,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG1$-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3001,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3002,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3003,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3004,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3005,
        "sentence": "@DRUG1$, theophylline, aminophylline, succinylcholine, @DRUG2$, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3006,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with @DRUG1$, sedatives, hypnotics, @DRUG2$, or tranquilizers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3007,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3008,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with @DRUG1$ should be monitored for sirolimus or nifedipine toxicity and sirolimus or @DRUG2$ dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3009,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG1$ (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3010,
        "sentence": "In adult diabetic patients under treatment with either @DRUG1$ or @DRUG2$ there is no change in the clinical effects of either TOLECTIN or the hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3011,
        "sentence": "CYP interactions: Inhibitors of cytochrome P450 enzymes would not be expected to affect @DRUG1$ elimination because @DRUG2$ is not appreciably metabolized by these enzymes in vivo or in vitro.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3012,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3013,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG1$ (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3014,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3015,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3016,
        "sentence": "Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, @DRUG1$, amikacin and @DRUG2$ showed resistances at comparatively lower levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3017,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, @DRUG1$, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3018,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG1$, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3019,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3020,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3021,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, @DRUG2$, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3022,
        "sentence": "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, @DRUG1$, and @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3023,
        "sentence": "If in certain cases, an @DRUG1$ is considered necessary, it may be advisable to replace @DRUG2$ with anastrozole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3024,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG1$ (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3025,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or @DRUG1$ (eg, erythromycin, @DRUG2$) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3026,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG1$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3027,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3028,
        "sentence": "Exert particular caution in combining @DRUG1$ with other @DRUG2$ (tricyclic antidepressants and antiparkinsonian-agents): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3029,
        "sentence": "As there is in vitro evidence that @DRUG1$ (e.g., olsalazine, @DRUG2$, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3030,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3031,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (MAOI) such as isocarboxazid (@DRUG2$), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3032,
        "sentence": "We also evaluated the effects of @DRUG1$ doses between 200 and 800 mg on absorption of 5 mg @DRUG2$ [as concentrated RBC (CRBC)].",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3033,
        "sentence": "When ZETIA is administered with an @DRUG1$ in a woman of childbearing potential, refer to the pregnancy category and package labeling for the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3034,
        "sentence": "@DRUG1$: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with @DRUG2$, simvastatin, pravastatin, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3035,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3036,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like @DRUG1$ or @DRUG2$) and sumatriptan within 24 hours of each other should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3037,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG2$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3038,
        "sentence": "Pharmacokinetic data indicate that @DRUG1$ markedly inhibits the metabolism of terfenadine, resulting in elevated plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3039,
        "sentence": "CNS depressant medications: Concurrent use of @DRUG1$ and @DRUG2$ may result in additive depressant effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3040,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and @DRUG1$ inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3041,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG2$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3042,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG2$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3043,
        "sentence": "Administration of @DRUG1$ in combination with HERCEPTIN resulted in a two-fold decrease in @DRUG2$ clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3044,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3045,
        "sentence": "The induction dose requirements of @DRUG1$ Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, @DRUG2$, meperidine, and fentanyl, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3046,
        "sentence": "The use of @DRUG1$, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to heparin and @DRUG2$ alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3047,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3048,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3049,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3050,
        "sentence": "There have been postmarketing reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including @DRUG1$, and @DRUG2$ concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3051,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG1$, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3052,
        "sentence": "Concurrent use of tetracyclines with oral @DRUG1$ may render oral @DRUG2$ less effective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3053,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG1$, and @DRUG2$ pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3054,
        "sentence": "@DRUG1$ decreases the clearance of @DRUG2$ by 19%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3055,
        "sentence": "@DRUG1$ inhibits the glucuronidation of acetaminophen and could possibly potentiate @DRUG2$ toxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3056,
        "sentence": "Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of @DRUG1$ (15 mg) had a minimal effect on plasma levels of @DRUG2$ (15 mg) in 12 healthy subjects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3057,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, @DRUG1$, rifabutin, @DRUG2$, and fluconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3058,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral @DRUG1$, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing @DRUG2$ has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3059,
        "sentence": "These include @DRUG1$, @DRUG2$, and oral and inhaled steroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3060,
        "sentence": "@DRUG1$ may also affect the effects of other drugs, which include some steroid medications, @DRUG2$, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3061,
        "sentence": "TOLECTIN and other @DRUG1$ have been reported to reduce the tubular secretion of @DRUG2$ in an animal model, possibly enhancing the toxicity of methotrexate.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3062,
        "sentence": "Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, @DRUG1$, @DRUG2$ and ciprofloxacin showed resistances at comparatively lower levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3063,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, @DRUG2$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3064,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, @DRUG1$, colistin, viomycin, or @DRUG2$, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3065,
        "sentence": "Several studies demonstrate a decrease in the bioavailability of @DRUG1$ when it is ingested with @DRUG2$ or ferrous gluconate.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3066,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3067,
        "sentence": "Adrenal steroids or @DRUG1$ In patients with edema, concomitant administration with adrenal cortical steroids or @DRUG2$ may increase the edema.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3068,
        "sentence": "Synergism was also noted when @DRUG1$ was combined with carbenicillin and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3069,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (@DRUG2$, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3070,
        "sentence": "Effect of Other Drugs on the Metabolism of @DRUG1$: Drugs that induce or inhibit CYP450 metabolism are not expected to alter the metabolism of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3071,
        "sentence": "Lithium: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving @DRUG1$ during therapy with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3072,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG1$, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3073,
        "sentence": "Although it was previously reported that @DRUG1$ combined with Herceptin improved the progression-free survival rate compared with lapatinib alone for patients with @DRUG2$-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3074,
        "sentence": "This implies that in vivo hepatic and first-pass CYP3A activities are significantly lower in patients receiving @DRUG1$ than in those receiving tacrolimus, indicating that, at the doses generally used in clinical practice, @DRUG2$ is the stronger of the two with respect to CYP3A inhibition.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3075,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with @DRUG1$ (PULMOZYME   , Genentech), @DRUG2$, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3076,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with @DRUG1$ (3900 mg/day), but concomitant administration of antacids has no effect on @DRUG2$ plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3077,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as @DRUG2$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3078,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3079,
        "sentence": "@DRUG1$ increases the clearance of @DRUG2$ by 15%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3080,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3081,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG1$, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3082,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3083,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when @DRUG1$ was co-administered with @DRUG2$, simvastatin, pravastatin, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3084,
        "sentence": "John   s Wort, and certain anticonvulsants (@DRUG1$, phenobarbital, @DRUG2$) may induce mifepristone metabolism (lowering serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3085,
        "sentence": "If @DRUG1$, which are metabolized by the cytochrome P450 system, are concomitantly administered with @DRUG2$, consideration should be given to decreasing the benzodiazepine dosage, and the patients should be appropriately monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3086,
        "sentence": "Coadministration of methyldopa with @DRUG1$ or @DRUG2$ is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3087,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3088,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG1$, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3089,
        "sentence": "Mixing @DRUG1$ and Insulin The pharmacokinetic parameters of @DRUG2$ were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3090,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, meperidine and @DRUG2$), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3091,
        "sentence": "The use of AGGRASTAT, in combination with heparin and @DRUG1$, has been associated with an increase in bleeding compared to @DRUG2$ and aspirin alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3092,
        "sentence": "Interaction with @DRUG1$: Although @DRUG2$ does not itself cause orthostatic hypotension, its administration to patients already receiving guanethidine can result in profound orthostatic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3093,
        "sentence": "In a large compassionate use program @DRUG1$    has been used concurrently with commonly employed antianginal, antihypertensive, and @DRUG2$ without observed interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3094,
        "sentence": "The objective of this study was to evaluate the effect of oral administration of @DRUG1$ (GSLS) on the humoral immune responses of chickens to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3095,
        "sentence": "Therefore, as @DRUG1$ absorption may be decreased with XENICAL, patients on chronic stable doses of @DRUG2$ who are prescribed XENICAL should be monitored closely for changes in coagulation parameters.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3096,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, tacrolimus, prednisolone, @DRUG2$, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3097,
        "sentence": "Interactions for Vitamin B2 (Riboflavin):  @DRUG1$ - impairs the intestinal absorption of @DRUG2$",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3098,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3099,
        "sentence": "No pharmacokinetic interaction was observed between rivastigmine and @DRUG1$, warfarin, @DRUG2$, or fluoxetine in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3100,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, @DRUG1$, miconazole) were potent, non-competitive inhibitors of @DRUG2$ metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3101,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, cisplatin, @DRUG1$ and @DRUG2$   celecoxib following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3102,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3103,
        "sentence": "Fluconazole tablets coadministered with ethinyl estradiol- and @DRUG1$-containing oral @DRUG2$ produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3104,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing @DRUG1$, @DRUG2$, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3105,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, @DRUG1$, or @DRUG2$ is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3106,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, @DRUG1$, digitalis, diuretics, @DRUG2$, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3107,
        "sentence": "DRUG INTERACTIONS  There are no known drug/drug interactions with oral @DRUG1$  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous @DRUG2$ has caused deaths in children due to haemorrhagic enterocolitis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3108,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), @DRUG2$, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3109,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3110,
        "sentence": "In a study conducted in healthy subjects, mean pre-dose @DRUG1$ concentration and AUC were increased by 21% in subjects receiving @DRUG2$ doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving lithium alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3111,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG1$, carbamazepine, rifampin, @DRUG2$, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3112,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG2$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3113,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, @DRUG2$, and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3114,
        "sentence": "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with @DRUG1$ have been reported with @DRUG2$ since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on coumarin-type anticoagulants and other highly protein-bound drugs.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3115,
        "sentence": "Potential for Other Drugs to Affect @DRUG1$    @DRUG2$ is not a substrate of CYP1A2, CYP2A6, CYP2C9, and CYP2C19, so that an interaction with inhibitors or inducers of these isozymes is unlikely.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3116,
        "sentence": "@DRUG1$ inhibits the glucuronidation of @DRUG2$ and could possibly potentiate acetaminophen toxicity.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3117,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3118,
        "sentence": "Cimetidine: Concomitant administration of 200 mg @DRUG1$ QID did not alter the single-dose pharmacokinetics of 30 mg @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3119,
        "sentence": "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, @DRUG1$, anticonvulsants, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3120,
        "sentence": "and combinations of opioids and sedatives (eg, @DRUG1$, barbiturates, @DRUG2$, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3121,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3122,
        "sentence": "We evaluated how @DRUG1$ interacts with Herceptin in HER2-positive breast cancer, with a particular focus on @DRUG2$-mediated antibody-dependent cellular cytotoxicity (ADCC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3123,
        "sentence": "@DRUG1$ may increase the effects of barbiturates, tolbutamide, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3124,
        "sentence": "However, the evidence for a calcium effect on @DRUG1$ absorption mainly comes from studies that did not isolate the effect of @DRUG2$ from that of other dietary components, because it was detected in single-meal studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3125,
        "sentence": "Therefore, the coadministration of @DRUG1$ with @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3126,
        "sentence": "ECG intervals (PR, QRS, and QT) were not affected by concurrent @DRUG1$    and digoxin, diuretics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3127,
        "sentence": "SKELAXIN may enhance the effects of @DRUG1$, barbiturates and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3128,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving @DRUG2$ 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3129,
        "sentence": "Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of @DRUG1$ (@DRUG2$), an orally active histone deacetylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3130,
        "sentence": "When administered concurrently, @DRUG1$ may increase the effects of oral @DRUG2$;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3131,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG2$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3132,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, @DRUG1$) and other drugs and foods with known high @DRUG2$ content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3133,
        "sentence": "Use of Anticoagulants and Antiplatelet Agents -- Streptase, @DRUG1$, alone or in combination with antiplatelet agents and @DRUG2$, may cause bleeding complications.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3134,
        "sentence": "The aim of the present study was to investigate whether HB-EGF is a therapeutic target for T-ALL, and to further elucidate the antitumor effects of a specific inhibitor of HB-EGF, @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3135,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, @DRUG1$) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3136,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3137,
        "sentence": "Phase I trial of @DRUG1$ and @DRUG2$ in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3138,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3139,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3140,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, @DRUG1$, theophyllines, phenytoins, @DRUG2$, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3141,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with @DRUG1$ (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . @DRUG2$, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3142,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3143,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG1$ (SSRIs) (e.g., @DRUG2$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3144,
        "sentence": "Warfarin users who initiated citalopram, @DRUG1$, @DRUG2$, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3145,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3146,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG2$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3147,
        "sentence": "Pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or @DRUG1$ or the combination of @DRUG2$ and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3148,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3149,
        "sentence": "There was no effect of a single dose or multiple doses of @DRUG1$ on mycophenolate mofetil, cyclosporine, @DRUG2$, prednisolone, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3150,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG2$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3151,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . @DRUG1$ plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If @DRUG2$ and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3152,
        "sentence": "When a single 100 mg dose of @DRUG1$ was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3153,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3154,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, morphine, meperidine and fentanyl), @DRUG2$, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3155,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., @DRUG2$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3156,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3157,
        "sentence": "Other eye drops or medications such as @DRUG1$ (Miochol) and carbachol (@DRUG2$, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3158,
        "sentence": "@DRUG1$ should be administered with caution to patients being treated with monoamine oxidase inhibitors or @DRUG2$, since the action of beta adrenergic agonists on the vascular system may be potentiated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3159,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3160,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3161,
        "sentence": "Anticoagulants (such as @DRUG1$ and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3162,
        "sentence": "morphine, theophylline, aminophylline, @DRUG1$, @DRUG2$, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3163,
        "sentence": "The pressor response of @DRUG1$ may also be potentiated by @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3164,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3165,
        "sentence": "Concomitant administration of @DRUG1$ with clarithromycin, @DRUG2$, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3166,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If @DRUG2$ and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3167,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, @DRUG1$) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3168,
        "sentence": "Sulfamethizole may increase the effects of barbiturates, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3169,
        "sentence": "MAO Inhibitors: The pressor effect of @DRUG1$ is markedly potentiated in patients receiving monoamine oxidase inhibitors (@DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3170,
        "sentence": "@DRUG1$ may antagonize the effect of levodopa and other @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3171,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, @DRUG2$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3172,
        "sentence": "@DRUG1$ may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, @DRUG2$, sedatives, and tranquillisers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3173,
        "sentence": "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (@DRUG1$/@DRUG2$ versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3174,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG1$, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3175,
        "sentence": "In clinical studies of @DRUG1$, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3176,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG1$, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3177,
        "sentence": "@DRUG1$ and lomefloxacin are @DRUG2$ used in treating urinary and respiratory tract infections.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3178,
        "sentence": "Caution is advised for patients receiving high-dose @DRUG1$ and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose @DRUG2$ and carbonic anhydrase inhibitors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3179,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral @DRUG1$, @DRUG2$, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3180,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG1$), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3181,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3182,
        "sentence": "Itraconazole: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of @DRUG1$ and @DRUG2$ in clinical trials of itraconazole and from foreign post-marketing sources.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3183,
        "sentence": "Co-administration of oral @DRUG1$ 200 mg twice daily increased retapamulin geometric mean AUC(0-24) and Cmax by 81% after topical application of @DRUG2$ ointment, 1% on the abraded skin of healthy adult males.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3184,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, @DRUG1$, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with @DRUG2$ is not recommended pending full examination of potential interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3185,
        "sentence": "@DRUG1$   failure in an HIV-positive woman on @DRUG2$ therapy resulting in two ectopic pregnancies.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3186,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3187,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG1$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3188,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3189,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3190,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3191,
        "sentence": "The combination of @DRUG1$ and @DRUG2$ can be synergistic against MRSA.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3192,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG-DRUG$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3193,
        "sentence": "@DRUG1$ Reports suggest that NSAIDs may diminish the antihypertensive effect of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3194,
        "sentence": "Food Interaction: Oral administration of @DRUG1$    Tablets with food does not significantly lower the rate or extent of @DRUG2$ absorption relative to the fasted state.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3195,
        "sentence": "In the presence of @DRUG1$, there was 1.6- and 1.8-fold increase in C (max) and AUC of @DRUG2$, respectively.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3196,
        "sentence": "@DRUG1$: Increased serum lithium levels and symptoms of @DRUG2$ toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3197,
        "sentence": "The effect of curcumin (100 mg/kg) was similar to that of @DRUG1$ and @DRUG2$ (p > 0.05) but its addition to fluoxetine and imipramine did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3198,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG1$, pancuronium, morphine, vancomycin, metformin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3199,
        "sentence": "Lithium: In clinical trials, @DRUG1$ have produced an elevation of plasma lithium levels and a reduction in renal @DRUG2$ clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3200,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, tacrolimus, prednisolone, @DRUG2$, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3201,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with alcohol, @DRUG1$, hypnotics, narcotics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3202,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG2$, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3203,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3204,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that dopamine antagonists, such as the @DRUG2$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3205,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3206,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, @DRUG1$, and other @DRUG2$) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3207,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3208,
        "sentence": "Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering @DRUG1$ concurrently with @DRUG2$ to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3209,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, @DRUG1$, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3210,
        "sentence": "Trimethoprim, given at a common clinical dosage, increased the @DRUG1$ half-life by 51% and decreased the @DRUG2$ metabolic clearance rate by 30%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3211,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (Miochol) and @DRUG1$ (@DRUG2$, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3212,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), @DRUG2$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3213,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG1$, primidone), phenylbutazone, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3214,
        "sentence": "Weekly intramuscular @DRUG1$ injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG2$ versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3215,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3216,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3217,
        "sentence": "Pyrimethamine may be used with sulfonamides, @DRUG1$ and other antimalarials, and with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3218,
        "sentence": "@DRUG1$ and Analogues: A pharmacokinetic interaction study showed a 30% reduction in @DRUG2$ supplement absorption when concomitantly administered with XENICAL.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3219,
        "sentence": "We evaluated the effects of calcium doses between 200 and 1500 mg on absorption of 5 mg @DRUG1$ (as @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3220,
        "sentence": "@DRUG1$ should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of @DRUG2$ on the vascular system may be potentiated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3221,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3222,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), @DRUG2$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3223,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG2$, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3224,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG2$, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3225,
        "sentence": "@DRUG1$ has no effect on the pharmacokinetic properties of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3226,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, @DRUG2$, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3227,
        "sentence": "Since @DRUG1$ (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3228,
        "sentence": "Interaction of @DRUG1$ with different @DRUG2$ is antagonistic in breast but not in other cancer cells.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3229,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., @DRUG1$ and @DRUG2$), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3230,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when @DRUG2$ is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3231,
        "sentence": "In vitro studies with human liver microsomes showed that @DRUG1$ does not inhibit the metabolism of tolbutamide, ethinylestradiol, @DRUG2$, and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3232,
        "sentence": "Concurrent use of alcohol and other @DRUG1$ may increase the CNS depressant effects of @DRUG2$ or these other medications.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3233,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, @DRUG1$, @DRUG2$, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3234,
        "sentence": "@DRUG1$: @DRUG2$-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3235,
        "sentence": "These medications included thyroid hormones, sedative hypnotics, @DRUG1$, benzodiazepines, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3236,
        "sentence": "@DRUG1$: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3237,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3238,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (@DRUG1$ 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (@DRUG2$ 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3239,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, @DRUG1$, @DRUG2$, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3240,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG1$, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3241,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3242,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, phenytoin, @DRUG2$, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3243,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG1$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3244,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, @DRUG1$, bacitracin, polymyxin B, colistin, @DRUG2$, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3245,
        "sentence": "Mexitil    does not alter serum @DRUG1$ levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3246,
        "sentence": "Accordingly, patients should be advised to avoid @DRUG1$ while taking REMERON SolTab. Diazepam: Concomitant administration of @DRUG2$ (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3247,
        "sentence": "@DRUG1$: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing @DRUG2$ (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3248,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3249,
        "sentence": "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of @DRUG1$, ethinylestradiol, @DRUG2$, and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3250,
        "sentence": "Interaction with @DRUG1$: Agonist/antagonist analgesics (i.e., @DRUG2$, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3251,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3252,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3253,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3254,
        "sentence": "Daily doses of @DRUG1$ 2 g (maximum 3 g) and weekly doses of @DRUG2$ 7.5 mg (maximum 15 mg) were administered alone or in combination to 310 rheumatoid arthritis patients in two controlled 52-week clinical studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3255,
        "sentence": "Interactions for Vitamin B1 (Thiamine):  Loop Diuretics, Oral Contraceptives, @DRUG1$, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3256,
        "sentence": "The pharmacokinetic interaction between @DRUG1$ and @DRUG2$ capsules was investigated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3257,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3258,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3259,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3260,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, @DRUG2$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3261,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3262,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3263,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some @DRUG2$- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3264,
        "sentence": "Caution should be observed in administering @DRUG1$ to patients receiving @DRUG2$ or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3265,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3266,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower @DRUG2$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3267,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - @DRUG1$, @DRUG2$, cisapride, cyclosporine, and tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3268,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG2$, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3269,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG1$, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3270,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG1$, carbamazepine, rifampin, rifabutin, rifapentin, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3271,
        "sentence": "Multiple dose studies of @DRUG1$ given in combination with HMG-CoA reductase inhibitors (statins) in rats and rabbits during organogenesis result in higher @DRUG2$ and statin exposures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3272,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG1$, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3273,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, @DRUG1$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3274,
        "sentence": "Terbinafine clearance is increased 100% by @DRUG1$, a CyP450 enzyme inducer, and decreased 33% by @DRUG2$, a CyP450 enzyme inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3275,
        "sentence": "Influence of @DRUG1$ on @DRUG2$ induced antinociception and its pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3276,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (@DRUG1$, ketoconazole, @DRUG2$) were potent, non-competitive inhibitors of trimetrexate metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3277,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3278,
        "sentence": "Drugs such as @DRUG1$, diltiazem, verapamil, ketoconazole, fluconazole and @DRUG2$ were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3279,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3280,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include @DRUG1$, rifampin, rifabutin, @DRUG2$, and fluconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3281,
        "sentence": "DRUG INTERACTIONS  There are no known drug/drug interactions with oral @DRUG1$  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  @DRUG2$ together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3282,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or @DRUG1$ (e.g., erythromycin and clarithromycin), may alter @DRUG2$ mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3283,
        "sentence": "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking @DRUG1$-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when @DRUG2$ was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3284,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing @DRUG1$   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3285,
        "sentence": "The safety of using @DRUG1$ in combination with clonidine or other centrally acting @DRUG2$ has not been systemically evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3286,
        "sentence": "@DRUG1$ reduces the metabolism of @DRUG2$, glyburide, and glipizide and increases the plasma concentration of these agents.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3287,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to @DRUG1$, @DRUG2$, doxorubicin and etoposide   celecoxib following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3288,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-@DRUG1$    values within 48 hours after discontinuing Mexitil   . If Mexitil and @DRUG2$ are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3289,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG1$, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3290,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, polymyxin B, @DRUG1$, viomycin, or @DRUG2$, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3291,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3292,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral @DRUG2$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3293,
        "sentence": "@DRUG1$ or @DRUG2$: May increase the risk of hypokalemia and increase salt and water retention.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3294,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3295,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (@DRUG1$   , Genentech), (beta)-agonists, inhaled corticosteroids, other @DRUG2$, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3296,
        "sentence": "Another study at a 400-mg and 800-mg daily dose of @DRUG1$ demonstrated that @DRUG2$ taken in doses of 400 mg per day or greater significantly increases plasma levels of terfenadine when taken concomitantly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3297,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3298,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG2$, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3299,
        "sentence": "However, @DRUG1$, a potent inhibitor of cytochrome P450 3A4, may increase plasma levels of @DRUG2$ during concomitant dosing.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3300,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3301,
        "sentence": "@DRUG1$-mediated retinal transduction is improved by co-injection of @DRUG2$ or chondroitin ABC lyase.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3302,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG1$, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3303,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3304,
        "sentence": "The effects of @DRUG1$ on gastrointestinal motility are antagonized by @DRUG2$ and narcotic analgesics.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3305,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3306,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3307,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, @DRUG1$, colistin, @DRUG2$, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3308,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3309,
        "sentence": "@DRUG1$    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3310,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG1$), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3311,
        "sentence": "No clinically significant changes to @DRUG1$ or @DRUG2$ pharmacokinetics were observed following concomitant administration of abacavir.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3312,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3313,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3314,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, @DRUG1$, @DRUG2$, or fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3315,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG2$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3316,
        "sentence": "Results revealed that the strains were resistant to many drugs at high levels, only @DRUG1$, carbenicillin, @DRUG2$ and ciprofloxacin showed resistances at comparatively lower levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3317,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, @DRUG1$, diazepam, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3318,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG1$, procainamide, pancuronium, @DRUG2$, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3319,
        "sentence": "In clinical studies of TOBI, patients taking @DRUG1$ concomitantly with dornase alfa (@DRUG2$   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3320,
        "sentence": "Dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, thioxanthines ) or @DRUG2$, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3321,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG1$), phenylbutazone, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3322,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3323,
        "sentence": "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, @DRUG1$, and abciximab) may increase the risk of bleeding if administered prior to or after @DRUG2$    therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3324,
        "sentence": "@DRUG1$ has been reported to accelerate the metabolism of @DRUG2$ by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3325,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3326,
        "sentence": "@DRUG1$ and @DRUG2$ are fluoroquinolone antibiotics used in treating urinary and respiratory tract infections.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3327,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3328,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG1$, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3329,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3330,
        "sentence": "Concomitant administration of low-dose @DRUG1$ with MOBIC may result in an increased rate of GI ulceration or other complications, compared to use of @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3331,
        "sentence": "Drugs such as erythromycin, diltiazem, verapamil, @DRUG1$, fluconazole and @DRUG2$ were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3332,
        "sentence": "and combinations of opioids and @DRUG1$ (eg, @DRUG2$, barbiturates, chloral hydrate, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3333,
        "sentence": "@DRUG1$ as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to sunitinib followed by @DRUG2$ and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3334,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3335,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3336,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3337,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3338,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, @DRUG1$ and @DRUG2$ Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3339,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3340,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, @DRUG1$, ethanol, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3341,
        "sentence": "- did not change the plasma concentration profile of @DRUG1$ (a substrate of cytochrome P450 3A4) or @DRUG2$, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with terfenadine 60 mg twice daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3342,
        "sentence": "The bioavailability of SKELID is decreased 80% by @DRUG1$, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3343,
        "sentence": "@DRUG1$ may reduce the antihypertensive effects of @DRUG2$, mecamylamine, reserpine and veratrum alkaloids.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3344,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, @DRUG1$, @DRUG2$, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3345,
        "sentence": "If a @DRUG1$ is also used, the risk of @DRUG2$ toxicity may be increased.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3346,
        "sentence": "One case of hypertensive crisis has been reported in a patient taking the recommended doses of @DRUG1$ and a sympathomimetic medication (@DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3347,
        "sentence": "Cyclosporine: @DRUG1$ may significantly increase @DRUG2$ levels in renal transplant patients with or without renal impairment.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3348,
        "sentence": "Coumarin-Derivative Anticoagulants: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving @DRUG1$ concomitantly with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3349,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3350,
        "sentence": "Phenytoin, @DRUG1$, and @DRUG2$: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3351,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as @DRUG1$, @DRUG2$, naproxen, ibuprofen, diazepam, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3352,
        "sentence": "@DRUG1$ may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, @DRUG2$, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3353,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3354,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3355,
        "sentence": "Fibrates: The safety and effectiveness of @DRUG1$ administered with @DRUG2$ have not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3356,
        "sentence": "Lithium: In clinical trials, @DRUG1$ have produced an elevation of plasma @DRUG2$ levels and a reduction in renal lithium clearance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3357,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG2$, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3358,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG1$, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3359,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (MAOI) such as isocarboxazid (Marplan), tranylcypromine (@DRUG2$), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3360,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, @DRUG2$, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3361,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3362,
        "sentence": "Accordingly, patients should be advised to avoid @DRUG1$ while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of @DRUG2$ (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3363,
        "sentence": "Drug-Drug Interactions Effect of @DRUG1$    (@DRUG2$) on the Metabolism of Other Drugs: Rivastigmine is primarily metabolized through hydrolysis by esterases.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3364,
        "sentence": "The CNS-depressant effect of @DRUG1$ is additive with that of other @DRUG2$, including alcohol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3365,
        "sentence": "Caution should be used when administering MOBIC with @DRUG1$ since patients on @DRUG2$ may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3366,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3367,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . @DRUG1$ plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and @DRUG2$ are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3368,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3369,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, @DRUG1$, H2 blockers, digoxin, oral @DRUG2$, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3370,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3371,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3372,
        "sentence": "@DRUG1$ inhibited absorption of a @DRUG2$ supplement by approximately 60%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3373,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3374,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3375,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with @DRUG1$ should be monitored for sirolimus or nifedipine toxicity and @DRUG2$ or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3376,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3377,
        "sentence": "Caution should be used when @DRUG1$ is coadministered with other highly protein-bound drugs, such as @DRUG2$, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3378,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3379,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3380,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG1$, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3381,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/@DRUG2$ 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3382,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG1$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3383,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG1$, penicillins, rifampin, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3384,
        "sentence": "We also found that Bcl-2 was overexpressed in @DRUG1$ insensitive cells, and cotreatment with DZNep and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of @DRUG2$ insensitive MM cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3385,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3386,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3387,
        "sentence": "When a single 100 mg dose of @DRUG1$ was administered one hour after the initiation of @DRUG2$ (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3388,
        "sentence": "In clinical trials, the concomitant use of @DRUG1$ or biguanides did not alter the adverse event profile of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3389,
        "sentence": "@DRUG1$: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of @DRUG2$ and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3390,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG1$, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3391,
        "sentence": "Caution should be observed in administering DEMSER to patients receiving @DRUG1$ or @DRUG2$ because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3392,
        "sentence": "Fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in @DRUG1$ and @DRUG2$ levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3393,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3394,
        "sentence": "If @DRUG1$    is administered following administration of @DRUG2$, it should not be given until recovery from succinylcholine has been observed.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3395,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, @DRUG1$, @DRUG2$, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3396,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3397,
        "sentence": "In @DRUG1$/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/A5/A7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in @DRUG2$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3398,
        "sentence": "The bioavailability of SKELID is decreased 80% by @DRUG1$, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or @DRUG2$-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3399,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3400,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, @DRUG2$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3401,
        "sentence": "@DRUG1$: @DRUG2$ 15 mg once daily for 7 days did not alter the plasma concentration profile of digoxin after b-acetyldigoxin administration for 7 days at clinical doses.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3402,
        "sentence": "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, @DRUG1$, meperidine, and @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3403,
        "sentence": "Other eye drops or medications such as @DRUG1$ (@DRUG2$) and carbachol (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3404,
        "sentence": "The effects of metoclopramide on gastrointestinal motility are antagonized by @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3405,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG2$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3406,
        "sentence": "@DRUG1$, particularly @DRUG2$, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3407,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, @DRUG1$, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3408,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that @DRUG1$ and mycophenolate mofetil inhibit purine metabolism, it is recommended that @DRUG2$ not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3409,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when @DRUG1$ are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3410,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3411,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3412,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3413,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3414,
        "sentence": "Drugs such as troleandomycin and @DRUG1$ may inhibit the metabolism of @DRUG2$ and thus decrease their clearance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3415,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when @DRUG1$ is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including @DRUG2$, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3416,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG1$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3417,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG1$, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3418,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3419,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of @DRUG1$, protease inhibitors, @DRUG2$, and macrolide antibiotics).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3420,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG2$, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3421,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG1$, procainamide, pancuronium, morphine, @DRUG2$, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3422,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3423,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG1$ such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3424,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (@DRUG1$ 15 mg/kg), group 6 (curcumin 100 mg/kg plus @DRUG2$ 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3425,
        "sentence": "Tetracycline, a bacteriostatic @DRUG1$, may antagonize the bactericidal effect of @DRUG2$ and concurrent use of these drugs should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3426,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3427,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or @DRUG2$-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3428,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3429,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (@DRUG1$ 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3430,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG1$, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3431,
        "sentence": "There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral terbinafine and @DRUG1$, however, a causal relationship between @DRUG2$    Tablets and these changes has not been established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3432,
        "sentence": "@DRUG1$ + @DRUG2$ vs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3433,
        "sentence": "Usage with @DRUG1$: Due to the potential for increased CNS depressants effects, alcohol should be used with caution in patients who are currently receiving @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3434,
        "sentence": "Agents that might be coadministered with @DRUG1$ in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, @DRUG2$, ketoconazole, and fluconazole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3435,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral @DRUG2$, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3436,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG1$ salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3437,
        "sentence": "@DRUG1$/Mycophenolate Mofetil: Given that azathioprine and @DRUG2$ inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3438,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that @DRUG1$ and @DRUG2$ inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3439,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - @DRUG1$, astemizole, @DRUG2$, cyclosporine, and tricyclic antidepressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3440,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3441,
        "sentence": "Although such a reaction has not been demonstrated with roxithromycin, concomitant administration of roxithromycin with @DRUG1$ or @DRUG2$ is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3442,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., @DRUG2$, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3443,
        "sentence": "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, @DRUG1$, ethoxycoumarin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3444,
        "sentence": "@DRUG1$ can also displace @DRUG2$ from plasma protein-binding sites, thus increasing free methotrexate concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3445,
        "sentence": "All patients had indications for antihypertensive therapy and were randomized either to fixed combination @DRUG1$/@DRUG2$ (n=43) or to therapy which corresponded to the hospital formulary (n=43).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3446,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3447,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3448,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG1$ (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3449,
        "sentence": "Use of @DRUG1$ (spironolactone, amiloride, triamterene and others), @DRUG2$ supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3450,
        "sentence": "@DRUG1$ or ACTH In patients with edema, concomitant administration with adrenal cortical steroids or @DRUG2$ may increase the edema.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3451,
        "sentence": "While there is evidence that @DRUG1$ can inhibit the metabolism of ethinyl estradiol and @DRUG2$, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3452,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3453,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, @DRUG2$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3454,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (MAOI) such as @DRUG2$ (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3455,
        "sentence": "Concomitant administrations not recommended:  - @DRUG1$ and astemizole: Certain @DRUG2$ interact with terfenadine and astemizole leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3456,
        "sentence": "Carbidopa/Levodopa: @DRUG1$/Levodopa does not influence the pharmacokinetics of @DRUG2$ in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3457,
        "sentence": "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with @DRUG1$ since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on @DRUG2$ and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3458,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, @DRUG2$, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3459,
        "sentence": "Mixing SYMLIN and Insulin The pharmacokinetic parameters of @DRUG1$ were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant @DRUG2$ immediately prior to injection.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3460,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG1$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3461,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3462,
        "sentence": "Given the primary CNS effects of @DRUG1$, INVEGA    should be used with caution in combination with other centrally acting drugs and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3463,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3464,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3465,
        "sentence": "Based on this experience, we suggest that low-dose @DRUG1$ added to @DRUG2$ may be associated with prevention of EA in children with a history of EA with propofol TIVA.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3466,
        "sentence": "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with @DRUG1$, gelusil, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3467,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG1$), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3468,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3469,
        "sentence": "@DRUG1$ can interact with CNS depressant, antichlolinergic, TCA, @DRUG2$, and alcohol.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3470,
        "sentence": "TRENTAL has been used concurrently with @DRUG1$, beta blockers, digitalis, @DRUG2$, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3471,
        "sentence": "Do not exceed a 5 mg daily dose of @DRUG1$ when administered with therapeutic doses of @DRUG2$ or other potent CYP3A4 inhibitors.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3472,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, theophylline, corticosteroids, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3473,
        "sentence": "Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain @DRUG1$ interact with @DRUG2$ and astemizole leading to increased serum concentrations of the latter.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3474,
        "sentence": "We found antagonism between celecoxib and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between @DRUG1$ and @DRUG2$ in all cell lines except for two combinations in HCT116 cells.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3475,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, @DRUG1$, vancomycin, metformin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3476,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3477,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3478,
        "sentence": "The neuromuscular blocking effect of @DRUG1$ may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, @DRUG2$, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3479,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3480,
        "sentence": "No significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of @DRUG1$, inhalational agents, @DRUG2$, and local anesthetic agents) have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3481,
        "sentence": "In the present study @DRUG1$ (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of @DRUG2$ evaluated by both acetic acid writhing and formalin test, when it was administered with ibuprofen.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3482,
        "sentence": "Use of @DRUG1$ (spironolactone, triamterene, @DRUG2$) or potassium supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3483,
        "sentence": "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of @DRUG1$ or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG2$ versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3484,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG1$ and fentanyl), propofol, ketamine, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3485,
        "sentence": "Furafylline and @DRUG1$ had no effect, while @DRUG2$ appeared to augment precocene I toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3486,
        "sentence": "Therefore, physicians should closely monitor patients for a change in @DRUG1$ dosage requirements when administering Mitotane to patients on @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3487,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3488,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, cyclosporine, tacrolimus, prednisolone, sirolimus, @DRUG2$, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3489,
        "sentence": "It has been reported that @DRUG1$ may prolong the prothrombin time in patients who are receiving the @DRUG2$ warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3490,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3491,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - @DRUG1$: may cause shortness of breath and bronchospasm - @DRUG2$: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3492,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG2$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3493,
        "sentence": "Concurrent use of Mexitil    and @DRUG1$ may lead to increased plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3494,
        "sentence": "@DRUG1$: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when @DRUG2$ was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3495,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), @DRUG1$ (@DRUG2$), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3496,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3497,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, @DRUG1$, antihistaminics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3498,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG1$, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3499,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3500,
        "sentence": "@DRUG1$ may reverse the analgesic activity of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3501,
        "sentence": "Interaction with @DRUG1$: @DRUG2$ (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3502,
        "sentence": "Pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, @DRUG1$, and @DRUG2$ without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3503,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (@DRUG1$), @DRUG2$ (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3504,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG1$, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3505,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3506,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), @DRUG1$, inhaled @DRUG2$, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3507,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, @DRUG1$, @DRUG2$, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3508,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3509,
        "sentence": "In the present study @DRUG1$ (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both acetic acid writhing and formalin test, when it was administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3510,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG1$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3511,
        "sentence": "Pyrimethamine may be used with sulfonamides, @DRUG1$ and other @DRUG2$, and with other antibiotics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3512,
        "sentence": "morphine, @DRUG1$, aminophylline, succinylcholine, reserpine, and @DRUG2$ should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3513,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3514,
        "sentence": "@DRUG1$: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of @DRUG2$ and should not be coadministered with EVISTA.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3515,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3516,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG1$) or macrolide antibiotics (eg, erythromycin, @DRUG2$) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3517,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3518,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG1$ (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3519,
        "sentence": "One case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3520,
        "sentence": "Concomitant use of omeprazole and @DRUG1$ was found to decrease the exposure (AUC) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by @DRUG2$ of CYP2C19, a cytochrome P450 (CYP) enzyme.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3521,
        "sentence": "Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (@DRUG1$), an orally active @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3522,
        "sentence": "@DRUG1$: Since @DRUG2$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3523,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and @DRUG2$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3524,
        "sentence": "Regulatory agencies state that the combination of @DRUG1$ and the CYP2C19 inhibitors @DRUG2$ and esomeprazole should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3525,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG1$, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3526,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3527,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), @DRUG2$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3528,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (@DRUG1$), tranylcypromine (@DRUG2$), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3529,
        "sentence": "Although it was previously reported that lapatinib combined with @DRUG1$ improved the progression-free survival rate compared with @DRUG2$ alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3530,
        "sentence": "@DRUG1$ Supplements and Potassium-Sparing Diuretics: @DRUG2$    Tablets may increase serum potassium because of its potential to decrease aldosterone production.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3531,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG1$, sirolimus, nifedipine, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3532,
        "sentence": "Mild hepatotoxicity has been reported in some patients when @DRUG1$ and @DRUG2$ were administered concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3533,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (@DRUG1$ 100 mg/kg), group 4 (@DRUG2$ 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3534,
        "sentence": "@DRUG1$ induced apoptosis, and furthermore, the combination of CRM197 plus @DRUG2$ enhanced cytotoxicity in a T-ALL cell line.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3535,
        "sentence": "When phenytoin or other hepatic enzyme inducers such as rifampin and @DRUG1$ have been taken concurrently with Mexitil   , lowered @DRUG2$    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3536,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3537,
        "sentence": "Methscopolamine may interact with @DRUG1$ (@DRUG2$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3538,
        "sentence": "Although such a reaction has not been demonstrated with @DRUG1$, concomitant administration of roxithromycin with terfenadine or @DRUG2$ is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3539,
        "sentence": "Therefore, as vitamin K absorption may be decreased with @DRUG1$, patients on chronic stable doses of warfarin who are prescribed @DRUG2$ should be monitored closely for changes in coagulation parameters.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3540,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG1$, oral @DRUG2$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3541,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG2$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3542,
        "sentence": "Drugs such as @DRUG1$, @DRUG2$, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3543,
        "sentence": "Accordingly, patients should be advised to avoid @DRUG1$ while taking @DRUG2$. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3544,
        "sentence": "Interactions for Vitamin B1 (@DRUG1$):  Loop Diuretics, Oral Contraceptives, @DRUG2$, Tricyclic Antidepressants",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3545,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3546,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., @DRUG1$, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3547,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3548,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3549,
        "sentence": "Use with @DRUG1$: Because of their mechanism of action, @DRUG2$ have the potential to interfere with the activity of anticholinergic medications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3550,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG2$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3551,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of @DRUG1$   . Therefore, caution should be used when @DRUG2$    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3552,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3553,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3554,
        "sentence": "This could lead to decreased @DRUG1$ serum levels or increase the risk of salicylate toxicity when @DRUG2$ is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3555,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), @DRUG1$, @DRUG2$, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3556,
        "sentence": "@DRUG1$ may decrease the hypotensive effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3557,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG1$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3558,
        "sentence": "In the absence of data regarding potential interaction between ALIMTA and NSAIDs with longer half-lives, all patients taking these @DRUG1$ should interrupt dosing for at least 5 days before, the day of, and 2 days following @DRUG2$ administration.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3559,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., @DRUG1$, pseudoephedrine, ephedrine, @DRUG2$ or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3560,
        "sentence": "Due to the chemical similarity of other @DRUG1$ (including fluconazole, @DRUG2$, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3561,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG1$, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3562,
        "sentence": "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as rifampin, @DRUG1$, and phenytoin, induce metabolism and caused a markedly decreased C max and AUC of oral @DRUG2$ in adult studies.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3563,
        "sentence": "Sympathomimetics may reduce the antihypertensive effects of @DRUG1$, mecamylamine, @DRUG2$ and veratrum alkaloids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3564,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3565,
        "sentence": "@DRUG1$ (@DRUG2$) should be administered until normal hematopoiesis is restored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3566,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar @DRUG1$ or @DRUG2$ such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3567,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG2$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3568,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other @DRUG1$ such as alcohol, sedatives, antihistaminics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3569,
        "sentence": "@DRUG1$/Levodopa: Carbidopa/Levodopa does not influence the pharmacokinetics of @DRUG2$ in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3570,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3571,
        "sentence": "The concomitant use of @DRUG1$ with other @DRUG2$ or with other agents which produce dry mouth, constipation, somnolence (drowsiness), and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3572,
        "sentence": "Drugs Affecting Hepatic Metabolism The metabolism and pharmacokinetics of @DRUG1$    (@DRUG2$) Orally Disintegrating Tablets may be affected by the induction or inhibition of drug-metab-olizing enzymes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3573,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3574,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3575,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - @DRUG2$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3576,
        "sentence": "Concomitant administrations not recommended:  - Terfenadine and @DRUG1$: Certain @DRUG2$ interact with terfenadine and astemizole leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3577,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3578,
        "sentence": "During maintenance of anesthesia or sedation, the rate of DIPRIVAN Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental @DRUG1$ (eg, @DRUG2$ or opioids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3579,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3580,
        "sentence": "It is recommended that plasma @DRUG1$ levels be monitored when initiating, adjusting and discontinuing @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3581,
        "sentence": "Because of profound and long lasting inhibition of gastric acid secretion, @DRUG1$ may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, @DRUG2$, ampicillin esters, and iron salts).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3582,
        "sentence": "Aspirin may decrease bioavailability of @DRUG1$ by up to 50% when taken 2 hours after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3583,
        "sentence": "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as @DRUG1$ or @DRUG2$, are co-administered with montelukast.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3584,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG1$, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3585,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3586,
        "sentence": "However, on the basis of available data, no dosage adjustment for @DRUG1$ is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of @DRUG2$.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3587,
        "sentence": "Sulfamethizole may increase the effects of @DRUG1$, @DRUG2$, and uricosurics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3588,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (@DRUG1$ 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (@DRUG2$ 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3589,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG1$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3590,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG1$, modafinil, penicillins, @DRUG2$, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3591,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3592,
        "sentence": "We evaluated mechanisms of interaction between the alkyating agent @DRUG1$ (DTIC) and the pro-oxidant, @DRUG2$, in the human A375 melanoma cell line.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3593,
        "sentence": "Both acyclovir/@DRUG1$ and @DRUG2$ concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3594,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other @DRUG2$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3595,
        "sentence": "Sunitinib as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to @DRUG1$ followed by @DRUG2$ and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3596,
        "sentence": "@DRUG1$ tablets coadministered with @DRUG2$- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3597,
        "sentence": "@DRUG1$, theophylline, aminophylline, @DRUG2$, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3598,
        "sentence": "Thus strong inhibitors of cytochrome P4501A2, such as @DRUG1$, given concomitantly during administration of Ropivacaine, can interact with Ropivacaine leading to increased @DRUG2$ plasma levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3599,
        "sentence": "We found antagonism between @DRUG1$ and the four drugs in the breast cancer cells MCF7 following all incubation schedules and between celecoxib and @DRUG2$ in all cell lines except for two combinations in HCT116 cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3600,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG1$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3601,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3602,
        "sentence": "Concurrent ingestion of antacid (20 mL of @DRUG1$ containing aluminum hydroxide, magnesium hydroxide, and @DRUG2$) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3603,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, @DRUG2$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3604,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of @DRUG1$ and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3605,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG1$, @DRUG2$, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3606,
        "sentence": "Although MIVACRON (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between @DRUG1$ and @DRUG2$ has not been systematically studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3607,
        "sentence": "The addition of @DRUG1$ to @DRUG2$ causes a minimal increase in the risk of minor bleeding (3.9% vs. 3.1%), but does not appear to increase the incidence of major bleeding (see",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3608,
        "sentence": "Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with @DRUG1$, digoxin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3609,
        "sentence": "Studies with @DRUG1$ agents and @DRUG2$ have not demonstrated a reduction in natriuretic effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3610,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3611,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, @DRUG1$, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3612,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as @DRUG2$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3613,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by @DRUG1$, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, @DRUG2$, levodopa, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3614,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG1$) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3615,
        "sentence": "Cisapride: There have been reports of cardiac events, including torsade de pointes in patients to whom @DRUG1$ and @DRUG2$ were coadministered.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3616,
        "sentence": "We evaluated how @DRUG1$ interacts with @DRUG2$ in HER2-positive breast cancer, with a particular focus on Herceptin-mediated antibody-dependent cellular cytotoxicity (ADCC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3617,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (@DRUG1$ 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3618,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG1$, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3619,
        "sentence": "Some @DRUG1$ can enhance @DRUG2$ toxicity by altering antibiotic concentrations in serum and tissue.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3620,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3621,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3622,
        "sentence": "Rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with @DRUG1$-free controls conditioned with @DRUG2$, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3623,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, @DRUG2$) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3624,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG1$), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3625,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, @DRUG2$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3626,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with @DRUG1$ should be monitored for @DRUG2$ or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3627,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3628,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3629,
        "sentence": "Use of @DRUG1$ (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (@DRUG2$, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3630,
        "sentence": "But the use of fixed combination amlodipine/@DRUG1$ compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of @DRUG2$ (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3631,
        "sentence": "This study investigates the ability of @DRUG1$ to sensitize cells from different origins to several @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3632,
        "sentence": "one fatality has been reported from hypoglycemia in association with combined @DRUG1$ and @DRUG2$ use.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3633,
        "sentence": "Calcium is the only known component in the diet that may affect absorption of both @DRUG-DRUG$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3634,
        "sentence": "e.g., other belladonna alkaloids, @DRUG1$ (including @DRUG2$), tricyclic antidepressants, and muscle relaxants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3635,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3636,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, griseofulvin, modafinil, penicillins, @DRUG2$, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3637,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (@DRUG1$) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3638,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3639,
        "sentence": "Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3640,
        "sentence": "Rats treated with neonatal @DRUG1$ enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with @DRUG2$ spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3641,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG1$, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3642,
        "sentence": "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-@DRUG1$ containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when @DRUG2$ was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3643,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3644,
        "sentence": "If @DRUG1$ is given concurrently with @DRUG2$, prothrombin time should be monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3645,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3646,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3647,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as @DRUG1$ (Marplan), tranylcypromine (Parnate), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3648,
        "sentence": "If short-acting benzodiazepines, which are metabolized by the cytochrome P450 system, are concomitantly administered with @DRUG1$, consideration should be given to decreasing the @DRUG2$ dosage, and the patients should be appropriately monitored.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3649,
        "sentence": "@DRUG1$: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3650,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3651,
        "sentence": "We concluded that the combined administration of @DRUG1$ with @DRUG2$ may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3652,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3653,
        "sentence": "Carbidopa/@DRUG1$: @DRUG2$/Levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3654,
        "sentence": "DIFLUCAN reduces the metabolism of @DRUG1$, @DRUG2$, and glipizide and increases the plasma concentration of these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3655,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG1$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3656,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when @DRUG1$ is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and @DRUG2$).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3657,
        "sentence": "Changes in @DRUG1$ and other diabetes drug therapies may be necessary during treatment with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3658,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG2$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3659,
        "sentence": "Use with Other @DRUG1$: The depressant effects of morphine are potentiated by the presence of other @DRUG2$ such as alcohol, sedatives, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3660,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3661,
        "sentence": "Anticoagulants: Metolazone, as well as other @DRUG1$, may affect the hypoprothrombinemic response to @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3662,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/@DRUG1$ 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3663,
        "sentence": "Treatment of HEY xenograft-bearing mice with @DRUG1$ plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs @DRUG2$: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3664,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, @DRUG2$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3665,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, @DRUG1$, narcotic analgesics, sedatives, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3666,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3667,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, @DRUG1$, cisapride, cyclosporine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3668,
        "sentence": "Effect of @DRUG1$-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (@DRUG2$), an orally active histone deacetylase inhibitor.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3669,
        "sentence": "When @DRUG1$ and @DRUG2$ are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when atropine is used alone.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3670,
        "sentence": "Other @DRUG1$ should not be used concomitantly with @DRUG2$    (metaproterenol sulfate USP) because they may have additive effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3671,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3672,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG1$ (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3673,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (@DRUG1$ 20 mg/kg), group 5 (@DRUG2$ 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3674,
        "sentence": "We evaluated mechanisms of interaction between the alkyating agent dacarbazine (@DRUG1$) and the pro-oxidant, @DRUG2$, in the human A375 melanoma cell line.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3675,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (@DRUG2$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3676,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - @DRUG2$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3677,
        "sentence": "Concurrent use with @DRUG1$ including @DRUG2$, sumatriptan, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3678,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3679,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG1$ or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3680,
        "sentence": "Also @DRUG1$, which is not believed to interact with @DRUG2$, increased the risk of GI bleeding (OR   =   1.75 [95% CI, 1.30-2.35]).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3681,
        "sentence": "@DRUG1$: Prolongation of prothrombin time (PT) and International Normalized Ratio (INR) were observed in patients receiving ZOLINZA concomitantly with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3682,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including @DRUG1$, barbiturates, hypnotics, narcotic analgesics, sedatives, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3683,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or @DRUG1$ (eg, @DRUG2$, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3684,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include @DRUG1$, rifampin, rifabutin, ketoconazole, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3685,
        "sentence": "Therefore, do not administer @DRUG1$ with @DRUG2$ or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of Myfortic.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3686,
        "sentence": "However, interactions may be expected and @DRUG1$ capsules should NOT be used in combination with other @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3687,
        "sentence": "@DRUG1$ and Drugs that Bind Bile Acids: These drugs interrupt enterohepatic recirculation and reduce @DRUG2$ exposure when coadministered with mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3688,
        "sentence": "@DRUG1$ can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - @DRUG2$: may decrease patient's response to the vaccine",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3689,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3690,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), @DRUG1$, ketamine, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3691,
        "sentence": "Azathioprine/@DRUG1$: Given that azathioprine and @DRUG2$ inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3692,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3693,
        "sentence": "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and @DRUG1$) There have been rare reports of serious adverse events in connection with the coadministration of certain @DRUG2$ (e.g. dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3694,
        "sentence": "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that @DRUG1$, @DRUG2$, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3695,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3696,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, @DRUG1$, sulfinpyrazone, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3697,
        "sentence": "Although it was previously reported that lapatinib combined with Herceptin improved the progression-free survival rate compared with @DRUG1$ alone for patients with @DRUG2$-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3698,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3699,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3700,
        "sentence": "Warfarin: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in @DRUG1$ half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in @DRUG2$ half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3701,
        "sentence": "@DRUG1$ can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - @DRUG2$: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3702,
        "sentence": "Anticoagulants (such as @DRUG1$ and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, @DRUG2$, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3703,
        "sentence": "Concurrent use of @DRUG1$ with oral contraceptives may render oral @DRUG2$ less effective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3704,
        "sentence": "In addition to bleeding associated with @DRUG1$ and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after @DRUG2$    therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3705,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3706,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3707,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3708,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3709,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3710,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3711,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3712,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3713,
        "sentence": "Rats treated with neonatal quinpirole enhanced time spent in the @DRUG1$-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with @DRUG2$ spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3714,
        "sentence": "Although it was previously reported that @DRUG1$ combined with Herceptin improved the progression-free survival rate compared with @DRUG2$ alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3715,
        "sentence": "Use of Anticoagulants and @DRUG1$ -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and @DRUG2$, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3716,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3717,
        "sentence": "@DRUG1$: Cimetidine, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in @DRUG2$ AUC and a 40% increase in half-life (N= 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3718,
        "sentence": "@DRUG1$ at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing norethindrone 1 mg/ethinyl @DRUG2$ 35 mcg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3719,
        "sentence": "Itraconazole: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of @DRUG1$ and itraconazole in clinical trials of @DRUG2$ and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3720,
        "sentence": "Other @DRUG1$ should not be used concomitantly with Alupent    (@DRUG2$ USP) because they may have additive effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3721,
        "sentence": "@DRUG1$: Excessive reductions in blood pressure may occur in patients on diuretic therapy when @DRUG2$ are started.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3722,
        "sentence": "Careful monitoring of @DRUG1$ concentrations and serum creatinine is recommended in patients receiving @DRUG2$ and cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3723,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3724,
        "sentence": "@DRUG1$ should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, @DRUG2$, or alcohol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3725,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3726,
        "sentence": "@DRUG1$ has been reported to prolong the elimination half-life of @DRUG2$ and may lead to severe bone marrow suppression;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3727,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, @DRUG1$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3728,
        "sentence": "Absorption of tetracyclines is impaired by @DRUG1$ containing aluminum, calcium or magnesium, and @DRUG2$-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3729,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3730,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower @DRUG2$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3731,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3732,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with alcohol, @DRUG1$, hypnotics, @DRUG2$, or tranquilizers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3733,
        "sentence": "In these subjects, @DRUG1$ did not alter @DRUG2$ pharmacokinetics and the average anticoagulant effect of warfarin as determined by prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3734,
        "sentence": "In another formal study (n = 8 extensive and n = 7 poor metabolizers of CYP2D6), coadministration of @DRUG1$ did not alter the kinetics of @DRUG2$ in the poor CYP2D6 metabolizer group.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3735,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain @DRUG2$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3736,
        "sentence": "Caution is recommended when administering @DRUG1$ with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3737,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3738,
        "sentence": "Caution is advised for patients receiving high-dose @DRUG1$ and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3739,
        "sentence": "@DRUG1$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving @DRUG2$ during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3740,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3741,
        "sentence": "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking @DRUG1$-@DRUG2$ containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3742,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3743,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3744,
        "sentence": "ProAmatine. @DRUG1$, such as @DRUG2$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3745,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG1$ (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3746,
        "sentence": "@DRUG1$ and @DRUG2$ had no effect, while quinidine appeared to augment precocene I toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3747,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG1$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3748,
        "sentence": "Some diuretics can enhance @DRUG1$ toxicity by altering @DRUG2$ concentrations in serum and tissue.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3749,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for @DRUG1$ or nifedipine toxicity and @DRUG2$ or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3750,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, @DRUG2$, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3751,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3752,
        "sentence": "Sympathomimetics: @DRUG1$ may decrease arterial responsiveness to @DRUG2$, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3753,
        "sentence": "@DRUG1$: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and @DRUG2$ in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3754,
        "sentence": "@DRUG1$ may enhance the hypoglycemic effect of oral @DRUG2$ of the sulfonylurea class.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3755,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3756,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG1$, procainamide, @DRUG2$, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3757,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral @DRUG1$ (@DRUG2$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3758,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., @DRUG1$) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., @DRUG2$, tetracycline, levodopa, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3759,
        "sentence": "The role of p27(Kip1) in @DRUG1$-enhanced @DRUG2$ cytotoxicity in human ovarian cancer cells.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3760,
        "sentence": "@DRUG1$/@DRUG2$: may be taken with Myfortic;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3761,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3762,
        "sentence": "Other Antihypertensives: When @DRUG1$ Tablets are used with other @DRUG2$, care must be taken, especially during initial therapy.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3763,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3764,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, @DRUG2$, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3765,
        "sentence": "The bioavailability of @DRUG1$ is increased 2-4 fold by indomethacin but is not significantly altered by coadministration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3766,
        "sentence": "Oral Contraceptives: Given the different metabolism of @DRUG1$ and oral @DRUG2$, no drug interaction between these two classes of drug is expected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3767,
        "sentence": "Phenytoin, @DRUG1$, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3768,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when @DRUG1$ was co-administered with atorvastatin, @DRUG2$, pravastatin, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3769,
        "sentence": "@DRUG1$: Clinical drug interaction studies indicate that erythromycin and @DRUG2$ can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3770,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG2$ (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3771,
        "sentence": "@DRUG1$ induced apoptosis, and furthermore, the combination of @DRUG2$ plus doxorubicin enhanced cytotoxicity in a T-ALL cell line.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3772,
        "sentence": "There are no controlled studies documenting the use of @DRUG1$    before or after other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3773,
        "sentence": "In clinical studies, patients on @DRUG1$ often needed higher serum @DRUG2$ concentrations to achieve appropriate IGF-I suppression compared with patients not receiving opioids.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3774,
        "sentence": "Sulfamethizole may increase the effects of @DRUG1$, tolbutamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3775,
        "sentence": "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and @DRUG1$) may increase the risk of bleeding if administered prior to or after @DRUG2$    therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3776,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3777,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as @DRUG1$ (@DRUG2$), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3778,
        "sentence": "Beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or @DRUG1$, since the action of @DRUG2$ on the vascular system may be potentiated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3779,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3780,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3781,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, @DRUG1$, pravastatin, @DRUG2$, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3782,
        "sentence": "This could lead to decreased @DRUG1$ serum levels or increase the risk of salicylate toxicity when @DRUG2$ is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3783,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as @DRUG1$ (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., @DRUG2$ and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3784,
        "sentence": "While there is evidence that @DRUG1$ can inhibit the metabolism of @DRUG2$ and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3785,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, @DRUG2$, nitrous oxide, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3786,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG2$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3787,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, @DRUG2$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3788,
        "sentence": "However, the co   administration of @DRUG1$ with other @DRUG2$   containing drugs (e.g., ipratropium) has not been studied and is therefore not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3789,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-@DRUG1$    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3790,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, @DRUG1$ (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3791,
        "sentence": "In a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, @DRUG1$ and sulfamethizole displaced protein-bound @DRUG2$ in fresh human serum to a small but significant extent.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3792,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG1$ (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3793,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3794,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, @DRUG1$, sulfinpyrazone, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3795,
        "sentence": "@DRUG1$/Levodopa: Carbidopa/@DRUG2$ does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3796,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and @DRUG1$), propofol, ketamine, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3797,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3798,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG1$-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3799,
        "sentence": "The synergistic antinociception activity of @DRUG1$ when administered with @DRUG2$ can be attributed to increased plasma concentration of ibuprofen.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3800,
        "sentence": "Careful monitoring of prothrombin time in patients receiving @DRUG1$ and @DRUG2$ is recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3801,
        "sentence": "- did not cause any clinically significant change in plasma profiles of prednisone or @DRUG1$ following administration of either oral prednisone or intravenous @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3802,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3803,
        "sentence": "With respect to toxicity, the order of CYP inhibitor effectiveness was @DRUG1$>diethyldithiocarbamate~@DRUG2$>ketoconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3804,
        "sentence": "If ZEMURON    is administered following administration of @DRUG1$, it should not be given until recovery from @DRUG2$ has been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3805,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3806,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, @DRUG1$, rifapentin, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3807,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3808,
        "sentence": "@DRUG1$: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3809,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3810,
        "sentence": "A variety of @DRUG1$ such as quinidine or @DRUG2$ were also added, sometimes with improved control of ventricular ectopy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3811,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3812,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG1$), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3813,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and @DRUG1$ are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3814,
        "sentence": "@DRUG1$: In clinical trials, NSAIDs have produced an elevation of plasma @DRUG2$ levels and a reduction in renal lithium clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3815,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (@DRUG1$, Isopto Carbachol) may decrease the effects of @DRUG2$ ophthalmic.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3816,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG1$ (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3817,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other @DRUG1$) or local @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3818,
        "sentence": "The bioavailability of SKELID is increased 2-4 fold by @DRUG1$ but is not significantly altered by coadministration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3819,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or @DRUG1$ or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3820,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3821,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and @DRUG1$), propofol, @DRUG2$, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3822,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3823,
        "sentence": "@DRUG1$: DIFLUCAN may significantly increase @DRUG2$ levels in renal transplant patients with or without renal impairment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3824,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3825,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3826,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3827,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG1$, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3828,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including @DRUG1$, @DRUG2$, hypnotics, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3829,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3830,
        "sentence": "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as @DRUG1$ or @DRUG2$, are co-administered with montelukast.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3831,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3832,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with @DRUG1$    Tablets, but an effect of digoxin on the plasma concentration of @DRUG2$/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3833,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, @DRUG2$, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3834,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3835,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3836,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3837,
        "sentence": "morphine, theophylline, @DRUG1$, @DRUG2$, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3838,
        "sentence": "The effects of @DRUG1$ on gastrointestinal motility are antagonized by anticholinergic drugs and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3839,
        "sentence": "@DRUG1$: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of @DRUG2$ and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3840,
        "sentence": "Drugs such as erythromycin, diltiazem, @DRUG1$, @DRUG2$, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3841,
        "sentence": "Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, @DRUG1$ + paclitaxel vs @DRUG2$: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3842,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3843,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3844,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3845,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3846,
        "sentence": "There is usually complete cross-resistance between @DRUG1$ (mercaptopurine) and @DRUG2$ brand Thioguanine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3847,
        "sentence": "TOLECTIN and other @DRUG1$ have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3848,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG1$, carbamazepine, and @DRUG2$), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3849,
        "sentence": "@DRUG1$: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, @DRUG2$, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3850,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  @DRUG1$: Although no pharmacokinetic drug interaction between @DRUG2$ and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3851,
        "sentence": "Use of Anticoagulants and @DRUG1$ -- Streptase, Streptokinase, alone or in combination with @DRUG2$ and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3852,
        "sentence": "This study aimed to evaluate the in vitro activity of minocycline combined with @DRUG1$ against isolates of @DRUG2$-resistant Staphylococcus aureus (MRSA).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3853,
        "sentence": "@DRUG1$ AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state @DRUG2$ compared with nifedipine alone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3854,
        "sentence": "@DRUG1$ has a much weaker effect on @DRUG2$'s pharmacokinetics and on platelet reactivity during concomitant use.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3855,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3856,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like @DRUG1$ or methysergide) and @DRUG2$ within 24 hours of each other should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3857,
        "sentence": "With respect to toxicity, the order of CYP inhibitor effectiveness was ABT>@DRUG1$~tranylcypromine>@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3858,
        "sentence": "Usage with @DRUG1$: Due to the potential for increased CNS depressants effects, @DRUG2$ should be used with caution in patients who are currently receiving pentazocine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3859,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG1$ (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3860,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3861,
        "sentence": "We sought to evaluate whether initiation of an @DRUG1$ increases the risk of hospitalization for gastrointestinal bleeding in @DRUG2$ users.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3862,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted @DRUG1$ (clotrimazole, @DRUG2$, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3863,
        "sentence": "Because of profound and long lasting inhibition of gastric acid secretion, @DRUG1$ may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, ampicillin esters, and @DRUG2$ salts).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3864,
        "sentence": "The effects of @DRUG1$, zidovudine or @DRUG2$ on the pharmacokinetics of megestrol acetate were not studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3865,
        "sentence": "Phenobarbital, which induces hepatic metabolism, decreased the AUC of @DRUG1$ approximately 40% following a single 10-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3866,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG2$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3867,
        "sentence": "Catecholamine-depleting drugs (e.g., @DRUG1$) may have an additive effect when given with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3868,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3869,
        "sentence": "@DRUG1$ administered concomitantly with @DRUG2$ may significantly decrease the serum concentrations of MPA.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3870,
        "sentence": "This effect on midazolam appears to be more pronounced following oral administration of @DRUG1$ than with @DRUG2$ administered intravenously.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3871,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG1$, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3872,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3873,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, @DRUG1$, @DRUG2$, ibuprofen, diazepam, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3874,
        "sentence": "In addition to bleeding associated with @DRUG1$ and vitamin K antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and @DRUG2$) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3875,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3876,
        "sentence": "Although not studied, the potent cytochrome P450 3A4 inhibitors ritonavir and @DRUG1$ may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3877,
        "sentence": "In post-marketing experience, as with other @DRUG1$, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving fluconazole concurrently with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3878,
        "sentence": "- did not cause any clinically significant change in plasma profiles of prednisone or prednisolone following administration of either oral @DRUG1$ or intravenous @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3879,
        "sentence": "@DRUG1$: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving @DRUG2$ 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of pravastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3880,
        "sentence": "@DRUG1$ (such as heparin and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3881,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3882,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG1$ and fentanyl), @DRUG2$, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3883,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3884,
        "sentence": "Macrolides: Clinical drug interaction studies indicate that @DRUG1$ and clarithromycin can exert an effect on @DRUG2$ metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3885,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG1$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3886,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, @DRUG2$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3887,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), @DRUG1$, ketamine, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3888,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3889,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3890,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3891,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3892,
        "sentence": "Glyburide: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, @DRUG1$ did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3893,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, @DRUG2$ (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3894,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3895,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3896,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG1$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3897,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG1$), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3898,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, @DRUG1$, rifampin, rifabutin, @DRUG2$, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3899,
        "sentence": "Paliperidone may antagonize the effect of @DRUG1$ and other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3900,
        "sentence": "@DRUG1$: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of @DRUG2$/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3901,
        "sentence": "In addition, @DRUG1$ insensitivity might be associated with overexpression of Bcl-2, and the combination of @DRUG2$ and DZNep could synergistically induced apoptosis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3902,
        "sentence": "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, @DRUG1$, @DRUG2$, or chondroitin ABC lyase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3903,
        "sentence": "Patients studied in clinical trials of @DRUG1$ were routinely treated with heparin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3904,
        "sentence": "To determine whether the co-injection of extracellular matrix degrading enzymes improves retinal transduction following intravitreal delivery of @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3905,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral @DRUG2$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3906,
        "sentence": "Patients with Congenital or Acquired QT Prolongation In a study of the effect of @DRUG1$ on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control @DRUG2$ at its therapeutic dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3907,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., @DRUG1$, @DRUG2$, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3908,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with @DRUG1$, similar neuromuscular blocking agents or @DRUG2$ such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3909,
        "sentence": "and combinations of opioids and @DRUG1$ (eg, benzodiazepines, barbiturates, chloral hydrate, @DRUG2$, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3910,
        "sentence": "@DRUG1$    does not alter serum @DRUG2$ levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3911,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, @DRUG2$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3912,
        "sentence": "In addition to bleeding associated with @DRUG1$ and vitamin K antagonists, drugs that alter platelet function (such as @DRUG2$, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3913,
        "sentence": "@DRUG1$ users who initiated citalopram, fluoxetine, @DRUG2$, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3914,
        "sentence": "Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral @DRUG1$ by 2.4-fold, whereas @DRUG2$ treatment did not increase the exposure to S-ketamine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3915,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG1$, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3916,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3917,
        "sentence": "Cyclosporine: Preliminary data from a XENICAL and cyclosporine drug interaction study indicate a reduction in @DRUG1$ plasma levels when XENICAL was coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3918,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3919,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other @DRUG2$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3920,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 3921,
        "sentence": "@DRUG1$ and Lomefloxacin reacts faster with sucralfate and @DRUG2$ in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3922,
        "sentence": "@DRUG1$: The use of fluconazole in patients concurrently taking @DRUG2$ or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3923,
        "sentence": "Drug Interactions: The use of @DRUG1$    (rocuronium bromide) Injection before @DRUG2$, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3924,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3925,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3926,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3927,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3928,
        "sentence": "A study published in 2002 found that @DRUG1$ causes a statistically significant increase in plasma clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3929,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3930,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, diphenylhydantoin, @DRUG2$), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3931,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3932,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3933,
        "sentence": "@DRUG1$ Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used @DRUG2$ (eg, succinylcholine and nondepolarizing muscle relaxants).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3934,
        "sentence": "@DRUG1$: Serum digitalis levels may be increased when hyperthyroid patients on a stable @DRUG2$ regimen become euthyroid;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3935,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG1$), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3936,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3937,
        "sentence": "@DRUG1$ may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3938,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3939,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3940,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3941,
        "sentence": "These results, if confirmed in-vivo, indicate that @DRUG1$ is not a suitable chemosensitizer for breast cancer or with @DRUG2$ for other cancers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3942,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG2$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3943,
        "sentence": "The use of MIVACRON before @DRUG1$ to attenuate some of the side effects of @DRUG2$ has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3944,
        "sentence": "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of @DRUG1$ (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), @DRUG2$ (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3945,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, triiodothyronine, @DRUG2$, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3946,
        "sentence": "Due to the chemical similarity of other @DRUG1$ (including @DRUG2$, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3947,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3948,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3949,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), @DRUG2$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3950,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3951,
        "sentence": "@DRUG1$ has been used concurrently with antihypertensive drugs, @DRUG2$, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3952,
        "sentence": "@DRUG1$ - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving @DRUG2$ (MAOI).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3953,
        "sentence": "This could lead to decreased salicylate serum levels or increase the risk of @DRUG1$ toxicity when @DRUG2$ is withdrawn.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3954,
        "sentence": "@DRUG1$ may be used with sulfonamides, @DRUG2$ and other antimalarials, and with other antibiotics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3955,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG1$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3956,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3957,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, @DRUG1$, @DRUG2$, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3958,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3959,
        "sentence": "@DRUG1$ reduces the metabolism of tolbutamide, @DRUG2$, and glipizide and increases the plasma concentration of these agents.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3960,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to 5-FU, @DRUG1$, doxorubicin and @DRUG2$   celecoxib following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3961,
        "sentence": "Drugs such as erythromycin, @DRUG1$, @DRUG2$, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3962,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, @DRUG1$, general anesthetics, phenothiazines, other opioids, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3963,
        "sentence": "Carbidopa/@DRUG1$: Carbidopa/@DRUG2$ does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3964,
        "sentence": "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as aspirin, @DRUG1$, and @DRUG2$) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3965,
        "sentence": "Aspirin: Concomitant administration of @DRUG1$ (1000 mg TID) to healthy volunteers tended to increase the AUC (10%) and Cmax (24%) of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3966,
        "sentence": "Concomitant administrations not recommended:  - Terfenadine and @DRUG1$: Certain macrolides interact with terfenadine and @DRUG2$ leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3967,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3968,
        "sentence": "Concurrent administration of @DRUG1$ (e.g., erythromycin, tetracycline) may diminish the bactericidal effects of @DRUG2$ by slowing the rate of bacterial growth.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3969,
        "sentence": "Such occurrences have been reported when @DRUG1$ was administered to patients on @DRUG2$, anticonvulsants, or warfarin-like drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3970,
        "sentence": "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of @DRUG1$ (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total @DRUG2$ clearance in the same subjects in the absence of cimetidine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3971,
        "sentence": "Absorption of tetracyclines is impaired by @DRUG1$ containing aluminum, calcium or @DRUG2$, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3972,
        "sentence": "- Cisapride, @DRUG1$: Other drugs such as cisapride or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 3973,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG1$, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3974,
        "sentence": "Concomitant administration of terfenadine with @DRUG1$, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other @DRUG2$, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3975,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (@DRUG1$) and @DRUG2$ (Carboptic, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3976,
        "sentence": "In clinical studies of @DRUG1$, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), @DRUG2$, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3977,
        "sentence": "However, on the basis of available data, no dosage adjustment for @DRUG1$ is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that @DRUG2$ may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3978,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, @DRUG2$, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3979,
        "sentence": "Oral @DRUG1$: Interaction studies with warfarin failed to identify any clinically important effect on the serum concentrations of the @DRUG2$ or on its anticoagulant effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3980,
        "sentence": "Drug interactions should be kept in mind when METROGEL (@DRUG1$ gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical @DRUG2$ administration because of low absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3981,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG2$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3982,
        "sentence": "In a pharmacokinetic study of 18 chronic hepatitis C patients concomitantly receiving methadone, treatment with @DRUG1$ once weekly for 4 weeks was associated with a mean increase of 16% in @DRUG2$ AUC;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3983,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3984,
        "sentence": "Other Agents: No clinically important pharmacokinetic interactions occurred when @DRUG1$    was administered concomitantly with hydrochlorothiazide, digoxin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3985,
        "sentence": "Digoxin: In 12 normal-weight subjects receiving @DRUG1$ 120 mg three times a day for 6 days, XENICAL did not alter the pharmacokinetics of a single dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3986,
        "sentence": "DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with @DRUG1$ are not recommended in immunocompromised individuals  Nalidixic acid together with high-dose intravenous @DRUG2$ has caused deaths in children due to haemorrhagic enterocolitis.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3987,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL @DRUG2$, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3988,
        "sentence": "The neuromuscular blocking effect of @DRUG1$ may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain @DRUG2$) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 3989,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, @DRUG1$, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3990,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3991,
        "sentence": "Dopamine antagonists: Since pramipexole is a @DRUG1$, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3992,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of @DRUG1$-containing or ergot-type medications (like dihydroergotamine or methysergide) and @DRUG2$ within 24 hours of each other should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 3993,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3994,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including @DRUG1$, metronidazole, and @DRUG2$) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3995,
        "sentence": "e.g., other @DRUG1$, antihistamines (including meclizine), @DRUG2$, and muscle relaxants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3996,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3997,
        "sentence": "Although ibuprofen (400 mg qid) can be administered with @DRUG1$ in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with @DRUG2$ to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3998,
        "sentence": "Macrolides: Clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on @DRUG1$ metabolism by a mechanism which may be similar to that of @DRUG2$, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 3999,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some @DRUG1$, @DRUG2$, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4000,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4001,
        "sentence": "@DRUG1$: Torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and @DRUG2$ in clinical trials of itraconazole and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4002,
        "sentence": "Patients receiving @DRUG1$ or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and sirolimus or @DRUG2$ dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4003,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4004,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4005,
        "sentence": "In addition to bleeding associated with heparin and vitamin K antagonists, drugs that alter platelet function (such as @DRUG1$, @DRUG2$, and abciximab) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4006,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG2$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4007,
        "sentence": "Several studies demonstrate a decrease in the bioavailability of @DRUG1$ when it is ingested with ferrous sulfate or @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4008,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as @DRUG1$, indomethacin, naproxen, ibuprofen, @DRUG2$, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4009,
        "sentence": "@DRUG1$ may antagonize the effect of @DRUG2$ and other dopamine agonists.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4010,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general @DRUG1$ - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4011,
        "sentence": "Diuretics: Patients on @DRUG1$, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of @DRUG2$    Tablets therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4012,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4013,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between @DRUG1$ and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4014,
        "sentence": "The FDA has approved ticagrelor (@DRUG1$-AstraZeneca), an oral @DRUG2$, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4015,
        "sentence": "The effects of @DRUG1$, such as @DRUG2$ and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4016,
        "sentence": "In the present study, the antidepressant like activity of curcumin and its combination with @DRUG1$ and @DRUG2$ was studied in acute model (three doses 24, 5 and 1 h before test) of forced swimming test (FST) in glass jar and tail suspension test (TST) in mice and in chronic model (14 day study) of FST with water wheel in rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4017,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, @DRUG1$, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4018,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and @DRUG1$ are administered at the same time, and 60% by some aluminum- or magnesium-containing @DRUG2$, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4019,
        "sentence": "CYP3A4 Inhibitors: @DRUG1$, an inhibitor of the drug metabolizing enzyme CYP3A4, significantly increased plasma concentrations of @DRUG2$ when coadministered to subjects who were poor metabolizers (see CLINICAL PHARMACOLOGY, Variability in Metabolism and Drug-Drug Interactions).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4020,
        "sentence": "@DRUG1$ or @DRUG2$ In patients with edema, concomitant administration with adrenal cortical steroids or ACTH may increase the edema.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4021,
        "sentence": "In vitro, @DRUG1$ did not displace @DRUG2$ from its human serum binding sites.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4022,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4023,
        "sentence": "@DRUG1$: The coadministration of @DRUG2$ and warfarin has not been assessed under chronic conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4024,
        "sentence": "Pharmacokinetic properties of @DRUG1$ were not altered by the addition of either lamivudine or zidovudine or the combination of @DRUG2$ and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4025,
        "sentence": "@DRUG1$: There have been reports of cardiac events, including torsade de pointes in patients to whom @DRUG2$ and cisapride were coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4026,
        "sentence": "The concomitant use of @DRUG1$ with other @DRUG2$ that produce dry mouth, constipation, and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4027,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG1$ (n=79), @DRUG2$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4028,
        "sentence": "The induction dose requirements of DIPRIVAN Injectable Emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with @DRUG1$ (eg, morphine, meperidine, and @DRUG2$, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4029,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG2$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4030,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG1$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4031,
        "sentence": "The data presently available indicate that the decreases in some individual ethinyl estradiol and @DRUG1$ AUC values with @DRUG2$ treatment are likely the result of random variation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4032,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4033,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4034,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG1$, @DRUG2$, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4035,
        "sentence": "Warfarin: A multidose study of @DRUG1$, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in @DRUG2$ half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4036,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, @DRUG2$, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4037,
        "sentence": "Weekly intramuscular @DRUG1$ injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus @DRUG2$/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4038,
        "sentence": "@DRUG1$    does not alter serum digoxin levels but @DRUG2$, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4039,
        "sentence": "@DRUG1$: No clinically significant pharmacokinetic interactions were seen when @DRUG2$ was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4040,
        "sentence": "These medications included @DRUG1$, @DRUG2$, non-steroidal anti-inflammatory agents, benzodiazepines, and decongestants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4041,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4042,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4043,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as @DRUG1$, @DRUG2$, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4044,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, medroxyprogesterone acetate, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4045,
        "sentence": "Anticoagulants (such as @DRUG1$ and vitamin K antagonists) and drugs that alter platelet function (such as @DRUG2$, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4046,
        "sentence": "@DRUG1$: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/@DRUG2$ has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4047,
        "sentence": "Phenothiazines are capable of potentiating @DRUG1$ (e.g., barbiturates, anesthetics, @DRUG2$, alcohol, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4048,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4049,
        "sentence": "@DRUG1$    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to @DRUG2$   , has been reported to lower serum digoxin levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4050,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4051,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4052,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4053,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4054,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, @DRUG1$, @DRUG2$, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4055,
        "sentence": "EA signs were observed in all 7 patients in association with @DRUG1$ TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4056,
        "sentence": "When @DRUG1$ is used concomitantly with these or other @DRUG2$, blood glucose concentrations should be carefully monitored and the dose of the sulfonylurea should be adjusted as necessary.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4057,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, @DRUG2$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4058,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG1$, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4059,
        "sentence": "@DRUG1$ (Brilinta)--better than clopidogrel (@DRUG2$)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4060,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, @DRUG1$, @DRUG2$, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4061,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4062,
        "sentence": "Concurrent ingestion of antacid (20 mL of @DRUG1$ containing aluminum hydroxide, @DRUG2$, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4063,
        "sentence": "Methyldopa does not interfere with measurement of VMA (@DRUG1$), a test for pheochromocytoma, by those methods which convert @DRUG2$ to vanillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4064,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG1$, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4065,
        "sentence": "The concurrent administration of potent inhalational agents (eg, isoflurane, @DRUG1$, and halothane) during maintenance with @DRUG2$ Injectable Emulsion has not been extensively evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4066,
        "sentence": "@DRUG1$ as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by @DRUG2$ is superior to sunitinib followed by docetaxel and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4067,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4068,
        "sentence": "@DRUG1$: Prothrombin time may be increased in patients receiving concomitant DIFLUCAN and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4069,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or @DRUG1$ (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4070,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4071,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4072,
        "sentence": "Ketoconazole: Spontaneous adverse reaction reports of patients taking concomitant @DRUG1$ with recommended doses of @DRUG2$ demonstrate QT interval prolongation and rare serious cardiac events, e.g.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4073,
        "sentence": "There is usually complete cross-resistance between PURINETHOL (@DRUG1$) and TABLOID brand @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4074,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4075,
        "sentence": "With respect to toxicity, the order of CYP inhibitor effectiveness was @DRUG1$>diethyldithiocarbamate~tranylcypromine>@DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4076,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG1$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4077,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4078,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: Agonist/antagonist analgesics (i.e., @DRUG1$, nalbuphine, butorphanol, or @DRUG2$) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4079,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG2$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4080,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), @DRUG2$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4081,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by @DRUG1$, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, @DRUG2$, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4082,
        "sentence": "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with @DRUG1$ for breast cancer, especially @DRUG2$ such as paroxetine and fluoxetine.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4083,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG1$, @DRUG2$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4084,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4085,
        "sentence": "Drugs which may potentiate the myeloproliferative effects of @DRUG1$, such as @DRUG2$ and corticosteroids, should be used with caution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4086,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG1$, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4087,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4088,
        "sentence": "Reduced absorption of folic acid and @DRUG1$ have been reported when those agents were administered concomitantly with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4089,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: @DRUG1$, prednisone, prednisolone, oral contraceptives (@DRUG2$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4090,
        "sentence": "The use of @DRUG1$ before succinylcholine to attenuate some of the side effects of @DRUG2$ has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4091,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, @DRUG1$, clarithromycin) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4092,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$ and @DRUG2$ may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4093,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4094,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4095,
        "sentence": "An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as @DRUG1$) may decrease the AUC of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4096,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, @DRUG2$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4097,
        "sentence": "Co-administration of @DRUG1$ with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4098,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG1$, OTHER @DRUG2$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4099,
        "sentence": "Carbidopa/@DRUG1$: Carbidopa/Levodopa does not influence the pharmacokinetics of @DRUG2$ in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4100,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other @DRUG1$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4101,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG2$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4102,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4103,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4104,
        "sentence": "It will compete with @DRUG1$ (@DRUG2$) and prasugrel (Effient) for such use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4105,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4106,
        "sentence": "The ratio of @DRUG1$ AUC(0-   ) to ketamine AUC(0-   ) was significantly decreased in the ticlopidine (P &lt; 0.001) and @DRUG2$ phases (P = 0.006) as compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4107,
        "sentence": "Being moxifloxacin and lomefloxacin @DRUG1$ the interaction study of was carried out with sucralfate, gelusil, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4108,
        "sentence": "MAO Inhibitors: The pressor effect of @DRUG1$ is markedly potentiated in patients receiving @DRUG2$ (MAOI).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4109,
        "sentence": "Nevertheless, during concomitant therapy with @DRUG1$ and @DRUG2$, patients should be observed closely for signs of declining renal function, as well as to assure diuretic efficacy.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4110,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (@DRUG2$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4111,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, miconazole) or macrolide antibiotics (eg, erythromycin, @DRUG2$) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4112,
        "sentence": "The in vitro binding of warfarin to human plasma proteins is unaffected by @DRUG1$, and @DRUG2$ does not alter the prothrombin time of normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4113,
        "sentence": "Laboratory Tests There have been reports of false-positive urine screening tests for @DRUG1$ (THC) in patients receiving most @DRUG2$, including pantoprazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4114,
        "sentence": "We concluded that the combined administration of @DRUG1$ with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of @DRUG2$ as an analgesic in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4115,
        "sentence": "SKELAXIN may enhance the effects of @DRUG1$, @DRUG2$ and other CNS depressants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4116,
        "sentence": "Mixing @DRUG1$ and @DRUG2$ The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4117,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4118,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4119,
        "sentence": "Anticholinesterases: Concurrent use of @DRUG1$ and anticholinesterase agents may result in increased systemic toxicity since @DRUG2$ inhibit the breakdown of procaine hydrochloride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4120,
        "sentence": "Triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, @DRUG1$, hypnotics, narcotic analgesics, sedatives, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4121,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing @DRUG1$ has been demonstrated in patients chronically administered @DRUG2$ or carbamazepine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4122,
        "sentence": "Due to its effects on gastric emptying, @DRUG1$ therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., @DRUG2$ such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4123,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4124,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (@DRUG2$ 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4125,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4126,
        "sentence": "Oral Contraceptives: In 20 normal-weight female subjects, the treatment of @DRUG1$ 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4127,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4128,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, @DRUG1$, @DRUG2$, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4129,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG1$, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4130,
        "sentence": "Careful monitoring of serum @DRUG1$ concentrations in patients receiving DIFLUCAN and @DRUG2$ is recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4131,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4132,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4133,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4134,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG1$ (@DRUG2$, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4135,
        "sentence": "Oral @DRUG1$: Interaction studies with @DRUG2$ failed to identify any clinically important effect on the serum concentrations of the anticoagulant or on its anticoagulant effect.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4136,
        "sentence": "Concurrent administration of @DRUG1$ (e.g., @DRUG2$, tetracycline) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4137,
        "sentence": "Agents that might be coadministered with @DRUG1$ in AIDS patients for other indications that could elicit this activity include erythromycin, @DRUG2$, rifabutin, ketoconazole, and fluconazole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4138,
        "sentence": "patients receiving @DRUG1$ and @DRUG2$ should have more frequent monitoring of neutrophil counts.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4139,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG1$ (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4140,
        "sentence": "The susceptibility results for @DRUG1$ and @DRUG2$ were interpreted according to the most relevant criteria.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4141,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4142,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4143,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL @DRUG1$, PHENOTHIAZINES, OTHER @DRUG2$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4144,
        "sentence": "@DRUG1$: Patients on @DRUG2$, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of ACEON    Tablets therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4145,
        "sentence": "Pyrimethamine may be used with @DRUG1$, quinine and other @DRUG2$, and with other antibiotics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4146,
        "sentence": "Caution should be exercised when Methergine    (@DRUG1$) is used concurrently with other vasoconstrictors or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4147,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or @DRUG1$ or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4148,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG1$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4149,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4150,
        "sentence": "AGGRASTAT has been studied on a background of @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4151,
        "sentence": "@DRUG1$: In a pharmacokinetic study, concomitant fenofibrate administration increased total @DRUG2$ concentrations approximately 1.5-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4152,
        "sentence": "The median duration of action of @DRUG1$    0.6 mg/kg administered after a 1 mg/kg dose of @DRUG2$ when T 1 returned to 75% of control was 36 minutes (range 14-57, n=12) vs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4153,
        "sentence": "Other Agents: No clinically important pharmacokinetic interactions occurred when @DRUG1$    was administered concomitantly with @DRUG2$, digoxin, or cimetidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4154,
        "sentence": "@DRUG1$: Clinical drug interaction studies indicate that @DRUG2$ and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4155,
        "sentence": "@DRUG1$ renal clearance is reduced by thiazides, increasing the risk of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4156,
        "sentence": "@DRUG1$ may increase the effects of barbiturates, @DRUG2$, and uricosurics.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4157,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, @DRUG1$ pharmacodynamics (fecal fat excretion), or systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4158,
        "sentence": "When a single 100 mg dose of rimantadine HCl was administered one hour after the initiation of @DRUG1$ (300 mg four times a day), the apparent total @DRUG2$ clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4159,
        "sentence": "Warfarin: Anticoagulant activity should be monitored, particularly in the first few days after initiating or changing @DRUG1$ therapy in patients receiving @DRUG2$ or similar agents, since these patients are at an increased risk of bleeding.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4160,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and @DRUG1$), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4161,
        "sentence": "Lithium: Increased serum @DRUG1$ levels and symptoms of @DRUG2$ toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4162,
        "sentence": "This may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, @DRUG1$ (@DRUG2$), and monoamine oxidase inhibitors (MAO-Is) Type B, if they have a narrow therapeutic window.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4163,
        "sentence": "It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with @DRUG1$ for breast cancer, especially SSRI antidepressants such as @DRUG2$ and fluoxetine.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4164,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4165,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral @DRUG1$, hormone replacement therapies, hypoglycemics, @DRUG2$, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4166,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4167,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4168,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), nortriptyline (@DRUG2$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4169,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4170,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4171,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4172,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), @DRUG1$ (Parnate), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4173,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, @DRUG2$, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4174,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4175,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for @DRUG1$ or nifedipine toxicity and sirolimus or @DRUG2$ dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4176,
        "sentence": "TRENTAL has been used concurrently with @DRUG1$, beta blockers, @DRUG2$, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4177,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG1$), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4178,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4179,
        "sentence": "MAO Inhibitors: The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4180,
        "sentence": "Fluconazole tablets coadministered with @DRUG1$- and levonorgestrel-containing oral @DRUG2$ produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4181,
        "sentence": "Coadministration of @DRUG1$ with clarithromycin resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased @DRUG2$ plasma concentrations (31%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4182,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that @DRUG1$ is a net inducer of ethinyl estradiol or @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4183,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4184,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of @DRUG1$ and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4185,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG1$, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4186,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4187,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4188,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4189,
        "sentence": "Caution should be used when @DRUG1$ is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, @DRUG2$, and diazoxide.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4190,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4191,
        "sentence": "Treatment of HEY xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + @DRUG1$ vs @DRUG2$: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4192,
        "sentence": "saline + saline, ephedrine (10   mg/kg) + saline, saline + @DRUG1$ (15     g/kg) and ephedrine (10   mg/kg) + @DRUG2$ (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4193,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, @DRUG1$, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4194,
        "sentence": "Drug Interactions: The use of ZEMURON    (@DRUG1$) Injection before succinylcholine, for the purpose of attenuating some of the side effects of @DRUG2$, has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4195,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG2$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4196,
        "sentence": "Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and @DRUG1$ and selective serotonin reuptake inhibitors and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4197,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG2$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4198,
        "sentence": "Drug Interactions: The use of @DRUG1$    (@DRUG2$) Injection before succinylcholine, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4199,
        "sentence": "Alcohol, Barbiturates, and @DRUG1$: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with @DRUG2$ therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4200,
        "sentence": "Pharmacokinetic properties of @DRUG1$ were not altered by the addition of either @DRUG2$ or zidovudine or the combination of lamivudine and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4201,
        "sentence": "@DRUG1$: Clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on @DRUG2$ metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4202,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of @DRUG1$.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4203,
        "sentence": "@DRUG1$: @DRUG2$, 100 mg, was given twice daily fro 13 days to 12 healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4204,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, @DRUG2$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4205,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4206,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, @DRUG1$, rifampin, @DRUG2$, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4207,
        "sentence": "@DRUG1$ should be used with care in patients taking other drugs that are capable of causing CNS effects such as @DRUG2$, tranquilizers, or alcohol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4208,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG1$), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4209,
        "sentence": "Administration of paclitaxel in combination with @DRUG1$ resulted in a two-fold decrease in @DRUG2$ clearance in a non-human primate study and in a 1.5-fold increase in HERCEPTIN serum levels in clinical studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4210,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4211,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, @DRUG1$, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4212,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, @DRUG1$, fluvoxamine, @DRUG2$, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4213,
        "sentence": "This study was aimed to investigate the efficacy of single use of @DRUG1$ and that of concurrent or sequential administration of sunitinib and @DRUG2$ in NSCLC cell lines that are resistant to EGFR TKIs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4214,
        "sentence": "However, on the basis of available data, no dosage adjustment for @DRUG1$ is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4215,
        "sentence": "Caution should be exercised when @DRUG1$    (methylergonovine maleate) is used concurrently with other @DRUG2$ or ergot alkaloids.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4216,
        "sentence": "If at all possible @DRUG1$ should be discontinued well before @DRUG2$ is begun.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4217,
        "sentence": "Less potent inhibitors include saquinavir, @DRUG1$, fluconazole, grapefruit juice, fluoxetine, @DRUG2$, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4218,
        "sentence": "Combination with @DRUG1$ (@DRUG2$) is associated with increased risk of seizures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4219,
        "sentence": "@DRUG1$: @DRUG2$ may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4220,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG2$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4221,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4222,
        "sentence": "Since bacteriostatic drugs may interfere with the bactericidal action of @DRUG1$, it is advisable to avoid giving tetracycline class drugs in conjunction with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4223,
        "sentence": "@DRUG1$: Diuretic-induced hypokalemia may enhance neuromuscular blocking effects of @DRUG2$ (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4224,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG2$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4225,
        "sentence": "@DRUG1$, which induces hepatic metabolism, decreased the AUC of @DRUG2$ approximately 40% following a single 10-mg dose of montelukast.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4226,
        "sentence": "@DRUG1$ Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, succinylcholine and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4227,
        "sentence": "To minimize CNS depression and possible potentiation, barbiturates, antihistamines, @DRUG1$, @DRUG2$ or phenothiazines should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4228,
        "sentence": "EA signs were observed in all 7 patients in association with @DRUG1$ TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low-dose @DRUG2$ was added to propofol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4229,
        "sentence": "Coadministration of a selective and potent inhibitor of CYP3A4, @DRUG1$ (100 mg bid for 2 days with @DRUG2$ infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4230,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - @DRUG1$: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4231,
        "sentence": "@DRUG1$: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of @DRUG2$ and thiazide diuretics in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4232,
        "sentence": "Questioning revealed the child was taking @DRUG1$ drops before feeds while on @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4233,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4234,
        "sentence": "The incubations were performed in the absence and presence of the non-specific CYP inhibitor, @DRUG1$ (@DRUG2$) and isoform-specific inhibitors.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4235,
        "sentence": "saline + saline, @DRUG1$ (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and @DRUG2$ (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4236,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4237,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4238,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted @DRUG1$ (clotrimazole, ketoconazole, miconazole) were potent, non-competitive inhibitors of @DRUG2$ metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4239,
        "sentence": "Some @DRUG1$ may interact with @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4240,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), @DRUG1$ (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG2$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4241,
        "sentence": "Oral Contraceptives: In 10 healthy women, the pharmacokinetic profiles of @DRUG1$ and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of @DRUG2$ were studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4242,
        "sentence": "Lithium: In clinical trials, NSAIDs have produced an elevation of plasma @DRUG1$ levels and a reduction in renal @DRUG2$ clearance.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4243,
        "sentence": "Absorption of @DRUG1$ is impaired by antacids containing aluminum, calcium or @DRUG2$, and iron-containing preparations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4244,
        "sentence": "Ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral @DRUG1$ by 2.4-fold, whereas itraconazole treatment did not increase the exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4245,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on @DRUG2$ plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4246,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4247,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG1$, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4248,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, @DRUG1$) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4249,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG1$ (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4250,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4251,
        "sentence": "@DRUG1$ may increase the responsiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4252,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, @DRUG1$, grapefruit juice, fluoxetine, fluvoxamine, @DRUG2$, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4253,
        "sentence": "@DRUG1$ competitively inhibits the intracellular phosphorylation of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4254,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, @DRUG1$, and simethicone) did not significantly affect the exposure of @DRUG2$ or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4255,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, @DRUG1$, primidone), @DRUG2$, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4256,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that @DRUG2$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4257,
        "sentence": "[Interaction between @DRUG1$ and @DRUG2$].",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4258,
        "sentence": "Coadministration with a high dose of antacid (170 mEq) results in a 28% decrease in plasma concentrations of @DRUG1$ and may decrease plasma concentrations of bismuth from @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4259,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, @DRUG2$, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4260,
        "sentence": "Therefore, do not administer @DRUG1$ with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4261,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4262,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4263,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG1$, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4264,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, @DRUG1$, and @DRUG2$ may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4265,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG2$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4266,
        "sentence": "@DRUG1$: @DRUG2$ clearance may decrease when hyperthyroid patients on a stable theophylline regimen become euthyroid;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4267,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and @DRUG1$ has been observed, data from 2 small studies indicate that @DRUG2$ may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4268,
        "sentence": "@DRUG1$: @DRUG2$, 100 mg, was given twice daily for 13 days to 12 healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4269,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4270,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, @DRUG1$, @DRUG2$ drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4271,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG1$, modafinil, penicillins, rifampin, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4272,
        "sentence": "In the hot plate test in mice, co-administration of 15     g/kg @DRUG1$ with 10   mg/kg @DRUG2$ intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by dexmedetomidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4273,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as @DRUG1$ (e.g., itraconazole and miconazole) or @DRUG2$ (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4274,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4275,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4276,
        "sentence": "An increase in intracellular levels of @DRUG1$ was observed in vitro in the presence of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4277,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4278,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4279,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, @DRUG2$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4280,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4281,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG1$, multivitamins, naproxen, omeprazole, @DRUG2$, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4282,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG2$, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4283,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . @DRUG1$ plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, @DRUG2$ blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4284,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4285,
        "sentence": "ARAMINE should be used with caution in digitalized patients, since the combination of @DRUG1$ and @DRUG2$ may cause ectopic arrhythmias.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4286,
        "sentence": "Patients studied in clinical trials of TNKase were routinely treated with @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4287,
        "sentence": "Itraconazole: Torsades de pointes and elevated parent @DRUG1$ levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of @DRUG2$ and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4288,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG2$, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4289,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4290,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4291,
        "sentence": "@DRUG1$ containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase III, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4292,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG1$ (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4293,
        "sentence": "Pyrimethamine may be used with @DRUG1$, @DRUG2$ and other antimalarials, and with other antibiotics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4294,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4295,
        "sentence": "Careful monitoring of serum @DRUG1$ concentrations in patients receiving @DRUG2$ and theophylline is recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4296,
        "sentence": "@DRUG1$: Diuretic-induced hypokalemia can increase the sensitivity of the myocardium to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4297,
        "sentence": "@DRUG1$ is not known to interact with other drugs including @DRUG2$ supplements;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4298,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, @DRUG1$, clarithromycin) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4299,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4300,
        "sentence": "Being moxifloxacin and lomefloxacin @DRUG1$ the interaction study of was carried out with sucralfate, gelusil, @DRUG2$ and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4301,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, @DRUG1$, @DRUG2$, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4302,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4303,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and @DRUG1$, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4304,
        "sentence": "The neuromuscular blocking effect of @DRUG1$ may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing @DRUG2$ has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4305,
        "sentence": "Oral hypoglycemic agents @DRUG1$ may inhibit the metabolism of oral @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4306,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of @DRUG1$ are potentiated by the presence of other CNS depressants such as alcohol, sedatives, @DRUG2$, or psychotropic drugs.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4307,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (@DRUG1$ 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (@DRUG2$ 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4308,
        "sentence": "No pharmacokinetic interaction was observed between rivastigmine and @DRUG1$, @DRUG2$, diazepam, or fluoxetine in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4309,
        "sentence": "In this crossover steady state study, the pharmacokinetics of @DRUG1$ were unaffected in either phenotype by the coadministration of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4310,
        "sentence": "Azathioprine/@DRUG1$: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4311,
        "sentence": "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of @DRUG1$ (OR   =   1.73 [95% CI, 1.25-2.38]), @DRUG2$ (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4312,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4313,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, @DRUG2$ and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4314,
        "sentence": "Contradictory results regarding the effect of @DRUG1$ on platelet reactivity and on clinical outcome in @DRUG2$-treated patients have been reported in literature.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4315,
        "sentence": "In the absence of data regarding potential interaction between ALIMTA and @DRUG1$ with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4316,
        "sentence": "@DRUG1$ Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, @DRUG2$ and nondepolarizing muscle relaxants).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4317,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, @DRUG1$, rifapentin, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4318,
        "sentence": "@DRUG1$ clearance is increased 100% by @DRUG2$, a CyP450 enzyme inducer, and decreased 33% by cimetidine, a CyP450 enzyme inhibitor.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4319,
        "sentence": "To minimize CNS depression and possible potentiation, barbiturates, @DRUG1$, narcotics, hypotensive agents or @DRUG2$ should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4320,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG1$ (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4321,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4322,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4323,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, @DRUG1$, naproxen, @DRUG2$, diazepam, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4324,
        "sentence": "While the effects of chronic phenytoin or @DRUG1$ therapy on the action of @DRUG2$ are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4325,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including @DRUG2$, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4326,
        "sentence": "Probenecid: @DRUG1$, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence @DRUG2$ pharmacokinetics (N= 12).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4327,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG1$, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4328,
        "sentence": "@DRUG1$    has been used in clinical trials concomitantly with @DRUG2$, diuretics, H2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4329,
        "sentence": "Catecholamine-depleting drugs (e.g., @DRUG1$) may have an additive effect when given with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4330,
        "sentence": "Acetazolamide: Concurrent use of @DRUG1$ and procaine hydrochloride may extend the plasma half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4331,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4332,
        "sentence": "Patients may require reduced doses of @DRUG1$ when on @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4333,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4334,
        "sentence": "DIFLUCAN reduces the metabolism of tolbutamide, @DRUG1$, and @DRUG2$ and increases the plasma concentration of these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4335,
        "sentence": "However, in a drug-drug interaction study, mean @DRUG1$ AUC was decreased by 15% when coadministered with @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4336,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of @DRUG1$/@DRUG2$ has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4337,
        "sentence": "DIPRIVAN Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used @DRUG1$ (eg, succinylcholine and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4338,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4339,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, @DRUG1$, theophyllines, phenytoins, thiazide diuretics, @DRUG2$, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4340,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4341,
        "sentence": "e.g., other @DRUG1$, @DRUG2$ (including meclizine), tricyclic antidepressants, and muscle relaxants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4342,
        "sentence": "Careful monitoring of serum theophylline concentrations in patients receiving @DRUG1$ and @DRUG2$ is recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4343,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, @DRUG2$ and tenofovir).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4344,
        "sentence": "Both @DRUG1$/@DRUG2$ and MPAG concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4345,
        "sentence": "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking @DRUG1$-aluminum containing @DRUG2$ (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4346,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that @DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4347,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (@DRUG1$) such as @DRUG2$ (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4348,
        "sentence": "In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4349,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with @DRUG1$, diuretics, H2 blockers, digoxin, oral @DRUG2$, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4350,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4351,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4352,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, @DRUG1$, tricyclic antidepressant drugs (e.g., @DRUG2$, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4353,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4354,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, @DRUG1$) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4355,
        "sentence": "ACE inhibitors Reports suggest that @DRUG1$ may diminish the antihypertensive effect of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4356,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar @DRUG1$ or cholinergic agonists such as @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4357,
        "sentence": "In vitro, @DRUG1$ did not affect the binding of @DRUG2$, phenytoin, or tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4358,
        "sentence": "Mequitazine can interact with @DRUG1$, antichlolinergic, TCA, MAOIs, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4359,
        "sentence": "Accordingly, patients should be advised to avoid @DRUG1$ while taking REMERON SolTab. @DRUG2$: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4360,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4361,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus @DRUG1$ 20 mg/kg) and group 7 (curcumin 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4362,
        "sentence": "Moxifloxacin and Lomefloxacin reacts faster with @DRUG1$ and gelusil in acidic media whereas with @DRUG2$ in basic media and multi-minerals in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4363,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4364,
        "sentence": "Drugs which may potentiate the myeloproliferative effects of @DRUG1$, such as lithium and @DRUG2$, should be used with caution.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4365,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of @DRUG1$ is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4366,
        "sentence": "Co-administration of @DRUG1$ with CYP3A inhibitors is feasible as the observed increase in @DRUG2$ PK parameters was not considered clinically relevant.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4367,
        "sentence": "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with @DRUG1$, gelusil, @DRUG2$ and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4368,
        "sentence": "Based on this experience, we suggest that low-dose @DRUG1$ added to propofol may be associated with prevention of EA in children with a history of EA with @DRUG2$ TIVA.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4369,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, colistin, and @DRUG2$), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4370,
        "sentence": "@DRUG1$/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4371,
        "sentence": "@DRUG1$ has been reported to enhance the sedative activity of barbiturates, alcohol, @DRUG2$, and reserpine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4372,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG1$, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4373,
        "sentence": "@DRUG1$ (such as suxamethonium chloride): Concurrent use of @DRUG2$ and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4374,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4375,
        "sentence": "Medical treatment with @DRUG1$ is effective in reducing plasma parathyroid hormone (PTH) levels, but its effect on @DRUG2$ dosing is unknown.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4376,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, @DRUG1$, diuretics, @DRUG2$, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4377,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4378,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or @DRUG1$) may enhance or potentiate the pressor effects of @DRUG2$   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4379,
        "sentence": "@DRUG1$ can also displace methotrexate from plasma protein-binding sites, thus increasing free @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4380,
        "sentence": "@DRUG1$, such as the neuroleptics (@DRUG2$, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4381,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, @DRUG1$, and @DRUG2$, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4382,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG1$, rifabutin, rifapentin, @DRUG2$, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4383,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4384,
        "sentence": "@DRUG1$ and Lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and @DRUG2$ in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4385,
        "sentence": "Exert particular caution in combining levomepromazine with other anticholinergic drugs (@DRUG1$ and @DRUG2$): Particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4386,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG1$, penicillins, rifampin, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4387,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG1$, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4388,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG2$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4389,
        "sentence": "The concurrent administration of potent inhalational agents (eg, isoflurane, enflurane, and @DRUG1$) during maintenance with @DRUG2$ Injectable Emulsion has not been extensively evaluated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4390,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled @DRUG1$, other @DRUG2$, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4391,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4392,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, @DRUG1$, hydroxyzine, and other muscle relaxants) or local @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4393,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG1$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4394,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4395,
        "sentence": "Lapatinib may have the potential to convert @DRUG1$-refractory to @DRUG2$-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4396,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4397,
        "sentence": "Oral @DRUG1$ @DRUG2$ may inhibit the metabolism of oral hypoglycemic agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4398,
        "sentence": "[Influence of @DRUG1$ and @DRUG2$ on MPTP-evoked behavior violations in C57BL/6 mice].",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4399,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4400,
        "sentence": "No significant adverse interactions with common premedications (such as @DRUG1$, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4401,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4402,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG1$, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4403,
        "sentence": "These medications included thyroid hormones, @DRUG1$, @DRUG2$, benzodiazepines, and decongestants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4404,
        "sentence": "and combinations of opioids and sedatives (eg, benzodiazepines, @DRUG1$, chloral hydrate, @DRUG2$, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4405,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4406,
        "sentence": "Azathioprine/@DRUG1$: Given that @DRUG2$ and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4407,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG2$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4408,
        "sentence": "There is usually complete cross-resistance between PURINETHOL (@DRUG1$) and @DRUG2$ brand Thioguanine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4409,
        "sentence": "Since @DRUG1$ (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of @DRUG2$ and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4410,
        "sentence": "The influence of the other @DRUG1$ when used simultaneously with @DRUG2$ has not yet been investigated in adequately randomized studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4411,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4412,
        "sentence": "Interactions for Vitamin B1 (Thiamine):  Loop Diuretics, Oral @DRUG1$, @DRUG2$, Tricyclic Antidepressants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4413,
        "sentence": "Use of Anticoagulants and Antiplatelet Agents -- @DRUG1$, @DRUG2$, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4414,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, @DRUG1$, @DRUG2$ and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4415,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4416,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (@DRUG1$), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4417,
        "sentence": "It will compete with @DRUG1$ (Plavix) and prasugrel (@DRUG2$) for such use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4418,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, @DRUG1$, or certain @DRUG2$) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4419,
        "sentence": "We have demonstrated appropriateness of inhospital administration of fixed @DRUG1$/@DRUG2$ combination as an approach allowing to achieve target BP in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4420,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4421,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG1$, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4422,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, @DRUG2$, pancuronium, morphine, vancomycin, metformin and tenofovir).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4423,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as @DRUG1$, indomethacin, naproxen, @DRUG2$, diazepam, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4424,
        "sentence": "Concurrent use of @DRUG1$    and theophylline may lead to increased plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4425,
        "sentence": "Drug-Drug Interactions Effect of @DRUG1$    (rivastigmine tartrate) on the Metabolism of Other Drugs: @DRUG2$ is primarily metabolized through hydrolysis by esterases.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4426,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG1$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4427,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with @DRUG1$ (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4428,
        "sentence": "When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with @DRUG1$   , lowered @DRUG2$    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4429,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4430,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4431,
        "sentence": "however, in some patients there were decreases up to 47% and 33% of @DRUG1$ and @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4432,
        "sentence": "When phenytoin or other hepatic enzyme inducers such as rifampin and @DRUG1$ have been taken concurrently with @DRUG2$   , lowered Mexitil    plasma levels have been reported.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4433,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4434,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4435,
        "sentence": "Drugs such as @DRUG1$, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4436,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that @DRUG1$, such as the @DRUG2$ (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4437,
        "sentence": "In 1984, Drs Rimmer and Richens at the University of Wales reported that administering @DRUG1$ with @DRUG2$ lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4438,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on @DRUG1$ plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4439,
        "sentence": "Pharmacokinetic properties of @DRUG1$ were not altered by the addition of either lamivudine or zidovudine or the combination of lamivudine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4440,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, @DRUG1$, @DRUG2$) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4441,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, meperidine and fentanyl), propofol, @DRUG2$, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4442,
        "sentence": "DIPRIVAN Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, @DRUG1$ and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4443,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4444,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$ is contraindicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4445,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4446,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4447,
        "sentence": "In vitro, @DRUG1$ did not affect the binding of warfarin, @DRUG2$, or tamoxifen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4448,
        "sentence": "Beta adrenergic agonists should be administered with caution to patients being treated with @DRUG1$ or tricyclic antidepressants, since the action of @DRUG2$ on the vascular system may be potentiated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4449,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, @DRUG1$, @DRUG2$, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4450,
        "sentence": "@DRUG1$. @DRUG2$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4451,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4452,
        "sentence": "The effects of @DRUG1$, such as atropine and @DRUG2$ may be enhanced by the concomitant administration of triprolidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4453,
        "sentence": "Phase I trial of lenalidomide and @DRUG1$ in patients with relapsed multiple myeloma: evidence for @DRUG2$-CCI-779 interaction via P-glycoprotein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4454,
        "sentence": "To minimize CNS depression and possible potentiation, barbiturates, antihistamines, @DRUG1$, hypotensive agents or @DRUG2$ should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4455,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, @DRUG1$, naproxen, ibuprofen, @DRUG2$, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4456,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (@DRUG1$) (e.g., fluoxetine, @DRUG2$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4457,
        "sentence": "The effects of @DRUG1$, such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4458,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG1$, @DRUG2$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4459,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4460,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, @DRUG1$, @DRUG2$, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4461,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4462,
        "sentence": "Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, @DRUG1$, @DRUG2$ and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4463,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, @DRUG2$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4464,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG1$ - local anesthetics such as procaine - general @DRUG2$ - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4465,
        "sentence": "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with @DRUG1$ have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering @DRUG2$ to patients on coumarin-type anticoagulants and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4466,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, @DRUG1$, fluvoxamine, zileuton, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4467,
        "sentence": "Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of @DRUG1$, protease inhibitors, calcium channel antagonists, and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4468,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4469,
        "sentence": "While there is evidence that @DRUG1$ can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of @DRUG2$ or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4470,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4471,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), @DRUG2$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4472,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, @DRUG2$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4473,
        "sentence": "@DRUG1$ are capable of potentiating @DRUG2$ (e.g., barbiturates, anesthetics, opiates, alcohol, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4474,
        "sentence": "Cimetidine: The effects of chronic @DRUG1$ use on the metabolism of @DRUG2$ are not known.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4475,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, @DRUG1$, phenytoins, @DRUG2$, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4476,
        "sentence": "Concurrent ingestion of @DRUG1$ (20 mL of antacid containing aluminum hydroxide, @DRUG2$, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4477,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4478,
        "sentence": "@DRUG1$: Concurrent use of procaine hydrochloride and @DRUG2$ may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4479,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4480,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of @DRUG1$ pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4481,
        "sentence": "Drug interactions should be kept in mind when @DRUG1$ (metronidazole gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical @DRUG2$ administration because of low absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4482,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4483,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - @DRUG1$: may potentiate the replication of the @DRUG2$ virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4484,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4485,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG1$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4486,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . @DRUG1$, including FELDENE, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4487,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG1$, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4488,
        "sentence": "Distinct and statistically significant synergism was observed between @DRUG1$ and @DRUG2$ by disc diffusion tests when compared with their individual effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4489,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4490,
        "sentence": "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with @DRUG1$ since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering @DRUG2$ to patients on coumarin-type anticoagulants and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4491,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4492,
        "sentence": "@DRUG1$: Rifampin enhances the metabolism of concurrently administered @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4493,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4494,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4495,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, @DRUG1$, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4496,
        "sentence": "In addition, DZNep insensitivity might be associated with overexpression of Bcl-2, and the combination of @DRUG1$ and @DRUG2$ could synergistically induced apoptosis.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4497,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, @DRUG1$, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline Please note that @DRUG2$ may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4498,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4499,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, @DRUG1$, and miconazole) to ketoconazole, and @DRUG2$, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4500,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG1$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4501,
        "sentence": "These behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG1$-treated animals than in @DRUG2$/vehicle-treated monkeys.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4502,
        "sentence": "Cyclosporine: When studied in stable renal transplant patients, @DRUG1$, USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4503,
        "sentence": "Warfarin: A multidose study of @DRUG1$, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with @DRUG2$, resulted in a mean increase in S-warfarin half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4504,
        "sentence": "Being @DRUG1$ and lomefloxacin @DRUG2$ the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4505,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4506,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), @DRUG2$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4507,
        "sentence": "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, @DRUG1$, and grapefruit juice may inhibit its metabolism (increasing serum levels of @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4508,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, @DRUG2$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4509,
        "sentence": "Agents that might be coadministered with trimetrexate in AIDS patients for other indications that could elicit this activity include erythromycin, @DRUG1$, rifabutin, ketoconazole, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4510,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG1$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4511,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG1$ (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4512,
        "sentence": "Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., @DRUG1$ such as @DRUG2$) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4513,
        "sentence": "The effect of @DRUG1$ on the absorption of supplemental vitamin D, vitamin A, and nutritionally-derived @DRUG2$ is not known at this time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4514,
        "sentence": "In the present study, the antidepressant like activity of @DRUG1$ and its combination with @DRUG2$ and imipramine was studied in acute model (three doses 24, 5 and 1 h before test) of forced swimming test (FST) in glass jar and tail suspension test (TST) in mice and in chronic model (14 day study) of FST with water wheel in rats.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4515,
        "sentence": "In addition, CNS toxicity has been reported (confusion, disorientation, respiratory depression, apnea, seizures) following coadministration of @DRUG1$ with @DRUG2$;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4516,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of @DRUG1$ were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG2$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4517,
        "sentence": "Therefore, @DRUG1$ capsules should be used with caution in combination with @DRUG2$, particularly at doses higher than 0.4 mg.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4518,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, @DRUG2$, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4519,
        "sentence": "Mixing SYMLIN and @DRUG1$ The pharmacokinetic parameters of @DRUG2$ were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4520,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain @DRUG1$) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing @DRUG2$ has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4521,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG2$ and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4522,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, @DRUG2$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4523,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4524,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4525,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, thioxanthenes) or @DRUG2$, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4526,
        "sentence": "@DRUG1$ competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4527,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4528,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4529,
        "sentence": "- Cisapride, pimozide: Other drugs such as @DRUG1$ or @DRUG2$, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4530,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG1$ (@DRUG2$) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4531,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG1$, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4532,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4533,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (@DRUG1$, @DRUG2$, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4534,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG1$, procainamide, pancuronium, morphine, vancomycin, metformin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4535,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral @DRUG1$, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, @DRUG2$, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4536,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, @DRUG1$, prednisolone, sirolimus, @DRUG2$, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4537,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, @DRUG2$ did not alter the pharmacokinetics of a single dose of digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4538,
        "sentence": "Acromegalic patients with diabetes mellitus being treated with @DRUG1$ and/or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4539,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4540,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG1$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4541,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, thioxanthines ) or @DRUG2$, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4542,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, @DRUG2$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4543,
        "sentence": "When a single 100 mg dose of @DRUG1$ was administered one hour after the initiation of Cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total @DRUG2$ clearance in the same subjects in the absence of cimetidine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4544,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as @DRUG2$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4545,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4546,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG1$, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4547,
        "sentence": "In clinical studies of @DRUG1$, patients taking @DRUG2$ concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4548,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with @DRUG1$, simvastatin, pravastatin, lovastatin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4549,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4550,
        "sentence": "@DRUG1$/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with @DRUG2$ or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4551,
        "sentence": "Less potent inhibitors include @DRUG1$, nefazodone, fluconazole, grapefruit juice, @DRUG2$, fluvoxamine, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4552,
        "sentence": "Hyaluronidase: @DRUG1$ may increase the diffusion rate of @DRUG2$, resulting in a decreased time of onset, but an increase in systemic toxicity.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4553,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of @DRUG1$-containing or ergot-type medications (like dihydroergotamine or @DRUG2$) and sumatriptan within 24 hours of each other should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4554,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other @DRUG1$ such as @DRUG2$, sedatives, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4555,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG2$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4556,
        "sentence": "@DRUG1$ users who initiated citalopram, @DRUG2$, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4557,
        "sentence": "Glyburide: In 12 normal-weight subjects receiving @DRUG1$ 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4558,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4559,
        "sentence": "Gemfibrozil: In a pharmacokinetic study, concomitant @DRUG1$ administration increased total @DRUG2$ concentrations approximately 1.7-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4560,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4561,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus @DRUG1$ 20 mg/kg) and group 7 (@DRUG2$ 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4562,
        "sentence": "@DRUG1$ decreases the elimination of @DRUG2$ causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4563,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG1$ and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4564,
        "sentence": "@DRUG1$ AUC was increased by 21% with no effect on Cmax in the presence of steady-state @DRUG2$ compared with sirolimus alone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4565,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4566,
        "sentence": "Phenytoin, @DRUG1$, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and @DRUG2$), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4567,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4568,
        "sentence": "Pindolol has been used with a variety of antihypertensive agents, including @DRUG1$, @DRUG2$, and guanethidine without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4569,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4570,
        "sentence": "Dose adjustment of @DRUG1$ Capsules may be required, and iPTH and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong CYP3A4 inhibitor such as @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4571,
        "sentence": "The findings suggest that the dosage of @DRUG1$ should be reduced in patients receiving @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4572,
        "sentence": "Cyclosporine: Preliminary data from a XENICAL and @DRUG1$ drug interaction study indicate a reduction in @DRUG2$ plasma levels when XENICAL was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4573,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG1$ (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4574,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG1$-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4575,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4576,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, @DRUG2$ ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4577,
        "sentence": "Antacids: Absorption of a single dose of Myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing @DRUG1$ (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when @DRUG2$ was administered alone under fasting conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4578,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, @DRUG1$, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including @DRUG2$, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4579,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4580,
        "sentence": "Drug Interactions: The use of @DRUG1$    (rocuronium bromide) Injection before succinylcholine, for the purpose of attenuating some of the side effects of @DRUG2$, has not been studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4581,
        "sentence": "Systemic and apparent oral midazolam clearance were 24% (269    73 vs. 354    102  ml/min, P = 0.022) and 31% (479    190 vs. 688    265  ml/min, P = 0.013), respectively, lower in @DRUG1$-treated patients (n = 20) than in matched @DRUG2$-treated patients (n = 20).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4582,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4583,
        "sentence": "In adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either @DRUG1$ or the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4584,
        "sentence": "Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for @DRUG1$-@DRUG2$ interaction via P-glycoprotein.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4585,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4586,
        "sentence": "CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and @DRUG1$) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. @DRUG2$ and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4587,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4588,
        "sentence": "Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving @DRUG1$ in conjunction with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4589,
        "sentence": "Drugs that induce hepatic enzymes such as phenobarbital, phenytoin and @DRUG1$ may increase the clearance of corticosteroids and may require increases in @DRUG2$ dose to achieve the desired response.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4590,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4591,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4592,
        "sentence": "Accordingly, patients should be advised to avoid @DRUG1$ and other similar drugs while taking @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4593,
        "sentence": "and combinations of opioids and @DRUG1$ (eg, benzodiazepines, barbiturates, @DRUG2$, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4594,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (@DRUG2$) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4595,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, @DRUG1$), HIV protease or @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4596,
        "sentence": "Given the primary CNS effects of @DRUG1$, @DRUG2$    should be used with caution in combination with other centrally acting drugs and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4597,
        "sentence": "and combinations of opioids and sedatives (eg, @DRUG1$, barbiturates, chloral hydrate, @DRUG2$, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4598,
        "sentence": "Administration of a higher dose of @DRUG1$ should be considered when coadministering with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4599,
        "sentence": "Mequitazine can interact with @DRUG1$, @DRUG2$, TCA, MAOIs, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4600,
        "sentence": "Use of Anticoagulants and Antiplatelet Agents -- @DRUG1$, Streptokinase, alone or in combination with @DRUG2$ and anticoagulants, may cause bleeding complications.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4601,
        "sentence": "Lithium: Increased serum lithium and symptoms of @DRUG1$ toxicity have been reported in patients receiving concomitant @DRUG2$ and ACE inhibitor therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4602,
        "sentence": "The use of AGGRASTAT, in combination with @DRUG1$ and aspirin, has been associated with an increase in bleeding compared to @DRUG2$ and aspirin alone (see",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4603,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4604,
        "sentence": "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including @DRUG1$, hyaluronan lyase, heparinase III, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4605,
        "sentence": "Concurrent administration of cimetidine and @DRUG1$    has been reported to increase, decrease, or leave unchanged @DRUG2$    plasma levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4606,
        "sentence": "Being moxifloxacin and lomefloxacin @DRUG1$ the interaction study of was carried out with @DRUG2$, gelusil, erythromycin and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4607,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, @DRUG1$, and rifampicin), the clearance of @DRUG2$ was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4608,
        "sentence": "The ratio of norketamine AUC(0-   ) to @DRUG1$ AUC(0-   ) was significantly decreased in the ticlopidine (P &lt; 0.001) and @DRUG2$ phases (P = 0.006) as compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4609,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when @DRUG1$ and SKELID are administered at the same time, and 60% by some aluminum- or @DRUG2$-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4610,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG1$, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4611,
        "sentence": "Patients receiving @DRUG1$ or nifedipine in combination with MYCAMINE should be monitored for sirolimus or nifedipine toxicity and @DRUG2$ or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4612,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4613,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG1$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4614,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG1$) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4615,
        "sentence": "In rabbits treated with @DRUG1$, an increased incidence of extra thoracic ribs was observed at 1000 mg/kg/day (150 times the human exposure at 10 mg daily based on AUC0-24hr for total @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4616,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, @DRUG1$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4617,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, @DRUG1$, zileuton, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4618,
        "sentence": "Because of profound and long lasting inhibition of gastric acid secretion, @DRUG1$ may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, @DRUG2$ esters, and iron salts).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4619,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG2$ (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4620,
        "sentence": "This could lead to decreased @DRUG1$ serum levels or increase the risk of @DRUG2$ toxicity when methylprednisolone is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4621,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG1$ such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4622,
        "sentence": "@DRUG1$: In a pharmacokinetic study, concomitant @DRUG2$ administration increased total ezetimibe concentrations approximately 1.5-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4623,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG1$ and @DRUG2$), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4624,
        "sentence": "Anticholinesterases: Concurrent use of @DRUG1$ and @DRUG2$ may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4625,
        "sentence": "Although it was previously reported that @DRUG1$ combined with @DRUG2$ improved the progression-free survival rate compared with lapatinib alone for patients with Herceptin-refractory HER2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4626,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG1$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4627,
        "sentence": "When @DRUG1$ therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of @DRUG2$ adjusted as necessary until a stable target INR or PT has been achieved.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4628,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and @DRUG2$), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4629,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG1$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4630,
        "sentence": "However, the evidence for a @DRUG1$ effect on @DRUG2$ absorption mainly comes from studies that did not isolate the effect of calcium from that of other dietary components, because it was detected in single-meal studies.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4631,
        "sentence": "Acetazolamide: Concurrent use of acetazolamide and @DRUG1$ may extend the plasma half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4632,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4633,
        "sentence": "When DIFLUCAN is used concomitantly with these or other @DRUG1$, blood glucose concentrations should be carefully monitored and the dose of the @DRUG2$ should be adjusted as necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4634,
        "sentence": "Caffeine and/or stimulantes of the @DRUG1$/@DRUG2$ type may counteract the specific actions of levomepromazine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4635,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG2$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4636,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG1$ (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4637,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4638,
        "sentence": "Sympathomimetics may reduce the antihypertensive effects of @DRUG1$, @DRUG2$, reserpine and veratrum alkaloids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4639,
        "sentence": "@DRUG1$: Metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4640,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including @DRUG1$, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with @DRUG2$ is not recommended pending full examination of potential interactions.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4641,
        "sentence": "saline + saline, ephedrine (10   mg/kg) + saline, saline + @DRUG1$ (15     g/kg) and @DRUG2$ (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4642,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, @DRUG1$ and others), @DRUG2$ supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4643,
        "sentence": "Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of @DRUG1$ and other @DRUG2$ (e.g., valproic acid).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4644,
        "sentence": "Drug interaction of @DRUG1$ with @DRUG2$ has not been reported previously and is not listed in the British National Formulary for Children.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4645,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG1$, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4646,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG1$ (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and @DRUG2$ (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4647,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4648,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4649,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., @DRUG2$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4650,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG1$, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4651,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with @DRUG1$, sedatives, hypnotics, narcotics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4652,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, @DRUG2$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4653,
        "sentence": "The effects of @DRUG1$, @DRUG2$ or rifabutin on the pharmacokinetics of megestrol acetate were not studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4654,
        "sentence": "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as @DRUG1$ or rifampin, are co-administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4655,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4656,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, @DRUG2$ blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4657,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or @DRUG1$ (like dihydroergotamine or @DRUG2$) and sumatriptan within 24 hours of each other should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4658,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, @DRUG2$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4659,
        "sentence": "Absorption of @DRUG1$ is impaired by antacids containing aluminum, calcium or magnesium, and @DRUG2$-containing preparations.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4660,
        "sentence": "Synergistic interaction between @DRUG1$ and @DRUG2$ is sequence dependent in human non-small lung cancer with EGFR TKIs-resistant mutation.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4661,
        "sentence": "Coadministration of TRITEC with @DRUG1$ resulted in increased plasma @DRUG2$ concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4662,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4663,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4664,
        "sentence": "As there is in vitro evidence that aminosalicylate derivatives (e.g., @DRUG1$, mesalazine, or @DRUG2$) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4665,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG1$), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4666,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG1$, @DRUG2$, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4667,
        "sentence": "@DRUG1$ competes with meropenem for active tubular secretion and thus inhibits the renal excretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4668,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, triamterene, amiloride) or potassium supplements concomitantly with @DRUG2$ can increase the risk of hyperkalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4669,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4670,
        "sentence": "@DRUG1$ Supplements and @DRUG2$: UNIVASC    can increase serum potassium because it decreases aldosterone secretion.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4671,
        "sentence": "Use of Anticoagulants and @DRUG1$ -- Streptase, @DRUG2$, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4672,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, @DRUG1$ drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high @DRUG2$ content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4673,
        "sentence": "@DRUG1$ antagonize the effects of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4674,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, @DRUG2$, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4675,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4676,
        "sentence": "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., @DRUG1$, @DRUG2$, anticonvulsants, cyclosporin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4677,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4678,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when @DRUG1$ and SKELID are administered at the same time, and 60% by some @DRUG2$- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4679,
        "sentence": "Multiple dose studies of ezetimibe given in combination with @DRUG1$ (statins) in rats and rabbits during organogenesis result in higher @DRUG2$ and statin exposures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4680,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG1$, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4681,
        "sentence": "Mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, @DRUG1$ and theophylline Please note that @DRUG2$ may interact with other drugs that are not listed here.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4682,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG1$), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4683,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4684,
        "sentence": "@DRUG1$ does not interfere with measurement of VMA (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert @DRUG2$ to vanillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4685,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, @DRUG1$, @DRUG2$, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4686,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG1$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4687,
        "sentence": "We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of @DRUG1$ as an @DRUG2$ in humans.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4688,
        "sentence": "Treatment of HEY xenograft-bearing mice with dasatinib plus @DRUG1$ inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + @DRUG2$ vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4689,
        "sentence": "Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with @DRUG1$ 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of @DRUG2$ 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4690,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4691,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, @DRUG1$ and fentanyl), propofol, @DRUG2$, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4692,
        "sentence": "Preliminary evidence suggests that cimetidine inhibits @DRUG1$ metabolism and may result in an increase in plasma concentrations of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4693,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (@DRUG1$, ketoconazole, miconazole) were potent, non-competitive inhibitors of @DRUG2$ metabolism.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4694,
        "sentence": "Reduction of PTH by @DRUG1$ is associated with a decrease in @DRUG2$ requirement.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4695,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG1$, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4696,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG2$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4697,
        "sentence": "Due to its effects on gastric emptying, SYMLIN therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., @DRUG1$ such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4698,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (@DRUG1$, @DRUG2$, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4699,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4700,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG2$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4701,
        "sentence": "Since Celontin (@DRUG1$) may interact with concurrently administered @DRUG2$, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4702,
        "sentence": "In the absence of data regarding potential interaction between @DRUG1$ and @DRUG2$ with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following ALIMTA administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4703,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of @DRUG1$ or @DRUG2$ metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4704,
        "sentence": "When @DRUG1$ therapy is initiated in a patient already receiving treatment with @DRUG2$, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4705,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4706,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4707,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4708,
        "sentence": "Use of Anticoagulants and Antiplatelet Agents -- Streptase, @DRUG1$, alone or in combination with @DRUG2$ and anticoagulants, may cause bleeding complications.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4709,
        "sentence": "Concomitant administration of @DRUG1$ with other chelation therapy, such as @DRUG2$ is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4710,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., @DRUG2$, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4711,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., @DRUG2$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4712,
        "sentence": "Weekly intramuscular @DRUG1$ injections (0.2-0.5 mg/kg body weight), in combination with daily administration of @DRUG2$ or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4713,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4714,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including @DRUG1$, clarithromycin, @DRUG2$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4715,
        "sentence": "however, as with other @DRUG1$, concomitant administration of meloxicam and @DRUG2$ is not generally recommended because of the potential for increased adverse effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4716,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral @DRUG2$: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4717,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG1$, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4718,
        "sentence": "Ethanol decreases the elimination of @DRUG1$ causing an increase in overall exposure . The addition of @DRUG2$ has no clinically significant effect on the pharmacokinetic properties of abacavir.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4719,
        "sentence": "Mexitil    does not alter serum digoxin levels but @DRUG1$, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum @DRUG2$ levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4720,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), @DRUG1$ supplements or other drugs capable of increasing serum potassium (indomethacin, @DRUG2$, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4721,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG1$ (i.e., @DRUG2$, nalbuphine, butorphanol, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4722,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and @DRUG2$, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4723,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4724,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4725,
        "sentence": "Phenothiazines are capable of potentiating @DRUG1$ (e.g., barbiturates, @DRUG2$, opiates, alcohol, etc.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4726,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of XENICAL and 40 grams of @DRUG1$ (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, @DRUG2$ pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4727,
        "sentence": "@DRUG1$: Clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of @DRUG2$, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4728,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4729,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4730,
        "sentence": "@DRUG1$ and Other @DRUG2$: May decrease the antihypertensive effects of MYKROX Tablets.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4731,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4732,
        "sentence": "@DRUG1$: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of @DRUG2$ on the plasma concentration of perindopril/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4733,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4734,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG2$, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4735,
        "sentence": "Improved parathyroid hormone control by @DRUG1$ is associated with reduction in @DRUG2$ requirement in patients with end-stage renal disease.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4736,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4737,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG1$, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4738,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, tranquilizers, general anesthetics, @DRUG2$, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4739,
        "sentence": "In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4740,
        "sentence": "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as @DRUG1$, carbamazepine, and @DRUG2$, induce metabolism and caused a markedly decreased C max and AUC of oral midazolam in adult studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4741,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, @DRUG1$, bacitracin, polymyxin B, @DRUG2$, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4742,
        "sentence": "Caution should be used if @DRUG1$ is administered concomitantly with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4743,
        "sentence": "e.g., other belladonna alkaloids, @DRUG1$ (including meclizine), tricyclic antidepressants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4744,
        "sentence": "@DRUG1$: The total @DRUG2$ level increased 12-fold in one renal transplant patient receiving multiple medications, including cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4745,
        "sentence": "Pindolol has been used with a variety of antihypertensive agents, including @DRUG1$, hydralazine, and @DRUG2$ without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4746,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, @DRUG1$ and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, @DRUG2$ and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4747,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG1$, indomethacin, @DRUG2$, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4748,
        "sentence": "The effect of @DRUG1$ (100 mg/kg) was similar to that of fluoxetine and imipramine (p > 0.05) but its addition to @DRUG2$ and imipramine did not improve their antidepressant activity (p > 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4749,
        "sentence": "Drugs such as erythromycin, diltiazem, @DRUG1$, ketoconazole, fluconazole and @DRUG2$ were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4750,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If @DRUG1$ and @DRUG2$ are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4751,
        "sentence": "@DRUG1$ are capable of potentiating CNS depressants (e.g., barbiturates, anesthetics, opiates, @DRUG2$, etc.)",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4752,
        "sentence": "@DRUG1$, an @DRUG2$, is the standard hormone treatment for breast cancer.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4753,
        "sentence": "Patients receiving antibiotics and @DRUG1$ generally should not be treated with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4754,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . @DRUG2$ (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4755,
        "sentence": "Cyclosporine: Preliminary data from a XENICAL and @DRUG1$ drug interaction study indicate a reduction in cyclosporine plasma levels when @DRUG2$ was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4756,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4757,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., @DRUG1$, tetracycline, levodopa, @DRUG2$, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4758,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG1$, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4759,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the @DRUG1$ virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4760,
        "sentence": "CYP 3A4 Inhibitors (e.g. @DRUG1$ and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. @DRUG2$ and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4761,
        "sentence": "The latter displayed midazolam clearances similar to those in two larger cohorts of nonmatched @DRUG1$-treated patients (n = 58 and n = 80) and to those receiving a @DRUG2$-free regimen (n = 6).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4762,
        "sentence": "No dosage adjustment of @DRUG1$ or @DRUG2$ is recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4763,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . @DRUG1$ plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4764,
        "sentence": "Use of @DRUG1$ and @DRUG2$ -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4765,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4766,
        "sentence": "Mequitazine can interact with @DRUG1$, antichlolinergic, @DRUG2$, MAOIs, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4767,
        "sentence": "No pharmacokinetic interaction was observed between rivastigmine and @DRUG1$, warfarin, diazepam, or @DRUG2$ in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4768,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, @DRUG1$, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4769,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing @DRUG2$   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4770,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG1$, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4771,
        "sentence": "Anticoagulants (such as @DRUG1$ and @DRUG2$) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4772,
        "sentence": "@DRUG1$ has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and @DRUG2$ without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4773,
        "sentence": "In clinical studies of TOBI, patients taking @DRUG1$ concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other @DRUG2$, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4774,
        "sentence": "Interaction with Guanethidine: Although @DRUG1$ does not itself cause orthostatic hypotension, its administration to patients already receiving @DRUG2$ can result in profound orthostatic effects.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4775,
        "sentence": "e.g., other @DRUG1$, antihistamines (including meclizine), tricyclic antidepressants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4776,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4777,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4778,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4779,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG1$, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4780,
        "sentence": "@DRUG1$ at a Dose of 10 mg Once Daily Dosed to Pharmacokinetic Steady State  - did not cause clinically significant changes in the kinetics of a single intravenous dose of @DRUG2$ (predominantly a cytochrome P450 1A2 substrate).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4781,
        "sentence": "In the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both @DRUG1$ writhing and formalin test, when it was administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4782,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), @DRUG1$, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4783,
        "sentence": "Moxifloxacin and @DRUG1$ are @DRUG2$ used in treating urinary and respiratory tract infections.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4784,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, @DRUG1$, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4785,
        "sentence": "Inducers of CYP3A4 Isozymes: Cytochrome P450 inducers, such as @DRUG1$, @DRUG2$, and phenytoin, induce metabolism and caused a markedly decreased C max and AUC of oral midazolam in adult studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4786,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, @DRUG1$, tacrolimus, @DRUG2$, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4787,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG2$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4788,
        "sentence": "Moxifloxacin and Lomefloxacin reacts faster with sucralfate and @DRUG1$ in acidic media whereas with erythromycin in basic media and @DRUG2$ in neutral media.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4789,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (@DRUG1$) and carbachol (@DRUG2$, Isopto Carbachol) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4790,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG1$, phenytoin, sulfinpyrazone, @DRUG2$, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4791,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4792,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing @DRUG1$   . If Mexitil and @DRUG2$ are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4793,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when @DRUG1$ was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4794,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG1$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4795,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., @DRUG1$, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when @DRUG2$    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4796,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, @DRUG2$, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4797,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including @DRUG1$, metronidazole, and miconazole) to @DRUG2$, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4798,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that @DRUG1$ not be administered concomitantly with @DRUG2$ or mycophenolate mofetil.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4799,
        "sentence": "Mequitazine can interact with CNS depressant, antichlolinergic, @DRUG1$, MAOIs, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4800,
        "sentence": "The sedative effect of @DRUG1$ is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4801,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4802,
        "sentence": "Patients who take both @DRUG1$ and @DRUG2$ should be carefully monitored.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4803,
        "sentence": "In these subjects, meloxicam did not alter @DRUG1$ pharmacokinetics and the average anticoagulant effect of @DRUG2$ as determined by prothrombin time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4804,
        "sentence": "@DRUG1$ AND OTHER @DRUG2$ WILL BE ADDITIVE TO DISALCID AND MAY INCREASE PLASMA CONCENTRATIONS OF SALICYLIC ACID TO TOXIC LEVELS.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4805,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG1$, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4806,
        "sentence": "We have demonstrated appropriateness of inhospital administration of fixed @DRUG1$/valsartan combination as an approach allowing to achieve target BP in shorter time, with the use of fewer @DRUG2$, and diminishing concealed inefficacy of treatment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4807,
        "sentence": "@DRUG1$: The use of @DRUG2$ in patients concurrently taking astemizole or other drugs metabolized by the cytochrome P450 system may be associated with elevations in serum levels of these drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4808,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG1$, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4809,
        "sentence": "Moxifloxacin and @DRUG1$ reacts faster with sucralfate and gelusil in acidic media whereas with @DRUG2$ in basic media and multi-minerals in neutral media.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4810,
        "sentence": "TRENTAL has been used concurrently with antihypertensive drugs, beta blockers, @DRUG1$, diuretics, antidiabetic agents, and @DRUG2$, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4811,
        "sentence": "@DRUG1$: @DRUG2$ and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4812,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG1$, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4813,
        "sentence": "This could lead to decreased @DRUG1$ serum levels or increase the risk of @DRUG2$ toxicity when corticosteroid is withdrawn.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4814,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), @DRUG1$ supplements or other drugs capable of increasing serum potassium (@DRUG2$, heparin, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4815,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG1$, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4816,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, @DRUG1$, ibuprofen, @DRUG2$, and diazoxide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4817,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4818,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving @DRUG1$ is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4819,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, @DRUG1$, thiazide diuretics, beta blockers, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4820,
        "sentence": "- Cisapride, @DRUG1$: Other drugs such as @DRUG2$ or pimozide, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4821,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, @DRUG2$ (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4822,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG1$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4823,
        "sentence": "@DRUG1$: Hyaluronidase may increase the diffusion rate of @DRUG2$, resulting in a decreased time of onset, but an increase in systemic toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4824,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, triamterene, @DRUG1$) or potassium supplements concomitantly with @DRUG2$ can increase the risk of hyperkalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4825,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, @DRUG2$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4826,
        "sentence": "Acromegalic patients with diabetes mellitus being treated with insulin and/or oral @DRUG1$ agents may require dose reductions of these therapeutic agents after the initiation of therapy with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4827,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG1$, phenytoin, sulfinpyrazone, naproxen, @DRUG2$, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4828,
        "sentence": "Adrenal steroids or ACTH In patients with edema, concomitant administration with @DRUG1$ or @DRUG2$ may increase the edema.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4829,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG1$, modafinil, penicillins, rifampin, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4830,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), @DRUG1$ and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4831,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or @DRUG1$, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4832,
        "sentence": "@DRUG1$ (such as @DRUG2$ and vitamin K antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4833,
        "sentence": "Rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with @DRUG1$-free controls conditioned with amphetamine, but only female controls conditioned with @DRUG2$ spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4834,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4835,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), @DRUG2$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4836,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, @DRUG1$, narcotics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4837,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with @DRUG1$, simvastatin, pravastatin, @DRUG2$, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4838,
        "sentence": "The effects of @DRUG1$ hemantane [@DRUG2$] (10 mg/kg, p. o.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4839,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of @DRUG2$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4840,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4841,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4842,
        "sentence": "CYP 3A4 Inhibitors (e.g. @DRUG1$ and Protease Inhibitors) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and @DRUG2$) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4843,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4844,
        "sentence": "In female rats, neonatal quinpirole treatment enhanced @DRUG1$ locomotor sensitization compared with quinpirole-free controls sensitized to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4845,
        "sentence": "Protective effect of @DRUG1$ and  @DRUG2$ against the acute toxicity of diepoxybutane to human lymphocytes.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4846,
        "sentence": "While in vitro studies have shown that @DRUG1$ is not a potent inhibitor of any of these enzymes, an indication that @DRUG2$ is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of REMERON SolTab with most other drugs metabolized by these enzymes has not been formally studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4847,
        "sentence": "In total, 430,455 @DRUG1$ users contributed 407,370 person-years of @DRUG2$ use.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4848,
        "sentence": "@DRUG1$/@DRUG2$: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that Myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4849,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4850,
        "sentence": "Exposure to oral S-ketamine is unaffected by @DRUG1$ but greatly increased by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4851,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4852,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG1$, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4853,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG1$ with oral @DRUG2$;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4854,
        "sentence": "@DRUG1$: Concomitant administration of 200 mg @DRUG2$ QID did not alter the single-dose pharmacokinetics of 30 mg meloxicam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4855,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, itraconazole, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4856,
        "sentence": "@DRUG1$ renal clearance is reduced by @DRUG2$, increasing the risk of lithium toxicity.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4857,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG1$, naproxen, omeprazole, paracetamol, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4858,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4859,
        "sentence": "The effects of anticholinergic drugs, such as @DRUG1$ and tricyclic antidepressants may be enhanced by the concomitant administration of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4860,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4861,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (@DRUG1$) and carbachol (Carboptic, @DRUG2$) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4862,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and @DRUG1$ has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of @DRUG2$.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4863,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), @DRUG1$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4864,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly @DRUG1$ (eg, @DRUG2$, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4865,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG1$, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4866,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - @DRUG2$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4867,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG2$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4868,
        "sentence": "@DRUG1$, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG2$, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4869,
        "sentence": "In addition to bleeding associated with heparin and @DRUG1$, drugs that alter platelet function (such as aspirin, dipyridamole, and @DRUG2$) may increase the risk of bleeding if administered prior to or after Retavase    therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4870,
        "sentence": "These data suggest that GH administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., @DRUG1$, sex steroids, @DRUG2$, cyclosporin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4871,
        "sentence": "An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of @DRUG1$ and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4872,
        "sentence": "An inhibitor of CYP2C8 (such as @DRUG1$) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as @DRUG2$) may decrease the AUC of rosiglitazone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4873,
        "sentence": "Absorption of tetracyclines is impaired by antacids containing @DRUG1$, @DRUG2$ or magnesium, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4874,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, @DRUG1$, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4875,
        "sentence": "Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as @DRUG1$, @DRUG2$, or alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4876,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, @DRUG1$, general @DRUG2$, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4877,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4878,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of @DRUG2$ is 2 mg daily.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4879,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4880,
        "sentence": "Interactions for @DRUG1$ (Thiamine):  Loop Diuretics, Oral @DRUG2$, Stavudine, Tricyclic Antidepressants",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4881,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG2$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4882,
        "sentence": "In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with @DRUG1$ lowered the serum @DRUG2$ concentration in patients with treatment-resistant epilepsy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4883,
        "sentence": "@DRUG1$ may interact with @DRUG2$ or mitotane (causing too great a decrease in adrenal function).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4884,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, @DRUG1$, H2 blockers, @DRUG2$, oral hypoglycemic agents, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4885,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, itraconazole, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4886,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, @DRUG1$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4887,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG1$, sirolimus, @DRUG2$, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4888,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or @DRUG1$ (eg, erythromycin, clarithromycin) or @DRUG2$ or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4889,
        "sentence": "If @DRUG1$ cannot be interrupted, close medical supervision should be provided with the first dose of @DRUG2$    Tablets, for at least two hours and until blood pressure has stabilized for another hour.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4890,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), @DRUG2$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4891,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma @DRUG1$ concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/@DRUG2$ has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4892,
        "sentence": "Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving XENICAL 120 mg three times a day for 6 days, @DRUG1$ did not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4893,
        "sentence": "@DRUG1$: Animal data have suggested the possibility of interaction between @DRUG2$ and gentamicin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4894,
        "sentence": "John   s Wort, and certain @DRUG1$ (phenytoin, phenobarbital, carbamazepine) may induce @DRUG2$ metabolism (lowering serum levels of mifepristone).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4895,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma @DRUG1$ concentrations when coadministered with @DRUG2$    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4896,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG1$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4897,
        "sentence": "and combinations of @DRUG1$ and sedatives (eg, benzodiazepines, barbiturates, chloral hydrate, @DRUG2$, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4898,
        "sentence": "Concurrent ingestion of @DRUG1$ (20 mL of @DRUG2$ containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4899,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, @DRUG1$, @DRUG2$, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4900,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4901,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG2$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4902,
        "sentence": "Coadministration of TRITEC with clarithromycin resulted in increased plasma @DRUG1$ concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased @DRUG2$ plasma concentrations (31%).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4903,
        "sentence": "The neuromuscular blocking effect of @DRUG1$ may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4904,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4905,
        "sentence": "@DRUG1$ (such as heparin and @DRUG2$) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4906,
        "sentence": "Macrolides: Clinical drug interaction studies indicate that @DRUG1$ and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of @DRUG2$, but to a lesser extent.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4907,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4908,
        "sentence": "Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of @DRUG1$, warfarin, @DRUG2$, or fluoxetine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4909,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled @DRUG2$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4910,
        "sentence": "Use of potassium-sparing diuretics (@DRUG1$, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, @DRUG2$, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4911,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4912,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, @DRUG1$, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of @DRUG2$   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4913,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4914,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4915,
        "sentence": "@DRUG1$ and fluoxetine reduce the plasma concentration of @DRUG2$ by about 50%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4916,
        "sentence": "These include sympathomimetic bronchodilators, @DRUG1$, and oral and inhaled @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4917,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, @DRUG1$, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4918,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4919,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4920,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4921,
        "sentence": "You cannot take @DRUG1$ if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or @DRUG2$ (Nardil) in the last 14 days.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4922,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., @DRUG1$, pseudoephedrine, @DRUG2$, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4923,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4924,
        "sentence": "Concurrent ingestion of antacid (20 mL of @DRUG1$ containing @DRUG2$, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4925,
        "sentence": "@DRUG1$ (@DRUG2$)--better than clopidogrel (Plavix)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4926,
        "sentence": "A 104-week dietary carcinogenicity study with @DRUG1$ was also conducted in mice at doses up to 500 mg/kg/day (>150 times the human exposure at 10 mg daily based on AUC0-24hr for total @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4927,
        "sentence": "Results revealed that the strains were resistant to many drugs at high levels, only piperacillin, carbenicillin, @DRUG1$ and @DRUG2$ showed resistances at comparatively lower levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4928,
        "sentence": "In the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of @DRUG1$ evaluated by both @DRUG2$ writhing and formalin test, when it was administered with ibuprofen.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4929,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, @DRUG2$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4930,
        "sentence": "@DRUG1$: Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4931,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4932,
        "sentence": "Being @DRUG1$ and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, @DRUG2$ and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4933,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4934,
        "sentence": "@DRUG1$ should be used cautiously in conjunction with @DRUG2$ in patients suffering from hypoprothrombinemia.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4935,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG1$, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4936,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), @DRUG2$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4937,
        "sentence": "Azathioprine/@DRUG1$: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that @DRUG2$ not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4938,
        "sentence": "Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4939,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as @DRUG1$, @DRUG2$, bacitracin, polymyxin B, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4940,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4941,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4942,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral @DRUG1$ (norethindrone 1 mg/ethinyl estradiol 35 mcg), @DRUG2$, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4943,
        "sentence": "Drugs such as troleandomycin and @DRUG1$ may inhibit the metabolism of @DRUG2$ and thus decrease its clearance.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4944,
        "sentence": "While there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and @DRUG1$, there is no evidence that @DRUG2$ is a net inducer of ethinyl estradiol or levonorgestrel metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4945,
        "sentence": "e.g., other belladonna alkaloids, antihistamines (including meclizine), @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4946,
        "sentence": "@DRUG1$ may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4947,
        "sentence": "@DRUG1$ inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, @DRUG2$, and tricyclic antidepressants.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4948,
        "sentence": "Mequitazine can interact with CNS depressant, antichlolinergic, @DRUG1$, @DRUG2$, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4949,
        "sentence": "While in vitro studies have shown that mirtazapine is not a potent inhibitor of any of these enzymes, an indication that @DRUG1$ is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of @DRUG2$ with most other drugs metabolized by these enzymes has not been formally studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4950,
        "sentence": "Interaction with Mixed Agonist/Antagonist Opioid Analgesics: @DRUG1$ (i.e., pentazocine, nalbuphine, butorphanol, or @DRUG2$) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4951,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, @DRUG1$, bacitracin, polymyxins, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4952,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, @DRUG1$, bacitracin, polymyxin B, colistin, viomycin, or @DRUG2$, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4953,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., @DRUG1$, phenytoin, carbamazepine, rifampin, rifabutin, @DRUG2$, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4954,
        "sentence": "Interactions for Vitamin B1 (@DRUG1$):  Loop Diuretics, Oral @DRUG2$, Stavudine, Tricyclic Antidepressants",
        "answer": "int",
        "label": 3
    },
    {
        "id": 4955,
        "sentence": "Distinct synergistic action of @DRUG1$ and @DRUG2$ against Pseudomonas aeruginosa.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4956,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, @DRUG1$, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4957,
        "sentence": "Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or @DRUG1$, and @DRUG2$-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4958,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG1$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG2$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4959,
        "sentence": "The sensitivity, cell cycle, apoptosis and DNA damage of five different cancer cell lines (HeLa, HCT116, HepG2, MCF7 and U251) to @DRUG1$, cisplatin, doxorubicin and etoposide   @DRUG2$ following different incubation schedules were analyzed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4960,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, @DRUG1$, @DRUG2$, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4961,
        "sentence": "@DRUG1$: The effects of chronic @DRUG2$ use on the metabolism of rimantadine are not known.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4962,
        "sentence": "Coumarin-type anticoagulants: Prothrombin time may be increased in patients receiving concomitant @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4963,
        "sentence": "A pharmacokinetic study demonstrated that coadministration of megestrol acetate and @DRUG1$ results in a significant decrease in the pharmacokinetic parameters (~36% for Cmax and ~28% for AUC) of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4964,
        "sentence": "Pravastatin: In a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving @DRUG1$ 120 mg three times a day for 6 days, XENICAL did not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4965,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG1$), @DRUG2$, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4966,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, @DRUG2$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4967,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, @DRUG1$, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered @DRUG2$ or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4968,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4969,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG2$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4970,
        "sentence": "@DRUG1$: Increased serum @DRUG2$ levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4971,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of @DRUG1$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4972,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4973,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (@DRUG1$ 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4974,
        "sentence": "To minimize CNS depression and possible potentiation, @DRUG1$, antihistamines, narcotics, hypotensive agents or @DRUG2$ should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4975,
        "sentence": "Pharmacokinetic properties of @DRUG1$ were not altered by the addition of either lamivudine or @DRUG2$ or the combination of lamivudine and zidovudine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4976,
        "sentence": "But the use of fixed combination @DRUG1$/valsartan compared with traditional therapy was associated with lower clinical and self measured BP, quicker achievement of target BP (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of @DRUG2$ (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4977,
        "sentence": "@DRUG1$: There have been reports of nephrotoxicity in patients to whom @DRUG2$ and tacrolimus were coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4978,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4979,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, @DRUG2$, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4980,
        "sentence": "Caution should be exercised when @DRUG1$    (methylergonovine maleate) is used concurrently with other vasoconstrictors or @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4981,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), @DRUG2$ (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4982,
        "sentence": "Additive sedative effects can occur when @DRUG1$ is given with alcohol, sedatives, hypnotics, @DRUG2$, or tranquilizers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4983,
        "sentence": "In a study conducted in healthy subjects, mean pre-dose lithium concentration and AUC were increased by 21% in subjects receiving @DRUG1$ doses ranging from 804 to 1072 mg BID with meloxicam 15 mg QD as compared to subjects receiving @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4984,
        "sentence": "The effects of indinavir, zidovudine or @DRUG1$ on the pharmacokinetics of @DRUG2$ were not studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4985,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG2$), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4986,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, @DRUG1$, @DRUG2$) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4987,
        "sentence": "@DRUG1$, such as the neuroleptics (phenothiazines, @DRUG2$, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4988,
        "sentence": "When phenytoin or other hepatic enzyme inducers such as @DRUG1$ and phenobarbital have been taken concurrently with Mexitil   , lowered @DRUG2$    plasma levels have been reported.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4989,
        "sentence": "@DRUG1$ has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, @DRUG2$, and antiarrhythmics, without observed problems.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4990,
        "sentence": "@DRUG1$ competes with @DRUG2$ for active tubular secretion and thus inhibits the renal excretion of meropenem.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4991,
        "sentence": "Limited evidence suggests that @DRUG1$ may influence the intensity and duration of action of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 4992,
        "sentence": "Therefore, physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering @DRUG1$ to patients on @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 4993,
        "sentence": "@DRUG1$: Preliminary data from a @DRUG2$ and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when XENICAL was coadministered with cyclosporine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4994,
        "sentence": "Concurrent use with @DRUG1$ including ergot alkaloids, sumatriptan, and @DRUG2$ (e.g. smoking) may result in enhanced vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4995,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that @DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 4996,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving @DRUG2$ 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of phenytoin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4997,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4998,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, diphenylhydantoin, primidone), phenylbutazone, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 4999,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG1$, procainamide, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5000,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, @DRUG1$, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG2$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5001,
        "sentence": "@DRUG1$ (extended-release tablets): In 17 normal-weight subjects receiving XENICAL 120 mg three times a day for 6 days, @DRUG2$ did not alter the bioavailability of nifedipine (extended-release tablets).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5002,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5003,
        "sentence": "In clinical studies, patients on opioids often needed higher serum @DRUG1$ concentrations to achieve appropriate IGF-I suppression compared with patients not receiving @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5004,
        "sentence": "morphine, @DRUG1$, @DRUG2$, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5005,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, @DRUG1$, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5006,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5007,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG2$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5008,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (@DRUG2$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5009,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5010,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG1$, and sodium colistimethate), magnesium salts, @DRUG2$, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5011,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that @DRUG1$ may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5012,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - @DRUG2$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5013,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, @DRUG1$, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5014,
        "sentence": "Multiple dose studies of @DRUG1$ given in combination with @DRUG2$ (statins) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5015,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5016,
        "sentence": "In humans, carmustine, @DRUG1$, and cisplatin do not affect the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5017,
        "sentence": "Concurrent administration of @DRUG1$ and Mexitil    has been reported to increase, decrease, or leave unchanged @DRUG2$    plasma levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5018,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG1$, carbamazepine, and rifampicin), the clearance of @DRUG2$ was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5019,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG2$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5020,
        "sentence": "Digitalis Glycosides: @DRUG1$-induced hypokalemia can increase the sensitivity of the myocardium to @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5021,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), @DRUG1$, naproxen, piroxicam, digoxin, ethanol, @DRUG2$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5022,
        "sentence": "TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of @DRUG1$ in an animal model, possibly enhancing the toxicity of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5023,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and @DRUG2$ (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5024,
        "sentence": "Interference of @DRUG1$ hydrolysis may lead to less @DRUG2$ available for absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5025,
        "sentence": "Co-administration of oral @DRUG1$ 200 mg twice daily increased @DRUG2$ geometric mean AUC(0-24) and Cmax by 81% after topical application of retapamulin ointment, 1% on the abraded skin of healthy adult males.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5026,
        "sentence": "With respect to toxicity, the order of CYP inhibitor effectiveness was @DRUG1$>@DRUG2$~tranylcypromine>ketoconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5027,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), @DRUG2$ (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5028,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG1$, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5029,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of @DRUG1$ was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5030,
        "sentence": "Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of @DRUG1$ (LBH589), an orally active @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5031,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5032,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), @DRUG2$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5033,
        "sentence": "Therefore, it is recommended that oral @DRUG1$ are co- administered with @DRUG2$ with caution and additional birth control methods be considered.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5034,
        "sentence": "TOBI should not be administered concomitantly with @DRUG1$, furosemide, @DRUG2$, or mannitol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5035,
        "sentence": "@DRUG1$ may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG2$, theophylline, corticosteroids, anticoagulants, and beta blockers.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5036,
        "sentence": "Patients receiving @DRUG1$ or nifedipine in combination with MYCAMINE should be monitored for sirolimus or @DRUG2$ toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5037,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5038,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local @DRUG2$, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5039,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5040,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, @DRUG1$, prednisolone, oral contraceptives (@DRUG2$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5041,
        "sentence": "We evaluated how lapatinib interacts with @DRUG1$ in HER2-positive breast cancer, with a particular focus on @DRUG2$-mediated antibody-dependent cellular cytotoxicity (ADCC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5042,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5043,
        "sentence": "The effect of @DRUG1$ on the anticoagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of @DRUG2$ that produced an INR (International Normalized Ratio) between 1.2 and 1.8.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5044,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., @DRUG1$ and clarithromycin), may alter @DRUG2$ mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5045,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), @DRUG1$ (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5046,
        "sentence": "Methotrexate: A study in 13 rheumatoid arthritis (RA) patients evaluated the effects of multiple doses of @DRUG1$ on the pharmacokinetics of @DRUG2$ taken once weekly.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5047,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of @DRUG2$ has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5048,
        "sentence": "Co-administration of @DRUG1$ with @DRUG2$ is not recommended until use in patients is studied.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5049,
        "sentence": "Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with @DRUG1$ 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control @DRUG2$ at its therapeutic dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5050,
        "sentence": "Pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or @DRUG1$ or the combination of lamivudine and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5051,
        "sentence": "Therefore, caution should be exercised with concomitant administration of @DRUG1$ and @DRUG2$ capsules.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5052,
        "sentence": "We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with @DRUG1$ and ABT-737, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of @DRUG2$ insensitive MM cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5053,
        "sentence": "However, on the basis of available data, no dosage adjustment for @DRUG1$ is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between @DRUG2$ and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5054,
        "sentence": "We also found that Bcl-2 was overexpressed in DZNep insensitive cells, and cotreatment with @DRUG1$ and @DRUG2$, a Bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of DZNep insensitive MM cells.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5055,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG1$ and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5056,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, @DRUG1$, ritonavir, saquinavir, telithromycin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5057,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (@DRUG2$), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5058,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, @DRUG1$, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5059,
        "sentence": "Patients receiving sirolimus or nifedipine in combination with MYCAMINE should be monitored for @DRUG1$ or @DRUG2$ toxicity and sirolimus or nifedipine dosage should be reduced if necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5060,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and @DRUG1$), may alter @DRUG2$ mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5061,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG1$, medroxyprogesterone acetate, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5062,
        "sentence": "- did not cause any clinically significant change in plasma profiles of @DRUG1$ or prednisolone following administration of either oral @DRUG2$ or intravenous prednisolone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5063,
        "sentence": "The effect of @DRUG1$ on oral @DRUG2$ is variable.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5064,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5065,
        "sentence": "Another study at a 400-mg and 800-mg daily dose of fluconazole demonstrated that @DRUG1$ taken in doses of 400 mg per day or greater significantly increases plasma levels of @DRUG2$ when taken concomitantly.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5066,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5067,
        "sentence": "Due to its effects on gastric emptying, @DRUG1$ therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., @DRUG2$).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5068,
        "sentence": "@DRUG1$: There have been reports of cardiac events, including torsade de pointes in patients to whom fluconazole and @DRUG2$ were coadministered.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5069,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5070,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), @DRUG2$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5071,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG1$ AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5072,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, @DRUG1$, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5073,
        "sentence": "In the absence of data regarding potential interaction between @DRUG1$ and NSAIDs with longer half-lives, all patients taking these NSAIDs should interrupt dosing for at least 5 days before, the day of, and 2 days following @DRUG2$ administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5074,
        "sentence": "@DRUG1$, which induces hepatic metabolism, decreased the AUC of @DRUG2$ approximately 40% following a single 10-mg dose of montelukast.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5075,
        "sentence": "John   s Wort, and certain anticonvulsants (@DRUG1$, @DRUG2$, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5076,
        "sentence": "A greater potentiation of the neuromuscular blocking effects of MIVACRON may be expected with higher concentrations of @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5077,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5078,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, @DRUG1$, miconazole) or macrolide antibiotics (eg, @DRUG2$, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5079,
        "sentence": "Sulfonamides: Concurrent use of procaine hydrochloride and @DRUG1$ may result in a reduction of the antibacterial action of the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5080,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, @DRUG1$ drugs (e.g., @DRUG2$, imipramine HCl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5081,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5082,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG1$ and nitrites, @DRUG2$, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5083,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, @DRUG1$, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5084,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as @DRUG1$ (e.g., itraconazole and @DRUG2$) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5085,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, @DRUG2$), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5086,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or @DRUG2$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5087,
        "sentence": "In addition to bleeding associated with heparin and @DRUG1$, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after @DRUG2$    therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5088,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to ketoconazole, and @DRUG1$, concomitant use of these products with @DRUG2$ is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5089,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, @DRUG2$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5090,
        "sentence": "@DRUG1$ and Analogues: A pharmacokinetic interaction study showed a 30% reduction in beta-carotene supplement absorption when concomitantly administered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5091,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG1$) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5092,
        "sentence": "Systemic and apparent oral @DRUG1$ clearance were 24% (269    73 vs. 354    102  ml/min, P = 0.022) and 31% (479    190 vs. 688    265  ml/min, P = 0.013), respectively, lower in @DRUG2$-treated patients (n = 20) than in matched tacrolimus-treated patients (n = 20).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5093,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG2$, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5094,
        "sentence": "Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, @DRUG1$, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5095,
        "sentence": "In oral (gavage) fertility studies of @DRUG1$ conducted in rats, there was no evidence of reproductive toxicity at doses up to 1000 mg/kg/day in male or female rats (~7 times the human exposure at 10 mg daily based on AUC0-24hr for total @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5096,
        "sentence": "Furafylline and sulfaphenazole had no effect, while @DRUG1$ appeared to augment @DRUG2$ toxicity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5097,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, @DRUG1$, theophylline, corticosteroids, anticoagulants, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5098,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG1$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), @DRUG2$ (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5099,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, triiodothyronine, phenytoin, @DRUG2$, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5100,
        "sentence": "@DRUG1$ users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), paroxetine (OR   =   1.64 [95% CI, 1.27-2.12]), @DRUG2$ (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5101,
        "sentence": "Although specific drug or food interactions with @DRUG1$ have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, @DRUG2$, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5102,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5103,
        "sentence": "The @DRUG1$ (@DRUG2$), one of S-adenosylhomocysteine (AdoHcy) hydrolase inhibitors, has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5104,
        "sentence": "The latter displayed @DRUG1$ clearances similar to those in two larger cohorts of nonmatched tacrolimus-treated patients (n = 58 and n = 80) and to those receiving a @DRUG2$-free regimen (n = 6).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5105,
        "sentence": "@DRUG1$ should not be administered concomitantly with ethacrynic acid, furosemide, @DRUG2$, or mannitol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5106,
        "sentence": "Regulatory agencies state that the combination of clopidogrel and the CYP2C19 inhibitors @DRUG1$ and @DRUG2$ should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5107,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5108,
        "sentence": "There is evidence that @DRUG1$ may reduce serum levels of @DRUG2$ to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/mL total valproate).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5109,
        "sentence": "Since Celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg @DRUG1$ may increase the plasma concentrations of @DRUG2$ and phenobarbital).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5110,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (@DRUG1$ 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus @DRUG2$ 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5111,
        "sentence": "@DRUG1$ may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5112,
        "sentence": "Dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or @DRUG1$, ordinarily should not be administered concurrently with Permax (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5113,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG1$, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5114,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5115,
        "sentence": "Use with Other @DRUG1$: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, @DRUG2$, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5116,
        "sentence": "Caffeine and/or stimulantes of the @DRUG1$/amphetamine type may counteract the specific actions of @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5117,
        "sentence": "Oral @DRUG1$: Given the different metabolism of Myfortic and oral @DRUG2$, no drug interaction between these two classes of drug is expected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5118,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG2$, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5119,
        "sentence": "The effect of orlistat on the absorption of supplemental @DRUG1$, @DRUG2$, and nutritionally-derived vitamin K is not known at this time.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5120,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, @DRUG1$, phenytoins, thiazide diuretics, @DRUG2$, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5121,
        "sentence": "@DRUG1$ does not interfere with measurement of VMA (@DRUG2$), a test for pheochromocytoma, by those methods which convert VMA to vanillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5122,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5123,
        "sentence": "@DRUG1$ locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5124,
        "sentence": "@DRUG1$: During treatment with Myfortic, the use of @DRUG2$ should be avoided and patients should be advised that vaccinations may be less effective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5125,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, @DRUG1$, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5126,
        "sentence": "morphine, theophylline, aminophylline, @DRUG1$, reserpine, and @DRUG2$ should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5127,
        "sentence": "Coadministration of a selective and potent inhibitor of CYP3A4, @DRUG1$ (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after @DRUG2$) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5128,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, @DRUG1$, glycopyrrolate, @DRUG2$, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5129,
        "sentence": "@DRUG1$: Patients on diuretics, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of @DRUG2$    Tablets therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5130,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - @DRUG2$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5131,
        "sentence": "Interactions for @DRUG1$ (@DRUG2$):  Loop Diuretics, Oral Contraceptives, Stavudine, Tricyclic Antidepressants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5132,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, @DRUG1$) or macrolide antibiotics (eg, @DRUG2$, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5133,
        "sentence": "@DRUG1$: @DRUG2$ causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with EVISTA.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5134,
        "sentence": "@DRUG1$ treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (AUC(0-   )) of oral ketamine by 2.4-fold, whereas itraconazole treatment did not increase the exposure to @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5135,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG1$ AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5136,
        "sentence": "Our objective was to establish potential effects of calcium on absorption of @DRUG-DRUG$ and the dose response for this effect in the absence of a meal.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5137,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5138,
        "sentence": "These are described in greater detail below:  Oral @DRUG1$, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5139,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5140,
        "sentence": "Beta adrenergic agonists should be administered with caution to patients being treated with @DRUG1$ or @DRUG2$, since the action of beta adrenergic agonists on the vascular system may be potentiated.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5141,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - @DRUG2$ or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5142,
        "sentence": "ECG intervals (PR, QRS, and QT) were not affected by concurrent @DRUG1$    and digoxin, @DRUG2$, or propranolol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5143,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5144,
        "sentence": "Coadministration with @DRUG1$ reduced the peak concentration and AUC values for @DRUG2$ by approximately 11%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5145,
        "sentence": "Based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, @DRUG1$, @DRUG2$) were potent, non-competitive inhibitors of trimetrexate metabolism.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5146,
        "sentence": "@DRUG1$: Prothrombin time may be increased in patients receiving concomitant @DRUG2$ and coumarin-type anticoagulants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5147,
        "sentence": "Being @DRUG1$ and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5148,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, miconazole) or macrolide antibiotics (eg, @DRUG2$, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5149,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, @DRUG1$, rifampin, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5150,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG2$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5151,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of @DRUG1$ has no effect on @DRUG2$ plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5152,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5153,
        "sentence": "@DRUG1$ may interact with antidepressants (@DRUG2$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5154,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (@DRUG1$ 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus @DRUG2$ 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5155,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, @DRUG1$, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, @DRUG2$) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5156,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, @DRUG2$, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5157,
        "sentence": "Interaction with @DRUG1$: Agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, @DRUG2$, or buprenorphine) should NOT be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5158,
        "sentence": "A 5.5-fold decrease in the mean @DRUG1$ dose from 6.13 mg/day to 1.13 mg/day (approximately 80-85% reduction of @DRUG2$ dose), was necessary to maintain a target INR of 1.5.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5159,
        "sentence": "Pindolol has been used with a variety of @DRUG1$, including @DRUG2$, hydralazine, and guanethidine without unexpected adverse interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5160,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, @DRUG1$, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5161,
        "sentence": "The latter displayed @DRUG1$ clearances similar to those in two larger cohorts of nonmatched @DRUG2$-treated patients (n = 58 and n = 80) and to those receiving a calcineurin inhibitor-free regimen (n = 6).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5162,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5163,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG1$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5164,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5165,
        "sentence": "ASPIRIN AND OTHER @DRUG1$ WILL BE ADDITIVE TO DISALCID AND MAY INCREASE PLASMA CONCENTRATIONS OF @DRUG2$ TO TOXIC LEVELS.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5166,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG1$ levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5167,
        "sentence": "Therefore, do not administer Myfortic with @DRUG1$ or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral @DRUG2$, because of the potential to reduce the efficacy of Myfortic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5168,
        "sentence": "@DRUG1$ did not increase blood levels of high-dose @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5169,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5170,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, @DRUG2$) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5171,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5172,
        "sentence": "It is reasonable to employ appropriate clinical monitoring when potent cytochrome P450 enzyme inducers, such as phenobarbital or @DRUG1$, are co-administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5173,
        "sentence": "Concurrent ingestion of antacid (20 mL of @DRUG1$ containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of @DRUG2$ or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5174,
        "sentence": "Concomitant administrations not recommended:  - Terfenadine and astemizole: Certain @DRUG1$ interact with terfenadine and @DRUG2$ leading to increased serum concentrations of the latter.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5175,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG1$), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5176,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG1$ (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5177,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5178,
        "sentence": "No pharmacokinetic interaction between 85 mg/m2 @DRUG1$ and infusional @DRUG2$ has been observed in patients treated every 2 weeks.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5179,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, @DRUG1$, morphine, vancomycin, metformin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5180,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, @DRUG1$, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5181,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, @DRUG2$, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5182,
        "sentence": "You cannot take mazindol if you have taken a @DRUG1$ (@DRUG2$) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5183,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG1$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5184,
        "sentence": "These medications included thyroid hormones, @DRUG1$, non-steroidal anti-inflammatory agents, @DRUG2$, and decongestants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5185,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, @DRUG1$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG2$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5186,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG1$ and @DRUG2$ may interfere with the efficacy of the corticosteroids).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5187,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5188,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, @DRUG1$, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5189,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, @DRUG1$, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of @DRUG2$ with other macrolide antibiotics, including azithromycin, is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5190,
        "sentence": "morphine, @DRUG1$, aminophylline, @DRUG2$, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5191,
        "sentence": "When @DRUG1$ and @DRUG2$ are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5192,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), @DRUG2$ salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5193,
        "sentence": "Phenytoin, Carbamazepine, and @DRUG1$: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and @DRUG2$ blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5194,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, @DRUG1$, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5195,
        "sentence": "While in vitro studies have shown that @DRUG1$ is not a potent inhibitor of any of these enzymes, an indication that mirtazapine is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome P450 enzymes, the concomitant use of @DRUG2$ with most other drugs metabolized by these enzymes has not been formally studied.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5196,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG1$, @DRUG2$, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5197,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain @DRUG1$ given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5198,
        "sentence": "Interaction study of @DRUG1$ and @DRUG2$ with co-administered drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5199,
        "sentence": "Barbiturates may decrease the effectiveness of oral contraceptives, certain @DRUG1$, quinidine, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5200,
        "sentence": "DIPRIVAN Injectable Emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used @DRUG1$ (eg, @DRUG2$ and nondepolarizing muscle relaxants).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5201,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), @DRUG1$ (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or @DRUG2$ (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5202,
        "sentence": "Sulfonamides: Concurrent use of @DRUG1$ and @DRUG2$ may result in a reduction of the antibacterial action of the sulfonamide.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5203,
        "sentence": "Lithium: Increased serum @DRUG1$ and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG2$ and ACE inhibitor therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5204,
        "sentence": "Concomitant administration of @DRUG1$ and theophylline-containing drugs leads to increased theophylline levels and @DRUG2$ toxicity in some individuals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5205,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., @DRUG1$, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5206,
        "sentence": "The action of @DRUG1$ may be potentiated by anesthesia, other @DRUG2$ and alcohol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5207,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5208,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG1$), phenylbutazone, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5209,
        "sentence": "There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, @DRUG1$, @DRUG2$, beta blockers, and calcium channel blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5210,
        "sentence": "Although this has not occurred in in vitro studies with @DRUG1$, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering FELDENE to patients on @DRUG2$ and other highly protein-bound drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5211,
        "sentence": "John   s Wort, and certain anticonvulsants (phenytoin, @DRUG1$, carbamazepine) may induce mifepristone metabolism (lowering serum levels of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5212,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5213,
        "sentence": "Warfarin: In 12 normal-weight subjects, administration of @DRUG1$ 120 mg three times a day for 16 days did not result in any change in either @DRUG2$ pharmacokinetics (both R- and S-enantiomers) or pharmacodynamics (prothrombin time and serum Factor VII).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5214,
        "sentence": "Studies with forced expression and siRNA knockdown of Bcl-2 and Cdk1 suggest that @DRUG1$-mediated induction of p27(Kip1) enhanced @DRUG2$-induced apoptosis by negatively regulating Bcl-2 and Cdk1 expression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5215,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5216,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG1$ by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5217,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), @DRUG1$ (n=177), @DRUG2$ (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5218,
        "sentence": "Being @DRUG1$ and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, @DRUG2$, erythromycin and multi minerals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5219,
        "sentence": "Thus strong inhibitors of cytochrome P4501A2, such as @DRUG1$, given concomitantly during administration of @DRUG2$, can interact with Ropivacaine leading to increased ropivacaine plasma levels.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5220,
        "sentence": "DIFLUCAN reduces the metabolism of @DRUG1$, glyburide, and @DRUG2$ and increases the plasma concentration of these agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5221,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5222,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5223,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of @DRUG1$, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5224,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5225,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5226,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of @DRUG1$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5227,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG1$ (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5228,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, tranquilizers, general anesthetics, @DRUG2$, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5229,
        "sentence": "In clinical studies of TOBI, patients taking @DRUG1$ concomitantly with dornase alfa (PULMOZYME   , Genentech), @DRUG2$, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5230,
        "sentence": "@DRUG1$: Increased serum lithium and symptoms of lithium toxicity have been reported in patients receiving concomitant @DRUG2$ and ACE inhibitor therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5231,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG1$ (coadministration of @DRUG2$ with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5232,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or @DRUG1$) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when @DRUG2$    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5233,
        "sentence": "@DRUG1$, a bacteriostatic @DRUG2$, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5234,
        "sentence": "Interaction with Other Central Nervous System Depressants: @DRUG1$ SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, @DRUG2$ (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5235,
        "sentence": "The use of @DRUG1$, in combination with @DRUG2$ and aspirin, has been associated with an increase in bleeding compared to heparin and aspirin alone (see",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5236,
        "sentence": "Concomitant administration of @DRUG1$ and @DRUG2$-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5237,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between @DRUG1$ and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5238,
        "sentence": "@DRUG1$ may inhibit the hepatic metabolism of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5239,
        "sentence": "@DRUG1$ can interact with CNS depressant, antichlolinergic, TCA, MAOIs, and @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5240,
        "sentence": "When @DRUG1$ and lithium are given concomitantly the patient should be carefully monitored for symptoms of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5241,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, @DRUG1$, nelfinavir, ritonavir, saquinavir, telithromycin, @DRUG2$) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5242,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5243,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, tranquilizers, general anesthetics, phenothiazines, other @DRUG2$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5244,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5245,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, @DRUG1$, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5246,
        "sentence": "Use of @DRUG1$ (spironolactone, triamterene, amiloride) or @DRUG2$ supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5247,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., digoxin) by @DRUG1$, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5248,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, @DRUG1$, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5249,
        "sentence": "@DRUG1$: Clinical studies, as well as post-marketing observations, have shown that @DRUG2$ can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5250,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5251,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5252,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5253,
        "sentence": "Drugs such as erythromycin, diltiazem, verapamil, @DRUG1$, @DRUG2$ and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5254,
        "sentence": "Interaction with Other @DRUG1$: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5255,
        "sentence": "It may also interact with thiazides (increased thrombocytopenia), @DRUG1$ (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG2$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5256,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5257,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, @DRUG2$ supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5258,
        "sentence": "- @DRUG1$, pimozide: Other drugs such as cisapride or @DRUG2$, which are metabolised by hepatic CYP3A isozymes have been associated with QT interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5259,
        "sentence": "@DRUG1$ may enhance the sedative effects of central nervous system depressants including @DRUG2$, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5260,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, @DRUG1$, @DRUG2$, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5261,
        "sentence": "This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, @DRUG1$ blood levels should be monitored, particularly when the @DRUG2$    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5262,
        "sentence": "and/or @DRUG1$ doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin @DRUG2$ (MPTP) (4 x 20 mg/kg, i. p.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5263,
        "sentence": "@DRUG1$. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, @DRUG2$, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5264,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (@DRUG2$ 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5265,
        "sentence": "Acetazolamide: Concurrent use of @DRUG1$ and @DRUG2$ may extend the plasma half-life of procaine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5266,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5267,
        "sentence": "Concomitant administrations not recommended:  - @DRUG1$ and @DRUG2$: Certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5268,
        "sentence": "@DRUG1$: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5269,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, @DRUG1$, general anesthetics, phenothiazines, other @DRUG2$, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5270,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., @DRUG1$, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5271,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and @DRUG1$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5272,
        "sentence": "@DRUG1$ - concurrent use decreases gastrointestinal absorption of @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5273,
        "sentence": "Dopamine antagonists: Since @DRUG1$ is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, @DRUG2$, thioxanthenes) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5274,
        "sentence": "Mequitazine can interact with CNS depressant, @DRUG1$, @DRUG2$, MAOIs, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5275,
        "sentence": "Thalidomide has been reported to enhance the sedative activity of barbiturates, @DRUG1$, chlorpromazine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5276,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, @DRUG1$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG2$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5277,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG2$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5278,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, @DRUG1$, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5279,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5280,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5281,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), @DRUG2$ (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5282,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with @DRUG1$ (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral @DRUG2$ demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5283,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, @DRUG2$, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5284,
        "sentence": "The ratio of norketamine AUC(0-   ) to @DRUG1$ AUC(0-   ) was significantly decreased in the @DRUG2$ (P &lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5285,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, @DRUG1$, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing @DRUG2$ has been demonstrated in patients chronically administered phenytoin or carbamazepine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5286,
        "sentence": "DRUG INTERACTIONS  There are no known drug/drug interactions with oral ALKERAN  Vaccinations with live organism vaccines are not recommended in immunocompromised individuals  @DRUG1$ together with high-dose intravenous @DRUG2$ has caused deaths in children due to haemorrhagic enterocolitis.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5287,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, @DRUG1$, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5288,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5289,
        "sentence": "Less potent inhibitors include saquinavir, @DRUG1$, fluconazole, grapefruit juice, @DRUG2$, fluvoxamine, zileuton, and clotrimazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5290,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (@DRUG1$), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5291,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on @DRUG1$ plasma levels . Nonsteroidal anti-inflammatory agents, including @DRUG2$, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5292,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, @DRUG1$, glycopyrrolate, diazepam, @DRUG2$, and other muscle relaxants) or local anesthetics have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5293,
        "sentence": "@DRUG1$: Torsades de pointes and elevated parent @DRUG2$ levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5294,
        "sentence": "Melatonin may interact with the following drugs: @DRUG1$ and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease @DRUG2$ levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5295,
        "sentence": "Addition of mexiletine to @DRUG1$ did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5296,
        "sentence": "Vasopressors, particularly @DRUG1$, may cause serious cardiac arrhythmias during @DRUG2$ anesthesia and therefore should be used only with great caution or not at all.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5297,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5298,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled @DRUG1$ AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG2$, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5299,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., @DRUG2$, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5300,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, @DRUG2$, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5301,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5302,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, @DRUG2$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5303,
        "sentence": "The in vitro binding of @DRUG1$ to human plasma proteins is unaffected by tolmetin, and @DRUG2$ does not alter the prothrombin time of normal volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5304,
        "sentence": "In the hot plate test in mice, co-administration of 15     g/kg dexmedetomidine with 10   mg/kg @DRUG1$ intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5305,
        "sentence": "@DRUG1$ and @DRUG2$ (administered with nitrous oxide/oxygen to achieve 1.25 M.C.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5306,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5307,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG1$, @DRUG2$, pancuronium, morphine, vancomycin, metformin and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5308,
        "sentence": "Concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin B, aminoglycosides, bacitracin, polymyxin B, @DRUG1$, @DRUG2$, or cisplatin, when indicated, requires careful monitoring.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5309,
        "sentence": "The authors report the case of an infant with confirmed congenital hypothyroidism on @DRUG1$ who experienced a possible drug interaction with @DRUG2$.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5310,
        "sentence": "Although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with FELDENE since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering @DRUG1$ to patients on @DRUG2$ and other highly protein-bound drugs.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5311,
        "sentence": "Alcohol: Concomitant administration of @DRUG1$ (equivalent to 60 g) had a minimal effect on plasma levels of @DRUG2$ (15 mg) in 6 healthy male subjects.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5312,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - @DRUG1$ - neostigmine - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5313,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, @DRUG2$, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5314,
        "sentence": "Although not studied, the potent cytochrome P450 3A4 inhibitors @DRUG1$ and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5315,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing @DRUG1$, when administered 1 hour before @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5316,
        "sentence": "The addition of @DRUG1$ to parenteral solutions containing @DRUG2$ should be avoided, except where compatibility has been previously established.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5317,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, @DRUG1$, @DRUG2$, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5318,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG1$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5319,
        "sentence": "In humans, carmustine, @DRUG1$, and @DRUG2$ do not affect the pharmacokinetics of ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5320,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5321,
        "sentence": "Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of @DRUG1$ has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma @DRUG2$ levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5322,
        "sentence": "Although specific drug or food interactions with @DRUG1$ have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that ketoconazole, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5323,
        "sentence": "Caution should be used when administering @DRUG1$ with warfarin since patients on @DRUG2$ may experience changes in INR and an increased risk of bleeding complications when a new medication is introduced.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5324,
        "sentence": "Nifedipine AUC and Cmax were increased by 18% and 42%, respectively, in the presence of steady-state @DRUG1$ compared with @DRUG2$ alone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5325,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), @DRUG2$ (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5326,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), @DRUG1$ (n=79), estrogens (n=70), @DRUG2$ (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5327,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5328,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, @DRUG2$, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5329,
        "sentence": "@DRUG1$-mediated retinal transduction is improved by co-injection of heparinase III or @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5330,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5331,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, @DRUG1$, Phenytoin, Cyclosporine, Rifampin, @DRUG2$, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5332,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), @DRUG1$, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5333,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG1$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, @DRUG2$ (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5334,
        "sentence": "Posicor inhibits some of the liver's ability to metabolize some other drugs - @DRUG1$, astemizole, cisapride, cyclosporine, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5335,
        "sentence": "Administration of @DRUG1$ decreases oral clearance of @DRUG2$ by about 5%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5336,
        "sentence": "Considering the variability in exposure following enzyme inhibition and the fact that chronic dosing of @DRUG1$ was not studied with CYP3A inhibitors, close monitoring of @DRUG2$-related adverse events is necessary.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5337,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, @DRUG1$, selegiline, @DRUG2$), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5338,
        "sentence": "Phenytoin, Carbamazepine, and @DRUG1$: In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and @DRUG2$), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5339,
        "sentence": "and combinations of @DRUG1$ and @DRUG2$ (eg, benzodiazepines, barbiturates, chloral hydrate, droperidol, etc.).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5340,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with @DRUG1$ and other strong P450 3A inhibitors including atazanavir, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5341,
        "sentence": "We have demonstrated appropriateness of inhospital administration of fixed amlodipine/@DRUG1$ combination as an approach allowing to achieve target BP in shorter time, with the use of fewer @DRUG2$, and diminishing concealed inefficacy of treatment.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5342,
        "sentence": "UNIVASC    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, H2 blockers, @DRUG1$, oral @DRUG2$, and cholesterol-lowering agents.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5343,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), @DRUG2$ (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5344,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with @DRUG1$ have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, @DRUG2$ and tenofovir).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5345,
        "sentence": "Preliminary evidence suggests that @DRUG1$ inhibits @DRUG2$ metabolism and may result in an increase in plasma concentrations of mebendazole.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5346,
        "sentence": "Mequitazine can interact with CNS depressant, antichlolinergic, TCA, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5347,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG2$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5348,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5349,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5350,
        "sentence": "This increase was observed at the first test point which was the second day after starting @DRUG1$   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and @DRUG2$ are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5351,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing aluminum hydroxide, magnesium hydroxide, and @DRUG1$) did not significantly affect the exposure of oxybutynin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5352,
        "sentence": "There was no effect of a single dose or multiple doses of @DRUG1$ on mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG2$, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5353,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, @DRUG1$, rifampin, @DRUG2$, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5354,
        "sentence": "@DRUG1$, such as the @DRUG2$ (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5355,
        "sentence": "Mazindol may reduce the effects of @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5356,
        "sentence": "Oral @DRUG1$: Given the different metabolism of @DRUG2$ and oral contraceptives, no drug interaction between these two classes of drug is expected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5357,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5358,
        "sentence": "Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with @DRUG1$    Tablets, but an effect of @DRUG2$ on the plasma concentration of perindopril/perindoprilat has not been excluded.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5359,
        "sentence": "The bioavailability of SKELID is decreased 80% by calcium, when calcium and SKELID are administered at the same time, and 60% by some @DRUG1$- or @DRUG2$-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5360,
        "sentence": "Pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or zidovudine or the combination of @DRUG1$ and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5361,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, @DRUG2$, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5362,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, @DRUG2$) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5363,
        "sentence": "Mixing SYMLIN and @DRUG1$ The pharmacokinetic parameters of SYMLIN were altered when mixed with regular, NPH, and 70/30 premixed formulations of recombinant @DRUG2$ immediately prior to injection.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5364,
        "sentence": "Selegiline: In healthy volunteers (N= 11), @DRUG1$ did not influence the pharmacokinetics of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5365,
        "sentence": "Short-acting Benzodiazepines: Following oral administration of midazolam, @DRUG1$ resulted in substantial increases in @DRUG2$ concentrations and psychomotor effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5366,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, @DRUG1$, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5367,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), @DRUG1$, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5368,
        "sentence": "Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, @DRUG1$ drugs (e.g., amitriptyline HCl, @DRUG2$) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5369,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5370,
        "sentence": "Mequitazine can interact with CNS depressant, @DRUG1$, TCA, @DRUG2$, and alcohol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5371,
        "sentence": "MAO Inhibitors - The pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving @DRUG1$ (@DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5372,
        "sentence": "@DRUG1$ can interact with @DRUG2$, antichlolinergic, TCA, MAOIs, and alcohol.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5373,
        "sentence": "Azathioprine/Mycophenolate Mofetil: Given that azathioprine and @DRUG1$ inhibit purine metabolism, it is recommended that @DRUG2$ not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5374,
        "sentence": "Drugs that induce hepatic enzymes such as @DRUG1$, phenytoin, and @DRUG2$ may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5375,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5376,
        "sentence": "Antacids: Absorption of a single dose of @DRUG1$ was decreased when administered to 12 stable renal transplant patients also taking magnesium-@DRUG2$ containing antacids (30 mL): the mean Cmax and AUC(0-t) values for MPA were 25% and 37% lower, respectively, than when Myfortic was administered alone under fasting conditions.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5377,
        "sentence": "Drugs such as erythromycin, @DRUG1$, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5378,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by calcium, when @DRUG2$ and SKELID are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5379,
        "sentence": "Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric pH is an important determinant of their bioavailability (eg, ketoconazole, @DRUG1$ esters, and @DRUG2$ salts).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5380,
        "sentence": "The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, @DRUG1$, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5381,
        "sentence": "Furosemide: Clinical studies, as well as post-marketing observations, have shown that @DRUG1$ can reduce the natriuretic effect of @DRUG2$ and thiazide diuretics in some patients.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5382,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (@DRUG1$, @DRUG2$, cyclosporine and others) can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5383,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (@DRUG1$), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5384,
        "sentence": "Co-administration of @DRUG1$ with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5385,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (@DRUG1$ 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (@DRUG2$ 20 mg/kg), group 5 (imipramine 15 mg/kg), group 6 (curcumin 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5386,
        "sentence": "Use of @DRUG1$ and Antiplatelet Agents -- Streptase, @DRUG2$, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5387,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5388,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG1$, @DRUG2$, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5389,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and @DRUG1$ (imipramine, clomipramine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5390,
        "sentence": "Treatment of HEY xenograft-bearing mice with @DRUG1$ plus @DRUG2$ inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5391,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5392,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, @DRUG1$ (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5393,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG2$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5394,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG1$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, @DRUG2$, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5395,
        "sentence": "@DRUG1$ may increase the effects of barbiturates, tolbutamide, and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5396,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, carbamazepine, @DRUG1$, rifabutin, @DRUG2$, phenobarbital, St. Johns Wort) may decrease sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5397,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, @DRUG2$, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5398,
        "sentence": "ECG intervals (PR, QRS, and QT) were not affected by concurrent Mexitil    and @DRUG1$, @DRUG2$, or propranolol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5399,
        "sentence": "@DRUG1$ exhibited dose-dependent growth inhibition in NSCLC cell lines and arrested cell cycle at G1 phase, whereas @DRUG2$ arrested at S phase.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5400,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., @DRUG2$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5401,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, @DRUG1$), phenylbutazone, and tricyclic drugs (imipramine, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5402,
        "sentence": "Methscopolamine may interact with antidepressants (@DRUG1$ type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5403,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., @DRUG1$, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5404,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG1$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5405,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, @DRUG1$, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5406,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower @DRUG1$ levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), @DRUG2$ (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5407,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other @DRUG1$ such as alcohol, @DRUG2$, antihistaminics, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5408,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), @DRUG2$ and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5409,
        "sentence": "You cannot take mazindol if you have taken a monoamine oxidase inhibitor (@DRUG1$) such as isocarboxazid (Marplan), tranylcypromine (@DRUG2$), or phenelzine (Nardil) in the last 14 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5410,
        "sentence": "Coadministration of a selective and potent inhibitor of CYP3A4, ketoconazole (100 mg bid for 2 days with @DRUG1$ infusion administered 1 hour after @DRUG2$) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5411,
        "sentence": "Concurrent use with vasoconstrictor agents including @DRUG1$, @DRUG2$, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5412,
        "sentence": "@DRUG1$: Spontaneous adverse reaction reports of patients taking concomitant @DRUG2$ with recommended doses of terfenadine demonstrate QT interval prolongation and rare serious cardiac events, e.g.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5413,
        "sentence": "Use with Cholinomimetics and Other @DRUG1$: A synergistic effect may be expected when @DRUG2$ are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5414,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other @DRUG1$, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5415,
        "sentence": "Dopamine antagonists: Since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, @DRUG2$) or metoclopramide, may diminish the effectiveness of MIRAPEX.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5416,
        "sentence": "@DRUG1$ may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, @DRUG2$, furosemide and theophylline Please note that Mephenytoin may interact with other drugs that are not listed here.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5417,
        "sentence": "Interaction with @DRUG1$: Although minoxidil does not itself cause orthostatic hypotension, its administration to patients already receiving @DRUG2$ can result in profound orthostatic effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5418,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as @DRUG1$ (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (Pamelor), @DRUG2$ (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5419,
        "sentence": "Thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5420,
        "sentence": "If concomitant treatment with @DRUG1$ and an @DRUG2$ is clinically warranted, appropriate observation of the patient is advised.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5421,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and @DRUG2$ (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5422,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, @DRUG1$,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5423,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, @DRUG1$, @DRUG2$, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5424,
        "sentence": "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), @DRUG1$ (OR   =   1.64 [95% CI, 1.27-2.12]), @DRUG2$ (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5425,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG1$, tranylcypromine, isocarboxazid, @DRUG2$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5426,
        "sentence": "These data suggest that @DRUG1$ administration may alter the clearance of compounds known to be metabolized by CP450 liver enzymes (e.g., corticosteroids, sex steroids, anticonvulsants, @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5427,
        "sentence": "Other HDAC Inhibitors Severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of @DRUG1$ and other HDAC inhibitors (e.g., @DRUG2$).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5428,
        "sentence": "Carbidopa/Levodopa: @DRUG1$/@DRUG2$ does not influence the pharmacokinetics of pramipexole in healthy volunteers (N= 10).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5429,
        "sentence": "Human pharmacologic studies have shown that @DRUG1$ may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), @DRUG2$, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5430,
        "sentence": "Diuretics: Furosemide and probably other @DRUG1$ given concomitantly with @DRUG2$ can cause unusually large or prolonged losses of fluid and electrolytes.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5431,
        "sentence": "Other Agents: No clinically important pharmacokinetic interactions occurred when UNIVASC    was administered concomitantly with hydrochlorothiazide, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5432,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG1$, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5433,
        "sentence": "Anticoagulants @DRUG1$ may increase sensitivity to oral @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5434,
        "sentence": "Interaction of @DRUG1$ and @DRUG2$, in vitro and in vivo, in human A375 melanoma cells.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5435,
        "sentence": "Drugs such as erythromycin, @DRUG1$, verapamil, @DRUG2$, fluconazole and itraconazole were shown to significantly increase the C max and AUC of orally administered midazolam.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5436,
        "sentence": "Dopamine antagonists, such as the neuroleptics (@DRUG1$, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with @DRUG2$ (a dopamine agonist);",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5437,
        "sentence": "@DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or @DRUG2$, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5438,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, @DRUG2$, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5439,
        "sentence": "After 21 weeks of @DRUG1$ treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the @DRUG2$/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5440,
        "sentence": "When oxandrolone therapy is initiated in a patient already receiving treatment with @DRUG1$, the INR or prothrombin time (PT) should be monitored closely and the dose of @DRUG2$ adjusted as necessary until a stable target INR or PT has been achieved.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5441,
        "sentence": "The concomitant use of other CNS depressants including sedatives, @DRUG1$, tranquilizers, general @DRUG2$, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5442,
        "sentence": "Concurrent ingestion of @DRUG1$ (20 mL of antacid containing @DRUG2$, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5443,
        "sentence": "@DRUG1$, Barbiturates, and @DRUG2$: The hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5444,
        "sentence": "Weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/@DRUG1$ versus @DRUG2$/vehicle).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5445,
        "sentence": "Caution should be used when @DRUG1$ is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5446,
        "sentence": "@DRUG1$ given concomitantly with @DRUG2$ may predispose to systemic bleeding.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5447,
        "sentence": "Itraconazole: Torsades de pointes and elevated parent @DRUG1$ levels have been reported during concomitant use of @DRUG2$ and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5448,
        "sentence": "Concurrent use with vasoconstrictor agents including ergot alkaloids, @DRUG1$, and @DRUG2$ (e.g. smoking) may result in enhanced vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5449,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5450,
        "sentence": "Concurrent use of @DRUG1$ with oral @DRUG2$ may render oral contraceptives less effective.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5451,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as @DRUG2$, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5452,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of @DRUG2$ with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5453,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of @DRUG1$ such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG2$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5454,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER @DRUG1$, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG2$), TRICYCLIC ANTIDEPRESSANTS AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5455,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as @DRUG1$ include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, @DRUG2$, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5456,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/@DRUG1$ 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5457,
        "sentence": "@DRUG1$ may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG2$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5458,
        "sentence": "@DRUG1$ should not be administered concomitantly with @DRUG2$, furosemide, urea, or mannitol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5459,
        "sentence": "Because @DRUG1$ exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline HCl, imipramine HCl) and other drugs and foods with known high @DRUG2$ content, such as wine, yogurt, ripe cheese and bananas, should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5460,
        "sentence": "@DRUG1$: A multidose study of oxandrolone, given as 5 or 10 mg BID in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in @DRUG2$ half-life from 26 to 48 hours and AUC from 4.55 to 12.08 ng*hr/mL: similar increases in R-warfarin half-life and AUC were also detected.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5461,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with @DRUG1$: Concomitant use of @DRUG2$, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5462,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5463,
        "sentence": "The occurrence of stupor, muscular rigidity, severe agitation, and elevated temperature has been reported in some patients receiving the combination of @DRUG1$ and @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5464,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, @DRUG1$, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5465,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., @DRUG2$-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5466,
        "sentence": "In a large compassionate use program Mexitil    has been used concurrently with commonly employed antianginal, @DRUG1$, and @DRUG2$ without observed interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5467,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG1$ (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5468,
        "sentence": "Montelukast at Doses of    100 mg Daily Dosed to Pharmacokinetic Steady State:  - did not significantly alter the plasma concentrations of either component of an oral @DRUG1$ containing norethindrone 1 mg/ethinyl @DRUG2$ 35 mcg.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5469,
        "sentence": "Cholestyramine: Pretreatment for four days with @DRUG1$ significantly increased the clearance of @DRUG2$ by 50%.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5470,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., @DRUG1$), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5471,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG1$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as @DRUG2$ - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5472,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), nortriptyline (@DRUG1$), imipramine (Tofranil), clomipramine (Anafranil), @DRUG2$ (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5473,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5474,
        "sentence": "Use of @DRUG1$ (spironolactone, triamterene, amiloride) or potassium supplements concomitantly with @DRUG2$ can increase the risk of hyperkalemia.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5475,
        "sentence": "ProAmatine. @DRUG1$, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5476,
        "sentence": "From this study it can be concluded that @DRUG1$ can be used as a bioenhancer along with @DRUG2$.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5477,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (@DRUG1$), @DRUG2$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5478,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of @DRUG2$. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5479,
        "sentence": "At a 1.6-g dose, @DRUG1$ produced a slight but significant increase in the half-life of @DRUG2$ but did not produce a corresponding decrease in the metabolic clearance rate.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5480,
        "sentence": "The ratio of @DRUG1$ AUC(0-   ) to @DRUG2$ AUC(0-   ) was significantly decreased in the ticlopidine (P &lt; 0.001) and itraconazole phases (P = 0.006) as compared to placebo.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5481,
        "sentence": "Fluconazole tablets coadministered with ethinyl estradiol- and @DRUG1$-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and @DRUG2$ levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5482,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, @DRUG1$, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5483,
        "sentence": "@DRUG1$: Theophylline clearance may decrease when hyperthyroid patients on a stable @DRUG2$ regimen become euthyroid;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5484,
        "sentence": "- did not cause any clinically significant change in plasma profiles of @DRUG1$ or prednisolone following administration of either oral prednisone or intravenous @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5485,
        "sentence": "The combined use of @DRUG1$ with @DRUG2$ is contraindicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5486,
        "sentence": "@DRUG1$ inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5487,
        "sentence": "Other inhibitors of the cytochrome P450 3A4 enzyme system, such as antimycotic agents (e.g., @DRUG1$ and miconazole) or macrolide antibiotics (e.g., erythromycin and @DRUG2$), may alter oxybutynin mean pharmacokinetic parameters (i.e., Cmax and AUC).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5488,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and @DRUG2$) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5489,
        "sentence": "Plasma levels of @DRUG1$ are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with @DRUG2$ (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5490,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, @DRUG1$, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5491,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, @DRUG2$, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5492,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/@DRUG2$), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5493,
        "sentence": "Rats treated with neonatal @DRUG1$ enhanced time spent in the @DRUG2$-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5494,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, @DRUG1$ or dihydroergotamine) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when @DRUG2$    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5495,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, @DRUG1$, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5496,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of @DRUG2$ (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5497,
        "sentence": "Depending on clinical circumstances, consideration should be given to increasing the dose of @DRUG1$ when it is administered with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5498,
        "sentence": "During maintenance of anesthesia or sedation, the rate of DIPRIVAN Injectable Emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, @DRUG1$ or @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5499,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, @DRUG2$ did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5500,
        "sentence": "Multiple dose studies of @DRUG1$ given in combination with HMG-CoA reductase inhibitors (@DRUG2$) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5501,
        "sentence": "As there is in vitro evidence that aminosalicylate derivatives (e.g., @DRUG1$, @DRUG2$, or sulphasalazine) inhibit the TPMT enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5502,
        "sentence": "Concurrent ingestion of antacid (20 mL of antacid containing @DRUG1$, magnesium hydroxide, and @DRUG2$) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5503,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, Astemizole, Rifabutin, @DRUG2$, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5504,
        "sentence": "These medications included @DRUG1$, sedative hypnotics, @DRUG2$, benzodiazepines, and decongestants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5505,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5506,
        "sentence": "Warfarin: The coadministration of @DRUG1$ and @DRUG2$ has not been assessed under chronic conditions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5507,
        "sentence": "Fluconazole tablets coadministered with ethinyl estradiol- and @DRUG1$-containing oral contraceptives produced an overall mean increase in @DRUG2$ and levonorgestrel levels;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5508,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5509,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5510,
        "sentence": "The use of @DRUG1$, in combination with heparin and @DRUG2$, has been associated with an increase in bleeding compared to heparin and aspirin alone (see",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5511,
        "sentence": "@DRUG1$: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of @DRUG2$ with the co-administration of 100 mg sitagliptin for 10 days.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5512,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, @DRUG1$, triiodothyronine, phenytoin, @DRUG2$, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5513,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. @DRUG2$, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5514,
        "sentence": "Therefore, the use of @DRUG1$ tablets in patients receiving MAO-A inhibitors is contraindicated . @DRUG2$ (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5515,
        "sentence": "It is recommended that @DRUG1$ and @DRUG2$ not be administered simultaneously.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5516,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG1$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of @DRUG2$ and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5517,
        "sentence": "The incremental LDL-C reduction due to adding @DRUG1$ to @DRUG2$ may be reduced by this interaction.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5518,
        "sentence": "NSCLC cell lines with EGFR T790M mutation and K-ras mutation were exposed to either @DRUG1$ or @DRUG2$ or both based on various sequential administrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5519,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, @DRUG1$, verapamil, quinidine, and @DRUG2$) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5520,
        "sentence": "Anticoagulants (such as heparin and @DRUG1$) and drugs that alter platelet function (such as acetylsalicylic acid, @DRUG2$, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after TNKase therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5521,
        "sentence": "Due to low systemic exposure to @DRUG1$ following topical application in patients, dosage adjustments for @DRUG2$ are unnecessary when co-administered with CYP3A4 inhibitors, such as ketoconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5522,
        "sentence": "The concomitant use of other CNS depressants including sedatives, hypnotics, tranquilizers, general anesthetics, @DRUG1$, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5523,
        "sentence": "Since Celontin (methsuximide) may interact with concurrently administered @DRUG1$, periodic serum level determinations of these drugs may be necessary (eg @DRUG2$ may increase the plasma concentrations of phenytoin and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5524,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of @DRUG1$ by about 20%, while those secreted by the anionic transport system (e.g., @DRUG2$, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5525,
        "sentence": "@DRUG1$: When studied in stable renal transplant patients, cyclosporine, USP (MODIFIED) pharmacokinetics were unaffected by steady state dosing of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5526,
        "sentence": "@DRUG1$    has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., @DRUG2$), with or without salt supplementation.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5527,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with @DRUG1$, @DRUG2$, pravastatin, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5528,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, Cyclosporine, @DRUG2$, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5529,
        "sentence": "The sedative effect of VERSED Syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and @DRUG1$), propofol, ketamine, nitrous oxide, secobarbital and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5530,
        "sentence": "Treatment of HEY xenograft-bearing mice with dasatinib plus @DRUG1$ inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs @DRUG2$: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [CI] = 0.44 to 0.62 cm3, P = .014);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5531,
        "sentence": "@DRUG1$ enhances @DRUG2$-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface HER2 expression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5532,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and @DRUG2$, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5533,
        "sentence": "Additive sedative effects and confusional states may emerge if levomepromazine is given with @DRUG1$ or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5534,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as @DRUG1$ or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG2$ or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5535,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG2$), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5536,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  @DRUG1$: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of @DRUG2$.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5537,
        "sentence": "In adult diabetic patients under treatment with either sulfonylureas or @DRUG1$ there is no change in the clinical effects of either TOLECTIN or the @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5538,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing @DRUG1$ with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG2$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5539,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, @DRUG1$, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, @DRUG2$, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5540,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, @DRUG1$, warfarin, methotrexate, and possibly @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5541,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5542,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, modafinil, @DRUG1$, rifampin, rifabutin, @DRUG2$, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5543,
        "sentence": "The concomitant use of other @DRUG1$ including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (MAO) inhibitors, and @DRUG2$ may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5544,
        "sentence": "In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that @DRUG1$ does not affect the clearance of @DRUG2$ or digoxin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5545,
        "sentence": "Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, @DRUG1$ has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, @DRUG2$, metformin and tenofovir).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5546,
        "sentence": "The bioavailability of @DRUG1$ is decreased 80% by calcium, when calcium and @DRUG2$ are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before SKELID.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5547,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG1$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5548,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, @DRUG1$, atazanavir, indinavir, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5549,
        "sentence": "@DRUG1$ blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5550,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG1$, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5551,
        "sentence": "Digoxin: There was a slight increase in the area under the curve (AUC, 11%) and mean peak drug concentration (Cmax, 18%) of @DRUG1$ with the co-administration of 100 mg @DRUG2$ for 10 days.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5552,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5553,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, @DRUG1$, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), @DRUG2$ (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5554,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), @DRUG1$ (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), @DRUG2$ (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5555,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the @DRUG1$ virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - @DRUG2$: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5556,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5557,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, @DRUG1$ (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5558,
        "sentence": "Since @DRUG1$ (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg @DRUG2$ may increase the plasma concentrations of phenytoin and phenobarbital).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5559,
        "sentence": "Use of @DRUG1$ and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with antiplatelet agents and @DRUG2$, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5560,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, Phenytoin, Cyclosporine, Rifampin, @DRUG1$, Terfenadine, Cisapride, @DRUG2$, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5561,
        "sentence": "@DRUG1$, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a @DRUG2$);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5562,
        "sentence": "Dopamine antagonists, such as the @DRUG1$ (phenothiazines, butyrophenones, @DRUG2$ ) or metoclopramide, ordinarily should not be administered concurrently with Permax (a dopamine agonist);",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5563,
        "sentence": "These medications included thyroid hormones, @DRUG1$, non-steroidal anti-inflammatory agents, benzodiazepines, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5564,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral @DRUG2$ (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5565,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (@DRUG1$, @DRUG2$, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5566,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, anticonvulsants (@DRUG2$, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5567,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, @DRUG1$, @DRUG2$, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5568,
        "sentence": "Since Celontin (@DRUG1$) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5569,
        "sentence": "In a formal study, @DRUG1$ were shown not to affect @DRUG2$    plasma concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5570,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$ or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5571,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, @DRUG2$, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5572,
        "sentence": "This interaction should be given consideration in patients taking @DRUG1$ concomitantly with @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5573,
        "sentence": "Interactions for Vitamin B1 (Thiamine):  @DRUG1$, Oral Contraceptives, Stavudine, @DRUG2$",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5574,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, @DRUG1$, @DRUG2$, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5575,
        "sentence": "No significant adverse interactions with common premedications (such as atropine, scopolamine, @DRUG1$, diazepam, hydroxyzine, and other muscle relaxants) or local @DRUG2$ have been observed.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5576,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on mycophenolate mofetil, cyclosporine, @DRUG1$, prednisolone, and @DRUG2$ pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5577,
        "sentence": "Use of Anticoagulants and Antiplatelet Agents -- @DRUG1$, Streptokinase, alone or in combination with antiplatelet agents and @DRUG2$, may cause bleeding complications.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5578,
        "sentence": "All the tests were carried out in the following seven groups (n = 6 in each group), drugs being given orally (doses for mice): Group 1 (vehicle), group 2 (curcumin 50 mg/kg), group 3 (curcumin 100 mg/kg), group 4 (fluoxetine 20 mg/kg), group 5 (@DRUG1$ 15 mg/kg), group 6 (@DRUG2$ 100 mg/kg plus fluoxetine 20 mg/kg) and group 7 (curcumin 100 mg/kg plus imipramine 15 mg/kg).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5579,
        "sentence": "@DRUG1$: The pressor effect of @DRUG2$ is markedly potentiated in patients receiving monoamine oxidase inhibitors (MAOI).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5580,
        "sentence": "No pharmacokinetic interaction was observed between @DRUG1$ and digoxin, @DRUG2$, diazepam, or fluoxetine in studies in healthy volunteers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5581,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably @DRUG1$, thiopental, thyroxine, triiodothyronine, @DRUG2$, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5582,
        "sentence": "However, the co   administration of @DRUG1$ with other anticholinergic   containing drugs (e.g., @DRUG2$) has not been studied and is therefore not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5583,
        "sentence": "Co-administration of SUTENT with inducers of the CYP3A4 family (e.g., dexamethasone, phenytoin, @DRUG1$, rifampin, rifabutin, rifapentin, phenobarbital, St. Johns Wort) may decrease @DRUG2$ concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5584,
        "sentence": "This study was aimed to investigate the efficacy of single use of @DRUG1$ and that of concurrent or sequential administration of @DRUG2$ and docetaxel in NSCLC cell lines that are resistant to EGFR TKIs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5585,
        "sentence": "However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between @DRUG1$ and tramadol has been observed, data from 2 small studies indicate that @DRUG2$ may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5586,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: @DRUG1$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, @DRUG2$, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5587,
        "sentence": "Use with Other @DRUG1$: The depressant effects of morphine are potentiated by the presence of other CNS depressants such as alcohol, sedatives, antihistaminics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5588,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and @DRUG1$) to @DRUG2$, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5589,
        "sentence": "@DRUG1$: Cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5590,
        "sentence": "Administration of paclitaxel in combination with HERCEPTIN resulted in a two-fold decrease in @DRUG1$ clearance in a non-human primate study and in a 1.5-fold increase in @DRUG2$ serum levels in clinical studies.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5591,
        "sentence": "e.g., other belladonna alkaloids, @DRUG1$ (including meclizine), @DRUG2$, and muscle relaxants.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5592,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), @DRUG2$ (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5593,
        "sentence": "Important Non-Thalidomide Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, @DRUG1$, modafinil, @DRUG2$, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5594,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5595,
        "sentence": "Concurrent ingestion of antacid (20 mL of @DRUG1$ containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5596,
        "sentence": "Severe toxicity has also been reported in patients receiving the combination of @DRUG1$ and ELDEPRYL and selective serotonin reuptake inhibitors and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5597,
        "sentence": "Other eye drops or medications such as acetylcholine chloride (Miochol) and carbachol (@DRUG1$, @DRUG2$) may decrease the effects of suprofen ophthalmic.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5598,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, @DRUG2$, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5599,
        "sentence": "Important Non-@DRUG1$ Drug Interactions Drugs That Interfere with Hormonal Contraceptives: Concomitant use of HIV-protease inhibitors, griseofulvin, @DRUG2$, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as St.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5600,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), benzodiazepines, MAO inhibitors, @DRUG2$ (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5601,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG2$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5602,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., @DRUG1$) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, @DRUG2$, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5603,
        "sentence": "Warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of @DRUG1$ (OR   =   1.73 [95% CI, 1.25-2.38]), fluoxetine (OR   =   1.63 [95% CI, 1.11-2.38]), @DRUG2$ (OR   =   1.64 [95% CI, 1.27-2.12]), amitriptyline (OR   =   1.47 [95% CI, 1.02-2.11]).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5604,
        "sentence": "Pyrimethamine may be used with sulfonamides, quinine and other @DRUG1$, and with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5605,
        "sentence": "Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, @DRUG1$, diazepam, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5606,
        "sentence": "Methscopolamine may interact with @DRUG1$ (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-@DRUG2$), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5607,
        "sentence": "@DRUG1$ decreases the elimination of abacavir causing an increase in overall exposure . The addition of @DRUG2$ has no clinically significant effect on the pharmacokinetic properties of abacavir.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5608,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that @DRUG1$ approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG2$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5609,
        "sentence": "@DRUG1$: In 12 normal-weight subjects receiving XENICAL 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5610,
        "sentence": "Anticoagulants (such as heparin and @DRUG1$) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and GP IIb/IIIa inhibitors) may increase the risk of bleeding if administered prior to, during, or after @DRUG2$ therapy.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5611,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (@DRUG1$, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (@DRUG2$, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5612,
        "sentence": "Combination therapy with @DRUG1$    (imiglucerase) and @DRUG2$    is not indicated.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5613,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - @DRUG2$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5614,
        "sentence": "Drug interactions should be kept in mind when @DRUG1$ (@DRUG2$ gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical metronidazole administration because of low absorption.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5615,
        "sentence": "Scopolamine should be used with care in patients taking other drugs that are capable of causing CNS effects such as @DRUG1$, tranquilizers, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5616,
        "sentence": "The use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, @DRUG1$, phenylpropanolamine or @DRUG2$) may enhance or potentiate the pressor effects of ProAmatine   . Therefore, caution should be used when ProAmatine    is administered concomitantly with agents that cause vasoconstriction.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5617,
        "sentence": "Evaluation of antidepressant like activity of curcumin and its combination with @DRUG1$ and @DRUG2$: an acute and chronic study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5618,
        "sentence": "Concurrent use of DEMSER with @DRUG1$ or other @DRUG2$ can increase their sedative effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5619,
        "sentence": "Due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to @DRUG1$, and itraconazole, concomitant use of these products with @DRUG2$ is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5620,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, @DRUG1$, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5621,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), @DRUG1$ (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5622,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, @DRUG1$, @DRUG2$, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5623,
        "sentence": "Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as @DRUG1$ (n=77), antihypertensives (n=72), @DRUG2$ (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5624,
        "sentence": "@DRUG1$: Metolazone, as well as other @DRUG2$, may affect the hypoprothrombinemic response to anticoagulants;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5625,
        "sentence": "Use with Other Central Nervous System Depressants: The depressant effects of morphine are potentiated by the presence of other @DRUG1$ such as alcohol, sedatives, @DRUG2$, or psychotropic drugs.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5626,
        "sentence": "Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of @DRUG1$, @DRUG2$ (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5627,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG1$, ethanol, glyburide, an oral contraceptive (@DRUG2$/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5628,
        "sentence": "To minimize CNS depression and possible potentiation, @DRUG1$, antihistamines, narcotics, @DRUG2$ or phenothiazines should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5629,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - @DRUG2$ - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5630,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, @DRUG2$, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5631,
        "sentence": "John   s Wort, and certain @DRUG1$ (phenytoin, phenobarbital, @DRUG2$) may induce mifepristone metabolism (lowering serum levels of mifepristone).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5632,
        "sentence": "Phenytoin, Carbamazepine, and Rifampicin: In patients treated with potent inducers of CYP3A4 (i.e., @DRUG1$, @DRUG2$, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5633,
        "sentence": "@DRUG1$/Mycophenolate Mofetil: Given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that @DRUG2$ not be administered concomitantly with azathioprine or mycophenolate mofetil.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5634,
        "sentence": "AAV2 containing cDNA encoding enhanced green fluorescent protein (GFP), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, @DRUG1$, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5635,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, @DRUG1$, @DRUG2$, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5636,
        "sentence": "Anticoagulants: @DRUG1$, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to @DRUG2$;",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5637,
        "sentence": "Use of Anticoagulants and Antiplatelet Agents -- Streptase, Streptokinase, alone or in combination with @DRUG1$ and @DRUG2$, may cause bleeding complications.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5638,
        "sentence": "Although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by CYP 3A4, it is possible that @DRUG1$, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of @DRUG2$).",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5639,
        "sentence": "The rate and extent of @DRUG1$ absorption and elimination are not affected by concomitant @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5640,
        "sentence": "@DRUG1$ may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., @DRUG2$, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).",
        "answer": "int",
        "label": 3
    },
    {
        "id": 5641,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., @DRUG1$), nitrates and nitrites, sympathomimetic agents, @DRUG2$, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5642,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG1$, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5643,
        "sentence": "Concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: Pending full characterization of potential interactions, concomitant administration of @DRUG1$ with other @DRUG2$, including azithromycin, is not recommended.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5644,
        "sentence": "Although such a reaction has not been demonstrated with @DRUG1$, concomitant administration of roxithromycin with @DRUG2$ or astemizole is not recommended.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5645,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., @DRUG1$), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5646,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as @DRUG1$, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, @DRUG2$, ranitidine, procainamide, triamterene, flecainide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5647,
        "sentence": "Absorption of drugs from the stomach may be diminished (e.g., @DRUG1$) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, @DRUG2$, levodopa, ethanol, cyclosporine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5648,
        "sentence": "There was no effect of a single dose or multiple doses of MYCAMINE on @DRUG1$, cyclosporine, tacrolimus, @DRUG2$, and fluconazole pharmacokinetics.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5649,
        "sentence": "Other @DRUG1$ should not be used concomitantly with @DRUG2$ because they may have additive effects.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5650,
        "sentence": "Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - @DRUG1$: can increase seizure activity - Live virus vaccines: may potentiate the replication of the @DRUG2$ virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5651,
        "sentence": "@DRUG1$ may have the potential to convert Herceptin-refractory to @DRUG2$-sensitive tumors in HER2-positive breast cancer by up-regulation of the cell surface expression of HER2.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5652,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5653,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), @DRUG1$ (Sinequan), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (@DRUG2$), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5654,
        "sentence": "Absorption of tetracyclines is impaired by antacids containing aluminum, @DRUG1$ or @DRUG2$, and iron-containing preparations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5655,
        "sentence": "In clinical studies of TOBI, patients taking TOBI concomitantly with dornase alfa (@DRUG1$   , Genentech), @DRUG2$, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5656,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and @DRUG1$, @DRUG2$, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5657,
        "sentence": "Mutual inhibition of metabolism occurs with concurrent use of @DRUG1$ and @DRUG2$;",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5658,
        "sentence": "morphine, theophylline, @DRUG1$, succinylcholine, reserpine, and @DRUG2$ should be avoided in patients with organophosphate poisoning.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5659,
        "sentence": "@DRUG1$ is the only known component in the diet that may affect absorption of both nonheme and @DRUG2$.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5660,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, @DRUG2$ (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5661,
        "sentence": "Salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, @DRUG1$, @DRUG2$, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5662,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG1$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, @DRUG2$, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5663,
        "sentence": "The concomitant use of other CNS depressants including @DRUG1$, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, @DRUG2$, monoamine oxidase (MAO) inhibitors, and alcohol may produce additive CNS depressant effects.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5664,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, @DRUG1$, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5665,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin B or @DRUG2$ - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5666,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER @DRUG1$, SEDATIVE-HYPNOTICS (INCLUDING BARBITURATES), TRICYCLIC ANTIDEPRESSANTS AND OTHER @DRUG2$ (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5667,
        "sentence": "@DRUG1$/Ganciclovir: may be taken with @DRUG2$;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5668,
        "sentence": "The following agents may increase certain actions or side effects of @DRUG1$: @DRUG2$, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5669,
        "sentence": "Given the primary CNS effects of @DRUG1$, INVEGA    should be used with caution in combination with other @DRUG2$ and alcohol.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5670,
        "sentence": "For patients receiving @DRUG1$ or other potent CYP3A4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or @DRUG2$ (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5671,
        "sentence": "We retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose @DRUG1$ in conjunction with @DRUG2$ for total intravenous anesthesia (TIVA) repeatedly for radiation therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5672,
        "sentence": "ECG intervals (PR, QRS, and QT) were not affected by concurrent Mexitil    and @DRUG1$, diuretics, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5673,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., ketoconazole, itraconazole, clarithromycin, @DRUG1$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5674,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, @DRUG1$, nefazodone, @DRUG2$, ritonavir, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5675,
        "sentence": "These are described in greater detail below:  Oral hypoglycemics, Coumarin-type anticoagulants, @DRUG1$, @DRUG2$, Rifampin, Theophylline, Terfenadine, Cisapride, Astemizole, Rifabutin, Tacrolimus, Short-acting benzodiazepines,  Oral hypoglycemics: Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents;",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5676,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG1$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, @DRUG2$, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5677,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, @DRUG2$, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5678,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, tacrolimus, prednisolone, sirolimus, @DRUG2$, fluconazole, ritonavir, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5679,
        "sentence": "These medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5680,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, @DRUG1$, nelfinavir, delavirdine) or azole antifungals (e.g., @DRUG2$, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5681,
        "sentence": "@DRUG1$: Concomitant cholestyramine administration decreased the mean AUC of total @DRUG2$ approximately 55%.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5682,
        "sentence": "Ropivacaine should be used with caution in patients receiving other local @DRUG1$ or agents structurally related to @DRUG2$, since the toxic effects of these drugs are additive.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5683,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral @DRUG1$ is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), @DRUG2$ (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5684,
        "sentence": "CYP 3A4 Inhibitors (e.g. @DRUG1$ and @DRUG2$) There have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and ergotamine) and potent CYP 3A4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5685,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, @DRUG2$, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5686,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, @DRUG1$, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), @DRUG2$, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5687,
        "sentence": "One case of hypertensive crisis has been reported in a patient taking the recommended doses of @DRUG1$ and a @DRUG2$ (ephedrine).",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5688,
        "sentence": "- did not change the plasma concentration profile of @DRUG1$ (a substrate of cytochrome P450 3A4) or fexofenadine, its carboxylated metabolite, and did not prolong the QTc interval following co-administration with @DRUG2$ 60 mg twice daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5689,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, @DRUG2$, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5690,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, @DRUG1$, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5691,
        "sentence": "Phenytoin: In 12 normal-weight subjects receiving @DRUG1$ 120 mg three times a day for 7 days, XENICAL did not alter the pharmacokinetics of a single 300-mg dose of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5692,
        "sentence": "and/or antibiotic drug doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin @DRUG1$ (@DRUG2$) (4 x 20 mg/kg, i. p.)",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5693,
        "sentence": "@DRUG1$ as a single agent exhibits anti-proliferative effects in vitro in NSCLC cell lines with EGFR T790M and K-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to @DRUG2$ followed by docetaxel and concurrent administration.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5694,
        "sentence": "In drug-interaction studies, the recommended clinical dose of @DRUG1$ did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (@DRUG2$ 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5695,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, @DRUG1$, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, @DRUG2$).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5696,
        "sentence": "Use of potassium-sparing diuretics (spironolactone, triamterene, @DRUG1$) or @DRUG2$ supplements concomitantly with ACE inhibitors can increase the risk of hyperkalemia.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5697,
        "sentence": "Concurrent use of @DRUG1$    and @DRUG2$ may lead to increased plasma theophylline levels.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5698,
        "sentence": "Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of @DRUG1$ 30 mg did not appear as large as that of the positive control @DRUG2$ at its therapeutic dose.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5699,
        "sentence": "Based on studies evaluating possible interactions of @DRUG1$ with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, @DRUG2$, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5700,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and @DRUG1$ le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5701,
        "sentence": "Barbiturates may decrease the effectiveness of oral @DRUG1$, certain antibiotics, quinidine, theophylline, @DRUG2$, anticoagulants, and beta blockers.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5702,
        "sentence": "Methscopolamine may interact with antidepressants (tricyclic type), MAO inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, @DRUG1$, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., @DRUG2$, promethazine).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5703,
        "sentence": "@DRUG1$-@DRUG2$ interaction and associated gastrointestinal bleeding risk in a case-control study.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5704,
        "sentence": "There have been postmarketing reports of increased INR and prothrombin time in patients receiving @DRUG1$, including pantoprazole, and @DRUG2$ concomitantly.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5705,
        "sentence": "It may also interact with @DRUG1$ (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of @DRUG2$), phenytoin (decreased hepatic clearance of phenytoin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5706,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, @DRUG1$, fluconazole, ritonavir, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5707,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), @DRUG1$, antipsychotic agents (e.g., @DRUG2$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5708,
        "sentence": "Due to the chemical similarity of other @DRUG1$ (including fluconazole, metronidazole, and @DRUG2$) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5709,
        "sentence": "To minimize CNS depression and possible potentiation, @DRUG1$, @DRUG2$, narcotics, hypotensive agents or phenothiazines should be used with caution.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5710,
        "sentence": "Melatonin may interact with the following drugs: aspirin and other @DRUG1$ (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with @DRUG2$ can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5711,
        "sentence": "Some drug interactions are:  - birth control pills - @DRUG1$ - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - @DRUG2$ - edrophonium - neostigmine - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5712,
        "sentence": "Alcohol: In a multiple-dose study in 30 normal weight subjects, coadministration of @DRUG1$ and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, @DRUG2$ pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5713,
        "sentence": "Interaction with Other Central Nervous System Depressants: MEPERIDINE SHOULD BE USED WITH GREAT CAUTION AND IN REDUCED DOSAGE IN PATIENTS WHO ARE CONCURRENTLY RECEIVING OTHER NARCOTIC ANALGESICS, GENERAL ANESTHETICS, PHENOTHIAZINES, OTHER TRANQUILIZERS, SEDATIVE-HYPNOTICS (INCLUDING @DRUG1$), @DRUG2$ AND OTHER CNS DEPRESSANTS (INCLUDING ALCOHOL).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5714,
        "sentence": "In drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (@DRUG1$ 1 mg/@DRUG2$ 35 mcg), terfenadine, digoxin, and warfarin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5715,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, @DRUG1$, @DRUG2$, lovastatin, or fluvastatin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5716,
        "sentence": "A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since @DRUG1$ is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, @DRUG2$, saquinavir, telithromycin or voriconazole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5717,
        "sentence": "While no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both Sj   grens efficacy studies: @DRUG1$, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, @DRUG2$, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5718,
        "sentence": "A total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between MYCAMINE and mycophenolate mofetil, @DRUG1$, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, @DRUG2$, and rifampin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5719,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, @DRUG1$ (e.g., @DRUG2$), benzodiazepines, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5720,
        "sentence": "Before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (Sinequan), @DRUG1$ (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or @DRUG2$ (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5721,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - @DRUG1$ or bacitracin - local @DRUG2$ such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5722,
        "sentence": "Because @DRUG1$ is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5723,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, @DRUG1$, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5724,
        "sentence": "Before taking this medication, tell your doctor if you are taking a @DRUG1$ such as amitriptyline (Elavil), amoxapine (Asendin), doxepin (@DRUG2$), nortriptyline (Pamelor), imipramine (Tofranil), clomipramine (Anafranil), protriptyline (Vivactil), or desipramine (Norpramin).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5725,
        "sentence": "@DRUG1$ may decrease bioavailability of SKELID by up to 50% when taken 2 hours after @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5726,
        "sentence": "For patients receiving ketoconazole or other potent CYP3A4 inhibitors such as other @DRUG1$ (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or @DRUG2$, the recommended dose of DETROL LA is 2 mg daily.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5727,
        "sentence": "The following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class I (e.g., quinidine), antihistamines, antipsychotic agents (e.g., @DRUG1$), @DRUG2$, MAO inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5728,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, @DRUG2$, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5729,
        "sentence": "There are no clinical data on the use of @DRUG1$ with other @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5730,
        "sentence": "Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when @DRUG1$ are given concurrently with succinylcholine, similar @DRUG2$ or cholinergic agonists such as bethanechol.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5731,
        "sentence": "@DRUG1$ should not be administered concomitantly with ethacrynic acid, furosemide, urea, or @DRUG2$.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5732,
        "sentence": "Concomitant administration of TRENTAL and @DRUG1$-containing drugs leads to increased theophylline levels and @DRUG2$ toxicity in some individuals.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5733,
        "sentence": "@DRUG1$: Increased serum lithium and symptoms of @DRUG2$ toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5734,
        "sentence": "Other drugs eliminated via renal secretion: Population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, @DRUG1$, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, @DRUG2$, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5735,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain @DRUG1$ (e.g., aminoglycosides, tetracyclines, bacitracin, @DRUG2$, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5736,
        "sentence": "Use with @DRUG1$ and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with @DRUG2$, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5737,
        "sentence": "@DRUG1$ has been studied on a background of @DRUG2$ and heparin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5738,
        "sentence": "Systemic and apparent oral @DRUG1$ clearance were 24% (269    73 vs. 354    102  ml/min, P = 0.022) and 31% (479    190 vs. 688    265  ml/min, P = 0.013), respectively, lower in cyclosporine-treated patients (n = 20) than in matched @DRUG2$-treated patients (n = 20).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5739,
        "sentence": "@DRUG1$: In a pharmacokinetic study, concomitant gemfibrozil administration increased total @DRUG2$ concentrations approximately 1.7-fold.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5740,
        "sentence": "Less potent inhibitors include saquinavir, nefazodone, @DRUG1$, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5741,
        "sentence": "HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, @DRUG1$, pravastatin, lovastatin, or @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5742,
        "sentence": "ProAmatine. Alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of ProAmatine. Potential for Drug Interactions: It appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, @DRUG1$, triamterene, @DRUG2$, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5743,
        "sentence": "An inhibitor of CYP2C8 (such as @DRUG1$) may increase the AUC of @DRUG2$ and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone.",
        "answer": "mechanism",
        "label": 1
    },
    {
        "id": 5744,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), @DRUG2$, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5745,
        "sentence": "Some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or @DRUG1$ - certain antibiotics given by injection - cisplatin - edrophonium - @DRUG2$ - polymyxin B or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5746,
        "sentence": "Co-administration of SUTENT with strong inhibitors of the CYP3A4 family (e.g., @DRUG1$, itraconazole, clarithromycin, @DRUG2$, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5747,
        "sentence": "Other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as MIVACRON include certain antibiotics (e.g., aminoglycosides, tetracyclines, @DRUG1$, polymyxins, lincomycin, @DRUG2$, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5748,
        "sentence": "Caution should be used when @DRUG1$ is coadministered with other highly protein-bound drugs, such as clofibrate, @DRUG2$, naproxen, ibuprofen, diazepam, and diazoxide.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5749,
        "sentence": "Although undercarboxylated osteocalcin, a marker of vitamin K nutritional status, was unaltered with @DRUG1$ administration, vitamin K levels tended to decline in subjects taking @DRUG2$.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5750,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: @DRUG1$, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, @DRUG2$, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5751,
        "sentence": "Thus strong inhibitors of cytochrome P4501A2, such as fluvoxamine, given concomitantly during administration of @DRUG1$, can interact with @DRUG2$ leading to increased ropivacaine plasma levels.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5752,
        "sentence": "Because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or @DRUG1$ (like dihydroergotamine or methysergide) and @DRUG2$ within 24 hours of each other should be avoided.",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5753,
        "sentence": "Based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, @DRUG1$), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, @DRUG2$, clarithromycin, metronidazole, or amoxicillin.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5754,
        "sentence": "Caution is recommended when administering @DRUG1$ with compounds that are metabolized/eliminated predominantly by the UGT1A1 pathway (e.g. @DRUG2$).",
        "answer": "advice",
        "label": 2
    },
    {
        "id": 5755,
        "sentence": "In clinical studies of @DRUG1$, patients taking TOBI concomitantly with dornase alfa (PULMOZYME   , Genentech), (beta)-agonists, inhaled corticosteroids, other @DRUG2$, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5756,
        "sentence": "Examples of some of the more potent CYP 3A4 inhibitors include @DRUG1$ (e.g., erythromycin, troleandomycin, clarithromycin), HIV protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, @DRUG2$, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5757,
        "sentence": "@DRUG1$ may increase the effects of @DRUG2$, tolbutamide, and uricosurics.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5758,
        "sentence": "@DRUG1$: During treatment with @DRUG2$, the use of live attenuated vaccines should be avoided and patients should be advised that vaccinations may be less effective.",
        "answer": "none",
        "label": 4
    },
    {
        "id": 5759,
        "sentence": "Inhibition of Src family and Abl kinases with either siRNAs or @DRUG1$ enhances @DRUG2$ sensitivity of ovarian cancer cells through p27(Kip1)-mediated suppression of Bcl-2 and Cdk1 expression.",
        "answer": "effect",
        "label": 0
    },
    {
        "id": 5760,
        "sentence": "When methyldopa and @DRUG1$ are given concomitantly the patient should be carefully monitored for symptoms of @DRUG2$ toxicity.",
        "answer": "none",
        "label": 4
    }
]